<SEC-DOCUMENT>0001159036-24-000011.txt : 20240304
<SEC-HEADER>0001159036-24-000011.hdr.sgml : 20240304
<ACCEPTANCE-DATETIME>20240304161348
ACCESSION NUMBER:		0001159036-24-000011
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		28
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240304
DATE AS OF CHANGE:		20240304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HALOZYME THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001159036
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				880488686
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32335
		FILM NUMBER:		24715108

	BUSINESS ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 794-8889

	MAIL ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HALOZYME THERAPEUTICS INC
		DATE OF NAME CHANGE:	20040312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL YACHT SERVICES INC
		DATE OF NAME CHANGE:	20010912
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>halo-20240304.htm
<DESCRIPTION>PRE 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022q4" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:halo="http://www.halozyme.com/20240304" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>halo-20240304</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-2">0001159036</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-3">PRE 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-4">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="halo-20240304.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4984be922b42495ba68692c141a7c99d_1"></div><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SCHEDULE 14A </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXY STATEMENT PURSUANT TO SECTION 14(a) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="margin-top:8pt;padding-left:11.25pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;padding-left:11.25pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box:</span></div><div style="margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:4.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Materials Pursuant to &#167;240.14a-12</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">Halozyme Therapeutics, Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Name of Registrant as Specified in Its Charter)</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of Filing Fee (Check all boxes that apply):</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20240304_g1.jpg" alt="halologobwa09.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"/></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March [       ], 2024 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Stockholder: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are cordially invited to attend the 2024 Annual Meeting of Stockholders of Halozyme Therapeutics, Inc., which will be held on April&#160;25, 2024, at 12:00 p.m. Pacific Time. The meeting will be online only, so there is no physical meeting location.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notice of Annual Meeting of Stockholders and a Proxy Statement, which describes the formal business to be conducted at the meeting, follow this letter. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important that you use this opportunity to take part in the affairs of Halozyme Therapeutics, Inc. by voting on the business to come before this meeting. Whether or not you plan to attend the Annual Meeting online, we hope you vote as soon as possible to assure your representation. You can vote your shares over the Internet, by telephone or if you requested printed proxy material by mail, by using a traditional proxy card. Instructions on each of these voting methods are outlined in the enclosed proxy statement. Regardless of the number of shares you own, your careful consideration of, and vote on, the matters before our stockholders is important. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of Halozyme&#8217;s Annual Report on Form 10-K accompanies these proxy materials for your information. At the Annual Meeting, we will review Halozyme&#8217;s activities over the past year and our plans for the future. The Board of Directors and management look forward to seeing you at the Annual Meeting. </span></div><div style="margin-top:12.6pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely yours, </span></div><div style="padding-left:306pt;text-indent:-45pt"><img src="halo-20240304_g2.jpg" alt="htsignaturea10.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:188px"/></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ELEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> I. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ORLEY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, M.B. Ch.B., M.R.C.P. </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">President and Chief Executive Officer</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:92.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_13">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_16">PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_16">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_22">SOLICITATION AND VOTING</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_22">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_25">PROPOSAL NO. 1 - ELECTION OF DIRECTORS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_25">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_28">CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_28">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_31">PROPOSAL NO. 2 - ADVISORY (NON-BINDING) VOTE ON EXECUTIVE COMPENSATION</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_31">(SAY-ON-PAY)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_31">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_34">PROPOSAL NO. 3 - APPROVAL OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO REFLECT DELAWARE LAW PROVISIONS REGARDING EXCULPATION OF OFFICERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_34">23</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_37">PROPOSAL NO. 4 - RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_37">25</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_40">REPORT OF THE AUDIT COMMITTEE</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_40">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_43">EXECUTIVE COMPENSATION AND RELATED INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_43">27</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_67">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_67">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_70">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_70">AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_70">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_73">STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_73">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_76">TRANSACTION OF OTHER BUSINESS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_76">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_79">DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4984be922b42495ba68692c141a7c99d_79">60</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_13"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20240304_g1.jpg" alt="Image3.jpg" style="height:74px;margin-bottom:5pt;vertical-align:text-bottom;width:184px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12390 El Camino Real </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">San Diego, California 92130 </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">To Be Held on April&#160;25, 2024 </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO THE STOCKHOLDERS OF HALOZYME THERAPEUTICS, INC.: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby given that the Annual Meeting of the Stockholders of Halozyme Therapeutics, Inc., a Delaware corporation, will be held on April&#160;25, 2024, at 12:00 p.m. Pacific Time. The meeting will be online only, so there is no physical meeting location. The Annual Meeting is being held for the following purposes: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect two Class II directors to hold office for a three-year term and until their respective successors are elected and qualified; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve, by a non-binding advisory vote, the compensation of our Named Executive Officers;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve an amendment to our Amended and Restated Certificate of Incorporation to reflect Delaware law provisions regarding exculpation of officers; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To transact such other business as may properly come before the Annual Meeting. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be able to attend the Annual Meeting, submit questions and vote during the live webcast by visiting </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/HALO2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and entering the 16 digit control number included in your Notice of Internet Availability, on your proxy card, or voting instruction form, or in the instructions you received by email. Please refer to the additional logistical details and recommendations in the accompanying proxy statement. Only stockholders of record at the close of business on February&#160;26, 2024 are entitled to notice of, and to vote at, this Annual Meeting and any adjournment or postponement thereof. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends that you vote FOR each of the nominees to the Board of Directors named in the accompanying Proxy Statement and FOR Proposals 2, 3 and 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-top:9pt;padding-left:306pt;text-indent:-45pt"><img src="halo-20240304_g3.jpg" alt="Mark's signature.jpg" style="height:105px;margin-bottom:5pt;vertical-align:text-bottom;width:278px"/></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mark Snyder</span></div><div style="margin-top:3pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Vice President, General Counsel, </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Corporate Secretary </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March [       ], 2024</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Annual Meeting of Stockholder To Be Held on April&#160;25, 2024 </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Proxy Statement and the 2023 Annual Report to Stockholders and the means to vote by Internet are available at www.proxyvote.com. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IMPORTANT: You are cordially invited to attend the virtual meeting online. Whether or not you expect to attend the virtual meeting online, please vote as soon as possible by using the Internet or telephone or for those receiving paper copies of these proxy materials by completing, signing, dating and mailing your proxy card in the accompanying postage-paid envelope. Even if you have voted by proxy, you may still vote in person if you attend the virtual meeting online. </span></td></tr></table></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_16"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying proxy is solicited on behalf of the Board of Directors of Halozyme Therapeutics, Inc., a Delaware corporation (&#8220;Halozyme&#8221; or the &#8220;Company&#8221;), for use at Halozyme&#8217;s Annual Meeting of Stockholders to be held online on April&#160;25, 2024 at 12:00 p.m. Pacific Time and at any adjournment or postponement thereof, for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. This Proxy Statement, notice, the notice of internet availability of the proxy materials, and the proxy card are first being made available and/or mailed to stockholders on or about March [    ], 2024. </span></div><div id="i4984be922b42495ba68692c141a7c99d_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL MEETING AGENDA AND BOARD OF DIRECTORS VOTE RECOMMENDATIONS</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders are being asked to vote on each of the following items at the Annual Meeting:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The election of two Class II director nominees named in this Proxy Statement to the Board of Directors, each to serve a three-year term and until their respective successors are elected and qualified;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The approval of a non-binding advisory resolution approving the compensation of our Named Executive Officers; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The approval of an amendment to our Amended and Restated Certificate of Incorporation to reflect Delaware law provisions regarding exculpation of officers; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends that you vote FOR the nominees to the Board of Directors named in this Proxy Statement and FOR Proposals 2, 3 and 4.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_22"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOLICITATION AND VOTING </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only stockholders of record as of the close of business on February&#160;26, 2024, the record date for the Annual Meeting, will be entitled to vote at the meeting and any adjournment or postponement thereof. As of that date, we had 127,054,240 shares of common stock outstanding, all of which are entitled to vote with respect to all matters to be acted upon at the Annual Meeting. Each stockholder of record as of that date is entitled to one vote for each share of common stock held by him or her. Our Bylaws provide that a majority of all of the shares of the stock entitled to vote, whether present in person or represented by proxy, shall constitute a quorum for the transaction of business at the meeting. When a quorum is present at the meeting, all matters other than the election of directors and the proposed amendment to our certificate of incorporation to reflect Delaware law provisions regarding the exculpation of officers, will be determined by a majority in voting power of the shares present in person or represented by proxy and entitled to vote on the matter. The election of directors will be determined by a majority in voting power of the shares present in person or represented by proxy at the meeting and voting on the matter. The proposed amendment to our certificate of incorporation to reflect Delaware law provisions regarding the exculpation of officers will be determined by a majority in voting power of the shares outstanding on the record date. Votes for and against, abstentions and &#8220;broker non-votes&#8221; will each be counted as present for purposes of determining the presence of a quorum.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted by rules adopted by the Securities and Exchange Commission (&#8220;SEC&#8221;), we are furnishing our proxy statement, 2023 Annual Report to Stockholders and proxy card over the internet to most of our stockholders. This means that most of our stockholders will initially receive only a Notice of Internet Availability of Proxy Materials containing instructions on how to access the proxy materials over the Internet. If you would like to receive a paper copy of the proxy materials, the Notice of Internet Availability of Proxy Materials contains instructions on how you can request copies of these documents at no cost to you.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting of Proxies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All valid proxies received before the meeting will be exercised. All shares represented by a proxy will be voted, and where a proxy specifies a stockholder&#8217;s choice with respect to any matter to be acted upon, the shares will be voted in accordance with that specification. If no choice is indicated on the proxy provided by a stockholder of record, the shares will be voted for the nominees and for proposals 2, 3 and 4. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may vote by attending the Annual Meeting online, by using the Internet or telephone to submit a proxy or by completing and returning a proxy by mail, if you requested printed proxy material by mail. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Internet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To vote by Internet, go to </span><span style="background-color:#ffffff;color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.proxyvote.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Internet voting is available 24 hours a day, although your vote by Internet must be received by 11:59 p.m. Eastern Time on April 24, 2024. You will need the control number found either on the Notice of Internet Availability of Proxy Materials or on the proxy card if you are receiving a printed copy of these materials. If you vote by Internet, you should not return your proxy card or voting instruction card. If you hold your shares in &#8220;street name&#8221; as explained below, please refer to the voting instruction form or notice provided to you by your broker, bank or other holder of record for Internet voting instructions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Telephone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To vote by telephone, call </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1-800-690-6903</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and follow the instructions. Telephone voting is available 24 hours a day, although your vote by telephone must be received by 11:59 p.m. Eastern Time on April 24, 2024. You will need the control number found on your Notice of Internet Availability of Proxy Materials, voting instruction form or on the proxy card if you are receiving a printed copy of these materials. If you vote by telephone, you should not return your proxy card or voting instruction card. If you hold your shares in &#8220;street name&#8221; as explained below, please refer to the Notice of Internet Availability of Proxy Materials or voting instruction card provided to you by your broker, bank or other holder of record for telephone voting instructions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Mail.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If you requested printed proxy materials by mail, by completing, signing and returning the proxy card in the prepaid and addressed envelope enclosed with proxy materials delivered by mail, you are authorizing the individuals named on the proxy card to vote your shares at the Annual Meeting in the manner you indicate. You are encouraged to sign and return the proxy card even if you plan to attend the Annual Meeting so that your shares will be voted if you are unable to attend the Annual Meeting. If you receive more than one proxy card, it is an indication that your shares are held in multiple accounts. Please complete, sign and return all proxy cards to ensure that all your shares are voted. </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Online During Annual Meeting. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are entitled to participate in the Annual Meeting if you were a shareholder as of the close of business on February&#160;26, 2024, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee. To be admitted to the Annual Meeting at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/HALO2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, you must enter the control number found on your Notice of Internet Availability of Proxy Materials, proxy card, or voting instruction form you previously received. You may vote during the Annual Meeting by following the instructions available on the meeting website during the meeting. The meeting&#8217;s virtual attendance format will provide you the ability to participate and ask questions in writing during the meeting. Whether or not you plan to participate in the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one of the methods described in the proxy materials for the Annual Meeting. If your shares are registered directly in your name with our transfer agent, EQ by Equiniti, you are considered the stockholder of record and you have the right to vote in person at the Annual Meeting. If your shares are held in the name of your broker or other nominee, you are considered the beneficial owner of shares held in &#8220;street name.&#8221; Beneficial owners whose stock is held in the name of a bank, broker or other nominee generally will receive instructions for voting from their banks, brokers or other nominees, rather than directly from us. You can vote your shares held through a bank, broker or other nominee by following the voting instructions sent to you by that institution. Shares for which you are the beneficial owner but not the stockholder of record may also be voted electronically during the Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revocability of Proxies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A stockholder giving a proxy has the power to revoke it at any time before it is exercised by delivering to the Secretary of Halozyme a written instrument revoking the proxy or by executing a duly executed proxy with a later date, or by attending the Annual Meeting online and voting in person.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broker Non-Votes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A broker non-vote occurs when a broker submits a proxy card with respect to shares held in street name on behalf of a beneficial owner but is prohibited from voting on a particular matter because the broker has not received voting instructions from the beneficial owner and therefore does not have discretion to vote the beneficial owner&#8217;s shares with respect to that matter. Under the rules that govern brokers who are voting with respect to shares held in street name, brokers have the discretion to vote such shares on routine matters, but not on non-routine matters. Routine matters include the ratification of our independent registered public accounting firm. Non-routine matters include the election of directors, the advisory vote on executive compensation matters and the proposed amendment to our Amended and Restated Certificate of Incorporation to reflect Delaware law provisions regarding officer exculpation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Solicitation of Proxies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We will bear the entire cost of soliciting proxies for the upcoming meeting. In addition to soliciting stockholders by mail through our employees, we will request banks, brokers and other custodians, nominees and fiduciaries to solicit customers for whom they hold our stock and will reimburse them for their reasonable, out-of-pocket costs. We may use the services of our officers, directors and others to solicit proxies, personally or by telephone, without additional compensation.</span></div><div><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 1</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELECTION OF DIRECTORS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a classified Board of Directors that currently consists of three Class I directors, two Class II directors and three Class III directors. Our directors are elected for a term of three years, with one class of directors up for election every year. At the 2024 Annual Meeting of Stockholders, we will be electing two Class II directors, while the Class III directors will be elected at the 2025 Annual Meeting of Stockholders and the Class I directors will be elected at the 2026 Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class II nominees recommended by the Board of Directors for election at the 2024 Annual Meeting are: Barbara Duncan and Mahesh Krishnan, M.D. Ms. Duncan is a current member of our Board of Directors and Dr. Krishnan is a new director nominee who, if elected, will join the Board of Directors following the 2024 Annual Meeting of Stockholders. Dr. Bizzari is not standing for re-election and his term will expire as of the meeting date. Based on Dr. Bizzari not standing for re-election, a vacancy is created with his Board seat. Dr. Krishnan was recommended to the chair of the Nominating and Corporate Governance Committee by Dr. Torley as a possible replacement candidate. He subsequently met with members of the Nominating and Corporate Governance Committee and then met with the other members of the Board of Directors. Based upon the Board&#8217;s assessment of his extensive industry experience as further described in this proxy statement, the Board recommended his nomination for election at the Annual Meeting. If elected, Ms. Duncan and Dr. Krishnan will serve as directors until our Annual Meeting in 2027 or until their successors are elected and qualified. If any nominee declines to serve or becomes unavailable for any reason, or if a vacancy occurs before the election (although we know of no reason to anticipate that this will occur), the proxies may be voted for such substitute nominees as our Board of Directors may designate.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Majority Voting Standard</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws provide that in any election of one or more directors at a meeting at which a quorum is present, other than in a contested election, each director shall be elected by the vote of a majority of the votes cast by the stockholders with respect to the director. If a director does not receive in an election, other than a contested election, a majority of the votes, the director must tender his or her resignation to the Board of Directors. Within 90 days after the date of the certification of the election results, the Nominating and Corporate Governance Committee of the Board of Directors (or other committee that may be designated by the Board of Directors) will make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. The Board of Directors will promptly act on such committee&#8217;s recommendation and publicly disclose within four business days on a Current Report on Form 8-K filed with the SEC its decision and the rationale behind such decision.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a quorum is present at the meeting, election of each of the two nominees for Class II directors requires the affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and voting on the matter. Abstentions and broker non-votes will have no effect on the outcome of the vote.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends a vote &#8220;FOR&#8221; each of the nominees named above.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Candidate Expertise Selection Criteria</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee, with input from the Board of Directors, has determined that the following areas of expertise are of particular importance in providing appropriate oversight of the Company&#8217;s business and operations. Accordingly, the Nominating and Corporate Governance Committee seeks candidates for the Board of Directors from diverse professional backgrounds in order to ensure that the Board of Directors is comprised of individuals possessing extensive expertise in one or more of the following areas:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Skill</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Rationale</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicine and Science</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a Company directly and indirectly involved in the development, approval and commercialization of drugs, expertise in medicine and science is a key to the ongoing assessment of potential new technologies we may acquire.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Business Leadership and Operations<br/></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in, and knowledge of, the pharmaceutical business contributes to deep understanding of business strategy, operations, key performance indicators and the competitive environment.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complementary Business/Industry Segment Experience</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diverse experience gained from adjacent and complementary industries contributes to identification and evaluation of new opportunities and ideas.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Business</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Business experience adds to our understanding of diverse business environments, economic conditions and cultural perspectives that informs our global business initiatives and strategy.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Human Capital Management</span></div><div><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of our strategy requires the development and retention of highly skilled and diverse set of leaders and team members.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance and Capital Markets</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience overseeing financial transactions provides knowledge and skills necessary to evaluate and oversee the Company&#8217;s design and implementation of financial and capital allocation strategies.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M&amp;A</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in the identification, negotiation and execution of M&amp;A transactions provides knowledge to oversee the Company&#8217;s potential M&amp;A activities.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Management</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in risk management contributes to the identification, prioritization, assessment and mitigation of significant risk facing the company.</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its review of each director&#8217;s and director nominee&#8217;s professional experience and background, the Nominating and Corporate Governance Committee has determined that our current board members and director nominee possess expertise in the following areas noted below:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Director</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Medicine and Science</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pharma Business Leadership and Operations</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Complementary Business/Industry Segment Experience</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">International Business</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Human Capital Management</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance and Capital Markets</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">M&amp;A</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Management</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernadette Connaughton</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey W. Henderson</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mahesh Krishnan, M.D.</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Connie L. Matsui</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matthew L. Posard</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moni Miyashita</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen I. Torley, M.B. Ch.B., M.R.C.P.</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon responses received from each of our directors with respect to diversity, the Company&#8217;s Board of Directors is currently comprised of individuals from the following diverse backgrounds:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.187%"><tr><td style="width:1.0%"/><td style="width:62.696%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.001%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.003%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Diversity Matrix (As of March [     ], 2024)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Number of Directors</span></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</span></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Female</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Male</span></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part I: Gender Identity</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Directors</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part II: Demographic Background</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">African American or Black</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alaskan Native or Native American</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Asian</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Hispanic or Latinx</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Native Hawaiian or Pacific Islander</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">White</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Two or More Races or Ethnicities</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To see our Board Diversity Matrix as of March 24, 2023, please see our proxy statement filed with the SEC on March 24, 2023.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Nominated for Election at the 2024 Annual Meeting</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Barbara Duncan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (age 59)<br/>Director Since: 2023</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Audit Committee and Compensation Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Pharma Business Leadership and Operations, International Business, Finance and Capital Markets, M&amp;A</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Atea Pharmaceuticals, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fusion Pharmaceuticals, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ovid Therapeutics, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Aevi Genomics Medicine, Inc., Adaptimmune Therapeutics, plc, Immunomedics, Inc., Innoviva, Inc., Jounce Therapeutics, Inc., ObsEva S.A.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan brings over 16 years of pharmaceutical and biotechnology industry experience to the Board of Directors. She retired from Intercept Pharmaceuticals, Inc., a biopharmaceutical company, where she served as Chief Financial Officer and Treasurer from May 2009 to June 2016. From 2001 to 2009, Ms. Duncan held various senior leadership roles of increasing responsibility at DOV Pharmaceutical, Inc., a biotechnology company, including Chief Financial Officer and ultimately serving as Chief Executive Officer prior to DOV&#8217;s sale in 2010 to Euthymics Bioscience, Inc. Prior to joining DOV, Ms.&#160;Duncan served as Vice President of Corporate Finance&#8201;-&#8201;Global Healthcare at Lehman Brothers Inc. from 1998 to 2001, and as Director of Corporate Finance at SBC Warburg Dillon Read Inc. from 1994 to 1998. She also worked for PepsiCo, Inc. from 1989 to 1992 in its international audit division, and was a certified public accountant in the audit division of Deloitte &amp; Touche LLP from 1986 to 1989. Ms. Duncan received her BBA from Louisiana State University and her MBA from the Wharton School of the University of Pennsylvania.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations and International Business</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, Ms. Duncan helped lead the operational and strategic plans of this biopharmaceutical company, including managing the buildout of international operations and preparing financial teams for commercial product launch. At DOV Pharmaceutical, Ms. Duncan developed and lead in the execution of strategic plans, restructured several of the company&#8217;s partnerships and led negotiations on licensing transactions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Finance and Capital Markets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan&#8217;s gained extensive financing experience serving as Chief Financial Officer for two public biopharmaceutical companies. Through the successful execution of both private and public financings, Ms. Duncan&#8217;s leadership supported operations and strategic plans. Ms. Duncan managed all phases of Intercept&#8217;s initial public offering and following on offerings. Further, while serving as Chief Financial Officer at both Intercept and DOV Pharmaceutical, Ms. Duncan managed the investor relations function and research analyst and investment banking relationships. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan gained extensive M&amp;A experience in her role as Vice President at Lehman Brothers with an emphasis in the healthcare space. While at Lehman, Ms. Duncan reviewed potential merger opportunities, reviewed valuation work product and authored advisory presentations to assist clients in formulating strategic corporate structuring strategies. While serving as Chief Executive Officer of DOV Pharmaceutical, she led the execution of the company&#8217;s sale to Euthymics.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: As further described in Ms. Duncan&#8217;s biography, the Nominating and Corporate Governance Committee believes that Ms. Duncan has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) finance and capital markets, (iii) international business and (iv) M&amp;A. Ms. Duncan&#8217;s extensive industry and financial experience, including her experience as chief financial officer at public biopharmaceutical companies, combined with her business acumen and experience serving on other public biopharmaceutical boards, provide our Board with valuable expertise, leading the Nominating and Corporate Governance Committee to determine that Ms. Duncan should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Mahesh Krishnan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 53)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Candidate</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: N/A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Medicine and Science, Pharma Business Leadership &amp; Operations, Complimentary Business/Industry Segment Experience, International Business, Finance &amp; Capital Markets, M&amp;A</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Chinook Therapeutics, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mahesh Krishnan, M.D., brings more than 20 years of health care practitioner and biotechnology and health service industry experience to the Board of Directors. Since 2009, Dr. Krishnan has served in various roles at DaVita, Inc., a provider of kidney dialysis services, including service as the co-lead of DaVita Venture Group, the external innovation arm of DaVita, Inc., where he is responsible for strategic partnerships in technology and research and development at DaVita, as well as medical policy in Washington, D.C. Since May 2019, Dr. Krishnan has also served as DaVita&#8217;s Group Vice President of Research and Development and prior to that role, Dr. Krishnan served as DaVita&#8217;s first international Chief Medical Officer from 2015 to May 2019. From 2004 to 2009, Dr. Krishnan served in various roles at Amgen Inc., a multinational biopharmaceutical company, including serving as the Global Development Leader for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and as Executive Director, Medical Policy for all of Amgen&#8217;s domestic products. From 2000 to 2004, Dr. Krishnan was a practicing nephrologist at Virginia Nephrology Group. He earned his M.D. from Jefferson Medical College at Thomas Jefferson University and his B.S. in pre-medicine from The Pennsylvania State University. He also holds an M.P.H. from Johns Hopkins University and an M.B.A. in health care management from the Johns Hopkins Carey School of Business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science; and Complementary Business/Industry Segment Expertise</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishnan served as a practicing nephrologist at Virginia Nephrology Group where he managed daily operations. While at Amgen, he oversaw clinical trial execution for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and served as the executive director for medical policy and as the executive director for medical affairs. He also served as Vice President, Clinical Research and Publishing, Vice President Clinical Innovation and Public Policy and as Founding International Chief Medical Officer for DaVita during which time he was involved in a wide variety of operational and commercial functions for a premier nephrology health services company. As a Chief Medical Officer for DaVita he gained extensive experience in multi-site and international medical services delivery.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations and International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishan gained extensive experience in pharma business leadership and operations in his role as executive director, medical affairs at Amgen. While at Amgen, he developed and executed on the medical affairs and marketing plan for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and negotiated multiple label iterations with the United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;). As global development leader for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> he also oversaw multiple aspects of the FDA regulatory advisory committee meetings and successfully implemented a large molecule manufacturing change clinical program. At DaVita, Dr. Krishnan served as the international chief medical officer and oversaw clinical, operational and safety performance for DaVita&#8217;s clinical healthcare operations in eleven countries. Dr. Krishnan has also authored two books on pharmaceutical sales training.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Finance and Capital Markets and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishnan currently serves as group vice president of DaVita Venture Group. In this capacity, he oversees corporate development and mergers and acquisitions. He has executed multiple industry partnerships including through the use of joint ventures, corporate spinouts and the founding of health care services, pharma, medical device and diagnostic companies. He has also overseen fundraising, venture capital investments in industry related companies and worked closely with corporate investor relations for capital market presentations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Dr. Krishnan&#8217;s biography, the Nominating and Corporate Governance Committee believes that Dr. Krishnan has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) medicine and science, (ii) pharma business leadership and operations, (iii) complimentary business and industry experience, (iv) international business, (v) finance and capital markets, and (vi) M&amp;A. Dr. Krishnan&#8217;s extensive industry, financial and M&amp;A experience, including his experience in senior management positions in the biopharmaceutical industry, combined with his experience as a healthcare professional and his business acumen, provide our Board with valuable expertise, leading the Nominating and Corporate Governance Committee to determine that Dr. Krishnan should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Continuing in Office Until the 2025 Annual Meeting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Jeffrey W. Henderson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(age 59)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2015</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Board Chair</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Audit Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, Complementary Business/Industry Segment Experience, International Business, Human Capital Management, Finance and Capital Markets, M&amp;A, Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: </span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Becton Dickinson and Company, a medical technology company</span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fibrogen, Inc., a biotechnology company</span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Qualcomm, Inc., a wireless communications and semiconductor company</span></div><div style="text-indent:72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson brings nearly 30 years of financial, commercial and pharmaceutical industry expertise to the Board of Directors. He has served as President of JWH Consulting LLC, an investment and business advisory firm, since January 2018. From 2015 to 2019, he served as a Healthcare Advisory Director to Berkshire Partners LLC. Mr. Henderson previously served as the Chief Financial Officer of Cardinal Health, Inc., a multinational health care services company, from May 2005 to November 2014, and in an executive capacity until his retirement from Cardinal in August 2015. From 1998 to 2005, Mr. Henderson held various senior management positions at Eli Lilly and Company, a multinational pharmaceutical company, including President and General Manager, Eli Lilly Canada, Inc. and Controller and Treasurer of Eli Lilly, Inc. He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations and International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson gained deep experience in a broad range of business and operational topics during his nearly 10-year tenure as Chief Financial Officer for Cardinal Health, a $100 billion health care products and services company. During a portion of this tenure he was also responsible for commercial operations in China and Canada. These experiences built on prior expertise, </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specifically gained in pharmaceuticals, when he served as general manager of Eli Lilly Canada and Controller/Treasurer of Eli Lilly Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Experience</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a member of the board of directors of Becton Dickinson, a leading global medical technology company, and during his time as an executive at Cardinal Health, Mr. Henderson has gained a deep exposure to, and experience in, key aspects of the medical device business and market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance and Capital Markets and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his almost 15 years experience as Chief Financial Officer at Cardinal Health and Controller/Treasurer at Eli Lilly, Mr. Henderson gained extensive experience in finance and capital markets. During his tenure at Cardinal Health, the company acquired more than 30 companies, spun-off or sold multi-billion-dollar businesses and expanded into new geographic locations and market segments. During his time with the PE firm of Berkshire Partners, he was involved in the identification, evaluation and execution of multiple acquisition opportunities in the healthcare sector.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his positions as a Chief Financial Officer for Cardinal Health and Controller/Treasurer at Eli Lilly, Mr. Henderson played a key role in risk identification and risk mitigation. Further, Mr. Henderson has been operationally accountable for commercial operations in both China (Cardinal Health) and Canada (Eli Lilly and Cardinal Health). These unique experiences in both staff and line roles enable a broad perspective on identifying potential risks and risk management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson has substantial experience leading organizations with multi-thousands of employees, including related aspects of organizational and compensation/incentive design.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  As further described in Mr. Henderson&#8217;s biography, the Nominating and Corporate Governance Committee believes Mr. Henderson has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors:  (i) pharma business leadership and operations, (ii) complementary business and industry segment experience, (iii) international business, (iv) human capital management, (v) finance and capital markets, (vi) M&amp;A and (vii) risk management. Mr. Henderson&#8217;s extensive experience serving in executive leadership positions, including as Chief Financial Officer, with large publicly-traded healthcare and pharmaceutical corporations, combined with his business acumen and judgment, including his qualifications as an audit committee financial expert, provide our Board with valuable financial, strategic and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Mr. Henderson should serve as one of our directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Connie L. Matsui</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 70)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2006</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Compensation Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Pharma Business Leadership and Operations, International Business, Human Capital Management, Risk Management, M&amp;A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Artelo Biosciences, Inc., a biopharmaceutical company </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sutro Biopharma, Inc., a biopharmaceutical company</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Matsui brings 30 years of pharmaceutical and biotech industry expertise to the Board of Directors. She retired from Biogen Idec Inc., a biotechnology company, in January 2009 as the Executive Vice President, Knowledge and Innovation Networks. She served as an Executive Committee member at both Biogen Idec and IDEC Pharmaceuticals, a predecessor of Biogen Idec. Among the many major roles she played after joining IDEC Pharmaceuticals in November 1992 was Senior Vice President, overseeing investor relations, corporate communications, human resources, project management and strategic planning. Prior to entering the biotechnology industry, Ms. Matsui worked for Wells Fargo Bank in general management, marketing and human resources. She received her BA and MBA from Stanford University.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Matsui gained deep experience in a broad range of business and operational topics during her tenure at IDEC Pharmaceuticals and then Biogen Idec, overseeing human resources, alliance management, investor relations, corporate communications, project management and strategic planning. In addition, she served as Collaboration Chair for the late stage development and commercialization of rituximab (tradenames: Rituxan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, MabThera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in partnership with Roche and Genentech, a position requiring strong alliance management and business expertise. She also served as project team leader for the late stage development and commercialization of Zevalin, the first FDA-approved radioimmunoconguate for the treatment of cancer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In her Collaboration Chair position for rituximab, Ms. Matsui served as the IDEC member of the collaboration oversight team with counterparts from Roche, Genentech and Zenyaku Kogyo, responsible for progress on all aspects of late stage development, manufacturing, regulatory approval and global commercialization. In addition, as IDEC&#8217;s Project Leader for Zevalin, she worked with leadership at global partner Schering AG based in Germany and radioisotope supplier Nordion, which had nuclear facilities in Canada and Belgium. At Biogen Idec, she was directly responsible for staff teams based in the U.S. and Europe.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Matsui also led Human Resources at IDEC Pharmaceuticals and Biogen Idec, where key experiences included the growth of IDEC from a 100-employee R&amp;D entity to a 1,000-employee fully integrated biotech company and, ultimately, to 4,000 employees worldwide following the merger of equals between IDEC and Biogen. Prior to this position, Ms. Matsui also held various operating positions, including a senior Human Resources position in the banking industry, where experiences were gained in the area of human capital management and integration of merged and acquired entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Co-Integration lead for the Biogen IDEC merger of equals, Ms. Matsui was engaged in assessing merger feasibility and strategic acceleration potential and had a leading role in communication and implementation of merger plans. This experience included the divestiture of IDEC&#8217;s large scale manufacturing plant and successful integration by Genentech and, later on, assimilation of a small-molecule company in San Diego. Ms. Matsui has also guided multiple nonprofit mergers to optimization and facilitated the rapid assimilation of acquired banks and savings &amp; loans while at Wells Fargo.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In her more than 30 years in the biotech industry, initially as an executive officer and then while serving on the board of directors for biotechnology and pharmaceutical companies, Ms. Matsui has provided guidance to companies in a highly regulated industry in managing and mitigating risks in the following areas: corporate restructuring, financing transactions, data communication, employee retention and ESG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Ms. Matsui&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Matsui has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) international business, (iii) human capital management, (iv) risk management and (v) M&amp;A. Ms. Matsui&#8217;s operational experience, including her extensive knowledge of the biotechnology industry, her service in other public company management teams and her prior business experience, combined with her business acumen and judgment, provide our Board with valuable management and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Ms. Matsui should serve as one of our directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Helen I. Torley, M.B. Ch.B., M.R.C.P.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 61)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2014</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">President and Chief Executive Officer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Medicine and Science, Pharma Business Leadership and Operations, Human Capital Management, Finance and Capital Markets, Risk Management </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Quest Diagnostics Incorporated, a diagnostic information services company</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr Torley brings over 30 years of drug development, drug commercialization and general management expertise in pharmaceutical and biotechnology to the Board of Directors. She has served as Chief Executive Officer (&#8220;CEO&#8221;) of Halozyme since 2014, successfully leading the company through a critical strategic transition in 2019. Dr Torley previously served as Chief Commercial Officer at Onyx Pharmaceuticals from 2011-2013, leading the successful US launch for Kyprolis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Carfilzomib), until the acquisition of Onyx by Amgen in 2013. From 2002-2011 Dr Torley held several senior commercial positions at Amgen including Vice President and General Manager US Bone Health and Vice President and General Manager US Nephrology. In these positions she led the successful launches of Prolia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(denosumab) and Sensipar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (cinacalcet) and significantly grew Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Epoetin alfa) and Aranesp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(darbepoetin alfa) revenue. From 1997-2002 she held a range of senior sales and marketing leadership positions at Bristol Myers Squib. She began her industry career at Sandoz, which merged with Ciba-Geigy to become Novartis in 1996, where she held a range of positions of increasing responsibility in Clinical Development, culminating in the position of Vice President of Medical Affairs, responsible for overseeing the design and conduct of a broad portfolio of clinical studies across nephrology, rheumatology, oncology and CNS indications. She received her M.B.Ch.B. degree (US equivalent to MD) from the University of Glasgow, Scotland and her M.R.C.P from the Royal College of Physicians, Glasgow, Scotland. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley is a trained physician who while in clinical practice specialized in Internal Medicine and Rheumatology. She served in leadership positions at Sandoz/Novartis from1990 to 1997, most recently as Vice President, Medical Affairs where she oversaw the design and conduct of Phase 1 through 4 clinical studies across multiple disease areas. While at Sandoz/Novartis she led clinical development programs for new products being evaluated in organ transplantation and rheumatoid arthritis and wrote and submitted New Drug Application filings. She has led and played key strategic positions in multiple successful FDA Advisory Committee meetings including for Neoral</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cyclosporin) in Rheumatoid Arthritis, Neoral (cyclosporin) in Organ Transplantation, Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Epoetin alfa) in anemia in chronic renal failure and HyQvia (immune Globulin infusion 10% with Recombinant Human Hyaluronidase) in Primary Immune Deficiency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley gained deep experience in a broad range of business and operational topics in her commercial positions. In particular, as General Manager of Bone Health and Nephrology at Amgen and as Chief Commercial Officer at Onyx, she was responsible for hiring and leading sales and marketing organizations, including hiring and training a more than 650-person team for a new drug launch, working on policy topics related to her products and leading three successful new product launches. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley has substantial experience leading large organizations, ranging from 120 to approximately 700 people. Her human capital management experiences include hiring and successfully onboarding large new sales teams into an established culture and effective reorganizations as dictated by changes in strategy. She has a strong focus on and understanding of the important role organizational culture, diverse teams, talent development and accountability play in driving results and success. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance and Capital Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As CEO of Halozyme, Dr. Torley has gained experience in Finance and Capital Markets including direct experience with raising over $1.5 billion through follow-on offerings and through three convertible debt offerings, and executing two share repurchase programs resulting in approximately $1.3 billion in capital returned to stockholders to date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In her position as CEO of Halozyme, Dr. Torley plays a key role in risk identification and mitigation. In addition, in her previous positions with other organizations as Chief Commercial Officer and General Manager in which she was accountable for commercial launches, a key accountability was risk identification and mitigation. This wide range of experiences enable a broad perspective on identifying potential risks and executing appropriate mitigations strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in her biography, the Nominating and Corporate Governance Committee believes Dr. Torley has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) medicine and science, (ii) pharma business leadership and operations, (iii) human capital management, (iv) finance and capital markets and (v) risk management. Dr. Torley&#8217;s extensive commercial and operational experience, including successful launches of products, and her deep knowledge of the biotechnology industry and the competitive environment, her service as our Chief Executive Officer, combined with her business acumen and judgment, </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide our Board with valuable commercial and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Dr. Torley should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Directors Continuing in Office Until the 2026 Annual Meeting</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Bernadette Connaughton</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 65)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2018</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Compensation Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, International Business, Human Capital Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Editas Medicine, Inc., a clinical stage biotechnology company</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zealand Pharma A/S, a biotechnology company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Syneos Health Inc., a biopharmaceutical services company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the Board of Directors. From 2004 to October, 2017, she served in senior management position at Bristol-Myers Squibb Pharmaceutical Company, most recently served as president, China, Latin America, Central and Eastern Europe and Middle East. In this position, she developed the multi-year strategy for the successful commercialization of a number of oncology, virology and immunology products, including Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Daklinza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to serving in that role, Ms. Connaughton served as Bristol-Myers Squibb&#8217;s president, European Markets, Canada and Australia; president, Intercontinental; and president, Japan, Pacific Rim, Australia and Canada; senior vice president, Cardiovascular and Metabolic Business Unit, U.S.; and senior vice president, Primary Care Marketing, U.S. Ms. Connaughton also served on the European Federation of Pharmaceutical Industry Association, Patient Access and European Markets Committees from 2014 to 2016. She received her Bachelor of Arts from Johns Hopkins University and her Master of Business Administration from The Wharton School, University of Pennsylvania.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Connaughton&#8217;s extensive experience in business and operations was developed during her 30-year career at Bristol-Myers Squibb where she built a consistent track record of achieving sales growth, improving profitability and transforming operational models in U.S. and international markets. She built expertise and demonstrated success across a wide range of therapeutic areas, including cardiovascular, metabolic diseases, virology and oncology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through her positions leading large global business regions for Bristol Myers Squibb, Ms. Connaughton brings deep experience in international markets. Specific achievements include developing and leading execution of the multi-year strategy for the successful commercialization of Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Daklinza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. She most recently served as President Intercontinental Region, which included China, Latin America, Central and Eastern Europe and Middle East. Other positions included President, European Markets, Canada and Australia; President, Intercontinental Region; and President, Japan, Pacific Rim, Australia and Canada.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of her senior management positions, Ms. Connaughton led diverse, cross-functional teams, building the capabilities to successfully develop and commercialize pharmaceutical products. She has broad experience selecting and developing talent and building high performance teams with the skills, motivation and culture to achieve sustainable results.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described in Ms. Connaughton&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Connaughton has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) international business and (iii) human capital management. Ms. Connaughton&#8217;s extensive operations and commercialization experience in the pharmaceutical industry including the development of successful commercialization strategies for a number of oncology products and her consistent track record of achieving sales growth provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Ms. Connaughton should serve as one of our directors.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Moni Miyashita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 68)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Nominating and Corporate Governance Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Complementary Business/Industry Segment Expertise, International Business, M&amp;A, Risk Management</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Miyashita brings over 25 years of global experience leading business transformations and building new businesses through strategy, new business models, and mergers &amp; acquisitions. Since May 2019, she has served as the Chief Strategy Officer of Valo Health, LLC, a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence computation. Prior to Valo Health, from August 2015 to May 2019, she was a Partner at Innosight Consulting, where she provided growth strategy consulting services for businesses in the biotech, healthcare and technology industries. From 2011 to 2015, she was a Senior Advisor at McKinsey where she advised senior executive leadership teams on executing strategic M&amp;A. Prior to McKinsey, she served as Vice President, Corporate Development at IBM Corporation, an information technology company, from 1998 to 2011. She received her BS degree in marketing from the University of Colorado and her MBA from the University of Denver.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Expertise</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Ms. Miyashita joined Valo Health as Chief Strategy Officer where she develops and drives complex business models, building a disruptive technology platform, and applying it to drug discovery, clinical development, and strategic partnerships across a regulated pharmaceutical ecosystem. While serving as Partner at Innosight Consulting, she advised and supported CEOs and their executive leadership teams on disruptive growth strategies in the biotech and healthcare industries. While serving as Senior Advisor at McKinsey, Ms. Miyashita provided global advisory services on M&amp;A to executive and senior leadership teams across the pharmaceutical, biotech, and healthcare industries.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During her tenure as Vice President at IBM, Ms. Miyashita was a key architect in developing and executing M&amp;A globally, anchored on strategy, with successful deal flow, transaction execution and post-merger integration. This strategy and effort resulted in over 40 quarters of double-digit earnings per share growth and creating the highest revenue and market capitalization in IBM&#8217;s history. Prior to this position, Ms. Miyashita had executive positions in IBM Asia. While serving as Senior Advisor at McKinsey, Ms. Miyashita helped build McKinsey&#8217;s M&amp;A practice and provided global advisory services to executive and senior leadership teams in the Americas, Europe, and Asia on transforming and growing their businesses through M&amp;A.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Miyashita has extensive human capital management experience having led human capital integration efforts in over 100 acquisitions during her tenure as Vice President at IBM. In her prior roles at McKinsey and Innosight, she advised chief executive officers and executive leadership teams on human capital management matters as they transitioned their companies when executing transformational M&amp;A transactions or when transforming their core business. In her current role at Valo Health, she influences the human capital management needed to build a novel platform to accelerate drug discovery and development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During her tenure as Vice President at IBM, Ms. Miyashita was involved in over 100 acquisitions or transactions and multiple business carve outs for divestiture from IBM to other companies which included developing cross functional processes and approaches to manage risk. Under her leadership, cross functional teams prepared for and passed multiple business audits to ensure risk was identified, mitigated and managed for executing all acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Ms. Miyashita&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Miyashita has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) complementary business and industry experience, (ii) international business, (iii) human capital management, (iv) M&amp;A and (v) risk management. Ms. Miyashita&#8217;s extensive experience in developing and executing complex corporate transactions and her experience providing strategy execution advice to senior leadership teams provide our Board with valuable strategic and operational expertise, leading the Nominating and Corporate Governance Committee to determine that Ms. Miyashita should serve as one of our directors.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Matthew L. Posard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 56)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2013</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Nominating and Corporate Governance Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Medicine and Science, Complementary Business/Industry Segment Expertise, International Business, Human Capital Management, M&amp;A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DermTech, Inc. (Chairman), a precision dermatology company</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Biotechnology, Inc., (Chairman) a development stage life sciences company </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Talis Biomedical, a developer of diagnostic tests for infectious diseases</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard brings over 30 years of general management and commercialization experience in the biotechnology and diagnostics industry to the Board of Directors. He is Founding Principal of Explore DNA, a life sciences executive consulting firm, a position he has held since March 2016. Since 2017, he has provided advisory services to CEOs for several emerging life sciences companies. From February 2017 to April 2018, Mr. Posard served as President and Chief Commercial Officer of GenePeeks, Inc., a genetic research company. From March 2015 to April 2016, he served as Chief Commercial Officer of Trovagene, Inc., a molecular diagnostic biotechnology company. From February 2006 to February 2015, he held various commercial and general management positions at Illumina, Inc., a genomics company focusing on DNA sequencing, including senior executive positions overseeing Global Sales, Marketing, and General Manager of Clinical and Consumer Genomics as well as New and Emerging Markets. Mr. Posard holds a BA degree in Management Science from the University of San Diego.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has deep expertise introducing novel and transformative products to medical and research markets while scaling organizations efficiently. He is a Founding Principal of Explore DNA and provides advisory services to executive officers of several emerging life sciences companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Expertise</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard adds to his biotech expertise with deep knowledge in the diagnostics area, having served in senior positions at Illumina, Biosite, Inc. and Gen-Probe, Inc. At Illumina he was part of the executive management team that led the company to its first $1 billion in revenue. At Biosite he was instrumental in the successful introduction of the company&#8217;s BNP congestive heart failure biomarker and its BNP co-marketing collaboration with Beckman Coulter. At Gen-Probe, Mr. Posard helped the company attain leading market positions in DNA probe-based infectious disease diagnostics and blood banking.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has extensive international business experience, having served as the Vice President of Global Sales for Illumina where he led an international commercial sales team. He also served as Senior Vice President and General Manager of Illumina&#8217;s Translational and Consumer Genomics and New and Emerging Markets business units and was responsible for over $100 million of sales growth in his first year in this position. This experience provided substantial exposure to commercial markets around the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his senior commercial marketing positions with various companies, Mr. Posard has managed and led a number of large and diverse marketing teams. A seasoned executive in the genomics and life science space, Mr. Posard has extensive background in effectively scaling organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has served on the board of directors and in senior leadership positions at a variety of startup and emerging companies and has extensive experience in the area of mergers and acquisitions in the biotech and diagnostics space. In his position as advisor to senior executives of life science companies, he has provided guidance and effective consultation in the execution of strategic acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described in his biography, the Nominating and Corporate Governance Committee believes Mr. Posard has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors:  (i) medicine and science, (ii) complementary business and industry segment expertise, </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) international business, (iv) human capital management and (v) M&amp;A. Mr. Posard&#8217;s general management, sales and marketing experience including the successful launch of products and management of sales operations provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Mr. Posard should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors (or &#8220;Board&#8221;) has determined that, other than Dr.&#160;Torley, each of Jeffrey W. Henderson, Bernadette Connaughton, Barbara Duncan, Mahesh Krishnan, M.D., Connie L. Matsui, Moni Miyashita, and Matthew L. Posard is an independent director within the meaning set forth under applicable rules of the NASDAQ Stock Market. Dr. Torley does not meet the requirements for director independence because she serves as the President and Chief Executive Officer of Halozyme</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has separated the Chief Executive Officer and Board Chair positions to: (i)&#160;provide a stronger corporate governance structure; (ii)&#160;improve overall Board effectiveness; and (iii)&#160;enhance communication between management and the Board. Mr. Henderson began serving as the non-employee Chair of the Board of Directors in May 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Tenure</span></div><div style="margin-top:4.5pt;text-align:center"><img src="halo-20240304_g4.jpg" alt="Board Tenure.jpg" style="height:412px;margin-bottom:5pt;vertical-align:text-bottom;width:616px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Sessions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent directors generally meet in executive session without management present each time the Board holds its regularly scheduled meetings. The Chair of the Board of Directors, acts as the presiding director for such executive sessions of independent directors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Meetings and Committees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors held ten meetings during the fiscal year ended December&#160;31, 2023. The Board of Directors has three standing committees: (i)&#160;Audit Committee; (ii)&#160;Compensation Committee; and (iii)&#160;Nominating and Corporate Governance Committee. During the last fiscal year, each director attended at least 75% of the total number of meetings of the Board for the period in which they served as a director and the committees of the Board on which such director served during that period. Our standing committees are currently comprised of the following directors:</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:5.873%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.240%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.933%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit Committee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation <br/>&#160;Committee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating / Corporate <br/>Governance Committee</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley, M.D. Ch.B., M.R.C.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Audit Committee are Jeffrey W. Henderson (Chair), Barbara Duncan and Matthew L. Posard. All members of the Audit Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market and Rule 10A-3 of the Exchange Act, and each of them is able to read and fundamentally understand financial statements. Mr. Henderson and Ms. Duncan are &#8220;audit committee financial experts,&#8221; as defined in the rules of the SEC. The Audit Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary purpose of the Audit Committee is to oversee our accounting and financial reporting processes and the functions of the Audit Committee include retaining our independent registered public accounting firm, reviewing its independence, reviewing and approving the planned scope of its annual audit, reviewing and approving any fee arrangements with our independent registered public accounting firm, overseeing its audit work, reviewing and pre-approving any non-audit services that may be performed by the independent registered public accounting firm, reviewing the adequacy of our accounting and financial controls, reviewing our critical accounting policies and reviewing, approving any related party transactions, overseeing the Company&#8217;s cybersecurity strategy, reviewing the Company&#8217;s cybersecurity risks and receiving periodic updates from management regarding cybersecurity. The Audit Committee held five meetings during the fiscal year ended December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information regarding the Audit Committee is set forth in the Report of the Audit Committee contained in this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Compensation Committee are Bernadette Connaughton (Chair), Barbara Duncan and Connie Matsui. All members of the Compensation Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market, and qualify as non-employee directors as defined in Rule 16b-3 under the Securities Exchange Act. The Compensation Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary purpose of the Compensation Committee is to discharge the Board&#8217;s responsibilities relating to compensation and benefits of our executive officers. More specifically, the Compensation Committee reviews and approves the salary and annual cash incentive earned by the Chief Executive Officer and other executive officers; approves equity awards to executive officers; approves employment and severance agreements of executive officers; and reviews the compensation of non-employee directors for service on the Board of Directors and its committees. The Compensation Committee held five meetings during the fiscal year ended December&#160;31, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Nominating and Corporate Governance Committee are Matthew L. Posard (Chair), Jean-Pierre Bizzari, M.D, and Moni Miyashita. All members of the Nominating and Corporate Governance Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market. The Nominating and Corporate Governance Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary responsibilities of the Nominating and Corporate Governance Committee are to (i)&#160;identify individuals qualified to become Board members; (ii)&#160;select, or recommend to the Board, director nominees for each election of directors; (iii)&#160;develop and recommend to the Board criteria for selecting qualified director candidates; (iv)&#160;consider committee member qualifications, appointment and removal; (v)&#160;recommend applicable corporate governance principles, codes of conduct and compliance mechanisms, and (vi)&#160;provide oversight in the evaluation of the Board and each committee. The Nominating and Corporate Governance Committee held four meetings during the fiscal year ended December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Board membership, the Nominating and Corporate Governance Committee&#8217;s goal is to assemble a Board of Directors that brings a variety of perspectives and skills derived from high quality business and professional experience. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no stated minimum criteria for director nominees. The Nominating and Corporate Governance Committee also believes it is appropriate for at least one key member of management to participate as a member of the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Halozyme Board of Directors believes that our Board should have diversity of knowledge base, professional experience and skills, and actively seeks director candidates who bring diversity of age, gender, nationality, race, ethnicity and sexual orientation. When considering whether to recommend any candidate for inclusion in the Board&#8217;s slate of recommended director nominees, including candidates recommended by our stockholders, the Nominating and Corporate Governance Committee will review the candidate&#8217;s integrity, business acumen, age, experience, commitment, diligence, conflicts of interest, existing time commitments and the ability to act in the interests of all stockholders. Once a potential qualified candidate is identified, multiple members of the Nominating and Corporate Governance Committee will interview that candidate. The committee may also ask the candidate to meet with non-committee members of the Board and/or members of management and, if the committee believes a candidate would be a valuable addition to the Board, it will recommend that candidate to the full Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of its charter and our Corporate Governance Guidelines, the Nominating and Corporate Governance Committee will consider qualified director candidates suggested by our stockholders. Stockholders may recommend individuals for the Nominating and Corporate Governance Committee to consider as potential director candidates by submitting the candidate&#8217;s name, contact information and biographical information in writing to the &#8220;Halozyme Nominating and Corporate Governance Committee&#8221; c/o Corporate Secretary, 12390 El Camino Real, San Diego, California 92130. The biographical information and background materials of any such candidate will be forwarded to the Nominating and Corporate Governance Committee for its review and consideration. The committee&#8217;s review process for candidates identified by our stockholders is essentially identical to the review process for candidates identified by the committee. In addition to the process discussed above regarding the consideration of the Nominating and Corporate Governance Committee of candidates suggested by our stockholders, our Bylaws contain provisions that address the process by which a stockholder may nominate an individual to stand for election to our Board at our Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate Enterprise Risk Management program is reviewed quarterly by the CEO and Halozyme Leadership Team, and annually by the Halozyme Board of Directors. Our Board is responsible for reviewing and assessing business enterprise risk and other major risks facing the Company, and evaluating management&#8217;s approach to addressing such risks. In connection with these reviews, our Board members rely on information from external sources as well as on their individual experiences identifying and managing business enterprise risk for other entities both within and outside of our industry. In addition, the committees of our Board consider and address risk as they perform their respective committee responsibilities. For example, financial risks and cyber security risks are overseen by our Audit Committee and our Compensation Committee periodically reviews our compensation programs to ensure they do not encourage excessive risk-taking. All committees report to the full Board as appropriate, including when a matter rises to the level of a material or enterprise risk.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior management team is responsible for day-to-day risk management and regularly reports on risks to our full Board or a relevant committee. Our legal, finance and regulatory areas serve as the primary monitoring and evaluation function for company-wide policies and procedures, and manage the day-to-day oversight of the risk management strategy for our business. This oversight includes identifying, evaluating, and addressing potential risks that may exist at the enterprise, strategic, financial, operational, compliance and reporting levels.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the division of risk management responsibilities described above is an effective approach for identifying and addressing the risks facing our Company, and that the leadership structure of our Board is effective in implementing this approach.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESG and Corporate Responsibility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme continues to build a sustainable, environmentally conscious business while fulfilling our mission of bringing disruptive solutions that can significantly improve patient experiences and outcomes for emerging and established therapies. We are driven by our mission and dedicated to our sustainability efforts across our entire ecosystem internally and externally. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see the discussion under the heading &#8220;Human Capital Management&#8221; in the Business section of our Annual Report on Form 10-K (which accompanies this Proxy Statement) for additional information on our human capital priorities and programs. We also recognize that certain stakeholders (such as customers, employees and non-governmental organizations) as well as some stockholders may be interested in more detailed information about our ESG programs and sustainability efforts. We encourage you to review the information available on our website at www.halozyme.com under the section titled &#8220;Responsibility&#8221; where our 2023 Environmental, Social &amp; Governance Report can be accessed. Information on our website is not part of this Proxy Statement.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybersecurity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate Enterprise Risk Management program, which includes information technology and cybersecurity risk, is reviewed quarterly by the CEO and Halozyme Leadership Team, and annually by the Halozyme Board of Directors. Additionally, Halozyme&#8217;s CEO is briefed quarterly and the Audit Committee is briefed annually or as determined by CIO and CEO, on our cybersecurity program. Our cybersecurity strategy is based on four fundamental areas: policy, procedure, people and technology. Halozyme maintains policies and procedures that describe our employees&#8217; responsibilities for accessing computerized systems, handling data and information, and reporting cybersecurity events in a timely manner. The Board of Directors receives educational updates from outside experts on key emergent topics. All employees and contractors are required to complete formal training on these policies. Halozyme has a well-defined and proven Business Continuity Plan (BCP). The IT Disaster Recovery Plan and the IT Incident Response Plan, which are standalone components of Halozyme&#8217;s BCP, provide the framework and guidance to manage risk. Please see the discussion under the heading &#8220;Cybersecurity&#8221; in the Business section of our Annual Report on Form 10-K (which accompanies this Proxy Statement) for additional information on our cybersecurity risk management, strategy and governance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Communications with Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders may communicate with any and all directors by transmitting correspondence by mail addressed as follows: &#8220;Halozyme Board of Directors&#8221; c/o Corporate Secretary, 12390 El Camino Real, San Diego, California 92130. The Corporate Secretary will transmit as soon as practicable such communications to the identified director addressee(s), unless there are safety or security concerns that mitigate against further transmission of the communication as determined by the Corporate Secretary. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Attendance at Annual Meetings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Corporate Governance Guidelines state that all directors shall make every effort to attend the Company&#8217;s Annual Meeting of Stockholders. All nine of our then-serving directors attended our Annual Meeting of Stockholders in 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Conduct and Ethics and Corporate Governance Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a Code of Conduct and Ethics that applies to all of our employees, officers and directors. The Board has also adopted Corporate Governance Guidelines. Copies of these documents are available on our website at: www.halozyme.com. Amendments to or waivers of our Code of Conduct and Ethics granted to any of our directors or executive officers will be published promptly within four business days on our website, www.halozyme.com.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that the information on our website is not incorporated by reference in this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the directors who served on the Compensation Committee during 2023 has ever been an officer or employee of ours or had a relationship in 2023 requiring disclosure under applicable SEC regulations. None of our executive officers currently serves, or served during 2023, on the compensation committee or board of directors of any other entity that has an executive officer serving as a member of our Board of Directors or Compensation Committee.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 2</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVISORY (NON-BINDING) VOTE </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ON EXECUTIVE COMPENSATION (SAY-ON-PAY)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory vote on executive compensation is a non-binding vote on the compensation of our Named Executive Officers, as described in the Compensation Discussion and Analysis (&#8220;CD&amp;A&#8221;) section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure, set forth in this Proxy Statement. Please read the Executive Compensation and Related Information section of this Proxy Statement for a detailed discussion about our executive compensation programs, including information about the fiscal year 2023 compensation of our Named Executive Officers. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory vote on executive compensation is not a vote on our general compensation policies, the compensation of our Board of Directors, or our compensation policies as they relate to risk management. The Dodd-Frank Wall Street Reform and Consumer Protection Act requires that we hold the advisory vote on executive compensation at least once every three years. Upon the recommendation of our stockholders at our 2023 Annual Meeting of Stockholders, our Board of Directors determined that we will hold the advisory vote on executive compensation annually until the next required non-binding stockholder advisory vote on the frequency of future non-binding stockholder advisory votes on the compensation of our Named Executive Officers which will occur no later than our 2030 Annual Meeting of Stockholders. Accordingly, as required by Section 14A of the Securities Exchange Act of 1934, as amended, we are asking our stockholders to cast an advisory vote to approve the executive compensation as described in this Proxy Statement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have many compensation practices that ensure consistent leadership, decision-making and actions without taking inappropriate or unnecessary risks. These compensation practices are discussed in detail in the Compensation Discussion and Analysis section of this Proxy Statement and have the following objectives:</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Properly align the interests of our stockholders with those of our executive leadership team;</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reward actions and achievements that are consistent with the short- and long-term goals of Halozyme&#8217;s business strategy; and</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Remain competitive to attract, retain and motivate employees with relevant experience and skills needed to achieve our business goals. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vote solicited by this Proposal No. 2 is advisory, and therefore is not binding on the Company, our Board of Directors or our Compensation Committee, nor will its outcome require the Company, our Board of Directors or our Compensation Committee to take any action. Moreover, the outcome of the vote will not be construed as overruling any decision by the Company, the Board of Directors or the Compensation Committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because this non-binding, advisory resolution primarily relates to the compensation of our Named Executive Officers that has already been paid or contractually committed, there is generally no opportunity for us to revisit these past decisions. However, our Board of Directors, including our Compensation Committee, values the opinions of our stockholders and, to the extent there is any significant vote against the Named Executive Officer compensation as disclosed in this Proxy Statement, we will consider our stockholders&#8217; concerns and evaluate what actions, if any, may be appropriate to address those concerns.&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders will be asked at the Annual Meeting to approve the following resolution pursuant to this Proposal No. 2: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOLVED, that the stockholders of Halozyme Therapeutics, Inc. approve, on an advisory basis, the compensation of the Company&#8217;s Named Executive&#160;Officers,&#160;disclosed pursuant to&#160;Item 402 of Regulation S-K in the Company&#8217;s Definitive Proxy Statement for the 2024 Annual Meeting of Stockholders</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval of this resolution requires the affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the matter. Abstentions will be treated as votes &#8220;against&#8221; the proposal. Broker non-votes will have no effect on the outcome of the vote. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors believes that the compensation of our Named Executive Officers, as described in the Compensation Discussion and Analysis and the tabular disclosures and accompanying narrative disclosures under the heading &#8220;Executive Compensation and Related Information&#8221; is appropriate for the reasons stated above. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Therefore, the Board of Directors unanimously recommends a vote &#8220;FOR&#8221; approval of the compensation for our Named Executive Officers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_34"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPOSAL NO. 3</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO REFLECT DELAWARE LAW PROVISIONS REGARDING EXCULPATION OF OFFICERS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Article VII of our Amended and Restated Certificate of Incorporation (Certificate) currently provides for the Company to limit the monetary liability of directors in certain circumstances pursuant to and consistent with the Delaware General Corporation Law (&#8220;DGCL&#8221;). The State of Delaware recently amended Section 102(b)(7) of the DGCL to allow Delaware corporations to extend similar protections to officers. Previously, exculpation was only available for directors. Specifically, the amendments to the DGCL allow Delaware corporations to exculpate their officers for personal liability for breaches of the duty of care in certain circumstances. For both directors and officers, the liability limitation does not apply to breaches of the duty of loyalty, acts or omissions not in good faith or acts or omissions that involve intentional misconduct or a knowing violation of law, or any transaction in which the director or officer derived an improper personal benefit. In addition, for officers, amended Section 102(b)(7) only permits exculpation for direct claims brought by stockholders, as opposed to claims brought by or on behalf of the Company (e.g., derivative claims).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adopting an officer exculpation provision that aligns with the protections afforded under the DGCL could prevent protracted or otherwise meritless litigation that distracts from our primary objective of creating stockholder value over the long term. The nature of the role of directors and officers often requires them to make decisions on crucial matters. Frequently, directors and officers must make decisions in response to time-sensitive opportunities and challenges, which can create substantial risk of investigations, claims, actions, suits or proceedings seeking to impose liability on the basis of hindsight, especially in the current litigious environment and regardless of merit. The Board believes that limiting concern about personal liability will empower officers to best exercise their business judgment in furtherance of stockholder interests without the distraction of potentially being subject to claims following actions taken in good faith.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Board believes it is important to provide protection to officers to the extent permitted by the DGCL to attract and retain key executive talent. This protection has long been afforded to directors, and Delaware law now permits expansion to certain officers. Several other public companies have updated their governing documents to align with amended Section 102(b)(7) of the DGCL, and we expect this practice to continue. Therefore, our ability to attract and retain highly qualified officer candidates may be adversely impacted if we do not implement the expanded protections now offered under Delaware law. For these reasons, the Board unanimously approved the amendment to our Certificate described in this proposal, subject to approval by stockholders.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Text of Proposed Certificate of Incorporation Amendment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate currently provides for the exculpation of directors and does not include a provision allowing for the exculpation of officers. If approved by our stockholders, Article SEVENTH of our Certificate would be amended and restated so that it would state in its entirety as follows:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;SEVENTH:  A director or officer of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except for liability (i) for any breach of the director&#8217;s or officer&#8217;s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involved intentional misconduct or a knowing violation of law, (iii) with respect to directors, under Section 174 of the Delaware General Corporation Law as the same exists or hereafter may be amended, or (iv) for any transaction from which the director or officer derived an improper personal benefit, or (v) with respect to officers, in any action by or in the right of the Corporation. For purposes of this Article SEVENTH, &#8220;officer&#8221; shall have the meaning provided in Section 102(b)(7) of the Delaware General Corporation Law as the same exists or hereafter may be amended.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Delaware General Corporation Law is hereafter amended to authorize the further elimination or limitation of the liability of a director or officer, then, in addition to the limitation on personal liability provided herein, the liability of a director or officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as so amended.</span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any repeal or modification of the foregoing provisions of this Article SEVENTH by the stockholders of the Corporation shall be prospective only and shall not adversely affect any limitation on personal liability or any other right or protection of a director or officer of the Corporation existing at the time of such repeal or modification.&#8221;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing and Effect of the Proposed Certificate of Incorporation Amendment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If the proposed amendment to our Certificate is approved by our stockholders, it will become effective immediately upon the filing of an Amended and Restated Certificate of Incorporation (the &#8220;Amended and Restated Certificate&#8221;) with the Secretary of State of the State of Delaware, which we expect to file promptly after the Annual Meeting. Other than replacement of the existing Article SEVENTH by the proposed Article SEVENTH, the remaining provision of our Certificate will be unchanged after effectiveness of the Amended and Restated Certificate. If the proposed Article SEVENTH is not approved by our stockholders, our Certificate will remain unchanged.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval of this amendment requires the affirmative vote of a majority of the outstanding common stock as of the record date for the Annual Meeting. Abstentions and broker non-votes will be treated as votes &#8220;against&#8221; the proposal. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beneficial owners of shares are urged to give their broker, bank, or other nominee instructions to vote their shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the reasons stated above, the Board has determined that the proposed amendment to the Certificate is advisable and in the best interests of our stockholders. Therefore, the Board of Directors unanimously recommends a vote &#8220;FOR&#8221; approval of the proposed amendment to our Amended and Restated Certificate of Incorporation.</span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_37"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 4</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RATIFICATION OF SELECTION OF </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board of Directors of Halozyme has selected Ernst &amp; Young LLP as the independent registered public accounting firm to audit the consolidated financial statements of Halozyme for the fiscal year ending December 31, 2024. Ernst &amp; Young LLP has acted in such capacity since its appointment on June 28, 2006. A representative of Ernst &amp; Young LLP is expected to be present at the Annual Meeting of Stockholders, with the opportunity to make a statement if the representative desires to do so, and is expected to be available to respond to appropriate questions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm is not required by our Bylaws or otherwise. However, the Board of Directors is submitting the selection of Ernst &amp; Young LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee in its discretion may appoint a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the matter shall ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. Abstentions will be treated as votes &#8220;against&#8221; the proposal. Broker non-votes will have no effect on the outcome of the vote.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors Recommendation </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors unanimously recommends a vote &#8220;FOR&#8221; the ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. </span></div><div style="margin-top:12.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL ACCOUNTING FEES AND SERVICES </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the aggregate fees billed to Halozyme for the fiscal years ended December&#160;31, 2023 and 2022 by Ernst &amp; Young LLP:</span></div><div style="margin-top:5pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:73.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Related Fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Fees</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Audit Fees consist of fees billed for professional services rendered for the audit of the Company&#8217;s consolidated annual financial statements, including the audit of internal control over financial reporting and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings or engagements. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">All Other Fees consist of fees for products and services other than the services reported above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee&#8217;s policy is to pre-approve all audit and permissible non-audit services provided by our independent registered public accounting firm. These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of services. The independent registered public accounting firm and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent registered public accounting firm in accordance with this pre-approval policy. The Chair of the Audit Committee is also authorized, pursuant to delegated authority, to pre-approve additional services on a case-by-case basis, provided that such approvals are communicated to the full Audit Committee at its next meeting. All of the services of Ernst &amp; Young LLP for 2023 and 2022 described above were pre-approved by the Audit Committee.</span></div><div style="height:85.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_40"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">REPORT OF THE AUDIT COMMITTEE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee oversees the Company&#8217;s financial reporting process on behalf of the Board of Directors and is comprised solely of independent directors as defined by the Nasdaq listing standards and Rule 10A-3 of the Securities Exchange Act of 1934. The Audit Committee is governed by a charter which describes in greater detail the full responsibilities of the Audit Committee. The Company&#8217;s management has the primary responsibility for the consolidated financial statements, for maintaining effective internal control over financial reporting, and for assessing the effectiveness of internal control over financial reporting. In fulfilling its oversight responsibilities, the Audit Committee reviews the consolidated financial statements, internal control over financial reporting, audit matters and reports from management. In connection with these reviews, the Audit Committee meets with management and the independent registered public accounting firm (Ernst &amp; Young LLP) at least once each quarter. These meetings include, whenever appropriate, executive sessions in which the Audit Committee meets separately with the independent registered public accounting firm, internal auditors, management personnel and legal counsel. The meetings of the Audit Committee are designed to facilitate and encourage communication among the Audit Committee, the Company, the Company&#8217;s internal audit function and the independent registered public accounting firm. The Audit Committee is directly and solely responsible for the appointment, compensation, retention, and oversight of the independent registered public accounting firm. The Audit Committee regularly considers the independence, qualifications, audit and non-audit fees and services, and performance of the independent registered public accounting firm.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has reviewed and discussed with the independent registered public accounting firm, which is responsible for expressing an opinion on the conformity of the audited consolidated financial statements with U.S. generally accepted accounting principles, its judgments as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (PCAOB) and the Securities and Exchange Commission, and other applicable regulations. In addition, the Audit Committee reviewed and discussed with Ernst &amp; Young LLP matters related to its independence, including a review of non-audit services and the written disclosures and the letter from Ernst &amp; Young LLP to the Audit Committee required by the PCAOB regarding its communications with the Audit Committee concerning Ernst &amp; Young LLP&#8217;s independence. The Audit Committee concluded that Ernst &amp; Young LLP is independent from the Company and its management.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee discussed with the Company&#8217;s independent registered public accounting firm the overall scope and plans for their respective audits. The Audit Committee has met the independent registered public accounting firm, with and without management present, to discuss the results of their examinations; their evaluations of the Company&#8217;s internal control, including internal control over financial reporting; the critical audit matters addressed during the audit and the overall quality of the Company&#8217;s financial reporting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also reviewed and discussed with management and the independent registered public accounting firm the Company&#8217;s audited consolidated financial statements and related schedule, the results of management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting and the independent registered public accounting firm&#8217;s audit of internal control over financial reporting for the year ended December&#160;31, 2023. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board of Directors, and the Board of Directors has approved, that the audited consolidated financial statements and management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting be included in the Annual Report on Form 10-K for the year ended December&#160;31, 2023 filed by the Company with the Securities and Exchange Commission. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;AUDIT COMMITTEE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Jeffrey W. Henderson (Chair)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Matthew L. Posard</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Barbara Duncan</span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_43"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION AND RELATED INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DISCUSSION AND ANALYSIS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee oversees the compensation program for the Company&#8217;s executive officers. In this role, the Compensation Committee reviews and approves all compensation decisions relating to our executive officers listed in the table below (referred to in this proxy statement as our &#8220;Named Executive Officers&#8221; or &#8220;NEOs&#8221;).</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NEOs for 2023 are:</span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.567%"><tr><td style="width:1.0%"/><td style="width:36.691%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:60.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Legal Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technical Officer</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation Highlights</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program ties a substantial portion of each executive&#8217;s overall compensation to the achievement of key strategic, financial and operational goals and aligns the interests of executive officers with stockholders by annually awarding long-term equity-based incentives, in the form of time-vesting restricted stock units (&#8220;RSUs&#8221;), performance-vesting stock units (&#8220;PSUs&#8221;) and stock options. Consistent with this approach, the compensation of our NEOs for 2023 featured:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">revenue and Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> growth performance goals were established for the threshold, base and maximum targets under our 2023 annual cash incentive program. Actual revenue attainment was $829.3 million, a 26% increase over prior year which was 97.5% to target and Adjusted EBITDA was $426.2 million a 19% increase over prior year, which was 87.2% to target. Actual cash payouts under the 2023 annual cash incentive program ranged from 106.7% to 128% of target, with the cash payouts driven by a corporate performance factor under the program of 106.7%. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a compensation package more heavily weighted toward long-term equity-based incentive compensation than salary and shorter-term annual cash incentives in order to emphasize the focus on our long-term performance and stockholder value,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term equity-based incentives that were heavily weighted toward performance &#8211; in addition to the value of all awards being dependent on our stock price, the awards granted in 2023 included PSUs which are subject to performance-based vesting conditions and stock options which have value only if our stock price increases after the date of grant of the awards,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">stock ownership and stock retention guidelines, encouraging executives to maintain a meaningful ownership position in the Company, focus on our long-term performance and discourage unreasonable risk-taking,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a recoupment (or &#8220;claw back&#8221;) policy covering certain compensation elements in the event of an accounting restatement due to material noncompliance with any financial reporting requirements,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a practice of not including tax gross-ups in ongoing compensation arrangements,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no &#8220;single trigger&#8221; provisions in executive and employee change-in-control agreements and arrangements (i.e., payout or vesting is not triggered automatically upon a change-in-control), and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no material perquisites.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Engagement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board and the Compensation Committee value the input of our stockholders regarding the Company&#8217;s governance practices and the design and effectiveness of our executive compensation program. Halozyme conducts regular outreach to our stockholders to build relationships and solicit feedback on these topics.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our stockholders are provided with an opportunity to cast an advisory vote on our executive compensation program every year through the &#8220;say-on-pay&#8221; proposal. At our 2023 annual meeting of stockholders, our stockholders approved, on a non-binding, advisory basis, the compensation paid to our NEOs described in our 2023 proxy statement. Approximately 95.9% of the votes cast on the matter were voted in favor of this &#8220;say-on-pay&#8221; proposal. The Compensation Committee considered the voting results and </span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> We use &#8220;EBITDA&#8221; to refer to the Company&#8217;s earnings excluding interest, taxes, depreciation and amortization, and &#8220;Adjusted EBITDA&#8221; means the Company&#8217;s EBITDA excluding one time items such as changes in contingent liabilities and impairment charges, and transaction costs for business combinations.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">high level of stockholder support when establishing our executive compensation programs for fiscal 2024 and, given the high level of stockholder support on our last &#8220;say-on-pay&#8221; proposal, established executive compensation programs for fiscal 2024 that are similar to those that were in place for fiscal 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When making future compensation decisions for our executive officers, the Compensation Committee will continue to consider the opinions that stockholders express through our stockholder engagement program and through our annual &#8220;say-on-pay&#8221; advisory votes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Business Highlights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme&#8217;s strong financial and operating performance in 2023 was supported by internal corporate developments and significant growth and advancements with our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> collaboration partners. The key developments and achievements in 2023 include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reported record total revenues of $829.3 million, which increased 26% from $660.1 million in 2022.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased revenues from royalties 24% year-over-year to $447.9 million driven primarily by continued strong sales from partnered products utilizing our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology including the subcutaneous formulations of DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (daratumumab) and Roche&#8217;s Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (pertuzumab/trastuzumab/hyaluronidase-zzxf).</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Continued our commitment to returning value to shareholders and repurchased 4.2 million shares of common stock for $150 million at an average price per share of $36.01 and announced an acceleration of the remaining $250 million under the current approved $750 million share repurchase plan authorized in 2021. The Company executed the $250 million share repurchase by entering into an accelerated share repurchase transaction with a financial institution.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Strengthened our balance sheet and redeemed all of the outstanding 1.25% convertible senior notes due 2024 in exchange for $13.5 million in cash and 288,886 shares of common stock.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Announced positive results of a clinical study with our proprietary high-volume auto-injector demonstrating subcutaneous (&#8220;SC&#8221;) administration of 10 mL of a representative biologic product co-formulated with our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology in approximately 30 seconds.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Entered into a global collaboration and non-exclusive license agreement with Acumen Pharmaceuticals that provides Acumen access to ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a single target. Acumen intends to explore the potential use of ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for ACU193, a clinical stage monoclonal antibody candidate to target Amyloid-&#946; Oligomers for the treatment of early Alzheimer&#8217;s disease.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Regulatory Submissions/Approvals</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx announced that the FDA had accepted for priority review a supplemental Biologics License Application (&#8220;sBLA&#8221;) for VYVGART Hytrulo for the treatment of CIDP. The application has been granted a Prescription Drug User Fee Act action date of June 21, 2024.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda submitted a New Drug Application in Japan seeking approval for TAK-771, subcutaneous 10% human immunoglobulin with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for treatment of primary immunodeficiency.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda announced that the FDA approved a sBLA to expand the use of HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to treat primary immunodeficiency in children.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx received FDA approval for VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo injection with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for SC use for the treatment of generalized myasthenia gravis (&#8220;gMG&#8221;) in adult patients who are anti-acetylcholine receptor (&#8220;AChR&#8221;) antibody positive. VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo was made available to patients, resulting in $33.0 million in milestone payments and the right to receive royalties on net product sales.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche announced the approval of Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by the Medicines and Healthcare products Regulatory Agency in Great Britain, resulting in an $8.0 million milestone payment to Halozyme and the right to receive royalties on net product sales.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Chugai Pharmaceuticals, a member of the Roche Group, obtained regulatory approval for Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the Ministry of Health, Labour and Welfare in Japan. Halozyme is entitled to receive royalties for Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sales in Japan under its agreement with Roche.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx received European Commission (&#8220;EC&#8221;) approval for SC injectable VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as an add-on to standard therapy for the treatment of gMG in adult patients who are AChR antibody positive. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Zai Lab Limited (argenx&#8217;s commercial partner in China) announced the Center for Drug Evaluation of the National Medical Products Administration granted Breakthrough Therapy Designation for efgartigimod alfa injection (SC injection) (efgartigimod SC) for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (&#8220;CIDP&#8221;). The Breakthrough Therapy Designation for efgartigimod SC was supported by data from both global and Chinese patients enrolled in the ADHERE study.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche received EC marketing authorization for Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC for all approved indications of Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> IV for multiple cancer types.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda received FDA approval for HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of CIDP as maintenance therapy to prevent the relapse of neuromuscular disability and impairment in adults.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda received EC approval for HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of CIDP as maintenance therapy in patients of all ages after stabilization with intravenous immunoglobulin therapy.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx received regulatory approval in Japan for VYVDURA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (efgartigimod alfa and hyaluronidase-qvfc) co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adult patients with gMG including options for self-administration, resulting in a $5.0 million milestone payment.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche filed Ocrelizumab SC with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with regulatory authorities in the U.S., European Union (&#8220;EU&#8221;) and Great Britain.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx submitted a sBLA to the FDA for VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo for CIDP with priority review voucher and if approved, argenx is expected to launch mid-2024.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Janssen announced submission of a sBLA to the FDA seeking approval of a new indication for DARZALEX FASPRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with bortezomib, lenalidomide and dexamethasone for induction and consolidation treatment and with lenalidomide for maintenance treatment of adult patients who are newly diagnosed with multiple myeloma and are eligible for autologous stem cell transplant.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Positive ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Clinical Data Announcements</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda announced positive results from a pivotal Phase 3 trial evaluating HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for maintenance treatment of CIDP and confirmed regulatory applications were under review in the U.S. and EU.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx reported positive data from the ADHERE study evaluating VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in adults with CIDP. The study met its primary endpoint resulting in a 61% reduction in risk of relapse compared to placebo.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche announced that the Phase III OCARINA II trial evaluating OCREVUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ocrelizumab) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a twice a year 10-minute subcutaneous injection met its primary and secondary endpoints in patients with relapsing forms of multiple sclerosis (&#8220;MS&#8221;) or primary progressive MS.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Bristol Myers Squibb reported positive topline results from the Phase 3 CheckMate-67T trial evaluating a SC formulation of Opdivo (nivolumab) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in patients with advanced or metastatic clear cell renal cell carcinoma who have received prior systemic therapy. The study met its co-primary pharmacokinetics (&#8220;PK&#8221;) endpoints and a key secondary endpoint.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Clinical Trial Advancements</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">BMS initiated a Phase 3 trial to demonstrate the drug exposure levels of nivolumab and relatlimab fixed-dose combination with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is not inferior to IV administration in participants with previously untreated metastatic or unresectable melanoma (RELATIVITY-127).</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda initiated a Phase 2/3 study to evaluate PK, safety, and tolerability of subcutaneous administration of TAK-881 in adult and pediatric participants with Primary Immunodeficiency Diseases.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ViiV initiated a Phase 2b study to evaluate the efficacy, safety, PK and tolerability of VH3810109 (N6LS) administered subcutaneously with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with cabotegravir.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ViiV achieved a development milestone, which resulting in a $5 million milestone payment.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Device Product Regulatory Approvals</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">Teva announced FDA approval of the generic version of Forteo, featuring our multi-dose auto-injector pen platform for the treatment of osteoporosis among certain women and men.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 CEO Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, the total target annual cash compensation for our CEO, Dr. Helen I. Torley, was $1,748,000 ($920,000 in base salary plus $828,000 in target annual cash incentive opportunity). Dr. Torley&#8217;s base salary was increased for 2023 by 5.5% as a result of the Compensation Committee&#8217;s assessment of her contribution to Halozyme&#8217;s performance during 2022 and its review of base salary paid to other peer group CEOs. (Our executive compensation peer group is discussed below under the heading &#8220;Competitive Peer Group.&#8221;) Dr. Torley&#8217;s target annual cash incentive opportunity for 2023 (assuming achievement of the corporate goals at 100%) was 90% of her base salary, which was a 10% increase (as a percentage of base salary) over her target annual cash incentive opportunity for 2022. The Compensation Committee believes this target annual cash incentive was appropriate based on her level of experience, the Compensation Committee&#8217;s review of annual cash incentive targets for other peer group CEOs, and the Compensation Committee&#8217;s belief that significant portions of total annual cash compensation should be tied to achievement of specified goals. As discussed in more detail below in this CD&amp;A, the annual cash incentive she earned for 2023 was $883,476 which represents approximately 107% of her target annual cash incentive opportunity. As CEO, Dr. Torley is the only NEO whose annual cash incentive is determined solely based on the performance of the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley also received a long-term equity incentive (LTI) award during 2023 that had a grant date fair value approximately $10,000,000, comprising the most significant element of her 2023 compensation opportunity. This award was granted based on the Compensation Committee&#8217;s assessment of her contribution to Halozyme&#8217;s performance during 2022, its review of LTI compensation paid to other peer group CEOs and the desire to link a significant portion of her compensation opportunity to Halozyme&#8217;s long-term performance. The Compensation Committee approved a mix of 28.75% PSUs (at target), 38% stock options and 33.25% RSUs for Dr. Torley, and a mix of 25% PSUs (at target), 40% stock options and 35% RSUs for each of the other NEOs, to emphasize Halozyme&#8217;s long-term stock price performance and to promote retention, with particular emphasis on performance (through the larger weight given to PSUs) in the mix for Dr. Torley. The stock options vest 25% on the one-year anniversary of the date of grant with the remaining 75% vesting monthly over the following three years, while RSUs vest in 25% annual installments over a four-year period following the grant date, subject to continued employment. PSUs granted to the NEOs in 2023 vest based on our relative total shareholder return measured against an applicable subset of companies in the NASDAQ Biotechnology Index over a three-year performance period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Halozyme&#8217;s Executive Compensation Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal elements of our executive compensation program are base salary, an annual cash incentive opportunity and an annual Long Term Incentive (&#8220;LTI&#8221;) award opportunity. The LTI awards for 2023 consisted of stock options, RSUs and PSUs.</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.986%"><tr><td style="width:1.0%"/><td style="width:2.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do Not Do</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay annual bonus based on the achievement of Company financial and strategic goals, and in the case of NEOs other than the CEO, individual performance, and contribution in achieving those goals</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No guaranteed annual bonus payouts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Grant PSUs as significant portion of annual LTI awards for all executive officers </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No severance payments or benefits for executives who voluntarily terminate their employment</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cap the annual bonus plan payout</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No buyback of stock awards or repricing of stock options without shareholder approval</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prohibit executive officer hedging and pledging of Company stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No executive single-trigger change in control benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain an executive officer recoupment (&#8220;claw back&#8221;) policy</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No material perquisites </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain robust stock ownership and retention guidelines for all executive officers</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No supplemental executive benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conduct an annual comprehensive compensation program risk assessment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No excise tax gross-ups</span></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Detailed Discussion and Analysis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This CD&amp;A describes the material elements of 2023 compensation for our NEOs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee makes all decisions relative to the compensation of all executive officers (including the CEO). Except as otherwise noted in this CD&amp;A, the Compensation Committee&#8217;s executive compensation determinations are subjective and the result of the Compensation Committee&#8217;s business judgment. Additional details regarding the role and responsibilities of the Compensation Committee are provided below.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Total Rewards Philosophy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee periodically reviews its total rewards philosophy for executive officers to confirm our programs continue to meet the objectives of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supporting Halozyme&#8217;s short- and long-term business strategy,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anchoring to market-based principles and being tailored to Halozyme&#8217;s culture, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">aligning the interests of the executive officers with the long-term interests of Halozyme stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material elements of 2023 compensation for our NEOs consisted of three primary elements, each has a specific purpose as described below:</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.126%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Element</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purpose</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Salary</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Provides a fixed amount of cash compensation for services rendered based on individual performance, job scope, experience and competitive market for talent</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Cash Incentive</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Motivates and rewards fiscal year contribution to company performance against pre-established financial and operational goals and objectives </span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Incentives (&#8220;LTI&#8221;)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Align compensation with the creation of stockholder value (in the case of stock options) and changes in stock price (in the case of RSUs)  and  relative total shareholder return performance (in the case of PSUs)</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Increases executive stock ownership and aligns with stockholder interests.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Serves as a key retention device</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our NEOs are eligible to receive severance payments and benefits in connection with a qualifying termination of employment under our executive Change-in-Control Agreements and our severance policy for covered terminations unrelated to a change in control, each as described in more detail below. We also provide our NEOs with the same package of benefits that are provided to substantially all our full-time employees, including Company matching contributions to a 401(k) plan, health insurance, group term life insurance, and disability income insurance. From time to time, we may also provide relocation assistance in connection with the recruitment of an officer or employee with needed skills and experience. No material perquisites or supplemental executive benefits were provided to our NEOs in 2023. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As shown below, the majority of our NEOs&#8217; target total direct compensation for 2023 (base salary, target annual cash incentive, and LTI awards, taken into account at their fair value on the grant date) was variable (target annual cash incentive and LTI awards), with the single largest component (LTI awards) based on Halozyme&#8217;s stock price performance. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><img src="halo-20240304_g5.jpg" alt="CEO CDA Chart.jpg" style="height:304px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:6pt;text-align:center"><img src="halo-20240304_g6.jpg" alt="NEOs CDA Charts.jpg" style="height:304px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee determines base salaries for NEOs each year based upon the following factors (with no specific weight applied to each factor):</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and complexity of the NEO&#8217;s responsibilities, </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a review of external market practices (a more detailed description of the methodology used to assess external market practices is provided below),</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the NEO&#8217;s experience, </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">internal pay equity, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the CEO&#8217;s evaluation of the NEO&#8217;s performance and contribution to the short- and long-term success of Halozyme (in the case of the CEO, the evaluation is done in executive session by the Compensation Committee with input from the other independent members of the Board of Directors). </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reflected in the table below, 2023 annual base salary levels were increased by 5.5% for the CEO, 12.5% for Ms. LaBrosse (to bring her salary closer to the peer median for her position and to recognize her growth in the role since being promoted at the start of 2022), and 4.0% and 3.5%, respectively, for Mr. Snyder and Dr. LaBarre. The base salary increases for our NEOs were approved by the </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Committee after taking into account the base salaries paid to peer group executives holding similar positions and other factors described above.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.322%"><tr><td style="width:1.0%"/><td style="width:60.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022  Base Salary ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023  Base Salary ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871,832</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">525,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">546,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">520,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">538,200</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Cash Incentive</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEOs participate each year in the Employee Bonus Plan (&#8220;EBP&#8221;). The actual cash incentive paid to each NEO with respect to 2023 was determined based on each NEO&#8217;s target annual cash incentive opportunity and based on the performance of Halozyme as measured by the level of achievement of six metrics, of which two are tied to financial performance and have a combined 70% weighting and four are tied to operational performance and have a combined 30% weighting (&#8220;Corporate Performance&#8221;). As CEO, Dr. Torley is responsible for overall corporate performance, and accordingly, her EBP incentive opportunity is based entirely on the attainment of objective, pre-established corporate performance goals without applying an individual performance adjustment. For the other NEOs, the Compensation Committee may modify final payouts based on individual performance during the year relative to the level of achievement of personal goals (&#8220;Individual Performance Factor&#8221;), and the NEO must achieve at least 60% of his/her individual performance objectives in order to be eligible for a cash incentive payment. In all events, an NEO&#8217;s total payout cannot exceed two times the target cash annual incentive opportunity for the NEO. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee sets each NEO&#8217;s target annual cash incentive opportunity as a percentage of the NEO&#8217;s base salary taking into account the same factors as are considered in NEO base salary determinations. As shown below, the 2023 target annual cash incentive opportunities for the NEOs (as a percentage of base salary) were increased over their 2022 target opportunities. These increases were approved by the Compensation Committee and set each NEO&#8217;s target opportunity at approximately the median for peer group executives holding similar positions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.980%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Executive Officer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2022 Target Bonus</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(% Salary)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2023 Target Bonus</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(% Salary)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2023 Target Bonus ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Helen I. Torley</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">80%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">828,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nicole LaBrosse</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">273,094</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mark Snyder</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">273,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Michael J. LaBarre</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">269,100</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Corporate goals were established by the Compensation Committee (with input from the full Board of Directors) to tie the compensation of our NEOs to the Company&#8217;s achievement of annual operating objectives that were viewed as long-term drivers of sustainable value creation. EBP funding ranges between 0% and 200% for each of the six metrics. The Board of Directors approved the threshold, target, and maximum goals/level of performance for each metric (except that for the organizational effectiveness category, the target level of performance had to be attained in order for there to be any payout based on that measure). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 EBP focused on achievement of key financial and strategic objectives that resulted in (i) revenue growth, (ii) increased Adjusted EBITDA and (iii) certain other operational goals as identified in the table below. The Compensation Committee is responsible for certifying actual performance relative to these goals following completion of the fiscal year. After reviewing the Company&#8217;s performance results in 2023, the Compensation Committee determined the corporate performance factor under the 2023 EBP was achieved at 106.7% of the targeted level for the NEOs (see table below). We used Adjusted EBITDA as one of the financial measures under the 2023 EBP in place of non-GAAP operating income (which had been used under the 2022 EBP) because EBITDA is a common metric used to evaluate earnings and widely understood by investors. Adjusted EBITDA also excludes one-time items such as changes in contingent liabilities and impairment charges, and transaction costs for business combinations that we feel are not reflective of our core operating performance. </span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.867%"><tr><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate Goal</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weight</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Threshold</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Result</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBP Funding</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$815.0M</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$830.0M</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$860.0M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$829.3M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$415M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$430M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$455M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$426.2M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add a particular new device agreement</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Submission of new patent applications</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Organizational Effectiveness:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Demonstrate increased efficiency in manufacturing and release of our products</span></div><div><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release a specific number of lots of ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> by December 15, 2023</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release a  specific number of lots of ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> by October 30, 2023</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achieved prior to October 30, 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Organizational Effectiveness &amp; Health:<br/>Continue to build our high performing culture by building upon the strengths and skills of employees:<br/>Increased team participation in facilitated learning courses and LinkedIn Learning courses above 2022 baseline<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% increase</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15% increase</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40% increase</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">increased participation by &gt;40%</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL CORPORATE PERFORMANCE FACTOR</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Individual Performance Factor.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee believes the actual payout to each NEO (other than for Dr. Torley whose payout, as noted above, is based entirely on the attainment of objective, pre-established corporate performance goals) should also reflect the executive&#8217;s:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance relative to individual goals and objectives established for the year,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contribution toward achieving the Corporate Performance results, and </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">demonstration of living Halozyme&#8217;s Leadership Attributes and Corporate Values during the year.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Ms. LaBrosse&#8217;s accomplishments and other factors, the Compensation Committee supported the CEO&#8217;s recommendation and awarded her an individual performance factor of 100%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ms. LaBrosse successfully led multiple financial transactions supporting execution of the corporate strategy and strengthened the company&#8217;s balance sheet. These activities included settlement of our 2024 convertible notes, continued execution of our share buy-back program, implementation of a FX hedging strategy and multiple actions to optimize taxes. Under Ms. LaBrosse leadership we further strengthened our Cybersecurity readiness and successfully completed full IT integration of Antares Pharma, Inc.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Mr. Snyder&#8217;s accomplishments and other factors, the Compensation Committee supported the CEO&#8217;s recommendation and awarded him an individual performance factor of 120%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Mr. Snyder played a key role in successful accomplishment of the corporate goals including support of the submission of multiple co-formulation patent applications achieving 200% attainment of this goal. In addition, Mr. Snyder led a detailed review of our patent portfolio and patents, taking actions to further add to our portfolio. He also played a key role in the successful negotiation of the ENHANZE Collaboration and Licensing Agreement with Acumen, expanding the number of collaboration partners. During the year, Mr. Snyder also led negotiation of multiple supplier and other contracts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Dr. LaBarre&#8217;s accomplishments and other factors, the Compensation Committee supported the CEOs recommendation and awarded him an individual performance factor of 100%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Dr. LaBarre played a key role in successful accomplishment of the corporate goals including helping identify the innovations that supported the submission of multiple co-formulation patent applications, achieving 200% attainment of this goal. In addition, he led the successful execution of the Phase 1 clinical study of the High Volume Auto-Injector Prototype, demonstrating feasibility and patient acceptance of rapid large volume drug delivery by autoinjector.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates the 2023 cash incentive calculation for each NEO based on the following formula (also reflected in the &#8220;Non-Equity Incentive Plan Compensation&#8221; column of the Summary Compensation Table). </span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><img src="halo-20240304_g7.jpg" alt="slide1b05.jpg" style="height:97px;margin-bottom:5pt;vertical-align:text-bottom;width:636px"/></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.065%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annualized Base Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Target<br/>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annualized<br/>Target Amount<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Performance Factor</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual Performance Factor</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Final Payout<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,094</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,200</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">As noted above, Dr. Torley&#8217;s payout is based entirely on the attainment of objective, pre-established corporate performance goals without applying an individual performance factor.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LTI Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All grants of LTI compensation are made under our stockholder-approved equity incentive plan. The Compensation Committee utilized three vehicles to deliver LTI awards to NEOs during 2023:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are strongly aligned with stockholder interests because they deliver value to the NEO only if the value of our stock at the time of exercise exceeds the stock price on the day of grant. As a result, the Compensation Committee believes stock options encourage executives to focus on the decisions and behaviors required to support long-term sustainable increases in our stock price. To ease the transition to retirement for long-serving employees, the Compensation Committee provided in 2023 that employees who retire from Halozyme at age 60 or older with at least seven years of service to Halozyme will have three years from the date of their termination of service to exercise their Halozyme options that are vested at the time of their separation (subject to the applicable maximum option term and subject to earlier termination in connection with certain change in control events).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Time-vesting RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide a counterbalance to the more uncertain value associated with stock options and PSUs while still maintaining alignment with the interests of our long-term stockholders, as the value of RSUs fluctuates (up or down) with changes in our stock price. As a result, the Compensation Committee believes time-vesting RSUs encourage executives to make decisions consistent with the long-term interests of our stockholders and help support retention.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and time-vesting RSUs granted to our NEOs in 2023 generally vest over a four-year period subject to continued employment.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> help link our equity incentive program to achievement of specific performance goals established by the Compensation Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee believes that the grant of PSUs furthers our executive compensation philosophy to tie achievement of company performance with executive compensation, aligns the interests of executive officers with our stockholders and encourages long-term performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSUs granted to the NEOs in 2023 are eligible to cliff vest after a three-year period provided they are earned based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index (excluding companies that had not been listed or traded on a national securities exchange for at least three consecutive years as of October 31, 2022, those that had gross revenue of less than $100 million dollars for the period of four consecutive calendar quarters ending with the last fiscal quarter for which there were publicly disclosed financial results as of October 31, 2022, and those that cease to be publicly-traded during the applicable performance period other than due to insolvency). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One-third of the target PSUs are earned based on three discrete performance periods each beginning on the grant date of the awards, with one performance period ending December 31, 2023, one performance period ending December 31, 2024, and one performance period ending December 31, 2025. For purposes of these awards, TSR for Halozyme and the applicable subset of component companies is based on a 20-trading day average trading price beginning on the PSU grant date and a 20-trading day average trading price ending on the last day of the applicable performance period. Dividend equivalents, if any, will be accrued as additional stock units and delivered with earned shares at vesting. The potential vesting percentages for the 2023 PSUs are as follows (with the percentage determined by linear interpolation for performance between the 25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentiles):</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.785%"><tr><td style="width:1.0%"/><td style="width:28.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Maximum</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile or Higher</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">150%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Target</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">100%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Threshold</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Below Threshold</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&lt; 25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">0%</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs eligible to vest based on performance become vested on the third anniversary of the grant date of the awards following certification of performance results and assuming continued employment. The three-year cliff vesting schedule serves as additional retention and incentive for stock price performance to support long-term alignment with our stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Annual LTI Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, the Compensation Committee awarded annual LTI compensation for the NEOs based on the grant date value the Committee determined appropriate considering their assessment of annual equity award grants to peer group executives holding similar positions, and taking into account their assessment of the executive&#8217;s experience, expected contribution to the long-term success of the Company, and skill-set relative to industry peers at biopharmaceutical companies (with no specific weight applied to each factor). The Compensation Committee also determined that the award value for each NEO would be allocated 25% PSUs (at target), 40% stock options and 35% RSUs (or 28.75%, 38% and 33.25%, respectively, for Dr. Torley). A greater weight was placed on PSUs in the equity award mix for Dr. Torley to increase the performance-based portion of her overall LTI award. Accordingly, the Compensation Committee awarded the following LTI values to our NEOs in 2023:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.801%"><tr><td style="width:1.0%"/><td style="width:42.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,325,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,875,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000,000</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400,000</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each NEO, the LTI value allocated to an award was converted into a number of shares based on (i) in the case of RSUs, the closing price of our stock on the grant date, and (ii) in the case of options and PSUs. the per share fair value of the award on the grant date awards as determined under applicable accounting rules, and rounding up to a whole share. The grant date fair value of the options was determined using the Black-Scholes option valuation methodology. The grant date fair value of the PSUs was determined using a Monte Carlo simulation. Differences between the LTI values approved by the Compensation Committee, as shown above, and the actual grant date fair values of the awards as included in the executive compensation tables following the CD&amp;A are due to the rounding of fractional share interests in accordance with the methodology approved by the Compensation Committee.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PSU Award Vesting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has determined that, as to the one-third of the PSUs awarded in 2023 that correspond to a performance period ended December 31, 2023, 70.45% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-14.7% and this placed us at the 35.2nd percentile against the comparison group of companies for that period). These PSUs remain unvested, with vesting subject to continued employment through the third anniversary of the grant date of the awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We awarded PSUs in 2021 to Dr. Torley and Dr. LaBarre and awarded PSUs in 2022 to each of the NEOs that are similar to the PSUs awarded in 2023. The Compensation Committee has determined that, as to the one-third of the PSUs awarded in 2021 that correspond to a performance period ended December 31, 2023, 150% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was -14.2% and this placed us at the 77.5th percentile against the comparison group of companies for that period). The PSUs vested on the third anniversary of the grant date of the awards. The Compensation Committee has also determined that, as to the one-third of the PSUs awarded in 2022 that correspond to a performance period ended December 31, 2023, 131.58% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was 11.7% and this placed us at the 65.8th percentile against the comparison group of companies for that period). These PSUs remain unvested, with vesting subject to continued employment through the third anniversary of the grant date of the awards.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Annual LTI Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, the 2023 annual LTI award mix for Dr. Torley was 28.75% PSUs (at target), 38% stock options and 33.25% RSUs, and the 2023 annual LTI award mix for our other NEOs was 25% PSUs (at target), 40% stock options and 35% RSUs. The Company granted its 2024 annual LTI awards in February 2024, with a mix for all NEOs, including Dr. Torley, that was 50% PSUs (at target), 15% stock options and 35% RSUs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two types of PSUs were awarded in 2024. Half of the target PSU value is earned based on our relative TSR performance against a subset of the Nasdaq Biotech Index, consistent with the design of our 2023 PSUs. One-third of these PSUs are eligible to be earned based on our relative TSR performance over three measurement periods, each beginning on the date of grant and ending at the end of 2024, 2025, and 2026, with 0%-150% of the one-third portion of the award allocated to each performance period eligible to be earned based on actual performance for that period. Earned shares, if any, cliff vest on the third anniversary of grant. The other half of the target PSU value is earned based on new target nominations by partners and new collaborations in 2024 related to ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our Auto-Injectors, aligned with our strategic goals. These PSUs are earned from 0%-200% of the target number of shares. Earned shares, if any, cliff vest on the third anniversary of grant.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Peer Group</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee annually selects a group of peer companies against which Halozyme benchmarks the competitiveness of executive pay levels and program design (referred to in this CD&amp;A as our &#8220;peer group&#8221; or &#8220;peer companies&#8221;). The peer group companies are identified based upon the Compensation Committee&#8217;s assessment of each company&#8217;s similarity with Halozyme with respect to science/business model, revenue, and market capitalization. The peer group is reviewed annually by the Compensation Committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023 compensation decisions, the Compensation Committee utilized proxy data from the following companies, listed below. The Compensation Committee&#8217;s objective in selecting this peer group was to include a group of similar-sized public companies in the life sciences sector, with an emphasis on pharmaceutical and biotechnology companies with commercialized products. Targeted companies generally had revenues and market capitalization between 0.25x to 4.0x Halozyme&#8217;s size at the time of the analysis with Halozyme near the median on both measures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.537%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="background-color:#00497f;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Peer Group</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acadia Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Agios Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alkermes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alnylam Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amicus Therapeutics</span></div><div><span><br/></span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BioMarin Pharmaceutical</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Blueprint Medicines</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exelixis</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ionis Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ironwood Pharmaceuticals</span></div><div><span><br/></span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals<br/>Neurocrine Biosciences<br/>Sarepta Therapeutics<br/>Ultragenyx Pharmaceuticals<br/>United Therapeutics<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/><br/></span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following changes to the peer group were made for 2023: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Alkermes, BioMarin Pharmaceutical and United Therapeutics were added to the group based on the Compensation Committee&#8217;s assessment of the criteria noted above.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acceleron Pharmaceuticals, FibroGen, Heron Therapeutics, and Nektar Therapeutics were removed from the group based on the Compensation Committee&#8217;s assessment of the criteria noted above and, in the case of Acceleron Pharmaceuticals, because it was no longer publicly-traded.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Compensation Consultant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee retains F.W. Cook &amp; Co., Inc. (&#8220;FW Cook&#8221;) as its independent compensation consultant to provide advice and counsel on matters related to our executive and non-employee director compensation program and FW Cook provides no other services to Halozyme. In 2023, FW Cook provided recommendations regarding the composition and selection of Halozyme&#8217;s peer group companies to be used with respect to 2023 and 2024 executive compensation decisions, performed a review of compensation levels and practices for similar executive positions at the peer group companies, advised regarding the compensation mix and levels for the NEOs, advised on the design and implementation of our annual LTI awards, reported on executive compensation trends and developments, and advised on the compensation arrangements for our non-employee directors. FW Cook reports directly to the Compensation Committee and regularly attends meetings of the Compensation Committee, as requested. The Compensation Committee assessed the independence of FW Cook pursuant to applicable rules and regulations of the SEC and NASDAQ and concluded that the engagement of FW Cook did not raise any conflicts of interest during fiscal 2023 and currently does not raise any conflicts of interest.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Risk Assessment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee, with assistance from its independent compensation consultant and with input from members of management, annually reviews our compensation programs, policies and practices to determine whether they encourage risk-taking that could have a material adverse effect on the Company. As part of this review, the Company evaluates the primary components of its compensations plans to identify whether those components properly balance compensation opportunities and risk. Our Compensation Committee considers various factors, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pay philosophy provides an effective balance in cash and equity award mix, short- and long-term performance periods, financial and non-financial performance, formulas and discretion.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s compensation programs include an appropriate mix of short- and long-term goals and incentives.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Compensation Committee has the discretion to make positive and negative adjustments to payouts under the Company&#8217;s compensation plans.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Policies are in place to manage or mitigate risk, such as stock ownership guidelines, vesting periods on equity awards, insider-trading prohibitions that also restrict hedging and pledging, recoupment policy and provisions, and independent Compensation Committee oversight.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s design and oversight principles also apply to its broad-based employee compensation plans.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this review, the Compensation Committee, based in part on the input from its compensation consultants, concluded that the risks arising from the Company&#8217;s compensation policies and practices, for both our executive officers and our other employees, are not reasonably likely to have a material adverse effect on Halozyme.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Compensation Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Ownership and Retention Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain stock ownership guidelines for our executive officers which stipulate that the CEO is required to own shares of Halozyme common stock with value equal to no less than six times the CEO&#8217;s current base salary and that all other executive officers are required to own shares of Halozyme common stock with value equal to no less than two times the officer&#8217;s current base salary. Certain other officers designated by the Compensation Committee are expected to own shares of Halozyme common stock with value no less than one times the officer&#8217;s current base salary. Each executive officer is expected to comply with the guidelines within five years of appointment as an executive officer, and has three years to comply with any incremental ownership required as a result of a promotion or other increase in applicable ownership multiple. Share ownership that counts for purposes of satisfying the applicable guideline level of ownership includes fully-owned shares (including shares held in trust and by immediate family members), vested but deferred shares, shares held in retirement accounts, and unvested stock units that are subject to time-based vesting only. Stock units subject to unsatisfied performance-based vesting conditions and unexercised stock options are not counted when evaluating compliance. Each executive officer is required to: (i) hold at least 50% of all net shares (after shares withheld or sold to pay tax obligations) of RSUs and PSUs that vest; and (ii) hold at least 50% of the underlying net gain (i.e., not including shares sold to pay the exercise price or to satisfy tax obligations) in shares of the Company&#8217;s common stock as a result of stock option exercises, until the executive officer comes into compliance with the stock ownership guidelines. The Compensation Committee annually reviews progress executive officers are making toward achieving compliance with these guidelines and has determined that all of our NEOs have achieved their specific ownership levels as of February 1, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Deductibility of Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Section 162(m) of the Internal Revenue Code generally disallows a tax deduction to public companies for compensation in excess of $1 million paid to a company&#8217;s chief executive officer and certain current and former executive officers. As a result, we expect that compensation paid per year to our NEOs and certain former executive officers in excess of $1 million generally will not be deductible, </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to limited exceptions. The Compensation Committee generally seeks to preserve tax deductions for executive compensation where available but may make compensation decisions based on other factors when it believes doing so is in the best interest of the Company and its stockholders. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into Change in Control Agreements with our executive officers. We believe that the occurrence or potential occurrence of a change in control transaction creates uncertainty regarding the continued employment of our executive officers. This uncertainty results from the fact that many change in control transactions are common in our industry and often result in significant organizational changes, particularly at the senior executive level. We provide additional severance protections under the Change in Control Agreements to help ensure that executives can objectively evaluate change in control transactions that may be in the best interest of stockholders despite the potential negative consequences such transactions may have on them personally and to encourage executives to remain employed with the Company during an important time when their prospects for continued employment following the transaction are often uncertain. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Change in Control Severance Policy</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has approved a Company-wide severance policy, outside of a change in control context, that is also applicable to our executive officers. We believe that such severance protections are only appropriate in the event an executive is involuntarily terminated without cause and that these severance benefits are appropriate in light of severance protections available to executives at our peer group companies, and are an important component of each executive&#8217;s overall compensation as they help us to attract and retain our key executives who could have other job alternatives that may appear to them to be more attractive absent these protections. The Compensation Committee amended the severance policy in December 2023 to better align the severance benefit level for our CEO with peer group practices. Despite the establishment of the severance policy, however, the Board of Directors or Compensation Committee retains the right to amend, alter or terminate the severance policy at any time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Compensation Recoupment (&#8220;Clawback Policy&#8221;)</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC and NASDAQ requirements, the Board has adopted an executive compensation recovery policy regarding the adjustment or recovery of certain incentive awards or payments made to current or former executive officers in the event that we are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws. In general, the policy provides that, unless an exception applies, we will seek to recover compensation that is awarded to an executive officer based on the Company&#8217;s attainment of a financial metric during the three-year period prior to the fiscal year in which the restatement occurs, to the extent such compensation exceeds the amount that would have been awarded based on the restated financial results.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedging and Pledging Restrictions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Insider Trading Policy prohibits the pledging of Company securities as collateral and entering into transactions to hedge the value of Company securities owned by executives subject to the policy. Under the policy all directors and employees (including officers), or their designees, are prohibited from purchasing financial instruments (including prepaid variable forward contracts, equity swaps, collars and exchange funds) or otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset, any decrease in the market value of Halozyme&#8217;s equity securities that are either (i) granted to the employee or director by Halozyme as part of the compensation of the employee or director or (ii) held, directly or indirectly, by the employee or director.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Report</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the Compensation Committee of the Board of Directors of Halozyme Therapeutics, Inc., have reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with management. Based on such review and discussion, we have recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COMPENSATION COMMITTEE</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span><br/></span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernadette Connaughton (Chair)</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barbara Duncan</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Connie Matsui</span></div><div style="padding-left:252pt;text-align:justify"><span><br/></span></div><div style="padding-left:252pt;text-align:justify"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_46"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Summary Compensation Table </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning the compensation earned during the fiscal years ended December&#160;31, 2023, 2022 and 2021 by each individual who acted as our principal executive officer, our principal financial officer, and our other most highly compensated executive officers during the fiscal year ended December&#160;31, 2023. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 SUMMARY COMPENSATION TABLE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name and Principal Position</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock <br/>Awards<br/>($)(1)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards<br/>($)(2)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Equity <br/>Incentive Plan <br/>Compensation<br/>($)(4)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All Other <br/>Compensation<br/>($)(5)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">920,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200,011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,800,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">883,476</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,364</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,820,858</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,950,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,300,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557,909</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,289</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,696,978</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">830,221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,060,081</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,740,001</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807,619</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,372</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,453,294</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nicole LaBrosse</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,188</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,800,055</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200,001</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,391</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,784</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,849,419</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President,<br/>Chief Financial Officer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467,836</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200,030</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,012</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,997</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,228</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,683,103</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Snyder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,620,053</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">349,549</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,322</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,612,927</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750,044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,450</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,701</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,740,202</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,200</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440,042</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960,005</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287,130</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,564</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,243,941</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technical Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440,041</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960,002</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,200</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,037</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,123,280</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050,040</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450,010</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,217</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,333</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279,600</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This column represents the grant date fair value of stock awards granted to the NEOs in fiscal years 2023, 2022 and 2021, in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 718. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeiture related to service-based vesting conditions. For additional information on the valuation assumptions used by us in calculating these amounts refer to Note 9 of the Notes to Consolidated Financial Statements, filed as part of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023 filed with the SEC on February&#160;20, 2024. Stock awards granted to executive officers consist of RSUs and PSUs. A portion of the amounts reported in this column for each NEO for 2022 and 2021 reflect the grant-date fair value of PSUs granted to the executives during that fiscal year. In accordance with applicable SEC rules, these amounts were determined based on the probable outcome (determined as of the date of grant of the awards) of the performance-based conditions applicable to the awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these purposes, the grant date fair value for the PSU awards granted to each of the NEOs was determined based on a Monte Carlo simulation pricing model (which probability weights multiple potential outcomes) as of such grant date. The significant assumptions used in the Monte Carlo simulation pricing model were as follows:</span></div><div style="margin-top:6pt;padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.245%"><tr><td style="width:1.0%"/><td style="width:43.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.96%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.27%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the aggregate grant-date fair value of these performance-based awards granted in fiscal 2023 and 2022 included in the &#8220;Stock Awards&#8221; column for those years and the aggregate grant-date fair value of these awards assuming that the highest level of performance conditions was achieved. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.573%"><tr><td style="width:1.0%"/><td style="width:19.434%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2023)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2022)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Name</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Maximum Performance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Maximum Performance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Helen I. Torley</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,875,010</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4,312,515</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,062,529</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3,093,794</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">750,028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,125,043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">500,013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">750,020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Mark Snyder</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">675,049</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,012,574</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">500,013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">750,020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Michael J. LaBarre</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">600,011</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">900,016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">600,008</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">900,012</span></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This column represents the grant date fair value of stock options granted to the NEOs in fiscal years 2023, 2022 and 2021, in accordance with FASB ASC Topic 718. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeiture related to service-based vesting conditions. For additional information on the valuation assumptions used by us in calculating these amounts refer to Note 9 of the Notes to Consolidated Financial Statements, filed as part of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023 filed with the SEC on February&#160;20, 2024. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts reported in the Summary Compensation Table for stock awards and option awards may not represent the amounts that the NEOs will actually realize from the awards. Whether, and to what extent, an NEO realizes value will depend on stock price fluctuations and the NEO&#8217;s continued employment. To see the exact share amounts and the value of awards made to the NEOs in fiscal 2023, see the 2023 Grants of Plan-Based Awards table below. Additional information on all outstanding awards is reflected in the Outstanding Equity Awards at December&#160;31, 2023 table.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Performance-based bonuses are generally paid pursuant to our annual incentive plans and reported as Non-Equity Incentive Plan Compensation. The performance-based bonuses represent amounts earned during each respective fiscal year based on applicable performance levels for such fiscal year, regardless of whether part or all of such amounts were paid in a subsequent fiscal year. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The table below lists the amounts set forth in this column which consist of other compensation including (i) Company contributions to Halozyme Therapeutics, Inc. 401(k) plan, and (ii) Company payments for group term insurance premiums.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.152%"><tr><td style="width:1.0%"/><td style="width:25.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.487%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.322%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">401(k) Plan Company Matching Contributions ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Payout of Accrued Paid Time Off ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Other Compensation ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Total ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">13,800</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">3,564</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">17,364</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">11,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">534</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">11,784</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">15,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">2,322</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">17,322</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">15,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">3,564</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">18,564</span></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Ms. LaBrosse was appointed as Chief Financial Officer on February 2, 2022.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_49"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Grants of Plan-Based Awards </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain summary information with respect to plan-based awards granted during the fiscal year ended December&#160;31, 2023 to our NEOs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:7.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.754%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.546%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.754%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.187%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.546%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.791%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.219%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Future Payouts Under <br/>Non-Equity Incentive Plan Awards(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Future Payouts Under<br/>Equity Incentive Plan Awards (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">All Other Stock Awards: Number of Shares or Units(#) (3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">All Other Option Awards: Number of Securities Underlying Options(#) (4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Exercise or Base Price of Option Awards<br/>($/Sh)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Grant Date Fair Value of Stock and Option Awards($) (5)</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Threshold<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Threshold<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helen I. <br/>Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">828,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,656,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,325,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,875,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,800,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">273,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,050,026&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,307&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750,028&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,200,001&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">273,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">945,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">675,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,080,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">269,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">538,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,053&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">840,031&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,046&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,091&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,011&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">960,005&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For a description of the elements of the annual incentive plan applicable to our NEOs, refer to &#8220;Compensation Discussion and Analysis - Elements of Executive Compensation for 2023&#8221; in this proxy statement. The actual amount of cash paid to each NEO pursuant to the incentive plan established for 2023 is set forth in the Summary Compensation Table under the heading, &#8220;Non-Equity Incentive Plan Compensation.&#8221; </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The PSU awards to our NEOs were granted on February 16, 2023 and vest based on our relative TSR measured against the applicable subset of component companies in the NASDAQ Biotechnology Index over a three-year performance period, subject to the NEO&#8217;s continued employment through the third anniversary of the grant date.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The RSU awards to our NEOs were granted on February 16, 2023 and vest one-fourth on each anniversary of the date of grant.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The option awards to our NEOs were granted on February 16, 2023 and vest one-fourth on the first anniversary of the date of grant and then 1/48 of the shares monthly over the three-year period thereafter.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts represent the grant date fair value of stock awards granted to our NEOs in fiscal year 2023 in accordance with the FASB ASC Topic 718. For information on the assumptions used in the accounting fair value computations, see footnotes (1) through (3) to the Summary Compensation Table above.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_52"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at December&#160;31, 2023 </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the value of all unexercised options and unvested stock awards previously awarded to our NEOs as of December&#160;31, 2023: </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.572%"><tr><td style="width:1.0%"/><td style="width:7.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.300%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.035%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OUTSTANDING EQUITY AWARDS AT </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="18" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Securities <br/>Underlying Unexercised <br/>Options (#) Exercisable</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Securities <br/>Underlying Unexercised <br/>Options (#) Unexercisable (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option <br/>Exercise <br/>Price<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option <br/>Expiration <br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Shares <br/>or Units of Stock <br/>That Have Not Vested (#)(2)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market Value <br/>of Shares <br/>or Units of Stock <br/>That Have Not Vested <br/>($)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: <br/>Number of Unearned Shares, <br/>Units or Other Rights <br/>That Have Not Vested (#)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: <br/>Market or Payout Value of <br/>Unearned Shares, Units or <br/>Other Rights That Have Not Vested <br/>($) (3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/6/2015</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/6/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2016</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,156,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">967,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,329,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">809,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,494,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">839,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/1/2015</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/1/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/1/2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">787,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/3/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/3/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">843,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2016</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/2/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">677,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:29.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Each option grant vests at the rate of one-fourth of the underlying shares on the first anniversary of the date of grant and one-forty-eighth of the shares each month thereafter. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Each RSU grant vests at the rate of one-fourth of the total number of stock units subject to the award on each of the first four anniversaries of the grant date. Reflects the number of outstanding and unvested RSUs subject to the award. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These values are computed by multiplying the closing trading price of our common stock on NASDAQ on December&#160;31, 2023, the last trading date in fiscal year 2023, of $36.96 by the number of shares or stock units, as applicable, set forth in this table.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2021 PSU awards corresponding to the performance periods ending in 2021, 2022 and 2023. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance periods.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2022 PSU awards corresponding to the performance periods ending in 2022 and 2023. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance periods.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2022 PSU awards corresponding to the performance period ending in 2024. Reflects the maximum number of stock units (131.58% of the target number of stock units) corresponding to this portion of the award that are eligible to vest on the third anniversary of the grant date because, had the performance period ended at the end of 2023, the performance level would have exceeded the target level.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2023 PSU awards corresponding to the performance period ending in 2023. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance period.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2023 PSU awards corresponding to the performance periods ending in 2024 and 2025. Reflects the maximum number of stock units (70.45% of the target number of stock units) corresponding to this portion of the award that are eligible to vest on the third anniversary of the grant date because, had the performance period ended at the end of 2023, the performance level would have exceeded the target level.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="height:29.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_55"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Exercises and Stock Awards Vested </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the exercise of stock options and vesting of stock awards by our NEOs during the fiscal year ended December&#160;31, 2023: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:19.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.505%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPTION EXERCISES AND STOCK AWARDS VESTED DURING FISCAL YEAR 2023</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares Acquired <br/>on Exercise<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value Realized <br/>on Exercise<br/>($)(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares Acquired <br/>on Vesting<br/>(#)(2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value Realized <br/>on Vesting<br/>($)(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,694,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,813,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The value realized on exercise is based on the difference between the closing trading price of Halozyme common stock on the date of exercise and the exercise price of each option.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts in this column represent the number of RSU or PSU shares that vested. The actual number of shares issued was the number of shares vested reduced by the number of shares withheld to satisfy applicable tax withholding obligations.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The value realized on vesting is based on the closing trading price of Halozyme common stock NASDAQ on the vest date. </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_58"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Payments Upon Termination or Change in Control </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section describes the benefits that may be provided to our NEOs upon certain terminations of their employment with the Company.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Termination Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our severance policy, if an executive officer&#8217;s employment is terminated by the Company without cause, the executive officer is entitled to receive cash severance equal to one times the executive officer&#8217;s then-current annual base salary (in the case of the CEO, one and one-half times the sum of (a) the CEO&#8217;s then-current base salary plus (b) the CEO&#8217;s target annual cash incentive amount), plus a pro-rated portion of the executive&#8217;s target annual cash incentive for the year of termination. Cash payments under the severance policy will normally be made in a lump sum payment, and will be conditioned upon the receipt of a release of claims from the executive officer. In addition to cash severance payments, the Company will also pay certain costs for the executive to continue healthcare coverage over the applicable severance period, and the executive&#8217;s vested options will remain exercisable for one year following the termination date (or, if earlier, until the expiration date of the option).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSU awards granted to our NEOs since 2021 provide that if the executive&#8217;s employment is terminated by the Company without cause or by the executive for good reason and the executive provides a release of claims, any PSUs credited based on performance during a performance period that has already been completed will fully vest on the executive&#8217;s termination, and PSUs subject to a performance period that has not yet been completed will remain outstanding and eligible to vest based on performance during that period, subject to pro-ration to reflect the executive&#8217;s employment during the performance period. If the executive&#8217;s employment terminates due to the executive&#8217;s death or disability, any PSUs credited based on performance during a performance period that has already been completed will fully vest on the executive&#8217;s termination, and the target number of PSUs for the next performance period scheduled to be completed after the termination date will vest pro-rata based on the executive&#8217;s employment during that performance period. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the benefits that would be provided to each of the NEOs assuming the NEO was terminated by us without cause (prior to a change in control of the Company) on December&#160;31, 2023 and executed a release of claims in a form satisfactory to the Company: </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023 Potential Payments Upon Termination Without Cause Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:17.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.845%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.643%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lump Sum <br/>Severance <br/>Payment ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-<br/>Termination <br/>Healthcare ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Awards ($) (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,208,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,362,991&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,600,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the market value of unvested PSUs that would have accelerated if the NEO was terminated without cause (or resigned for good reason) as described above on December&#160;31, 2023. Values were derived using the closing trading price of our common stock on NASDAQ on December&#160;31, 2023, the last trading date in fiscal year 2023, of $36.96. The number of accelerated PSUs for the 2023 performance period was determined based on our relative TSR through December&#160;31, 2023. We did not include any amount for the PSUs allocated to the 2023-2024, or the 2023-2025 performance periods because the number of PSUs that will vest with respect to those periods is not known as it will depend on our future performance (the maximum value of those PSUs at December&#160;31, 2023 was $850,081 for Dr. Torley, $212,040 for Ms. LaBrosse, $203,613 for Mr. Snyder, and $220,764 for Mr. LaBarre. These amounts were calculated solely for purposes of this disclosure, and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column.</span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the benefits that would be provided to each of the NEOs assuming the NEO&#8217;s employment terminated due to death or disability (prior to a change in control of the Company) on December&#160;31, 2023:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023 Potential Payments Upon Termination Due to Death/Disability Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.502%"><tr><td style="width:1.0%"/><td style="width:28.138%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.820%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Awards ($) (1)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,041,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the spread value of unvested equity awards that would have accelerated if the NEO&#8217;s employment terminated due to death or disability on December&#160;31, 2023. Please see the note to the 2023 Potential Payments Upon Termination Without Cause Prior to Change in Control table above for the calculation of these amounts. The number of accelerated PSUs for the 2023 performance period was determined based on our relative TSR through December&#160;31, 2023, and the number of accelerated PSUs for the 2023-2024 and the 2023-2025 performance periods represents the target number of PSUs allocated to each such period (pro-rated for the executive&#8217;s period of employment). These amounts were calculated solely for purposes of this disclosure, and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into Change in Control Agreements with each of our executive officers. The Change in Control Agreements provide for cash severance, continued healthcare coverage and accelerated vesting of equity awards if the executive is terminated without cause, resigns for good reason, or is terminated due to death or disability (as such terms are defined in the Change in Control Agreements), in each case on or within 12 months following a change in control transaction. The cash severance, to be made in a lump sum payment, will equal: a multiple (two times for the CEO and one-and-one-half times for the other executive officers) of the sum of (i) the executive&#8217;s then-current annual base salary; and (ii) the amount of the executive&#8217;s target annual cash incentive opportunity (based on the target percentage of annual base salary) in respect of the year the termination of employment occurs. The Company will also make a cash lump sum payment intended to provide the executive officer sufficient amounts to pay expected heath care premiums under the Company&#8217;s group health plans for 18 months after termination of employment (24 months in the case of the CEO). In addition, the Change in Control Agreement provides that the executive&#8217;s outstanding and unvested equity awards granted by the Company will be fully vested upon the executive&#8217;s termination (with equity awards that are subject to performance-based vesting to accelerate based on the greater of (x) the target performance level for the applicable portion of the award and (y) the actual performance level achieved for the applicable portion of the award through the executive&#8217;s termination date). However, the PSU awards granted to the NEOs in 2021, 2022 and 2023 provide that if a change in control occurs any performance period then in progress will terminate and the number of PSUs to be credited under the award will be determined based on performance through the change in control. Such credited PSUs will remain subject to time-based vesting through the third anniversary of the grant date, subject to accelerated vesting if the credited PSUs are not assumed by the acquiring company or if within two years after the change in control the executive&#8217;s employment is terminated by the Company without cause, by the executive for good reason, or due to the executive&#8217;s death or disability. An executive officer will not be entitled to severance benefits under our severance policy described above if the executive is entitled to severance benefits under the executive&#8217;s Change in Control Agreement. The Change in Control Agreements also provide that if an executive officer&#8217;s severance benefits would be subject to the parachute payment taxes of Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended, and a reduction in benefits to avoid such taxes would put the executive in a better after-tax position, then the executive&#8217;s benefits will be reduced to the extent necessary to avoid such taxes.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming a change in control took place on December&#160;31, 2023 and each of the NEOs was terminated without cause, resigned for good reason or was terminated due to death or disability in each case on December&#160;31, 2023, the NEOs would have received the following benefits as a result of such terminations:</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023 Potential Payments Upon Change in Control Termination</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:22.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.177%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity <br/>Awards ($) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lump Sum <br/>Cash Severance ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-<br/>Termination <br/>Healthcare ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total ($)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,861,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,496,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,447,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,130,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,917,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the value of the unvested equity awards that would have accelerated if the NEO&#8217;s employment terminated in the circumstances described above on December&#160;31, 2023 in connection with a change in control. Please see the note to the 2023 Potential Payments Upon Termination Without Cause Prior to Change in Control table above for the calculation of these amounts. The number of accelerated PSUs was determined based on our relative TSR through December&#160;31, 2023. These amounts were calculated solely for purposes of this disclosure and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">CEO Pay Ratio </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, Dr. Torley&#8217;s total compensation was $11,820,858, as shown in the Summary Compensation Table above. The total compensation for our median employee (excluding the CEO) in 2023 was $201,360. Therefore, Dr. Torley&#8217;s total compensation for 2023 was 59 times that of the median employee&#8217;s total compensation in 2023. The Company believes the pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records, as well as the methodology described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation elements that were considered in the identification of the median employee were annualized base pay, target cash bonus opportunity and target long-term incentive award grant date fair value for 2023 for all employees, excluding the CEO, as of December 31, 2023. The total number of our employees as of December 31, 2023 (excluding the CEO) was 382. We used this population to determine the median employee. The total compensation for the median employee was calculated according to the requirements of the Summary Compensation Table.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_61"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the relationship between our CEO&#8217;s, and our other Named Executive Officers&#8217;, total compensation paid and our financial performance for the years shown in the table (in this discussion, our CEO is also referred to as our principal executive officer or &#8220;PEO&#8221;, and our Named Executive Officers other than our CEO are referred to as our &#8220;Non-PEO NEOs&#8221;): </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-5" escape="true"><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.582%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Pay-Versus-Performance Table</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based on:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary of Compensation Table for PEO ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid to PEO ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Compensation Actually Paid to Non-PEO NEOs ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Peer Group Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Millions) ($) (5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue (Millions) ($) (6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-6">11,820,858</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-7">3,608,264</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-8">3,568,762</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">160,639</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-10">208.46</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-11">118.87</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-12">281.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-13">829.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">9,696,978</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">22,817,187</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">2,415,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-17">3,154,512</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-18">320.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-19">113.65</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-20">202.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-21">660.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">7,453,294</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-23">5,992,078</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">2,398,657</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-25">591,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-26">226.79</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-27">126.45</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-28">402.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-29">443.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">6,518,876</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">24,374,731</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">1,812,287</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-33">4,356,681</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-34">240.89</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-35">126.42</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-36">129.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-37">268.0</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-38" continuedAt="f-38-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"><ix:nonNumeric contextRef="c-1" name="ecd:PeoName" id="f-39"><ix:nonNumeric contextRef="c-4" name="ecd:PeoName" id="f-40"><ix:nonNumeric contextRef="c-3" name="ecd:PeoName" id="f-41"><ix:nonNumeric contextRef="c-2" name="ecd:PeoName" id="f-42">Helen I Torley</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> was our CEO for each of the four years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#8217;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span></ix:nonNumeric></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"><ix:continuation id="f-38-1">See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2023, 2022 and 2021. The 2020 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar year 2021. The average compensation for the Non-PEO NEOs for 2023 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in calendar year 2023, 2022 and 2021, respectively.</ix:continuation> </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-44" continuedAt="f-44-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-43" continuedAt="f-43-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-44-1" continuedAt="f-44-2"><ix:continuation id="f-43-1" continuedAt="f-43-2"><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div></ix:continuation></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-44-2"><ix:continuation id="f-43-2" continuedAt="f-43-3"><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2023.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"/><td style="width:83.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.663%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2023 ($)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-45">11,820,858</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-46">10,000,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-47">6,462,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-48">8,088,804</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-50">3,803,183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-52">3,608,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-43-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2023 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"/><td style="width:82.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2023 ($)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-53">3,568,762</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-54">2,700,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-55">1,755,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-56">1,806,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-58">657,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-60">160,639</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(4)</span><ix:nonNumeric contextRef="c-1" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-62" continuedAt="f-62-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-61" continuedAt="f-61-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span></ix:nonNumeric></ix:nonNumeric></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-62-1"><ix:continuation id="f-61-1"><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img src="halo-20240304_g8.jpg" alt="CAP vs TSR.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/></div></ix:continuation></ix:continuation><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-63" continuedAt="f-63-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This column shows Halozyme&#8217;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our net income for each of those years.</span></ix:nonNumeric></div><ix:continuation id="f-63-1"><div style="text-align:center"><img src="halo-20240304_g9.jpg" alt="CAP vs Net Income.jpg" style="height:369px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(6)</span><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="f-64" continuedAt="f-64-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">This column shows Halozyme&#8217;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2023 executive compensation program because it is used in </span></ix:nonNumeric></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-64-1"><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">determining each of our NEO&#8217;s annual 2023 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our revenue for each of those years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><img src="halo-20240304_g10.jpg" alt="CAP vs Revenue.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The f<ix:nonNumeric contextRef="c-1" name="ecd:TabularListTableTextBlock" id="f-65" continuedAt="f-65-1" escape="true">ollowing is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2023 with Halozyme performance.</ix:nonNumeric></span></div><ix:continuation id="f-65-1"><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="c-17" name="ecd:MeasureName" id="f-66">Revenue</ix:nonNumeric> (as used in our 2023 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="c-18" name="ecd:MeasureName" id="f-67">Adjusted EBITDA</ix:nonNumeric> (as used in our 2023 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock Price (including <ix:nonNumeric contextRef="c-19" name="ecd:MeasureName" id="f-68">relative TSR</ix:nonNumeric>, as used in our PSUs awarded in 2021, 2022 and 2023 and as described in the Compensation Discussion and Analysis above)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial performance measures listed above, we view our <ix:nonNumeric contextRef="c-20" name="ecd:MeasureName" id="f-69">stock price</ix:nonNumeric>, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_64"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation of Directors </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning the compensation earned during the fiscal year ended December&#160;31, 2023 by each individual who served as a non-employee director at any time during the fiscal year: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.853%"><tr><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.743%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.967%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 DIRECTOR COMPENSATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fees Earned <br/>or Paid in Cash<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options<br/>($)(1)(3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards<br/>($)(1)(3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,462</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458,479</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,017</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,580</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,563</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,145</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Daly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,017</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555,017</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,017</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,017</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,808</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,825</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Represents the grant date fair value of restricted stock unit awards granted in fiscal year 2023 in accordance with FASB ASC Topic 718.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Ms. Duncan was elected to the Board on February 3, 2023 and Mr. Daly resigned from the Board effective December 31, 2023.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The aggregate numbers of shares subject to unvested outstanding stock options, unvested restricted stock unit awards and vested stock units deferred under the Equity Deferral Plan (discussed below), held by the non-employee directors as of December&#160;31, 2023 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.286%"><tr><td style="width:1.0%"/><td style="width:38.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Number of Option Awards Outstanding (#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate&#160;Number&#160;<br/>of&#160;Unvested Stock Awards <br/>Outstanding <br/>(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Number of Vested Deferred Stock Awards Outstanding (#)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Daly</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,253</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr></table></div><div style="padding-left:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation program for our non-employee directors is as follows: </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Annual award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Immediately following each Annual Meeting, each non-employee director then in office automatically receives (i) an annual restricted stock unit grant having a value of approximately $250,000 (with the number of shares of Company common stock subject to the award equal to $250,000 divided by the closing trading price of the Company&#8217;s common stock on NASDAQ on the date of grant, with any fraction rounded up to the nearest whole share) and (ii) an annual stock option grant with a value of approximately $150,000 (with the number of shares of Company common stock subject to the award equal to $150,000 divided by the per-share value of Company stock options determined based on the valuation method and assumptions then generally used by the Company in valuing its options for financial statement purposes). Subject to acceleration in the event of a change of control of the Company, these annual awards will vest in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting following the date of the annual grants. All awards granted after our 2021 annual meeting are granted under our 2021 Stock Plan. Vested options granted to our non-employee directors (including the initial option grants described below) generally remain exercisable for three years following the termination of the director&#8217;s service (subject to earlier termination at the end of the term of the option or in connection with a change in control).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(2) Initial award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - each non-employee director receives an initial restricted stock unit grant and stock option grant upon joining the Board (with the number of shares of Company common stock subject to each award determined in the same manner as for the annual award grants described above); provided that, the grant date value of each award for a director first elected or appointed between Annual Meetings shall be prorated based on the number of full quarters the individual is scheduled to serve as a non-employee director from the date of election or appointment until the next Annual Meeting of the Stockholders such that the recipient will receive a grant of restricted stock units valued at $187,500 and a stock option grant valued at $112,500 for a period of service exceeding three quarters, a grant of restricted stock units valued at $125,000 and a stock option grant valued at $75,000 for a period of service exceeding two-quarters (but no more than three quarters), a grant of restricted stock units valued at $62,500 and a stock option grant valued at $37,500 for a period of service exceeding one quarter (but no more than two quarters), and no award for a period of service of one quarter or less. Subject to acceleration in the event of a change of control of the Company, these initial grants will vest upon the date of the next Annual Meeting following the date of grant. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-employee directors also receive an annual retainer of $50,000 for service on the Board (provided that our Chair of the Board of Directors receives an annual retainer of $125,000), as well as an additional annual retainer for service on any committee of the Board. Non-employee directors who serve on the Audit Committee receive an annual retainer of $15,000, provided that the Chair of that committee receives an annual retainer of $30,000. Non-employee directors who serve on the Compensation Committee receive an annual retainer of $10,000, provided that the Chair of that committee receives an annual retainer of $20,000. Non-employee directors who serve on the Nominating and Corporate Governance Committee receive an annual retainer of $5,000, provided that the Chair of that committee receives an annual retainer of $10,000. Employee directors (including our CEO) do not receive any compensation for service on the Board of Directors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain stock ownership guidelines for our non-employee directors which stipulate that each non-employee director is expected to own shares of Halozyme common stock with value equal to no less than five times the non-employee director&#8217;s base annual retainer for service on the Board of Directors. Each non-employee director is expected to comply with the guidelines within five years of election or appointment to the Board of Directors. Share ownership that counts for purposes of satisfying the applicable guideline level of ownership is the same as under our executive stock ownership guidelines, as described in the CD&amp;A above. The same retention requirements apply to a non-employee director whose level of stock ownership does not satisfy the applicable guideline level of ownership as under our executive stock ownership guidelines, as described in the CD&amp;A above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains the Halozyme Nonqualified Deferred Compensation Plan (the &#8220;Cash Deferral Plan&#8221;) and the Halozyme Therapeutics, Inc. Directors Deferred Equity Compensation Plan (the &#8220;Equity Deferral Plan&#8221;). Under the Cash Deferral Plan, a non-employee director may elect to defer payment of all or a portion of the director&#8217;s annual cash compensation, deferrals are credited with earnings or losses based on investment fund elections made by the director, and the deferred amounts (as adjusted for such earnings or losses) will be paid to the director (in a lump sum or annual installments over up to five years, as elected by the director) when the director no longer serves on the Board of Directors or an earlier distribution date elected by the director in accordance with the plan. Under the Equity Deferral Plan, a non-employee director may elect (1) to convert all or a portion of the director&#8217;s annual cash compensation into Company restricted stock units awarded under our 2021 Stock Plan and/or (2) to defer the payment of the director&#8217;s annual restricted stock unit award from the Company. If a non-employee director elects to convert all or a portion of the director&#8217;s cash retainers into restricted stock units, the director will be credited with additional restricted stock units on the date the retainers would have otherwise been paid to the director equal to (1) the amount being deferred to the Equity Deferral Plan that would have otherwise been paid to the director </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on that date, divided by (2) the average closing price for a share of Company common stock over the period of ten consecutive trading days ending with the last trading day prior to the crediting date. Deferred restricted stock units will be credited with dividend equivalents to preserve the value of the awards if/when the Company were to ever pay a dividend. A non-employee director&#8217;s deferred restricted stock units will be paid in Company common stock (in a lump sum or annual installments over up to five years as elected by the director) when the director no longer serves on the Board of Directors or, if earlier, upon a change in control of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i4984be922b42495ba68692c141a7c99d_67"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our Code of Conduct and Ethics, our executive officers, directors, and principal stockholders, including their immediate family members and affiliates, are prohibited from entering into transactions which create, or would appear to create, a conflict of interest with us. Our Audit Committee is responsible for reviewing and approving related party transactions. Our Audit Committee shall approve only those agreements that, in light of known circumstances, are in, or are not inconsistent with, our best interests, as our Audit Committee determines in the good faith exercise of its discretion. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_70"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, as of February&#160;26, 2024, certain information with respect to the beneficial ownership of our common stock by (i) each stockholder known by Halozyme to be the beneficial owner of more than 5% of our common stock, (ii) each director and director-nominee of Halozyme, (iii) each executive officer named in the Summary Compensation Table above, and (iv) all directors and current executive officers of Halozyme as a group:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"/><td style="width:35.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.076%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beneficial Owner(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares <br/>Beneficially <br/>Owned(2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BlackRock, Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,629,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 Hudson Yards, New York, NY 10001</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vanguard Group Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,259,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 Vanguard Blvd., Malvern, PA 19355</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artisan Partners Limited Partnership</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,689,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 East Wisconsin Avenue, Suite 800, Milwaukee, WI 53202</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mahesh Krishnan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors and current executive officers as a group (12 persons)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7%</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Less than 1%.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Except as otherwise indicated, the persons named in this table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and to the information contained in the footnotes to this table. Unless otherwise noted, the address for each beneficial owner is: c/o Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Under the rules of the SEC, a person is deemed to be the beneficial owner of shares that can be acquired by such person within 60 days upon the exercise of options or warrants and vesting of stock awards.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Calculated on the basis of 127,054,420 shares of common stock outstanding as of February&#160;26, 2024, provided that any additional shares of common stock that a stockholder has the right to acquire within 60 days after February&#160;26, 2024 are deemed to be outstanding for the purpose of calculating that stockholder&#8217;s percentage beneficial ownership. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by BlackRock, Inc. with the SEC on January&#160;23, 2024. BlackRock, Inc. beneficially owned 18,629,818 shares, with sole voting power over 18,441,079 shares and sole dispositive power over </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,629,818 shares and shared voting and dispositive power over 0 shares, which shares are reported by BlackRock, Inc. as a parent holding company of its subsidiaries. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by The Vanguard Group with the SEC on February&#160;13, 2024. The Vanguard Group beneficially owned 13,259,514 shares, with sole voting power over 0 shares, shared voting power over 238,774 shares, sole dispositive power over 12,881,335 shares and shared dispositive power over 378,179 shares, which shares are reported by The Vanguard Group as in its own capacity and on behalf of its subsidiaries.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by Artisan Partners Limited Partnership (and affiliated companies pursuant to a joint filing agreement) with the SEC on February&#160;12, 2024. Artisan beneficially owned 6,689,058 shares, with shared voting power over 5,896,607 shares and shared dispositive power over 6,689,058 shares and sole voting and dispositive power over 0 shares.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 1,723,296 shares subject to options that may be exercised within 60 days after February&#160;26, 2024.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 150,727 shares subject to options that may be exercised within 60 days after February&#160;26, 2024.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 280,833 shares subject to options that may be exercised within 60 days after February&#160;26, 2024.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 62,793 shares subject to options that may be exercised within 60 days after February&#160;26, 2024.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corrected Section 16(a) Reports  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based solely on Halozyme&#8217;s review of the Section 16(a) reports that have been filed by or on behalf of its officers, directors and persons who own more than 10% of a registered class of Halozyme&#8217;s equity securities, and on written representations from the reporting persons, we believe that all such persons complied on a timely basis with all Section 16(a) filing requirements during the fiscal year ended December 31, 2023, except that one Form 4 was subsequently amended to correct a clerical error and report an exercise of 2,984 options to purchase common stock for Dr. LaBarre.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_73"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder proposals, including nominations for candidates for membership on our Board of Directors, may be included in our proxy materials for an Annual Meeting so long as they are provided to us on a timely basis and satisfy the other conditions set forth in applicable SEC rules. For a stockholder proposal to be included in our proxy materials for the 2025 Annual Meeting, the proposal must be received at our principal executive offices, addressed to the Secretary, not later than November&#160;15, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder business that is not intended for inclusion in our proxy materials may be brought before the 2025 Annual Meeting so long as we receive notice of the proposal as specified by our Bylaws, addressed to the Secretary at our principal executive offices, not later than November&#160;15, 2024, in accordance with the specific procedural requirements in our Bylaws. If the Secretary fails to receive notice of the proposal within such timeframe, any such proposal will be considered untimely. Failure to comply with our Bylaw procedures and deadlines may preclude presentation of the proposal at our 2025 Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to satisfying the requirements of our Bylaws, including the earlier notice deadlines set forth above and therein,to comply with universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must also provide notice that sets forth the information required by Rule 14a-19 of the Securities Exchange Act of 1934, as amended, no later than February 24, 2025.</span></div><div id="i4984be922b42495ba68692c141a7c99d_76"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSACTION OF OTHER BUSINESS </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the date of this Proxy Statement, the Board of Directors knows of no other business that will be conducted at the 2024 Annual Meeting other than as described in this Proxy Statement. If any other matter or matters are properly brought before the meeting, or any adjournment or postponement of the meeting, it is the intention of the persons named in the accompanying form of proxy to vote the proxy on such matters in accordance with their best judgment.</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_79"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may satisfy SEC&#8217;s rules regarding delivery of proxy statements and annual reports by delivering a Notice of Internet Availability of Proxy Materials to an address shared by two or more stockholders. This process is known as &#8220;householding.&#8221; This delivery method can result in meaningful cost savings for us. In order to take advantage of this opportunity, we have delivered only one Notice of Internet Availability of Proxy Materials to multiple stockholders who share an address, unless contrary instructions were received prior to the mailing date. Accordingly, for many stockholders who hold their shares through a bank, brokerage firm or other holder of record (i.e., in &#8220;street name&#8221;) and share a single address, only one Notice of Internet Availability of Proxy Materials is being delivered to that address unless contrary instructions from any stockholder at that address were received. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We undertake to deliver promptly upon written or oral request a separate copy of Notice of the Internet Availability of Proxy Materials, proxy statement and/or annual report, as requested, to a stockholder at a shared address to which a single copy of these documents was delivered. If you hold stock as a record stockholder and prefer to receive separate copies of a proxy statement or annual report either now or in the future, please contact our Secretary at 12390 El Camino Real, San Diego, California 92130, or by telephone at (858) 794-8889. If your stock is held by a brokerage firm or bank and you prefer to receive separate copies of a proxy statement or annual report either now or in the future, please contact your brokerage or bank. The voting instruction sent to a street-name stockholder should provide information on how to request (1) householding of future company materials or (2) separate materials if only one set of documents is being sent to a household. If it does not, a stockholder who would like to make one of these requests should contact us as indicated above.</span></div><div style="margin-top:12pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-top:12pt;padding-left:306pt;text-indent:-45pt"><img src="halo-20240304_g3.jpg" alt="Mark's signature.jpg" style="height:105px;margin-bottom:5pt;vertical-align:text-bottom;width:278px"/></div><div style="margin-top:5.25pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark Snyder</span></div><div style="margin-top:3pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Vice President, General Counsel, </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Corporate Secretary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March [     ], 2024 </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i4984be922b42495ba68692c141a7c99d_82"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="halo-20240304_g11.jpg" alt="Proxy Card 1.jpg" style="height:897px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20240304_g12.jpg" alt="Proxy Card 2.jpg" style="height:892px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>halo-20240304.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:2c49a24f-38bb-4b75-9a02-fb955a20a1d6,g:977df6d5-91dc-4499-a149-85a9f92c0e51-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:halo="http://www.halozyme.com/20240304" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.halozyme.com/20240304">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2022q4" schemaLocation="https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2022q4" schemaLocation="https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20240304_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20240304_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20240304_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" abstract="true" name="EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockReportedValueMember" abstract="true" name="EquityAwardsOptionsAndStockReportedValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" abstract="true" name="EquityAwardsOptionsAndStockOutstandingUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" abstract="true" name="EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockVestedMember" abstract="true" name="EquityAwardsOptionsAndStockVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" abstract="true" name="EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>halo-20240304_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:2c49a24f-38bb-4b75-9a02-fb955a20a1d6,g:977df6d5-91dc-4499-a149-85a9f92c0e51-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember_6ff233ac-4a05-46db-ae12-f1f7bf2f3343" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockReportedValueMember_6ff233ac-4a05-46db-ae12-f1f7bf2f3343" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_85bd512b-4645-4742-8b2d-082b05ca2b83" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_85bd512b-4645-4742-8b2d-082b05ca2b83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_feef9cfc-7820-43ed-8189-38a5e7cdaff1" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_feef9cfc-7820-43ed-8189-38a5e7cdaff1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember_929c7c5c-2457-418a-ae3e-cfd6f62d6111" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockVestedMember_929c7c5c-2457-418a-ae3e-cfd6f62d6111" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_87723527-f4f7-4584-b6a8-6fdf9f2b906c" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_87723527-f4f7-4584-b6a8-6fdf9f2b906c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_3708e759-fe68-4d0b-b671-db851eff72f8" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_3708e759-fe68-4d0b-b671-db851eff72f8" xlink:type="arc" order="6"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>halo-20240304_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:2c49a24f-38bb-4b75-9a02-fb955a20a1d6,g:977df6d5-91dc-4499-a149-85a9f92c0e51-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_halo_EquityAwardsOptionsAndStockVestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockReportedValueMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Reported Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Outstanding, Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>halo-20240304_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:2c49a24f-38bb-4b75-9a02-fb955a20a1d6,g:977df6d5-91dc-4499-a149-85a9f92c0e51-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:href="halo-20240304.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>halo-20240304_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X2!417AI9@  34T *@    @ ! $2  ,
M   !  $   $R  (    4   (2H=I  0    !   (7NH<  <   @,    /@
M$'X<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 #(P,38Z,#,Z
M,#,@,#DZ,S(Z,#0   :0 P "    %   $$:0!  "    %   $#*2D0 "
M S P  "2D@ "     S P  "D(  "    (0  $%KJ'  '   'A@  "*P
M'.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                ,C Q-CHP,SHP
M,R P.3HS,3HR-  R,#$V.C S.C S(# Y.C,Q.C(T #%!,$(U-#1$,3DX,30S
M,T-!0C0R,D0Q1C@Q-S=$1#4X       & 0,  P    $ !@   1H !0    $
M !#, 1L !0    $  !#4 2@  P    $  @   @$ !     $  !#< @( !
M  $   ]P               !          '_V/_; $, " 8&!P8%" <'!PD)
M" H,% T,"PL,&1(3#Q0=&A\>'1H<'" D+B<@(BPC'!PH-RDL,#$T-#0?)SD]
M.#(\+C,T,O_; $,!"0D)# L,& T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_  !$( &L!  ,!(0 "
M$0$#$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  "
M 0,# @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1
M\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W
MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ?
M 0 # 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$
M!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0T
MX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _
M /?Z* "B@ J&>Y@M(C+<2QPQCJSL% _$T 16FHV5\";2[AGV]?+D#8_*K= !
M10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 !Z5XIXNU>XU37[
ME))&\F"1HHD[  XS]3B@#'L[RXL+N.YMI&CEC.58&O=M+OAJ&E6MYC;YT2N5
M]"1TH GN+JWM(O-N9XX8Q_%(P4?K7-7?Q!T*V)"2S7!'_/*/^IQ0!2'Q.TO=
M@V=X%]0%S_.M?3_&NAZBZQI=^3(W19QL_7I^M &^K!AD$$'H13J "B@ HH *
M* "B@ HH ** "B@ HH ** "B@!*:TJ)]YU'U- #L@C(((KRCQAX3OK?5)[ZT
M@>>VG8R'RUR48\D$#MGO0!BZ3X9U35[E8XK:2.,GYYI%*JH_'K]*[W7/%=IX
M8L8M*T\+/=0QB, GY8P!C+>I]J /-M0U2]U6X,U[</,YZ9/ ^@Z"K^@>%[_7
MI,PKY5L#AIW' ]AZF@#T?2_ FBZ>JM+!]KF'5YN1_P!\]*V_['TW;M_L^UQZ
M>2O^% %F&"*WB$4,:QQKT51@#\*DH ** "B@ HH ** "B@ HH ** "B@ HH
M*J:CJ-II5C->WTRPV\2[F=C_ )R?:@#Q+Q1\6-4U*5[?1BUC:9P)!_K7]\_P
M_AS[UY_<7=S=3-+<W$LLC'+/(Y8G\30!UG@/QI>^']9MX)KEWTV9PDL3L2J9
M_B'IC]:^BQR,T <SXS\1_P!A:8(X&'VRXR(_]D=VKQUV9W+NQ9F.22<DF@#J
M/"'A2379_M-R"EA&W)Z&0^@_J:]<M[>*V@2&"-8XT&U548 % $M% !10 44
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MRZ1:W,BC"SK,J@^Y&>?TK-U3PMKVJ&#4+R6.:]\U?W$;!8X8^2<9ZG./_KT
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MX'T'^R-'$\RXNKK#OZJO8?Y]:ZG% "T4 %% !10 44 %% !10 44 %% !10
M44 %% !10 44 %% %>2TCDO8;IMV^%'11GCYL9/U^7]37/:G9_V]XHM;-QFS
MT]1//Z-(?NJ?P&?H: .H I: "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH
M ** "B@ HH 0U7M+1+7SBO+32&1V/<G_  &!^% %FB@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCTO2-)M4Q+(TW_HN*&+SIIIO]3#%#++7&E?^6A)5_P Z_;G_ ()C?&+]AO\
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MRE_X+.?M$7O[.G_!/WXVZ[HMX]AXJ\;Z;;_"SPM<V\IM[F"XUZ;['=2PR_\
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M._X?5_L??] KXS?^$3I__P LJ /UVK^7S]K;_E,Q\*_^RR_"?_T;X;K]#?\
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M /@ES^Q1X]T:YTZ/X0P>"+]X/*M?$?@+6K[0M5TX_P#/2*$RR6LA_P"NT,E
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MTYO.L))._E2GS;6;J?)O)L?/BONKJ@ ZM\H[4 E2JC)4YYQTH _B _X)\?\
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MQ_X+?_%$_"[_ ()K_M WMM(%U3QC8Z;\.=-B,OD/<?VSJEG97@7'I9-J$O\
MVQH _P Y#5KVYU'4-0O;J4SW=]J$]Y=3R')FDE8_O*_2K_@D3^RU)^U9^W+\
M'O!U[I_V[P5X-U;_ (6A\0\V_P!IM8M-T&6&\6WN!_SRNK[^SK ^VH&OS);[
MTCG^_P _C7]O?_!M5^RI_P *_P#V>?'G[4&OV?EZ[\=M<_X1WP9+/"#);:#X
M?FEMYIH6Z@W>HM>"4=QI5M0!_30D4=K;Q1(N%AB6,<X"C;UK\*_^"F'_  4O
M/PN?6?V?/@'J\,OQ"FADLO'?C^PF#Q^!>#_Q*]/Y(.I$$^;+TM1_TUS]F^TO
M^"CW[3FH?LQ?LYZYK_A2Y2#X@^,+V/P9X(GDS/\ V9<7D<TEU?"/_IUMH;B6
M,']WYJVX/!K^,B[N[G49;N]O;JYOM4U":2ZN[JYF\^>62;_7233?\]: &7-Q
M=ZC+<WU[=W%[?WTTEU/<7$OVBXEDF_UTDTW_ #UK^H#_ ((V_LGCX>?#:]_:
M(\6Z<(_&'Q+M?L'@J.YB_P!(TGP]%)_Q\1GJ/[0DC6;IS#;VA'WS7X8?L2?L
MS:I^U)\?O"7P[\BY7PE93CQ#\1M3@7R_[/TFTDA^U0^8/]7)=_N[6+'_ "TN
MC+_RRK^W;2='T_0=.TS2M+M;>PTS2K..PL[*TC%O;6T,,8ACCCC P$C7 P/3
M@4 ;BJH'&>OXM2Y=<\+C/ )Z4'AP <_+P!7DWQ@^,'@/X&^!=<^(7Q$URST/
MPYH5JUU=75TX\R5\?NK>WBSNEGE(VQQ1C<Q- 'Q=_P %4/C9I_PC_9.\=Z0;
MJ)?$WQ4M)/AQX=T]G&Z\&HQ,NI2<G.R*R^V'/0RM%'UD%?BY_P $E/V3;OXP
M?&>S^-WB[2Y!\,OA#J<=]I4UQ WV?Q/XBC_>6$<>.0+0F&ZF/:6*V3HYKW"T
M^#?QW_X*V_&^U^+OCRWUGX5?LO\ A:232_!1O&VZG=V!D7SX])@,9BGN+N2(
M?:K[_51>4(OWWV?RZ_H0^&7PU\%?![P5H'P]^'VBPZ#X3\-V*Z?I6G6B?(J#
M;YCR2=7EEE\V6264F22261B2220#U)0%554855P!Z5^>/_!5O_DP7X^?]RO_
M .IEX<K]#QT'TK\\/^"K7_)@OQ\_[E?_ -3+PY0!^9/_  2L_8G_ &9OVD/V
M>?&'CCXS?#7_ (3+Q5I?QBU#PC8ZK_PFGB+PW]GT^+0?#EY%;^397MO%D2ZA
M=_O3$)/WU?IQ_P .I_V!_P#H@G_F4/&7_P MZ^=?^"'7_)J/Q _[.&UC_P!1
MOPC7[,4 ?GC_ ,.I_P!@?_H@G_F4/&7_ ,MZ_#OXM?"'X>_ C_@JW\&?AK\*
MO#I\*>"]'^-WPPN;#1_[8O\ 6O*DO-0T&\NC]JO999GS)-*<>97]:5?R^?M;
M?\IF/A7_ -EE^$__ *-\-T >V?\ !=SQ7J4=G^SEX'AFE31[V[\0>+M0MS)^
MYN[BS_L>SM)?^V,5YJ'_ (&5^Q7[)?PYT/X4_LV_!/P-H-M;V]GI/PYTNZO'
MM^5O;^]M8]0U"Z_[;75U=2_]M:_+3_@N-\)]2\0?##X/_%_3;>2:U^'?B?4/
M#'B,6\/,%OKT=G-:74W_ $RBN=)$7_774HJ^\/\ @GK\?M"^/_[+WPVU2QO(
MV\4>!]"L_AWX]L/. N[34-(M8;/[5+W\N\CBBNXCCI.8^L4E 'W11110!_*[
M_P %,_ &B>!O^"CWPUU31($@E^)5OX/^(&MVT$8BA6\_MZ\TF60_]=1HL,O_
M %UFDK]]OVY_^3.OVEO^R-ZY_P"D,E?SA?MT_'/0_CK_ ,%#?"VI>&+NWU3P
MU\.O%'AOX4Z/J]O,)X=2_LW6OMFH2Q8XDC^VZAJ$44HXEBABD&17]'O[<_\
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MK_!/XJ^'OC?\*/ 'Q:\*N/[$\=^&;?7H+;S?-FTR>4;;RQF_Z;6EQ'-:R_\
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M_CVN8C)Q>#RO]=*89H_,DBB_JTIA&[Y& 93ZB@#\$/!__!=3P)-HB?\ "=_
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MXGPU^SM^S]X,O8]2\'_ SX.^$M2BD\Z+4?#7PPT70KV.2/\ Y:>=;VT;?RH
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M/MY+.WU[4KN41B:.%^0D5K#9VP'I:COT^NZ** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>halo-20240304_g10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g10.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,W,0  DI(  @    ,W,0  ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
M                                               R,#(T.C R.C(S
M(#$V.C,R.C$S #(P,C0Z,#(Z,C,@,38Z,S(Z,3,   !' &4 = !A ', 90!W
M "  60!E ', 90!G &$ =    /_A!")H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O #P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(CX\<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G
M+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W
M-3$X,F8Q8B(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT
M<R\Q+C$O(B\^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F
M-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX;7 ]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E1&%T
M93XR,#(T+3 R+3(S5#$V.C,R.C$S+C<Q,3PO>&UP.D-R96%T941A=&4^/"]R
M9&8Z1&5S8W)I<'1I;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U
M:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN
M<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD8SIC
M<F5A=&]R/CQR9&8Z4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y'971A<V5W(%EE
M<V5G870\+W)D9CIL:3X\+W)D9CI397$^#0H)"0D\+V1C.F-R96%T;W(^/"]R
M9&8Z1&5S8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0])W<G/S[_
MVP!#  <%!08%! <&!08(!P<("A$+"@D)"A4/$ P1&!4:&1@5&!<;'B<A&QTE
M'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_VP!# 0<(" H)"A0+"Q0J'!@<*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BK_P  1" &E P4# 2(  A$! Q$!_\0 'P   04! 0$! 0$           $"
M P0%!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A
M!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9
MFJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?H
MZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+
M_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1
MH;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G
MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W
M^/GZ_]H # ,!  (1 Q$ /P#Z1HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ****  D*I+' '))[51@UO2KJY^SVVIV<T^<>5'<(S?D#FN4^*^H7%K
MX:M[2V=HQ>W BD93_!@DC\3C\O>MRS\%Z!8QVGD:9");1E>.<+B0L.Y8<GGL
M>*!]#3O=3L--"'4;VWM!(2$,\JINQUQD\U-+/##;M/-*D<*KN:1V 4#U)Z8K
MS7Q/8-XT\7ZI:1,6AT;3V$>T9!G;G']/^ U<MM7_ +9^"EU*YS+!:-;R_50
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MNBD!SAE//'RGO0%F=/1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
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MPABC88V< 9.".IYP<57\'^";G2+;4O[>FAN;B^C6W+PL3B(+MQD@?Y KM**
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD-R7'1B3(<]#ZYKZ J,/B%63TM8SPF+6)3TM8****Z3M"BBB@ HHHH ****
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MP?Q%3]6G:VG]==B5@JJ5KI_T]=M_ZN2Z7/;WFCVUE<3H]P]DAFB\S$F"@!)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %1_9X?M/VCRD\_9L\W:-VW.=
MN>N,\XJ2B@ HHI"P526( '4F@!:*X/QQXWGTN>*RT.:$R,F^2==K[><!1U&>
M._M6;H?Q/E@MI$UV)[J08,4D*JI/J&Z#\0*Y7BJ49\C9PRQ]"-3V;?SZ'IU%
M>;O\1]8U%BFA:)N/3)#2G\EQBD^R_$+6O];.;&-NGSK%C_OGYJ/K,7\";^0O
MKT)?PXN7HCT6>Y@M8]]S-'"G]Z1@H_,UA7OCKP]99#:@LS#^&!2^?Q''ZUSD
M'PNGN)/-UC6&D<]1&I8G_@3'^E;EE\._#UI@O;273#O/(3^@P/THYJ\MHI>H
M>TQ<_A@H^KO^1CW?Q5M]VS3-,FF8\*97"_H,YJM_;WCS6?\ D'Z<;1&Z,(=O
M'^])_2O0+33;*P7;96D%N/\ IE&%_E5FCV-67QS^[0/J]>?\2H_EH>;?\(/X
MHU?G6M9V(W5#*TF/^ \+^M:5E\+=)AP;RYN;IO0$(I_ <_K7;T4UA:2U:OZE
M1P-!.[5WYZF19>%=#T_'V;3+<,.C.N]A^+9-:P 50%  '0#M2T5O&,8Z)'7&
M$8*T58****HH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M",)CC[H]J8O@C0HO$-MK%O916\MNFU(88D2+.2=Y4+]X9X.>PJW_ ,)3X?\
M^@[IO_@9'_C1_P )3X?_ .@[IO\ X&1_XU'-B//L5RX7RWOTW,B7X<Z--X9&
MB2279MQ<FY63>OF*YZX.W&,>U:B^&+"/7;'58C*DMC:_9(8U8; G/48SGGUI
M_P#PE/A__H.Z;_X&1_XT?\)3X?\ ^@[IO_@9'_C3<L0][]?QW!0PL=5;I^&Q
MJT57L]0L]1A,NGW<%U&K;2\$@< ]<9!Z\BK%<S33LSK335T%%%%(84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!Y?XKN+;2O$&KZUHFOV*7OEK'?:9>H#YVU0 J@\G( Z?G4WB
M'Q79/X9L;*&TL[;5M9L$C(FVQQVL+#JS'HHY*C\?KV5_X6TK4M<MM5O+9))[
M=64*T:%9,@#+97)(QQSQ5F\T+2-0F$U_I5E=2A0H>:W1V '09(Z5Z2Q-*T.9
M-V_I+S7_  QY+PE>\^5I)_KN_)_\.<-<:QH?@[P;I]AIEQ8ZIJ#Q/;V\X="@
M+,2[,YX5-S="?ZFM'PE<Z!X-\(VUO+K=K<F:XVR2V\GFJ9F'W1MS@  <GZ\9
MKHV\,:"\:1MHFG,B9V*;2/"YZX&.*DCT#1XH!#%I-BD0D$HC6V0*''1L8ZCU
MZU$J].4.5WU=WMJ:0PU6$U)6T5EOI_5CR'Q)=*^J>+/L-_;V-L9E2ZL;EQYM
MVR-R8\KD#/IGUJ;6--37M=G:PA:W>+PW#=VD9;+1%6C8+GUVY%>M7&AZ3=W7
MVF[TNRGG_P">LMNC-^9&:G6RM4O#=K;0K<F/RS.(QO*9SMW=<>U;+'QBERK5
M?\#[]CG>6RDWS2T;_P _NWZ>IXAXBOIO%VBZAXEN$*PVL5O90*1@>82&E(_'
M]"*]VJE_8NEBQ-E_9MG]D9MYM_(7RRWKMQC/O5VN;$8B-6*C%62O;TT_R.O"
MX65"4IS=W*U_77_,****XSO"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ^9/%W_ ".NM?\ 7_-_Z&:QZV/%W_(ZZU_U
M_P W_H9K'K[VE_#CZ(_-*W\67JPHHHK0R"BBB@ HHHH ]N^"O_(GWG_7^W_H
MM*]%KSKX*_\ (GWG_7^W_HM*]%KXK'?[S/U/T'+?]TI^@4445QG>%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5S_BGQEIWA!;5M3BN9!=%@GD(K8VXSG+#^\*Z"O*/CC_J=%_WIOY)
M77@Z4:U>,)[/_(XL?6G0PTJD-U;\T:O_  NCPY_SZZE_WZ3_ .+H_P"%T>'/
M^?74O^_2?_%UX=17T7]E8;S^\^5_MK%]U]Q[C_PNCPY_SZZE_P!^D_\ BZ/^
M%T>'/^?74O\ OTG_ ,77AU%']E8;S^\/[:Q?=?<>X_\ "Z/#G_/KJ7_?I/\
MXNC_ (71X<_Y]=2_[])_\77AU%']E8;S^\/[:Q?=?<>X_P#"Z/#G_/KJ7_?I
M/_BZT-#^)^B:_K5OIEE;WR3W!8(TL:!1A2W)#$]!Z5\_5U7PS_Y*-I7^])_Z
M+:L:V68>%*4E>Z3ZF^'S?%5*T(2M9M+;S/HFBBBOF#[ **** "BBB@ HHHH
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M_P!%I7HM?%8[_>9^I^@Y;_NE/T"BBBN,[PHHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?,GB[_D==:_Z_YO\ T,UCUL>+O^1UUK_K
M_F_]#-8]?>TOX<?1'YI6_BR]6%%%%:&04444 %%%% 'MWP5_Y$^\_P"O]O\
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MO;B[MY3<"..WBCV'<55E)..OO^=8SQ.+Y9I7UVTVLKOIUT0KL[&-]\:OC&X
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M^?\ !_Y!_9.-_D_%?YGEE?37@_\ Y$G1?^O&'_T 5YQ_PI&X_P"@TG_@-_\
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M (#?_9T?\*1N/^@TG_@-_P#9U]+_ &EA/Y_P?^1\C_9.-_D_%?YGEE%>I_\
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M/^?N/_O@U^2_4,Q[/_P)?YGU_+(Q/[7U'_G_ +G_ +^M_C1_:^H_\_\ <_\
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M^'_"N6<'"3C):G7"<:D5*+NF+!!';6Z0P+LC085<YP*DJ+?<?\\8_P#OX?\
M"C?<?\\8_P#OX?\ "H225D62T5%ON/\ GC'_ -_#_A1ON/\ GC'_ -_#_A3
MEHJ+?<?\\8_^_A_PHWW'_/&/_OX?\* ):*BW7'_/*/\ [^'_  HW3_\ /./_
M +^'_P")H EHIB&4M\Z(!ZAR?Z4^@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YE
M\8?\CMK7_7]-_P"AFL:O>-3^$FAZIJMU?SWFH++<RM*ZI(FT%CDXRG2JO_"E
M?#__ #_:E_W\C_\ B*^JIYIAXP2;>W8^,JY/BI5)226K[GB-%>W?\*5\/_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ***Y.^U:\\3:9JFD:9IFK:9=_9W\JZO+?R8V
M((&%?)Y.>/;-:4Z;F_(RJ5537GT7<Z&TU.SO[F[M[27S)+.3RIQM(V-C.,D8
M/'I5NO+?!MCI]AKG]CWNFZCH>LS63Q.R7!>.Y&/FD!YPPP2,<"J6A69T+XF:
M4+S2KC0A/&Z!6NC="\<J1EG!P.6'0=<=.M=LL'&\E&6RNMM?Q_*_F>?''3Y8
MN4=W9[Z>MUY];>1Z_17$?%+4+JVT.QL[/S@;^\2&00OM9TP<H#VSQ7':@UE8
M>#O%&D1:'-HU[&EJ\T+WGVA6'FKA@W0'YN<?TJ:.#=6"E?=_JE??S[%U\>J,
MY0MLK]=[-VV:Z=6OF>T45X]9ZW=:%X2U7PJC.U^;A(-/!/S-'.,C'T&3QW85
MT/PJLAIL?B"P5MPM=2>$-Z[>,_I14P;IPE-O;;S6FOXA2QZJU(TU'??R>NGX
M'H%%%%<!Z04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>halo-20240304_g11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g11.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,T-0  DI(  @    ,T-0  ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
M                                               R,#(T.C S.C Q
M(# X.C4Q.C4S #(P,C0Z,#,Z,#$@,#@Z-3$Z-3,   !' &4 = !A ', 90!W
M "  60!E ', 90!G &$ =    /_A!")H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O #P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(CX\<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G
M+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W
M-3$X,F8Q8B(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT
M<R\Q+C$O(B\^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F
M-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX;7 ]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E1&%T
M93XR,#(T+3 S+3 Q5# X.C4Q.C4S+C0T-SPO>&UP.D-R96%T941A=&4^/"]R
M9&8Z1&5S8W)I<'1I;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U
M:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN
M<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD8SIC
M<F5A=&]R/CQR9&8Z4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y'971A<V5W(%EE
M<V5G870\+W)D9CIL:3X\+W)D9CI397$^#0H)"0D\+V1C.F-R96%T;W(^/"]R
M9&8Z1&5S8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0])W<G/S[_
MVP!#  <%!08%! <&!08(!P<("A$+"@D)"A4/$ P1&!4:&1@5&!<;'B<A&QTE
M'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_VP!# 0<(" H)"A0+"Q0J'!@<*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BK_P  1" .) K(# 2(  A$! Q$!_\0 'P   04! 0$! 0$           $"
M P0%!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A
M!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9
MFJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?H
MZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+
M_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1
MH;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G
MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W
M^/GZ_]H # ,!  (1 Q$ /P#Z1HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH XWX@:?9:K>^$K+5+."]M9=:;S(+B)9$?%C=D95
M@0<$ _44S_A7O@O_ *%#0?\ P60__$U<\8_\AOP?_P!AJ3_T@NZUJ .=_P"%
M>^"_^A0T'_P60_\ Q-'_  KWP7_T*&@_^"R'_P")KHJ* .=_X5[X+_Z%#0?_
M  60_P#Q-'_"O?!?_0H:#_X+(?\ XFNBHH YW_A7O@O_ *%#0?\ P60__$T?
M\*]\%_\ 0H:#_P""R'_XFNBHH YW_A7O@O\ Z%#0?_!9#_\ $T?\*]\%_P#0
MH:#_ ."R'_XFMUKF)+R.U9\32QO(BX/*J5#'/3@NOYU+0!SO_"O?!?\ T*&@
M_P#@LA_^)H_X5[X+_P"A0T'_ ,%D/_Q-=%10!SO_  KWP7_T*&@_^"R'_P")
MH_X5[X+_ .A0T'_P60__ !-;LUS%!+!'*^U[B0QQ#!.Y@K-CV^56//I4M '.
M_P#"O?!?_0H:#_X+(?\ XFC_ (5[X+_Z%#0?_!9#_P#$UT5% '._\*]\%_\
M0H:#_P""R'_XFC_A7O@O_H4-!_\ !9#_ /$UT5175S%96<UU<OLA@C:21L$[
M549)P.>@H PO^%>^"_\ H4-!_P#!9#_\31_PKWP7_P!"AH/_ (+(?_B:Z*B@
M#G?^%>^"_P#H4-!_\%D/_P 31_PKWP7_ -"AH/\ X+(?_B:Z*B@#G?\ A7O@
MO_H4-!_\%D/_ ,31_P *]\%_]"AH/_@LA_\ B:Z*HK6YBO;.&ZMGWPSQK)&V
M"-RL,@X//0T 87_"O?!?_0H:#_X+(?\ XFC_ (5[X+_Z%#0?_!9#_P#$UNK<
MQ/>26JOF:*-)'7!X5BP4YZ<E&_*AKF)+R.U9\32QO(BX/*J5#'/3@NOYT 87
M_"O?!?\ T*&@_P#@LA_^)H_X5[X+_P"A0T'_ ,%D/_Q-=%10!SO_  KWP7_T
M*&@_^"R'_P")H_X5[X+_ .A0T'_P60__ !-=%10!SO\ PKWP7_T*&@_^"R'_
M .)H_P"%>^"_^A0T'_P60_\ Q-=%10!SO_"O?!?_ $*&@_\ @LA_^)H_X5[X
M+_Z%#0?_  60_P#Q-=%10!S7A+1M,T/XB>(+;1=.M-.@;2M.D:*T@6)2QEO
M6(4 9P ,^PKN*Y/1O^2G:]_V!]._]'7M=90 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '+>,?^
M0WX/_P"PU)_Z07=:U9/C'_D-^#_^PU)_Z07=:U !1110 4444 %%%% &5<?\
MC?I__7A=?^C+>M6LJX_Y&_3_ /KPNO\ T9;UJT %%%% &5J__(4T+_K_ &_]
M)IZU:RM7_P"0IH7_ %_M_P"DT]:M !1110 5E>*/^10UC_KPG_\ 1;5JUE>*
M/^10UC_KPG_]%M0!JT444 %%%% !65X7_P"10T?_ *\(/_1:UJUE>%_^10T?
M_KP@_P#1:T %O_R-^H?]>%K_ .C+BBX_Y&_3_P#KPNO_ $9;T6__ "-^H?\
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M%>"PMI+F58M<E+%44L0 ;0#.!W(KN*XKXA?\DQ\4?]@>[_\ 1+UVM !1110
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,GP=_R&_&'_8:C_\
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M[M+9%E;+<Y<#)S]:C^+%G:^$_AC%)X7TZTT@ZC-#;7UU8VJQ/Y)!)RR@'!(
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M\ZB*[E7L98ERJG'N#GL>M $OQ6U#6],\"7-SX9:X6_7=L-O'O?\ U3D<8/\
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M "BBB@ HHHH R?!W_(;\8?\ 8:C_ /2"TKJ:Y;P=_P AOQA_V&H__2"TKJ:
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M=K0 4444 %%%% !1110 4444 %<9X,_Y EY_V&M4_P#2^>NSKC/!G_($O/\
ML-:I_P"E\] '0445F>))[^V\-W\FC(SZAY)6V 3=B0\*2,'@$@G@\"@:U9IT
M5Y-/XJ^($>7?1[^*)4NHY'AL?. E.[RMHVB1E4*IW>7ABY!.0 =?Q#XGUE;B
M&?28M>%F+='"VVC.9)LEUD+"2(E&7";5P,ELD,N:-A'H5%<!I5SXJCA@EFU*
M_P!0MS8O=S&XTP12B1&.(%7RD.6R <KDA,@#=QBZ?J/Q#_X2JQTW6KRZ%OYB
MK+<6NG&..3Y8S]_[/*O4OG)C&1PPQ32N["NK7/6:*YKQ8NL&ZTW^QK_4+2,-
M*UT+.WBDWHL;, =\;X8L% QC.3U.,<;IVL?$"?7=,L]9^UV418+<26UJS))A
M8^?,^R.HR3)E3Y8[!^,E+5V&]%<]7HKR<^(/B%%I5](FGZA-=37*S01_9$;[
M-;#YSC*)DD,D>P[W!#D;NE/U'4?B!$T5P9[J&VU"^<1QP6QDDMH 7V[MMG(8
MR1L^^KYP?F6G;^OZ_K<'H>JT5YQ+<>,=2N7AMK_5=.6"\6W+I81?O%:<@MF2
M$@JL*AMRX7<_4XQ5K^T==CL]:F%[K4D2:A%:PLVE@RPPA4\R:-!"#(2Q?!PZ
M]"!@&DM5?^NG^8=;'>T5PVAZQK,6OW']M7&I/IT-J@S<Z>(0)"5 SMC^=R2>
M8W*CH54@$[_B^]N]/\(ZC/IGVK[:(2+<VEL9Y!(>%(0*V1GKD$8H8+5V-JBO
M-GU?QK:ZE?Q%;V?3XHMT%T;$&0@%(F)14&YL[Y0 .0  ,<5VF@SS-IL$=W/>
MW,S(9!+>6@AD*;CC>%4*&QCC /\ LBGYB-6BBBD,**** "BBB@ HHHH ****
M "BBB@ HHHH R?!W_(;\8?\ 8:C_ /2"TKJ:Y;P=_P AOQA_V&H__2"TKJ:
M"BBB@ HHHH S]8UJVT."WFO5D\F>YCM_,4#$;.<*6R1@9P.,\D5SL/Q,TNX6
M&:'3M3:TD$!DNO+C$<'G'$(?+[OFRI^4$ ,-V*VO$T&EW^DKI6NVK75GJ<JV
MK1*2,DY()(((^[U!S7&7^O?#6VNGU/5FELGTQ4\U62X$0$4GEQ[U3,<C!@"H
M.Y@"#@5*:OJ^OZ:_,3WLNWZER^^*^FV%G]IU70-3LU^W-IZ_:IK*,&559F&]
MKC8H 7J6&20!FK?B;XBZ'X4ETN/4K.=FU*$SQ>4]OA5!0$?-(-[?.,+'O)YP
M#47B*W\'Q>$8=>N(+Z>P:[2^@FTJ>X68RSD1^8IB=7Y$G('8G SQ65>Z[\-/
M$[:$FL7EY'<W:&RLX+F6\MY9%<1LT4H!&X,#&<R$JV1@G-5&]TGOI?[MOO\
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MR!]T5HP:EH%GX/UNSTGPW>16=A*MJ^F&181(K/C=&N_Y%)9CD[2<5#YG@_Q
M;SQ)=:/J,<UFT5]\UPR&Y!VB)PB2[&!,*X5\8*Y(&<T=?+_/7^D--;O?]2W#
MKWP]N([/P+#J"M]K3_1K423AW Q(&$W7=GD-NSD'G(-5+JU^&VD0G3+A;B-H
M96E*HUX\T3K\IE+KEUQL)\S(&!NSWK'TWQ3X;TN]N)=%\)ZI:3Z=.;)8H;T1
MH\I)=XI%$NQF4R2$$[TZX89Q4,OB+PMJNMZBMQX?UW4+FZN [CS8H7E'[N.-
M8C'(BO"RR'.Y^0#N![.Z;5^NK^]6_P P7;M^&EW^1V]OK/A"WL['PS:R2R13
M;8;>W2&XE) =P,N 3C="^68X^7).",Y%OJ_PX\(^())89)[;4/WEIN:&[E^5
M3N=$R"OEH4R=ORI_LAN5:\\%^%8K/Q5'IU\AU.#[3#*)7DP&^8H$:3"D":1]
MJC& Y'2L5M8\#64VIZEJNC:N]];N\L\%W*KLAN$F9HT19?+P4#9 Z@KDDCAV
MES>>M^]]%;\?Q0TER_=^6K^_;\SH-0\0^ KV^^UZA=7B3W<)ADA:.\A\U%Z^
M9"  =H;)9E^56#9 (-32:5X+M-.L' U)X&EDM[-+>>]E8@\/&JH2WD_)]W'E
M@*#C&#6#XCB\,>'[.UEE\/>)$O7LWD22UG%U<V_FE8MA$DKB21BZH!B0<+GA
M1BXVO>'YM%T^QB\-^(/(TUHK>U6-Q9S)+Y(?R3^^C<$1<L&PA&1DGBILN5V_
MX&[O_7=_?*O?3^OZ3^XI&_\ A/?VO]E WERELTL<ELL=^[DEE)60 ;GR[*5#
MYRQ&WFM6ZN?!$=CIVOW-MJ%JM[^^@G@:X68'<J!=L3;\L7 V@'.<$5RVDZGX
M&:V:70?"6NO!J#0QM<R7C@^4)=D;QDSM(N&B(0*%(V#[H(-=-/JOA:V^'NFZ
MNV@ZE+:Z?($M;!)5>ZC9'#XQYN'(,0;&XG Z'D4V[*[W3U_7^OO'9.?+T-'Q
M5J?A'5=)THZ\EW<6&I*QMYK=)UPI3YMYCPZH5;!W#;_>Q6-8Z]\,;:2&"VN[
MG%O=.D<4HO72U=3'D;7!$4>6CQG:G(Q51O&OA+4/#*P6_AG59[:WMI(K*W=T
M3SX<2!RK>;PN('R6PW' .:9+;>#]!U)K$^$[^X6YL8)]T=^TVY6RYCQ+*,*B
MVBGKC";0.S#5I23V_JU_N_JPUKO_ %T?YHV-*B\!-I=S<65O>6.G6#)I[AWN
M8(I P5TS%N&X?O1AG7//!Q@E-*\<>"=%O]3N%U2Z<:@%U*?4)[5O)*LAVIN5
M %PD? 8 GU9MV#5#X5T70[W2(O#^IZK87EJFH7B13^8=A 6/+33*V3Y84!<X
MV\XK FUOP);:/J7F^"=>BMK:?RI4\DJ)F1IG<Q-YNU_+9IBVULC'&0!@>C=N
MWZJ_X@M5I_7;\ U_6/A[?^!_$4OAJ>2>[O=&O+B"7;<M&,V\_P JLXV)QYQ\
MOC^([>]>H5Y%K7B+0-7\%:W;6_AW7ENUT:^F2^G:6ZABVP7$2&2<NWS,A? ;
MUYY KUVJ=K:$P=]0HHHI%A1110!SOQ"_Y)CXH_[ ]W_Z)>NUKBOB%_R3'Q1_
MV![O_P!$O7:T %%%% !1110 4444 %%%% !7&>#/^0)>?]AK5/\ TOGKLZ\S
M\-W7B>.RU!=+TC2;FU&M:GY<MQJLL+M_IT^<HMNX'.1]X\<\=* .YHKG?MOC
M3_H :#_X/)O_ )$H^V^-/^@!H/\ X/)O_D2@#HJ*YW[;XT_Z &@_^#R;_P"1
M*/MOC3_H :#_ .#R;_Y$H Z*BN=^V^-/^@!H/_@\F_\ D2C[;XT_Z &@_P#@
M\F_^1* .BHKG?MOC3_H :#_X/)O_ )$H^V^-/^@!H/\ X/)O_D2@#HJ*YW[;
MXT_Z &@_^#R;_P"1*/MOC3_H :#_ .#R;_Y$H Z*BN=^V^-/^@!H/_@\F_\
MD2C[;XT_Z &@_P#@\F_^1* .BHKG?MOC3_H :#_X/)O_ )$H^V^-/^@!H/\
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M DVZ3:R@DR@="P..:TII]!TSQ7:Z@UGJ"00RW$"7(:)K9)]G[QL%O-+;8RO
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MZ>"T#(Y)8Y3Y#ND+ G&[<67.2:-+\>^$+B:.PTO480Q6X=8DMW10(6Q*3\H
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M:2"-W4HS*"588(..E<YX9U=YYM0TNZ&H+?17=TRO<6<PC$?G-LVRLNQAM*X
M8\?2GU8E\'S7ZE>ST?6+;PU:Z?#)-;2#5)#+)$8U<VYF=MW QDJ5)(&>?6JE
MW;^,V;1!#/,B(I%VR)$[%A(N"^748V9Z9ZGC.*LV#:Y:^%[6"WW1W;ZI+#++
M) [XB\^3]YM8D@%0".<#(QQ@56N]>\5HVB+!91J+A3]J=[:4@N)%7;A%;9E<
MMDX'O@&C[7S_ $_+]12W?]=7_7H=P>AXS[>M<EX0TFXL-<UF[_LR:PM;UHY
MMT(/,WC(*KY)(\L#;C=SG=ZYKK:YCP?<:TUQJ<&O:;-:R";SA,\BNLA?)VK@
MGA0%';ISR:2W&]CJ**** "BBB@ HHHH **** "BBB@#C-.N]4MO$/BO^RM,C
MO]VL)OWW0AV?Z!:8ZJ<]ZZG3I+N73H7U*%8+HK^]C1MR@^Q]*Q_#7_(P>+_^
MPQ'_ .D%I714 8NH7^OQ7C1:?HL,\ 9<3O>!2PXW?)MZ]1UK:HHH XZ?3;B'
MQ4M\?#MC(3*&^TI/(6 +A=^S;MWX.?P/-7_B%_R3'Q1_V![O_P!$O715SOQ"
M_P"28^*/^P/=_P#HEZ.E@ZW-;QI;Z1?^'3IVOWDME;WT\4$4\)VR),7!C*M@
M[6W 8)&*Y=;+P'+?>7#XG2S@MRD=QIC7444<YLSPS*Z[\)L&2A"G;SD"NH\8
MV>AWNB+'XFU&/3[-90PFDN$A ?!Q\S< \DCOD9K@KOP7\.=0NA"_C-=T?F*U
MNNI6K'>(F5S\RE@P5R6P1G@L#@4H7YOG_E;[M?P]0DOZ^^_Z?B;#^&/!OQ L
M)+?3-=6^2WU.34'-N;:Y E<,IRDD;HR<G!*GD9!XJ+Q7X?\ !'B2YLTUCQ+'
M%+HEO);R-'):XA7Y"QD+1D0N-JX*^61D[<5=23POX5UR^U&W\41V0FNE?4;:
M1T=)W*.%1>,A_NG"Y.$ (YS6/K>B>%'CO-3T_P <PVEY>7FRTE\R">*WN1(K
M[4A0+O<, 2"2>?FR*2T2Y?+[]%^7WZ$WO>_G]UV_S_4[#P_=^%[O7M2N] UR
MRU&\N8H3<QV]Y',41%(5L*<C(;J<YXKA+7P!\,&U*<V?BB%KK5#+;LD6IV^^
M;<?WL:X&<G/('//K6_H>B^$_A^T,-_XGMH[^UM93.;NZAA+"9H]TA3@J"T2@
M<X&2.>,98\#^ /#=Y=C5?%02XO4@GD%]?6T3F-)$*-PBD@F-06.2WKGFBVJ_
MKY EI\]/\R3_ (1/P)?Z-<2V7B>XBT_3;J3-T+])$MY9&AE($LJMN^9$/);E
MF!]!T^F^-?#,%A902^+;:^FG$822YEB6=_,&Z,NB*NS(Z95:P["V\&IX=U!8
M?&7[I+U99;Z:ZMT>VEB B4<H$ Q"0-RG."<GK67IW@3P'J0DO]+\73:G%IUF
M()#:7EM/Y,(5002D9;D(>">,MMVDU3;VZ*WY:_U^95M+=?U/2K?7M(N[&*\M
M-5L9[69BD<\5RC([ $D!@<$@*21['TJ-/$V@RO,L>MZ<[6^?."W<9,>%+_-S
MQ\H+<]@37$1Z;X13X>PZ-IVO6D.ES:F+5[A[6*(O*K_-%B)8E5SM*[BIR.N[
M(-.N?!?A36+/[?:^);Q[.\FDMK>:PGADCC$Q</$C"-AAFD;EB2"0 PZ4=;+^
MMO\ /^M$YOW_ *U?Z+[_ )V[-O%'A]+&2]?7--6TBF,$EP;N,1I(.J%LX##T
MZU&GC'PP]P;=/$>DM,&93&+Z(L"HRPQNSD#D^E<IJC^$CH-GI</BN/35TV^\
MUF!C-P"\CQ9VLO ,DF Y0KCG_:J&W\)^#--\/B[TG7;@Z9IA,4WV!X[D,RS-
M(BL%C9BR/(<*N"> P:IN[-_UYCULN_Z]ON.[M-=TB_E,5CJEE<R+)Y12&X1R
M'V[MN >NWG'IS58^+_#:N$;Q#I08S&W"F]CSYHZI][[P].M<+X7C\#^&-4M)
M$\4VEM':VC6EK8ZHPM+I-TA8EUD*,<%BJY0$!FY;=2ZQX2\%ZI8P:'J/CAUA
MLK@016AO;,&)F*LD.#'G=\@VD_O,9&X@FF[]/ZU_K[_O(O?F_K0[FQ\7^'=4
MU"&QTO6["^N9XS+'':W"RDH.K?*3@>YZTB>,O##W26R>(]):=YC D0OHBS2C
M&4 W9+#(XZ\US6G6_@S1]<BU&T\50L84D@CLEO('0R)$B2$*J[RX2),J#@8^
MZ,UC6'A7X=V]S?ZO_P )C'<>:Z03RS7]J!$P=) C,$!W_N@/G)8@')SR'N]-
MOZM_7_# KV][?^K_ '?UW.^C\7^');6]NDUS3_LMA((KJY-PHBB<]%+D[<\X
MQGKQ3(_&WA>;4(;*#Q!ILMQ,65$CN4;+*5!7(. V74;3R<\"L8>%?#WAS1_(
MU37)$MKB\M9(I+ZXAC&Z$H88E.U01B-1@Y8COGFL;3? ?@Q[][+1]>>#4 \D
MBQ0"UCN %F4[B/)W2!9(1AWW9P<LP--;Z[?\! MM3LG\;>%8K];&3Q-HZ7;,
M%6W:_B$A)Z +NSDYXJR?$6DKKRZ*UZBZBR,ZVY!!8*%+8.,' =3^/L<>>Z9I
MO@"R66SDU^\@99)(C/J@^S"9V$<3;))(U60YM\90GDMZC'2I=>$)?$MOKL/B
MBR-Q=),L*)?PF.X7:BOM'4[?*4D@\$'/'%3T37]:?Y_@'4VK#Q7H&IK+_9^L
M6=P\, N)8DF4R11E0P9T^\HP0>0*J67C[PEJ%M/<6OB/33%;(LDS/<JGEHP!
M5FW$8!W#GIDXZUS.A7'P\TN>V.G>*;:9S!-;1AKN,^8A5 [\ 94"W'S_ '>O
M/3%!O#_PZU+1H8+CQ9#+&%E\N2ZN+4^8$,:L^QX]CJOV4<E2I 8\\$/KY6_'
M7]!ZWT[O_@'H\VNZ1;W%I!<:K9137HS:QO<(K3CU0$Y;\,U1F\<>%H+1KE_$
M6F-$L<DF8[M'++&,R%54DMMQR #BL/5?"VA:AIEEJDNK,-!L-/"LEDD7E7$2
M,L@.44_*"@.(PN>W'%9-KX,\+:AJ,%O_ &WK/VV_LY6,,\"V\TL.P0_O%,"L
MH5<!0=N>20W)HUNUZ_K^BN*+VO\ UM_7W;WT[1/&GA>2T>Z3Q)I!MXW$;RB^
MBVJQ&0I.[@D#..M6HO$&C3V=U=PZO826UFQ2YF2Y0I PZAVSA2/>O)=2\&^&
MO+F-EX[N;6ZO[R33KNZO[6*1I!$DGG1?*D84[6;,C9P ,'I6I'X7^&EOH5SI
MUIK^@^;<D26UW*;)IK<OPK(ZJK,3T#.68^II;K3^MOZ_K4;:T?\ 7]/3^K+O
ME\8>&W9$AUW3YY)(UE2."Y21V1F"APJDDKD@9QBG0>*_#]S;7US!K-B]MI[;
M+NX$Z^5"WHSYVC'?GCO7G[^%_ -IJ::G=^,6N)5NGA*M=VSE[EV!=<)'N#$X
M)C4A1UVCK6E;>'O!5WH=SX>'BF'4$U.=(XU>ZM9'#6X4+$B;-K[ BY5E8G^+
M.:->G]?TOO\ (.NNW]?\'T\SL(?%/A^XO?L<&NZ;+=;5?R$O(V?:P!4[0<X(
M((/?-,'B[PZ[$1:W82[7V.8KA7$9\MI/G()"#8K-EL# KAKWPWX#L_-TRZU2
MZMI66=BD$0A93''!O*".(!2!%&0% SN; /0367@[X?S3WW]F:Y9[GNFDD6UF
MM \$AW)M+JF\X:8861FP2HZ<%Z/;MH%SLX_%_AJ56,7B'2G"PFX8K>QG$0ZN
M?F^[R.>E63KNDBV@N#JED(+E0\$IN$VRJ6505.<$9=1QW8#N*\WU7P%X:T>Y
MN;77=5UJ^_MB62Z2W@T\W+-*%57F=8H6!.6Z$+'AL%35O5-*^'VL:'9Z%<^)
M;>VBTA_)62WN+>U_>.&PAVHL8<,N_:H!#(I(]5T_KY_U_P ,GL]?/_@?K_6_
M>6FOZ/?O.FGZK9W;VZ"29+>X61HU(R"0I) (Y'K5&V\<^%+RWMY[?Q)I3)<J
MSPYO(P7"C+8!.?E'4=N^*P/#6B^!] O]2DT76K!GN?\ 194$MJ6B;(4IYBJ)
M"<D#:[, 2  .!68_A7P"=2CU-_%L9BL)K<20O?VS0AUB6.,-E<H65?X2I;)Z
MC !UT\OZ_(3>_P _T_X)N_$/7=(E^'_BK3HM5LGOFT2]86JW"&4@0/D[,YX^
ME=!7ENO>$?!MIX7\52:#J"WVI:3X>NXY]RP7#KNBFP6E,9=7SOR%=?<<BO4J
MKH"O>S,V77K2&9XGAU LC%24TVX921Z$(01[CBF?\)%9?\\-2_\ !7<__&ZU
M:*0S/MM:M;NX6&**^5VS@RV$\:\#/+,@ _$UH444 <[\0O\ DF/BC_L#W?\
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M?CD66))$(*NH8$'.0:S=$U.;4["YGEC0/%=W$"JG&1'*R+U/4A1FM-0%4*H
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M HHHH **** "BJ]Y?V>G0B74+N"UC9MH>>0(I/7&3WX/Y52_X2C0/^@YIO\
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M"VEJXE9@NYS'-%(JDE 1M (R1FL2^^$*M]G&E>(KRU"!8)OM%O%,6M1_RP3
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MK0HHH YWXA?\DQ\4?]@>[_\ 1+UVM<5\0O\ DF/BC_L#W?\ Z)>NUH ****
M"BBB@ HHHH **** "N,\&?\ ($O/^PUJG_I?/79UQG@S_D"7G_8:U3_TOGH
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MA?\ ),?%'_8'N_\ T2]=%7._$+_DF/BC_L#W?_HEZ .UHHHH **** "BBB@
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M]I?:\_\ "/:AC9]K\['^HZ[>/KWQS0!U]W>_9;JQA\O?]KG,.=V-F(G?/O\
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MZX61/^6'95.??UZT:7K=K9?V-YMIK9^P::UI+M\/:ARY\GD?N.G[MNN.HXH
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M)KDH.Z&9XF/%H>"R$CVQTZ5<_MGQI_T+F@_^#V;_ .1*K>!_^1?N?^PQJ?\
MZ7SUT5 &-_;/C3_H7-!_\'LW_P B4?VSXT_Z%S0?_![-_P#(E;-% &-_;/C3
M_H7-!_\ ![-_\B4?VSXT_P"A<T'_ ,'LW_R)6S10!C?VSXT_Z%S0?_![-_\
M(E']L^-/^A<T'_P>S?\ R)6S10!C?VSXT_Z%S0?_  >S?_(E']L^-/\ H7-!
M_P#![-_\B5LT4 8W]L^-/^A<T'_P>S?_ ")1_;/C3_H7-!_\'LW_ ,B5LT4
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M-_;/C3_H7-!_\'LW_P B4?VSXT_Z%S0?_![-_P#(E;-% &-_;/C3_H7-!_\
M![-_\B4?VSXT_P"A<T'_ ,'LW_R)6S10!C?VSXT_Z%S0?_![-_\ (E']L^-/
M^A<T'_P>S?\ R)6S10!RGB-O&GB#PKJNC?V'H-O_ &C936GG?VW,_E^8A3=M
M^R#.,YQD59^V^-/^@!H/_@\F_P#D2NBHH YW[;XT_P"@!H/_ (/)O_D2C[;X
MT_Z &@_^#R;_ .1*Z*B@#G?MOC3_ * &@_\ @\F_^1*/MOC3_H :#_X/)O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNS;I($5F3)/)&%.,]L5GBXU'5+#6IC-+'+J,UK)"N\_NP\K!0/PQ1_7]?UT
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M4\4E_D/K8]&HK@)=7U6;XE:8MS:WUO9YDBAB*@+(-G,AYYY/X #U-'A>=_\
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MN+-4L[6))[=)LW%QA96;JB2 ;,CU)P:W?$&KG1=$:ZMK=9KF5TC@AS_K)&(
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M-OG^SQ3-//*S@^>&#$YP,<DYXP!BGH'4H6_B7518ZU<W=C:.NF*5!MYF*R2
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M*?\ "86FAV\'F"17\Z?/",%W;!ZG&"?3(JMH/BI]7\1WED8K:**)I AW,)9
MC;=V"N".O0G%6#X.T&/7;74H[<0W43LZA6P)6QU(/)QUXQ4MCHEG!KIO/[2N
M+NXB#K%#-,'\@.<L!QNZ^I.*%T^8/;[C<HHHH **** "BBB@#G?B%_R3'Q1_
MV![O_P!$O7:UQ7Q"_P"28^*/^P/=_P#HEZ[6@ HHHH **** "BBB@#EO&/\
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M_:S2%H9K%I4G=6.0&&&B.>=P/((-=OXL\12^'[&%K.V%W<S.=L)./D52SM^
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MD:=3(I-M.T90XYY!X/&><U*Z_P!=!OH;&AVGAU=:6WTW6Y[J:S5UM[1K@,D
M/#;..<=.2<5T9TNVFTZ.ROT&H1H!DW:K(7([GC&?PKG_  _::O9IIMC=Z+;1
MQZ=$R&[:1'+G&!Y6#E=W?(%;LHU&\TN,V[KIEVP#,)8Q/L]5X8 _4&J8(J>(
M[72CI<4FIW1T^.UD5H+B)PC1-C V\'MQC!K)CTS0;O3-/-KK=R3)?&:&[256
MDEG*G(.5(SC/&!TK1\0Z??3-I5[9Q+>S:?/YKP;A'YH*E21G@$9R,G\:S+RR
MUB>/3KT:)%'+#J9N9+6VDC5]FTC<S%@K.<\X-);_ #_R_KY ]OZ\_P"OF6M7
MT+1(5M[WQ1>RWD<*F!#>LNW+MG.%4?-QCZ#\:S-0T/P[I8BTNZ\0W=FDT0B>
MW:=2)8]QVAOE^4<X!XX%3^)-(UCQ8]E!]B2QM8XY))1>,L@\PC8HPC=0"6!Z
M=/I65>Z)XBN+>%I-,F%\;1+=I8;F(QR%21B9&)#+_$,#/.*$!L>(K+0%OEMK
M_7)M.^U0I%):I*-LL8X7.0=OIGBM+Q+'HL&F6G]K7K:>D$B_9;B-]KQL <8.
M#VSU!K#\3:)JUSJ!ELK"1YI+9(A-;S((G8=5FCDX91U&!6QXBLM0E&B3VEG]
MKDLKI99HXG1. C XW$#J:.GS_4/\OT+OARWT^'2M^E7C7T4\C2O<O(':1CU)
M(P/PP*UJP_"^GW5E#?SWT(MGO;Q[@6X8-Y0( P2.,\9./6MRFQ!1112&%%%%
M !1110 4444 %%%% !1110!SO@?_ )%^Y_[#&I_^E\]=%7.^!_\ D7[G_L,:
MG_Z7SUT5 !1110 4444 %%%% !1110 4444 %%%% !1110!E3PZ>_BJUFDN2
M-0CMI%C@##E"1EB,9Z@=ZP+2PT&+4=7\GQ->&:02/>)]J5=G8MD*#\O3KQTK
M3?0S%X\@U6UM56)[:1;F8,,LY*[<C.>@^E95M9:N=?OKVX\.($2*2.RB\^)8
MBI.3N R=SD=2,#]:73Y,?7YHT-(T^UGT>5]!U>2YDN+I9)[QG&YBI7*D  #Y
M1C&!UHL_#/ARP\3M)8!8+_[,<P1R8VJQP7QU![9S4.@K?:%I5Y/=6,H^TWX:
M*%Y%:;#E5)8C@X.3ZX%4M(\-Z]8^,KO4+UK:=+JU=9)XV*EF+?*HR200 !G&
M,#UI_P"7Z;"Z?UWW"&P\,W-I?3-X@ENWA6(-=R3*7M@C$QX.W!.?7)-:^F6=
MK;Z+8S:1J;-8PRO<SSEP?/!#%MV!C[QSVQBN6B\+:R-(FMH;:[M[:%K=TMI;
MI'D9T;+^6X. ,=,XY["NHT%[_2='T^UU&WDDFN+ATP75FB0[F4N1]XX !/OU
MI_U_7]>H%>Q/AB\\,WVE6VJ+<VFV26YE,HW*'8L6)P!U]NU4#9>'/^$?>8^(
MYQ'-=;I;OS%#2/MQM*[<<+SC;QUJ[_8FHS^%-:\^W3^U=2:4E)65AMSB-<@X
MX4#'H36$OAK6(](,L=C=?:%O6DA)FB,X1HMA+YRK<\=<@<U/?T0_\V=G;Z7$
MD5DEE<?\2J*T:+R@^5E4@;3^0/.>]9?ARQT"VM;^33M5-XBQ""65Y%/DQ*#M
M48 X )Y.<^M6-/M[FPT.P\/2QEIFT]U>=6RL;  8/?JW7VK&T+PO=RVMW'K.
MGA(Q8P6J0R.K"5X\G=P<8R1C-.77^N_]?,4=E_7;^OD7-3T[0&\':9!<:S<6
MVF0E#!,DB@S$#Y<Y4Y]>E=!IELD4,=Q%J5Q>PO JHTLBLK#D[^ .3GK["N<N
M-/UJT\!Z7I]CI:SW\<:Q2L7CW6XQABI8XW8X&/6MG2[/=HT>DW6E/;V:VJQE
M9)E?/4%#M/7 !ST.:;W?J);(Q+_3O#<GAJ-)-<G@T\7KRB6.5?GEW$E?NG(!
MS@8[5/K%MHLVGV$.H^([E(9XC&K&X7%VA()W<8]/F '7K5+^Q]9T[PB+#3M(
M22Y:\F*D/%FWB9C\R;CC)4X'IGFI=:TB_F\+6.EZ?HLBXA"#_28RT+*1A9,\
M,AQDX)Z=*2_R_(?7[_S-"3PQX:M_$UA=!$M]0W/)%&K_ .N..20>3CKQBDTN
MWT?_ (2J4Q:S-?7]N)%2VEF#_9PS N!QD\X')..E9Q\.:^/']EK$SVL\(9PS
MKD>3'MP%P3]<8'4G-3^'M'U*P\432BWN+:T<S-<>?<K*DKL^5,8&"..N0/3F
MFNGS$]ON.QHHHI#"BBB@ HHHH YWXA?\DQ\4?]@>[_\ 1+UVM<5\0O\ DF/B
MC_L#W?\ Z)>NUH **** "BBB@ HHHH Y;QC_ ,AOP?\ ]AJ3_P!(+NM:LGQC
M_P AOP?_ -AJ3_T@NZUJ "L[71?#299-,O$M)H5,A=X1(& !.W&1CZUHUGZU
M?P:?IDDEW;7-Q"X*.EM$9&"D')('08[TI;#CN<O'X@UBRT30K^]N/MIU*X0O
M'!:@,J-&3L !.3D=>*K7'BW5YM/$EJSP22:Q):*/LGF2+&%R!Y>1EOQK6LM1
MT"[L=&$=C=PP1W"QZ?YT;I\VPX8$GYEVYY.15;4)O"_V9_-LKR7_ (FLB[+8
MR^8;K;\Q7:V>GIQ[53W?]=OZ^9*V_KS_ *^1I?VM>Z;X*N=3O3)=7,*.X$UM
M]G)P< %,G ]\]*JRZKK&B:9>7FI7UCJ 6R^T1Q(GER*WT!.4Y^]UK1T]],C\
M-SR26]U;6&',R:EYA;;CG(D).,5DZ++X4A6]$%E-:#[+OE^WQR?/;^J[R?D]
MA^5)]1KH21:KK.G:E:VNI7=O>K?6DLR-%!Y9A=%#8ZG<O/4UR]A\1-8NUTFW
M/EBZDN@MV?+&/*9DV$>F=WZ5T>@MX9CNI5L[.\MYGMF,8O5E!>#OY>\_=]AB
MJ5M=^!O)TZ[M[20&\FCMX,%]P:(@+D;NQ*\]^^::^+^N[_X873^NW],?I'B3
M6[SQ#Y0D^TVPO9H9HOL3*L$2D@/YW0G@<57M/'MU=IKK)-;GR[:2YT\)@E51
MBN''J>&P>QK:T[6M ,TVCVUO=P1W5S-$SO&XCEE).]5DSU//0BJSGP?<V]]
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M;1M,N8FCN--M)8VD,K*\"L"YZM@CK[]:K?\ "':E_P!#QX@_[\V'_P BT?\
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M)6=?HQ&14T=O##)(\44:/*VZ1E4 N<8R3W.!BLW_ (0[4O\ H>/$'_?FP_\
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M+0!3\#_\B_<_]AC4_P#TOGKHJYKP%"UOX9F@DGDN&CU;4T::4*'D(OIQN;:
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M7_"PO!?_ $-^@_\ @SA_^*H_X6%X+_Z&_0?_  9P_P#Q5=K10!Q7_"PO!?\
MT-^@_P#@SA_^*H_X6%X+_P"AOT'_ ,&</_Q5=K10!Q7_  L+P7_T-^@_^#.'
M_P"*H_X6%X+_ .AOT'_P9P__ !5=K10!Q7_"PO!?_0WZ#_X,X?\ XJC_ (6%
MX+_Z&_0?_!G#_P#%5VM% '%?\+"\%_\ 0WZ#_P"#.'_XJC_A87@O_H;]!_\
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MP7$+B2*6+385>-@<AE(7(((R"*EU#P5X5U>_DOM5\-:/?7<N/,N+FPBDD?
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MG^'_ (9O=0O+2.Y>76&VS29#  '[+)D!8Q@L5X(X%.TS4=!T308?$\/P_P!
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MK32-4O%AUZ03265I/(9T6Q$<<R^6"<,RJ<] Q.3P:]J_X2.V_P">%S_WP/\
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M6M65X=_Y!"_[[5JT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME1,Y*+M5,# (&!P,5G?\*B^-'_10O_*U>?\ Q%?1%% 'SO\ \*B^-'_10O\
MRM7G_P 11_PJ+XT?]%"_\K5Y_P#$5]$44 >!_"$^+=(^-NM>%_%WB*[U9['2
MC(RO?2SP[F:!@RB3'(5\9P.IKWRO&?#7_)WGB_\ [ \?_H%I7LU &)XF.(;
M_P#3U_[2DHT'QW%K&JP6"V:Q^<#L*722.FT9_>1CE.F.>_%)XG!,%B!U^U''
M_?J2ET#2?$]I=Z>VI7MO-#'&WVB13\\N5X1AM^8@X(?(XR".]"W!['74444
M%%%% &5X=_Y!"_[[5JUE>'?^00O^^U:M !1110 4444 %%%% !1110 4444
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M0WF@W3R+<_+_ ,LT,:JN#S\K'@=^M"U=@>BN>CT444 %%%% &5X=_P"00O\
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M"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M65X=_P"00O\ OM6K0 45SGB+Q<OAV],5Q8N\ T^XO#<&554F+;^[ ZY.X<\
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=%C;YV;*J6*CDG^\WYU>HI60K*]PHHHIC"BBB@ HHHH **** "BBB@ HHHH
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ME]XRU;Q%J6DW&D175G;VD5M=21M*3&TC,Q\MF 'S@#G/!KL***H76YE>(O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOJ!OGA!N&@^SER3S'G.W'3K6);?#[PS:&-H--97B8-'(;F5G4AD(PQ;.!Y:
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M)V[:T8O!=C#IE_IZ7=Y]FO[-;29"R=!$(@X.S(;8H']WVH7F*-^9<VW7\/\
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MK.8;-@8D-\GRG"M@-@G'&:GM_&.AW7EB*[D#2L$1)+:5'+&01XVLH(^8CJ.
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M \ICAP -F[8N0V!6]J6FZ+I?C?1'N9W$D,MQ<IE))&+RX4*=B;54D?+N8$L
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M,!^]"1L.7!D' V\,.<]5J6FZ?XZTNXTZ[6\M([&\,3J/+R65 01]\8PX(/#
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MVK5KG/'FDWFM>$IK;38Q-<QSP7"1%@OF>7*DA4$\ D*0,\9I/_+[NHT5]/\
M%6L#7K+3/$GAU-+-_P"8MM+#?K<AF1=Q# *I7C.#ST[5U=</#+K/B;QAHMY<
M^&K_ $6VTMII))+Z6 ^87C*!5$<C'/.3G XKN*9"O=A6)XG\0OH%O9K:V1O[
MV_N1:VMOYHC5W*LWS.0=HPIYP:VZY;QOI^H7 T74=+LGOY-)U%;N2UB=5DE3
MRW0A2Y"Y^<'!(Z4GT]5^9?1^C^^VGXDFA^)]1O-=?1]?T0:3>FV^U1".\%PD
MD8;:?F"K@@D<8[]:Z6N-T1=6UGQS_;M_H=WHUO!IS6BQWDL3/*[2!L@1NP
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MD:1A1E3P5C .<GDX(XQJT4+38?6X4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH RO$7_ ""&_P!]:TX_]4G^Z*S/$7_((;_?6M./_5)_
MNB@!U%%% !12.BR(R.H96&""."*YJV\):!X7-O<^&_#FG6UUYL<+7$5HOG>6
MS@.2X&X\<DDGWHZV!Z*YH^'?^00O^^U:M97AW_D$+_OM6K0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)$\A(&,L0H)"C(RQP!D9/-4X_&V@3:?;7T-\TMK<R^5%,EO*REL@')"_* 6
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MY #M?7PU?1W=YI^HW1O%:'4$E:"40QL5A5,.(6 8B)"%(8[B<J1Q6DN5*_\
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M%P3&-P'WE!SQP7..F:4;MZ_UM_P?N%[U_G^&ITE%%%,H**** "BBB@ HHHH
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M.V2>SW[RMTJL'+1L(QY@15)*-@@9[5I:7X$M])6,07LKE)4ERT:*"RR"0<*
M!EAS@#.2>I)I)O!DLNL6LPU!ELX7FFEA"#]]))<K.%;C.P.O8@\ '/-.-N:+
M?])+3_+_ (<SY;1DDNO^=_\ @'9:AID&H7%C/<-(IL)S<1A",%O+=,'CIAST
MQSBN&\/IX:AM]/\ [(O-6U"WEOH!#)+&L?D;8B(@0R(QC*=& 8GUZUUMN^I1
M6[1W%[%<N7<AVM]I +$A<!L< @9ZG&3S7.>'?"$VD:/8P7=^;BYMVAD9R@(!
MB3:J#&W*#)QD;N>34]?FOS_3H:RNX_)K\'^K-*U\3^&=,FU%X[^=C->>9/FV
ME8(Q&S<,)_J_W1^?E<@_-6=)>^%4TF^,NKWHL6U43E?L[?).DIF;R_W>YDW1
ML6;Y@ K8( XS[KX7:==JX:\>,-+YGR6T/ RQ"\H<X+MACEQV:K%Q\.[.ZCNQ
M->.[75T;IG:WB;#%64C:5*GY7(RP+<#YN!2C=6\K?A;^OD+5/RW^>O\ 7SZ&
MUK%KH^DZ;?3ZIJ5VMEJERDHBCC$FV3AOW81"YSLR<[N <8K.L[CPMX6UK6M4
M,MY$WG%)5:RW?-(#,_EA(_-<'!8DE@ #C %:&OZ&?$.@C2;FX6"W&W'DP@G
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M"_+MW'&S;[YK0T[07L-%O=-FO6OX[XL9Y+F,;WW($(^3:!\JCM1KK;Y??I^
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MB03*JLT>TG (/1@5(XY!!!&000:/M-[_ ,](/^_3?_%4?:;W_GI!_P!^F_\
MBJ;U5BKZW_K^M"O;>%[*V\'Q^'$EG-K%"(DE^02+@Y##"A00<$?+CCI67+\.
MM/N?/^V:GJ=R;B.02F66,EI'C:(RYV<-L<J ,(!C"\5N?:;W_GI!_P!^F_\
MBJ/M-[_ST@_[]-_\51UN)>[:QAZGX$BUKQ#<W>HWDXLVMXDAMX648D195\PY
M3.0)>,''J.!5ZU\&V-K;W48NKQWO()89IFD4.WF.SL^548;+GI@#CBKWVF]_
MYZ0?]^F_^*H^TWO_ #T@_P"_3?\ Q5*R8DK*R_JVW]?YF3H7@+3_  Z]B^G7
MEVIL_/ &R%5D65E9D*K&% RBD;0IXZTV\^'NEWJ+')<WJQ_-YJ(R8F_>M*N[
M*$_*[DC&/?-;'VF]_P">D'_?IO\ XJC[3>_\](/^_3?_ !5-ZVOT!)+8-/T*
MUTVSNK:)I)([IMT@D(/_ "S5,# '91^M9^B^"['1-2COX;J\N+E(WBWSNAW*
MRQ* 0JCHL" 8]\Y)S6A]IO?^>D'_ 'Z;_P"*H^TWO_/2#_OTW_Q5-.SNO0$D
ME9&E16;]IO?^>D'_ 'Z;_P"*H^TWO_/2#_OTW_Q5(9I45F_:;W_GI!_WZ;_X
MJC[3>_\ /2#_ +]-_P#%4 :5%9OVF]_YZ0?]^F_^*H^TWO\ ST@_[]-_\50!
MI45F_:;W_GI!_P!^F_\ BJ/M-[_ST@_[]-_\50!I45F_:;W_ )Z0?]^F_P#B
MJ/M-[_ST@_[]-_\ %4 :5%9OVF]_YZ0?]^F_^*H^TWO_ #T@_P"_3?\ Q5 &
ME16;]IO?^>D'_?IO_BJ/M-[_ ,](/^_3?_%4 :5%9OVF]_YZ0?\ ?IO_ (JC
M[3>_\](/^_3?_%4 :5%9OVF]_P">D'_?IO\ XJC[3>_\](/^_3?_ !5 &E16
M;]IO?^>D'_?IO_BJ/M-[_P ](/\ OTW_ ,50 SQ%_P @AO\ ?6M./_5)_NBL
M#69KE].(F>(KN'"QD'_T(UOQ_P"J3_=% #J*** (KI/,LYD$8EW1L/+)P'XZ
M9[9KS_P?::J/$%L+^[O;V*U1E^SW-DT":>=@ 5)"Q\WNN?FZYR._H4L8FA>,
MLRAU*EE.",]P?6N:T+P6FC:E%=":TQ;HR1_9K!8)) 0 ?-<$[^F>B\\XXI+X
MF_ZZ_P!?E;K,U=+^NW]?UI-H_P#R#Q_O&K]4-'_Y!X_WC5^F48NL^(FTK5+/
M3K;2+_5+J[AFG6.S:%=B1-&K%C+(@ZRI@#)ZU7_X275?^A(U[_O_ &'_ ,DT
M7O\ R4[1/^P/J'_HZRKHJ .=_P"$EU7_ *$C7O\ O_8?_)-'_"2ZK_T)&O?]
M_P"P_P#DFNBHH YW_A)=5_Z$C7O^_P#8?_)-'_"2ZK_T)&O?]_[#_P"2:Z*B
M@#G?^$EU7_H2->_[_P!A_P#)-'_"2ZK_ -"1KW_?^P_^2:Z*B@#G?^$EU7_H
M2->_[_V'_P DT?\ "2ZK_P!"1KW_ '_L/_DFNBHH YW_ (275?\ H2->_P"_
M]A_\DT?\)+JO_0D:]_W_ +#_ .2:Z*B@#G?^$EU7_H2->_[_ -A_\DT?\)+J
MO_0D:]_W_L/_ ))KHJ* .=_X275?^A(U[_O_ &'_ ,DT?\)+JO\ T)&O?]_[
M#_Y)KHJ* .=_X275?^A(U[_O_8?_ "31_P )+JO_ $)&O?\ ?^P_^2:Z*B@#
MG?\ A)=5_P"A(U[_ +_V'_R31_PDNJ_]"1KW_?\ L/\ Y)KHJ* .=_X275?^
MA(U[_O\ V'_R35:^\:WFFVZSWO@W7HXWFB@5O-L3EY)%C0<7/=G49Z#//%=7
M7.^./^1?MO\ L,:9_P"E\% !_P )+JO_ $)&O?\ ?^P_^2:/^$EU7_H2->_[
M_P!A_P#)-=%10!SO_"2ZK_T)&O?]_P"P_P#DFC_A)=5_Z$C7O^_]A_\ )-=%
M10!RFH^-;S2M+NM1O_!NO16MI"\\\GFV+;$52S' N23@ \#FNKKG?B%_R3'Q
M1_V![O\ ]$O714 %%%% !1110 4444 %%%% !1110 4444 9VNZS'H.DF^EM
MKB[_ 'T,"06^S?(\LJQ(!O95^\XY) Q6=_PDNJ_]"1KW_?\ L/\ Y)H\<?\
M(OVW_88TS_TO@KHJ .=_X275?^A(U[_O_8?_ "31_P )+JO_ $)&O?\ ?^P_
M^2:Z*B@#G?\ A)=5_P"A(U[_ +_V'_R31_PDNJ_]"1KW_?\ L/\ Y)KHJ* .
M=_X275?^A(U[_O\ V'_R31_PDNJ_]"1KW_?^P_\ DFNBHH YW_A)=5_Z$C7O
M^_\ 8?\ R31_PDNJ_P#0D:]_W_L/_DFNBHH YW_A)=5_Z$C7O^_]A_\ )-'_
M  DNJ_\ 0D:]_P!_[#_Y)KHJ* .=_P"$EU7_ *$C7O\ O_8?_)-'_"2ZK_T)
M&O?]_P"P_P#DFNBHH YW_A)=5_Z$C7O^_P#8?_)-'_"2ZK_T)&O?]_[#_P"2
M:Z*B@#G?^$EU7_H2->_[_P!A_P#)-'_"2ZK_ -"1KW_?^P_^2:Z*B@#G?^$E
MU7_H2->_[_V'_P DT?\ "2ZK_P!"1KW_ '_L/_DFNBHH YW_ (275?\ H2->
M_P"_]A_\DU6U'QK>:5I=UJ-_X-UZ*UM(7GGD\VQ;8BJ68X%R2< '@<UU=<[\
M0O\ DF/BC_L#W?\ Z)>@ _X275?^A(U[_O\ V'_R31_PDNJ_]"1KW_?^P_\
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M_P"P_P#DFC_A)=5_Z$C7O^_]A_\ )- '145SO_"2ZK_T)&O?]_[#_P"2:/\
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M_P!_[#_Y)J3P-:7FG^ ="L=3M)+.\L["&VFAD=&*M&@0G*,RD';D<]",X.0
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M\IYP>:TW^T[=4(B\231K=3- LT]XK%OM!"[BZL2OE;,!QL/S'@@FO3?[(O\
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M;W.&E?7;OP.?[3BOX+W^U-LRP-<!O+63!*F']YY9 R-O8UEW4OB"738GG'B
M7XBA6%;42KOC*G>Q& N_(!^<;A\N<9->F_V1?_\ 01'_ '[H_LB__P"@B/\
MOW2#K<Y#3?[3%EH$FLRWD>J#4GCO%\Z18G8QR$A5R%:+A2N0<8'\6:[6JDOA
MZ>::*::ZBDEA),3O "T9(P=I[<>E2_V1?_\ 01'_ '[IWN']?F35D^)Q,WAB
M_%M]I\PQ8'V4N)>O.W9\V<9^[SZ5H?V1?_\ 01'_ '[H_LB__P"@B/\ OW2
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M7_\ T$1_W[H_LB__ .@B/^_= $U%0_V1?_\ 01'_ '[H_LB__P"@B/\ OW0
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MC_OW1_9%_P#]!$?]^Z )J1551A0 ,YX%1?V1?_\ 01'_ '[H_LB__P"@B/\
MOW0!*0""",@]134ABC=GCC168 ,54 G'3-,_LB__ .@B/^_=']D7_P#T$1_W
M[H E5510J*% Z #%+4/]D7__ $$1_P!^Z/[(O_\ H(C_ +]T 345#_9%_P#]
M!$?]^Z/[(O\ _H(C_OW0!-14/]D7_P#T$1_W[H_LB_\ ^@B/^_= %;6/^0>?
M]X5T$?\ JE^@K'_L*>66,W=[YJ(P)39P?;K6U0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>halo-20240304_g12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g12.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,U-   DI(  @    ,U-   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M_P 37144 <[_ ,*]\%_]"AH/_@LA_P#B:/\ A7O@O_H4-!_\%D/_ ,37144
M<[_PKWP7_P!"AH/_ (+(?_B:/^%>^"_^A0T'_P %D/\ \37144 <[_PKWP7_
M -"AH/\ X+(?_B:/^%>^"_\ H4-!_P#!9#_\37144 <[_P *]\%_]"AH/_@L
MA_\ B:/^%>^"_P#H4-!_\%D/_P 37144 <[_ ,*]\%_]"AH/_@LA_P#B:/\
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M&_\ T ?#_P#X/9__ )$KKJ* .1W>-_\ H ^'_P#P>S__ ")1N\;_ /0!\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N
M6\8_\AOP?_V&I/\ T@NZZFN6\8_\AOP?_P!AJ3_T@NZ -:BBB@ HHHH *PM=
M_P"1H\'?]AB3_P!(+NMVL+7?^1H\'?\ 88D_](+N@#L**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML+7?^1H\'?\ 88D_](+N@#L**** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N6\8_\AOP?_V&I/\ T@NZZFN6\8_\AOP?_P!AJ3_T
M@NZ -:BBB@ HHHH *PM=_P"1H\'?]AB3_P!(+NMVL+7?^1H\'?\ 88D_](+N
M@#L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N
M6\8_\AOP?_V&I/\ T@NZZFN6\8_\AOP?_P!AJ3_T@NZ -:BBB@ HHHH *PM=
M_P"1H\'?]AB3_P!(+NMVL+7?^1H\'?\ 88D_](+N@#L**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML+7?^1H\'?\ 88D_](+N@#L**** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N6\8_\AOP?_V&I/\ T@NZZFN6\8_\AOP?_P!AJ3_T
M@NZ -:BBB@ HHHH *PM=_P"1H\'?]AB3_P!(+NMVL+7?^1H\'?\ 88D_](+N
M@#L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2VNX+R-GM95E5)&C8J<X9258?4$$5-7#GPM<:7X*\0:?::7 \UU>S75HNG%
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M?>C;"_,IP,@\'%5O^%<>"/\ H3?#_P#X*X/_ (F@#I**R+'PGX<TNUN[73-
MTNSM[Y/+NHK>RCC2X7!&UP  PPS#!SU/K5+_ (5QX(_Z$WP__P""N#_XF@#I
M**R(O"?AR#1IM(@T#2X],N'$DUDEE&(9&X^9D VD_*O)'\(]*I?\*X\$?]";
MX?\ _!7!_P#$T =)161+X3\.3Z-#I$^@:7)IENYDALGLHS#&W/S*A&T'YFY
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MZ$WP_P#^"N#_ .)H Z2BLBQ\)^'-+M;NUTS0-+L[>^3R[J*WLHXTN%P1M<
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M_0 \3_\ @%%_\=H ]EHKQK_AISPG_P! #Q/_ . 47_QVC_AISPG_ - #Q/\
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M/"?_ $ /$_\ X!1?_':/^&G/"?\ T /$_P#X!1?_ !V@#V6BO&O^&G/"?_0
M\3_^ 47_ ,=H_P"&G/"?_0 \3_\ @%%_\=H ]EHKQK_AISPG_P! #Q/_ . 4
M7_QVC_AISPG_ - #Q/\ ^ 47_P =H ]EHKQK_AISPG_T /$__@%%_P#':/\
MAISPG_T /$__ (!1?_': /9:*\:_X:<\)_\ 0 \3_P#@%%_\=H_X:<\)_P#0
M \3_ /@%%_\ ': /9:*\:_X:<\)_] #Q/_X!1?\ QVC_ (:<\)_] #Q/_P"
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M_;/C3_H7-!_\'LW_ ,B4?VSXT_Z%S0?_  >S?_(E;-% &-_;/C3_ *%S0?\
MP>S?_(E']L^-/^A<T'_P>S?_ ")6S10!C?VSXT_Z%S0?_![-_P#(E']L^-/^
MA<T'_P 'LW_R)6S10!C?VSXT_P"A<T'_ ,'LW_R)1_;/C3_H7-!_\'LW_P B
M5LT4 8W]L^-/^A<T'_P>S?\ R)1_;/C3_H7-!_\ ![-_\B5LT4 8W]L^-/\
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M&",D$XJ./XD^&I8]\<VHE/LPNV?^Q[L*D)W8=CY6%4A&()QD#BA[6_K^NO\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XS\?\ _D+?#_\
M[#T?_H25[-7C/Q__ .0M\/\ _L/1_P#H25[-0 4444 %<W\1_P#DEGBO_L"W
MG_HAZZ2N;^(__)+/%?\ V!;S_P!$/0!S?P?_ .20>'/^O0?^A&NUKBO@_P#\
MD@\.?]>@_P#0C7:T %%%% !1110 4444 %%%% !1110 4444 %%%% !6%KO_
M "-'@[_L,2?^D%W6[6%KO_(T>#O^PQ)_Z07= '84444 %%%% !1110 4444
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MWZC:H49P!CDYI:**D84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /R%OA__ -AZ/_T)*]FKQGX__P#(6^'_ /V'H_\ T)*]FH **** "N;^(_\
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M<YP.:S+GXH:592(M]INJVP"R^>[P)MMWC5W:-B'.YMJ$_)N !4D@,,MW>_\
M77]?Q0DNW]=/T.THKC+3XGZ3<W,,5Q8:G8I(LQDGNH4$<+1;MZ,P<Y(V'E=R
MC*@D%@#T/A_6[?Q)H-KJUE'/%!<J61+A-DBX)'S+DX/'2E9BNMC2HHHI#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH \9^/_P#R%OA__P!AZ/\ ]"2O9J\9^/\ _P A;X?_ /8>C_\
M0DKV:@ HHHH *YOXC_\ )+/%?_8%O/\ T0]=)7-_$?\ Y)9XK_[ MY_Z(>@#
M+^#'_)&?#7_7F/\ T(UW%</\&/\ DC/AK_KS'_H1KN* "BBB@ HHHH ****
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M_P#]AZ/_ -"2O9J\9^/_ /R%OA__ -AZ/_T)*]FH **** "N;^(__)+/%?\
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MM1BNA<V:+&\UPV_S>,Y#Y.[C@GUS3Z7"^IL4444AA1110!XS\?\ _D+?#_\
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M\[^S;ZVO/L\ABF^SS+)Y;CJK8/!'H>:H)XO\/2EA;:Q:76R0Q/\ 991-L<$
MJVS.TY8<&L_P9X,_X1&"ZC^W-=F8)''(S3EEC3.U3YDT@R-Q^X$7_9K*L_AO
M>1ZI<:AJ7B%KZXG2-7=K=^=C9!^:5@,C&0NU<Y( SB@'Y'97FL:9IUS;VVH:
MC:6L]SD013SJC2X&3M!.6Q[5G6_C7P_=^'X=<M]2C;3)[@6T5RP**[F3RP!N
M R-W&>AZ]*BUWPM+K.KPW4=]';P%8TN8FM_,>18Y!(NQ]PV'<.20V1V!&:ED
M\.R?\(K9Z1!>*DEHT#+.\.X,8G5^5##KMQUXS2Z#?D.M?&?AJ]T]+ZWU[3S;
M/(L0=[E4Q(PRJ$,00Y!^Z<'VK0O]6T[2A"=4O[6R%Q((H3<3+'YCGHJ[B,D^
M@YKA+OX2K<0VBIJY4V]G%:,NR:-)44,'W>3/&QW!NF[ QR&[=%XG\*W&NKII
ML-4;3);%R1*B.S[2 #M974@\?Q%E/\2M3TO\_P !=2P/&OAC[-<SR:_IT,5I
M+Y-PT]RD7DON*[7#$;22IQGKCC-3'Q7X=%P8#K^EB82I"8_MD>[S'&53&?O$
M<@=37.77P\NWBV:?K[6?F"9)RD# RI)-)(5W)(K CS."&'(!Y!*U3/PG']E:
M=9_VNS?9&=9#MGB6>-Q&&4B&=#G]V.K,O/*FB.KU$[]#NK/5=/U&:YAT^_M;
MJ6U?R[A()E=H6_NL ?E/L:S;CQMX:MKR"T;6K26YGO!8I#;OYS^?_<*IDJ1W
MS@#OBH?#'A>X\.WFHO)JCW5O=2;XK8(R)#EF)."[#<=W.P(IQG;DDFGI/@:7
M3M9M;^XU..<61V6\<=KY?[H+* KG>=SYE)+8 ./N\DTENK_U_7]>;Z,V-6\5
MZ#H;3)JNL65K-#%Y[PR7""01YQNVDYQD@9Z4]O$V@I%>2/K>G+'8L%NW-W&!
M;D] YS\I/OBL+6O ]YJ?B"\U&TULV<=U;^6UOY#,K.%PI<"15=1@'E=^> X'
M%0CP!>K.+A-8MO/MG9K$MI^4C#.SL)5\S][RQP04Q[G))V!^1U%AKNEZI<W%
MOI]]#//;-MEC5OF7WQW'/WAP?6J.H^-O#6EJ_P!LUJTWQW*6CQ0R>;(LSG"Q
ME$RP8^F.@)Z"LWP?X#_X1#5]2O(=2-PFI;#-#]G6,!T 564*=J_+D$!0.G3'
M*V?@>6WU1+J;4XY([>;?;1I:["J&4RLKMO.]MQP& 7 [$DFGI=?C^O\ 7_#$
MZV?X?U_7ZG07NLV&G+=M>3^6+.V^U3_(QV1?-\W Y^ZW YXJ#_A*-"-[)9KJ
M]D]S"X2:".=6>$D$C>H.4X!Y;%9?BGP%I?BR2[EU.WLYII;'[+;2W%HLS6C9
M8^8A/(/S#IC[HYK(U'X9W6L:Q<7NI^(9)DDBE@CC\AOW<;G(&#(4RO3*HN0!
MG)&2ET+=NG]?UJ=))XV\*Q6]M/+XFT=(;O/V>1K^(+-@X.P[OFP>#BK$_B;0
M;4QBZUO3H3* 8Q)=QKO! ((R><@@_0US:>"-934+>\EUNPN,7)NKNV;2V\J:
M3:B*47SQL(1,#<7&YBV.@%;P]\/##HMO]M8V\V7/D3(LK1)Y\<D<996Q\L<,
M<?!(XZG'+LB3L;?7M'N[BWM[35;&>:ZA\^".*Y1FFB_OJ <LON.*IW_C'2-,
MUH:7>&^6Z,9E&S3+EX]@ W-YBQE,#<,G.!D XK%TWX=)IOBJ+5UU RQ)(\QM
MSYZ@.=X!55F$?"N1\T;$]B.@WM5T#^T]36\^T^5ML+BSV>7G_6E#NSGMY?3O
MGJ*3VT\_^ 5&U]18/%GAZXLK>[AUS3FM[F400R?:D DE_P">8R?O_P"SU]J:
MGC'PS)<K;Q^(M):=G=%B6^B+%D^\ -V<CN.U<OJ'PL2]N4E75"@#!9(ML\:/
M'Y,,;*?)FC))\D'DE1G!4XS1K7PZU"]TJUM+?7&-M9()$M!"RB6579P<B0+S
MNVD.&P0K#&#DE9;"5W_74ZU?%&@/:P7*:YIK07$WV>&47<9667IY:G."WL.:
MCO\ Q;H.F>1]LU:T3[0P6("4,6)#$8 Y.?+<#U*D=:Y&3X73W\%I-J&K(+M?
MEN$BCG@BDB*1IY>V&X0YQ$O)9E)S\N, 68_AS>)(['7(F 58H%-B?DB!GX;]
MY\S8G(W<#*@X[4Y*VP1LU=]OQ.GD\6>'H8YGGUW381 46;S;M$\HN,H&!/RD
M]@<$U>O;^VT[39[^\E\NUMXFEDD +;4 R3@9)X]*X2[^&-Y/%'';>(([=;:9
MY;5DL-LB%V+/NE219"<L=NQD&.&#UU-YH]YJOA._T?4+J,274,MLEPB%B$8%
M59@2,MCDXP,]*- 6ZOL3'Q1H ^V;M;TX?81NN\W:#[.,D9DY^3D$<XZ5HQS1
M30+/#(DD3J'616!5E/((/<5R4W@-B%DM-0BBN8II9XWDM-Z[WN!.-R[AN QM
MQD$]016W::3<0>'Y-,FNHI 83%')#;B'8"F/NJ<=<D8 P,#G&2G\+:W!?%9[
M%(>/O"WVHP2:W:0R!U3]])Y8#,H=02V,9##&<9[9K8M=4T^^NKFVLKZVN)[1
M@EQ%#,KM"QY < Y4^QKD7\"7&I6LAO+N*U^T630FW%MN\F1K<0L0P?! V@@8
M'?GGB[X2\$#PMJ5[<_;FO%GR(@[3EHU+ER#OF9,;CQL1/?-.RO86MD_Z_K_(
MN2>-]!CC=C<W#E)GA9([*=WW)M+'8J%MHW+E\;1D<U:'BC0&\[&MZ=F!$DF'
MVM,Q*^-C,,_*&R,$]<BHM9T6^O-1M]0T;48K"\BB>W9I[4SHT;E2<*'4A@5&
M#DCKD&L1OA_--?+)=ZNL\$4XGB5K,"0L98Y)/,<-A\F( 85=N?XL"DM=RNO]
M?U_7R-S_ (3#PS]G,_\ PD6D^2'5#)]NCV[F&Y5SNQDCD#N*?+XK\/0O=I-K
MVF1M8X^UJ]Y&#;YZ;^?ES[XKE=0^'UXNHV,ND7EO&>8YI);,.J+BX).W>"2?
MM&!@\$9.02*EMOAQ/'KD-]>ZZ]Y%;A$@AEA8[8TF215.9"N1LV[E5<C!.2,E
MZ7_K^OZ^^7=+34Z.Y\6:#:Z<;Y]5MY;<.J;K=O.)9@"  F2>&4\#H0>G-78M
M4LIK2:Z6X588"?->3*"/ R=V[&!CG)[<US'ASPC)I'C"YO2L@MHK&.VB8E0D
MTF27D5 25PHC3)P3M.!CD[5GI;O)K9O$"QZC.<)D?<$21Y..YVD_3%+H5I?4
M-0\7>'M*V'4=:L;=7E:$-).H57498,<X7 '.<8R!U(I\OBC0X'*3ZK:QON9%
M1Y &D*H'(0'E\*0?ES7):-\*QI=Q%//K+7DBS"=R]J%WN8I$D;AN"Q<,?]W'
M?(DC^&<T%L8(=:BV30QPW!ET]9&98T0*4W,0AW)DG!X/&" U'075'6VOB'2+
M_1I=6L=2M;BPA5FDN(I0RH%&6W$="!U!Y%4['QOX9U&.9[;7;$B"$3RAYU4I
M&55MYR?N89?FZ<]:-)\,KI5IJ-NMSO6^"#B+;Y>V!(NF><[,]NN.V:YNZ^%[
MWNEB"XUD+<B43>?!;O%\XCB0?=E#@9A!X<'G (QFF[7=O*WZ@ME?YG<)J5C)
M817R7ENUI-M\NX$JF-]Q 7#9P<D@#UR*K'Q)H8O4LSK.GBZ<,R0?:DWL%)#$
M+G)P5;/I@^E9@\(NG@>/08+U(IXG29;DI+*OFK*)=Q625G(+#D&0GD\BLK_A
M6BRZ7=6MYJ:RR71)DF2U"GEIV. 6/_/<_E[T.W0%TN=#:^,/#EZJ-:ZY82)+
M<?9H7%PH6:7:&VQDG#G# _+FFKXU\,.K&#Q!ILY"/)L@NDE<JGWB%4DG'? X
MKEY/A?/<WR7M[K,4D[7+2W*003VT4JD1Y4)%<+SF('+%QS]TU(?AG<*+6.#7
MVAABT];*98[=E\_:I4%@) I7YLX968$<,H)!:MI?^OZ9.MF=/<>+O#=H\Z77
MB'2H6MGV3K)>QJ8FQG:V6^4^QJ>;Q%HEO+/%/K%A%);P"XF1[I 8HCTD8$\+
M_M'BN(TKP5J4_BMY]00V^G:>\@L_/@BWS!S+G)25\@&7.Y@A.,%<Y8R#X5-'
M>FXAUCYD6%X!-'.ZQSQB,;O+\\1%#Y0RNP-S]_I4QU6I3T=D=G!X@TFYT;^U
MH]0MQIQ8J+IW"1Y#[/O-@8W# /?MUJNWC'PPMFUVWB/21;(RHTQOHMBLPW*"
MV[&2.0.XJK:^$S#X3AT6>[CE*7:W3RK;[58BY\\J$W' _AZGU]JR-0^'5S<6
MTL&GZY]ACN81!<B.W93*F^9C\R2*P.9N.<?+R&!Q3?6P1U6IV4&HV5S)Y=M>
M03.=PVQRJQ^4@-P#V) /ID50C\6>'Y;6\N1K5@L-BYCNWDN%3[.P)7$F2-G(
MXSC/:LKPGX8DT;Q!J][*LJQS+##"'9<-LC4/*H!.T.0O!Y^3-9EW\,[B[CF$
MFN!'69Y;-H+>2#R@TK2$2&*97<Y?&59.![G*?2PE?J=K=:I86.FG4+Z^MK:R
M50QN9IE2, ]#N)QCFLZ]\9>&]/CN6N==T]6M8A--&+I"\:' #%<Y .X<^XJE
MJO@Q;_P;8Z':WC6;V/EF&9&G !08ZK,LN.3_ ,M<^Y[T8?AREII36EE>Q0OM
M<(YMW<*3'$@SND+,!Y0/+9(.,\9IZ7?X!T1L6_C?PY=7DUK#JUN98,^:"V/+
MP')+9^Z,1L<G XJ?_A*] ,UC%'K-C+)J&#:)%.LAG!XW*%)RO^UT]ZYJ\^&L
MM]%-%-K(6.1C*/*MV1UD)D.=PD! _>#@8/RGYN>%TOX<3:9?64R:I R13I<W
M*-;2R/+*I<[EDEG=T!\QL@E^>01D@G7^OF+7E\_^!_G_ %WZ2_\ %6@Z5J$M
MGJFKV5C-%"D[BYG6,*C,54Y8CJPQ_P#KK2>ZMXA&9)XT$N?+W.!OP"QQZ\ G
MZ"N<\0^%+W5M<M]4T[4[>SF@155;BR,ZE@)%R<2+QME<8ZYVG. 07ZIX-2^\
M&6?A^VU":T^QK%''=*H9]JC8P[<LA9<]MV:73S+TOY%R?QAX=@W[M;L&:.6*
M&18[E&:-I2!&& /&<C&>W-7['5-/U/SO[-OK:\^SR&*;[/,LGEN.JM@\$>AY
MKDS\/YOMCRQZK"D<4S26<8LL&(/<).XD(<>9\R *0%P#SNJ[X,\&?\(C!=1_
M;FNS,$CCD9IRRQIG:I\R:09&X_<"+_LT]+"-"#QAX=NM0@L;/6["ZN9Y7A2.
M"Y20^8B[F4X/! [=:9<>-?#EGJDNGWNLV=M<PRK#(DTH0*[*&"DG@$@C&>O0
M5C:)X$U'2_$@UF\\0?VA<,R^=YMN_P ZJCJ,9E(0G>"=H"Y#84;N+&M>"'UC
M4-0F?4(XXKR&5%C^S;FC9X/)+;M_(P <8'?GG@!:NS.CM=4T^^NKFVLKZVN)
M[1@EQ%#,KM"QY < Y4^QJM_PD>CB[U&V?48(Y=,"->>8VQ8 XRI9C@<CWK'\
M)>"!X6U*]N?M[7:S@B(.TY:-2Y<@[YF3&X\;$3WS50?#>%+J6\34IFN[PO\
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MDDT?3)HRDNG6CH005:!2""23QCN6;\SZT=?G_7]?TA:)7.-G^)%[:VLTL^@
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MU5XEW('A5G)\X'!5!P<$\$Z_A+Q5>^(KR\^V65O9VZ6UO<VPCG\UF27>07.
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MO/\ [+T^ULOM$AEF^SPK'YKGJS;0,GW/-&G]?(E7L6Z***0PHHHH \9^/_\
MR%OA_P#]AZ/_ -"2O9J\9^/_ /R%OA__ -AZ/_T)*]FH **** "N;^(__)+/
M%?\ V!;S_P!$/725S?Q'_P"26>*_^P+>?^B'H R_@Q_R1GPU_P!>8_\ 0C7<
M5P_P8_Y(SX:_Z\Q_Z$:[B@ HHHH *\^\7VVOR^.K!=(U+6;."6)06L[</"FU
M9RQ8F-ESDQC#'!R."0"/0:KM?V::@E@]W MY)&94MC(!(R X+!>I )'/O2ZC
M3LF>7?VU\0[R_,3+=6"RQ6H_=V;,T8<Q!W4-;&,.-TF0TIP!G8,9J>'6/&PE
MU./4YM0M[:*Z6-IK2P:>XBCW, \2?9 CY 3.TS$9)XZ#TR.\MIKB2WAN(9)H
MO]9&K@LGU'4=:E9@JEF(  R2>U4VMR4M+'%^!FU*&[O9?$UWJ+:EJ3JT5M<Y
M$4:)#&6\M -J?,YSW)'<@U1U34_&8\;R:?:0W0TK>(UG6T4JP;;)NWXXVJDD
M?U=>^*]!BECGA26%UDC=0R.AR&!Z$'N*1YHHY(XY)$1Y21&K, 7(&2 ._ )_
M"D]QIGD^F+XO@N$E2_UXO C2RQ7%KN24DVV(\M'\PVF3D$L"&^;AA74>/=4U
MVQGTZ/P['J32M('?[-;B2%T#+N5SY,A!VDD#='G!^;.!77W%Q%:V\D]S(L4,
M2EW=C@*!U)J2G)W2\B5&U_,XOPS/K-MX/U.?4VO%NHH(WB:[#%@1:1$D;_\
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MX_* "$%"SA_O#G/'0UZ'15<SNO(E1237<\N_X5OK GOS)!HEW;7%ZUP+:=F
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M.?0:*=]_,=_>YC@_!G@;4_#M[9R7MQ:R1VUNT.(FYQOD*@ (J@ ,HP  ,8
MQ6)J'PMU*\TV\B%IHGG.QV%I'Q<.5E4W,A\L[9?WHX ;[GWNF/5Z*3UES"C[
MBLCR^\^%]^=2M#ITMM;Z?;7IFBM8)$B\@,L69$WV\F'W(_"["=Y^<9(K77X>
M0_\ "%:)H4EIIY2S<R7<83]W-(8)$+8V_,2[@DD<X)KN:*'JK!'W=OZ_JYY;
M>_#'4RD%MIT>CQVT=TEVLCC][#(J0[F0M$V-[1R$E2C'<&W9R*IW7PEOVM;B
M'3[/1K))+A966UD1/M(!E W[[6100'5@=K$," 1@,?7J*;=Q6L>9W/PSO1J]
MGJ5DFEM=QW[7$US<JKR.N$"LV8F#L K#@(1N^5U&0;7B/X=/K>L:I=+::7MN
ME>2*63/F>=]G$:,P"?P,H8-DD9X (Y]"HI=+?U_6@UH[GF)^'6K3>-/[;O+;
M0Y5$Z2%% 3S=DJLLK8AW>8$W#+,_(&"H8XT?$/PY77-2U2^>"Q>XNFD,,LN[
M<G^C(D>3CC;*F_CI@$<CCO:*:=E9 M'<\BU;P%KD6J7>IH+.WO;VZBCMWTR#
M=@F1E:63;$NW]S)("SL^#T/(%=#XF\)W.K>)K%-/LK58;6TC5+R8LK6FV3/[
MK"D%BHVD97ANI&0>\HJ;:)?UM8//^OZT/)+OX97>E:%(FG6&F*8-+*&:T#"X
M9Q;LCP(@0;D=VWD[@2W52<$6(?AGJW]KZ;?!K2RMX+@3"PLYU6.SP5R8B]LS
M$OM)8+Y1.Y@6->IT55[NX?943RC_ (5Q-I*:+:V<4$$TC007;65NQ26/;)]J
M\Q@H #@C#'DL!6_XK\%W^MZU-=6D>G$26OE1W-S)*);?"N&C0)CY'W#<=PQC
M[K<8[BBANX=;GG$/PR^T)&=1L-)C1)8WBLH2SPVB><&DCCRB_*4##[JYWL,8
M)R_PW\/=2T3QI;ZI/=1R6L%N(HQ',@,:B/8(<& NT?&[_7* ?X,C)]$HH3ML
M+N>2ZE\+=9O8[L0_V9;+)=/,\4,HQJ(:1V#3F6WD4,@=0/D?[O!'&+=W\+[H
MY-I#ILLLK'=/<N?-A<PPHMT&6/#S(T;D<+G>2&7)%>GT41?+L/=W/,K/X7W=
MAXBT:_@DMHX[5O,N/L[1QMYOF,[2 M;NS%P55L/&2%P2PQBQKGPWFU77=3O8
M[;2U$_G2VTK9\Q9VC@"2$!."K0L=P)/(KT6BA.P'!^%O ^I:);^($O+I)I=2
M1D23S4*R$AOG=5@0AOFP2S2D@#YN*S+_ .%#_8[I-&%C8RS KNC./,C*PDQ-
MNC9=K/'(3E6'SDD,217I]%+_ (8=];GDT'PHU07$?VJZCFA^P26P22XA80[H
MW7RN+12T66SA3&HP/D)%6D^&5T+%IIET^SO84'V66TW2&S'GS2.(SL!^Y*JC
M &<$8Q7I]%-L+Z6.#^&-C=V5GJ#C18-+M+FZ#)$B2PX"PQ)N6.2)'PS*Q.X+
MS_>SFN\HHH;N(****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% 'C/Q__ .0M\/\ _L/1_P#H25[-7C/Q_P#^0M\/_P#L/1_^A)7LU !1
M110 5S?Q'_Y)9XK_ .P+>?\ HAZZ2N;^(_\ R2SQ7_V!;S_T0] &7\&/^2,^
M&O\ KS'_ *$:[BN'^#'_ "1GPU_UYC_T(UW% !1110 445R'C'Q=J_AFZ06.
MBV5_;M:3W)DFU%X''DKN==HA<=,8.[D]<=:3:0TFW9'7T5PMC\5])N]8TW29
M=+U:VOKZ0Q.C0*Z6K] )'1B &[$9]\4[4/BA9VMY>6MGI%[>SV=XEHT:RP(T
MQ+;6:,&3)VG@[@@]Z?\ 7]?>3=6N=Q17GI^,NA-J-O96FFZM=RW21/;F&.+;
M-Y@4[0S2 !E#KN#8(R.N11I7QF\/ZO-:16UEJD375P85-U%' $7Y,2DO(,HW
MFIC&2=PXIJ+>@'H5%<-X@^*^D>&]3N[.^TO5Y1:W*6SSVUNDB%C&)20 ^[:J
M'<Q*CVS56;XSZ)!JR:>^DZP9Y'G\K$<.)(X2XEE'[WA5,;<'#'C"FETN5;H>
MAT5YQ'\;_#9LX[JYLM4LH3%)+,;R*.$P!<@!E:0$EB/E"!LY'2I$^,6F7%E'
M-::'K3-)"SE)H8XC"^Z1%CD#2 ABT;#@$#C)%#T5P6IZ'17FUI\:-,E9+*31
MM7;5##$WDQP((Y9616:-)&?9E0X)R1P1C)XJ_>?$Z.PLO#UY<:-<R0:QI[7T
MIMI49K10(R<AMN\?O>HYXX4YXKE?]?UY$II['=45QLWQ#@N?!.I:_H>G75T;
M$K'Y,FQ"9#MW+]_&4+889ZJ0*QT^,UHEC'<:AH-_9.&?SH9)(F8($F960JQ#
M9-NRX)7!]L$JS&>E45R5]\1-/L?#NGZO_9]]<)?2/&L%NT#R1%$=WWGS=GRB
M-L@,3D8QFJ=M\5M)NY5$.F:IY+SO$)RD03:DJQ&7'F;MN]U7&-W.=N,FBSO8
M.ESN:*XRR^)^CWUY;VT5GJ"R75T]I#N2/]Y*CJDBC#GE-Q)_V48C('*:_P#%
M'1O#VIW=A<VE_//;G8JP+&?M$NU',489P6<+(K8Q@] 21BETN.SO8[2BO.+O
MXS:<NEW-YIFA:K>K"A>-B88DDQ"LS')DW *KIGY<\\!L&MC7_B7HOAO78=(U
M&&\-Y.J-$L4:LK[LA<$L.K#8,_Q$?6FTUN3=6N=?17#>&?B1_P )%JD%G_97
MV;S8&FW_ &G?C$44F,;1_P ]L?\  ??C.L_C;I+Z=ITNHZ+JUK<WQC_<0Q+<
M!$<<3;E;_5]LD!O]FBS*:<=STJBN6UGX@Z3HFLW&EW4%V]W! +@QQ(IW1G #
M#+#@N0G./FZX'-<U=?&W3=/U:6&^T75EME6-0884ED23?*LH=5<X5/);)&1\
MK$$\92UV$]%<].HKC]-^(MEJ5[JX%C<6]CIEJ;G[7/)&HG"R2(VU=WR@&)N7
M*GV Y,.@_%/1_$&K6>G6UCJ%M<7*MN%VL47D,&==C R9+$Q/@(&Z4[-ALKG;
M45Y_?_%BUL]6GMH]'NY+6W=D:Z>1%$A24QOL4$DX*D?-MSCCCFHD^-6B-?BQ
M?1M<BNVCC:.)[>/$COL*QAQ(4WXDC)RP ##)SQ27O*Z!Z-Q>Z/1:*\R3XW:1
M%<'[?INI+:S72QVLT%N)1Y1BB?S9 &RHS,@Z9^9>ISC<TGXBVNIZ'JNKRZ9>
M6EK8/$(T=D:6X62-'0@*Q5=WF* "WUV\@.SM<.MCL:*YCP[XYM/$NL7&G66F
MZA%):PB2YDG$02%_,>/RSB0DMNC?E05X^]R*@L_&]S>^-I=!AT1S% MPTEY]
MJ7'[HH  A&227'< <<GG"V=O5_<)M+?T.NHKS"T^,N;".74?#MU;R301R1-Y
MT9C9W5FV$@DJ=J$@X(/?:>*Z/3_B)I6H^']1U>*VNTAL9 AB8Q&27)PK*JN<
M!CP-^WWQ0] OK8ZRBO/;SXS:'9W$$!TO5YI9U4(L,<)Q,7">0Q\S"N"<\G:1
MR&-:>C?$*VUB^U-#IMW9VFG6OVEKBX9"9 ))$?:B,W ,3#)()],8).EQ[G7T
M5PEO\6]%N)FB&GZFCQ;?M(:.+_1B^?+#8D.=^.-F['\6VJ8^,%J]TA70M22W
M6VDEE20P"82 P^6BCS=K%A.F #G+*.N<.S#K8]'HKSJQ^,NDWKQD:5J(MYI%
M"3($/EQE8/GD4L"OS7*+A=_0FM:Q^)&F:AX1N/$%K8WSPPRQQ"V!A,TAD*A"
M ),*&WJ1N*G':AQ: Z^BN2TGXBZ7K&IV=E!9W\377R>9*D86*7:S^4V')W;4
M8Y *\?>JA+\7-'CBF>/3=2F:*ZDM_+C-OO8(LC-*%,H(3$,F,X)QP#2 [RBO
M.;/XW^&-0M)KFSM-6DAC?"NUH(Q-'M=C,FYAE (W_P!KY2 I/%55^,Q358UN
MO#TD.E>4SR7PO%9@=LS +%MRV1 >25P3^)?*Q<R[GJ%%<I=?$32K+P]::O=6
MM\D5U<26HBV(9$G0L/*.&V[BR%1@D$XYYS6'K'Q>@LKN.#3M$O;GFX9GE:.-
M7CBCF+,IWDCYX67E0< D \9+#6NAZ/17"+\5M.+2Q_V/JK3+)Y4,:K#_ *4P
M<HWEDR   @_?V>V:GU#XDVEE!H]S'I=[=0:O9+=0)$8Q-EY(8T3:S!<DSC)W
M@#'>A)O8#M**\VN/C+ITHB31M*O;F626U3$KP1_ZUH\J%,H8LJRKG VY(YQS
M5R#XOZ&^GK>W6GZI90M$DZ^?'$2T;I,ZOA)&XQ _'7D<<\%G:X^5WL=[17FG
M_"X[9=6N4GT:[MK"U"+/-.R;XFVSLXVHS;L"#  X///3-Z[^+NCV"AK[2M6@
M"9^TEDA/V4[E4;]LISDNN-F[KSC!PA/3<[VBL/0_%%OX@\,MK-C:SH%5R;65
MXC*"HSM.QV4$C!P6[C.*XC2?C?;2:/)=Z[X=U.SD6-&B6W$<_P!J8I"=B!7R
M&)G3 /&".0<J'9W:[ M;6/4Z*\XF^.'AJ*W>86>J2#RXC%&D4?FW#R*C"*.(
MR;V<!P3\N!ZUMW?Q$TFVET5!#<R#6;87,$A,<:QH=H7?O<$$EU "ACD]*+-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+TC4O%4>@P6UR+E\89Y;<8RF_/E^;YN,?Q!-N>]:'_"$:$+62 0W>'=7$O\
M:%QYL97.T)+OWQJ-S *I  8C')JU;>&-'LS$;6S\IH95FC99'RK",1YSG.-B
M@$=#WR:K2XNA5G\86D:((+.\NKB0NBVT*IO,BN4\OYF"@DJY&2!A&)(JA=?$
M.*U;]YX>U@QI;37$T@-L!"(<"56!F!RI(' (.002.:V;CPQI-R;TR6S*]\Z2
M321SR1ON485E96!0CU4CDD]2:3_A%M'^PBT-JQB%O-;'=-(69)2#)EBVYF8J
M"6)+9YSR:70:M?78HZ/XXT_6?#XUBW@E%N;I+4*EQ;W!+,RJ#F"5UQEQD;L^
MW3,FG>,K+4=(FU!;:XB2&=('C8QLX9V51G:Y (+#*DAASD5;MO#.FVVFFPQ=
MW-N9EFVWE_/<MN4@KAI'9@ 5'RYQ[<FDM/"VDV=K+;PP2-'*T;-YMQ)(?W9!
M0 LQ(52.%''MR:;MK;^MO^"2KZ7.<O?BWH%EI=E?&"\=+RW-PJGR8O+'FK%A
MVDD5$)9N,MC"L<^MZV^(-A=V<-Y;Z??R63*IGND\EH[8L<*&(D.[.1\T>]<$
M'.#FK]MX*\/V<T,MOI^QX2AC/G2';L"!>K=O+7\<GN<V+[PSI6I:DE]>02/,
MN,JMQ(D<F/NEXU8(Y'8L"1VQ0]M"M+^1S&G_ !7L-6TMK_2M#U.^C26&)EMI
M[*0J93M3)%P5!W$ J3N&02 .:NW7Q-T"SO=2LYS<?:M+-N+R&-%D:+SB .%8
MYVY&[&<=LUM)X:TF-=L=J54B %1*^#Y)!C)&>2"!SU( !R!BFS>%M&GGM)I;
M/,EG*\L+>:X(9G#MG!^8%@#ALC('I1I?0GIYE&T\:1W^M6UA9:-J4\5P9ME\
MC6_DXBD\MVYEWX!*]%.0PQWQ9U/Q79:1JR:?>P72RR)YJ.(P4:,9,C[L\! ,
MMG'5<9) J6Q\+:-IEM%;Z=9_98H4FCB6"5T\M97#R!2#QE@#QTQQBKMWIEG?
M2![N 2D120_,3@H^-P(Z'.T4/R*TN9^G^+]%U23RK2ZD\W<B&*:VEB=2^[:&
M5U!7.QCR!Q@]",Y]W\2_"ECJEUIUWJ4D=W:-MGB^QSGRQM9BQ(3&P!&)?[HQ
MUJS:>!M L;^WO;>VN/M-N=RR27T\A8\X+[G.\@,0"V2 <# I$\!>'$U.ZO\
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M+"X=Y%8@#:%0ECE@"HR1W JQ=^/?#]G!'/)=R-$ZLY:.WD8HHC\S<5 SRN,
M DYX!YPD7P_\-PZK!J,=C*+FWQY9-Y,44@*N[87V[B%4%L9.!DFG0>!]&BEF
M>2.6<2>4J)(^!"D<91$4K@D ,WWBQRW7@8:M;43OT)=.\9Z'JU]%9V-S,\\N
M=JO9S1@, 248L@"N "2APP].15)OB5X769(?MMT974NJ+IUR691@;@!']TE@
MH/1F.T9/%2VG@33+'Q@?$%M<WR2%7Q9>?_HPD<DM+LQDR')&XD\<#@"BS\ >
M'[.V>(6]Q*TD/DM-+=RF3;E6 5@WR8901LV[3R,9-(:WU'IX^\-R7<5JNH,)
MY5#B-K:52BGC+Y7Y!D%<MCYOE^]Q3M0\;Z)I4L*7TUQ&+B*.6)TM)9-RN'()
M"J2H C8DL  .IJO=?#S0;B%TBCN;=I85MY9$N&=I8@X8HWF;@0Q!).-V68@@
MDFM:^\/:7J,S2WEKYCO"8"?,9?DPPQ@$=G;\Z>@M3-O_ !UI&F:XVEWJ7R2(
MZHTRV4CQ LH8'>H(Q@\MT7N1Q44?Q*\(2Z+JNK1ZW"UCH\IAOI1&_P"Z?.,8
MVY;)X!4$'MFM.Z\,:3>WL]W=6S22W$7E2?OY I7&/NAL XXR!G@<\"F)X4TE
M-*N--6.Z^R7$@D,9OISY3 @CRCOS%@@$!"H';%3K_7]>HUYF=!\2O"MUG[)J
M$UP-BNI@L;B02;@A"H50[VQ(AVKEAGD5/)X\T""2:.ZN)X&A#E]]I*0-N202
M%(#$*2$/SD#[M33^#-$N8@LUO<,P;<)A>S"4-A!N$@?>&Q&GS9SQ[G*2>"M"
MDN7G:WN!+(K*S+>SKN+ @OP_W\,0'^\ 3@BF_("DOQ-\(OJ$E@NJL;V.W2X:
MU^RS>=L?&T!-FXL=R_(!NY'%27'Q$\,64>D'4M1%D^L@FRBGC8-)CUP#M[=<
M<G'6I(/ 7AZVMY(+>WNHHI5571-1N "P((D_UG$F0/WGW^/O5:/A/2/+LD2&
M>-;&,Q0B*\F3*'JKX<>8/9\T/R H)\1_"K:9)J#ZD\-M&N]VN+2:%@NTMG:Z
M!L;1NZ=,'H13;?XD^%[NQAO;;4'ELYT$D<\=O(ZE>068!2452,,SA0N1DU>E
M\&:!.^^73U9PC(&\Q\@,BQG!SP=L:C(Y&,CDFF7/@G0[R&..Z@N9O+4)ODOI
MV=U_NNQ?,BG/*L2#@9!P*;MT!7ZE-OB;X0C:P6;5Q ^HS""U2>WEC:5B 00&
M4$*0PPQ^4Y&#6OJWB72-#FABU:]6V>8@1AD8[B<],#V/^2*S]/\  >AZ;#:+
M:K>K):8\N?[?,)#PHVL0XRGRK\GW.!A15C4/!^BZQ;V<>LVS:@UG%Y4<D\K%
MR#MR6((W$E 23[^IH=@*-O\ $;P_<K*P:]C\IG5U>RE#'#^6-J[<R;FX78&R
M01U&*N6/C+2]1;4$@6\273T9Y8Y[.2$LJ]2I< -[@'()P0#2S^"]!N69I+)@
M[)Y>^.XE1E'F&3*LK J0[%@PP1V/ JU!X<TRV5A' YWQ21,TD\CLRN07RS,2
M22HYZT@[?UZE:W\8:+=:5=:C%/,;:TE\F9C:2@[\@84;<OR0,KD9[U4_X6+X
M8,,LHOYBD*Y<BRG.&R 8_N<R D QCYQGD"K)\&:/]@OK2);J-+^5);A_M<KN
M2K!@%9F)09'1< 9.,5"O@#P[''*D=K<QB:,QOLU"X4G.-S9#Y#M@;G'S-W)H
M!>96?XG>%X)(TOKRXL3-/)!$UU931K(R#)PQ7'(Z9()Y YXJ>U^(GA:[UNRT
M>/5-FI7P<P6L]O+%(VTD,"KJ-IR#PV"<'%5[OX8>%KN'RS9W$0 P@2]FVJ<8
M!\LL4..H#*0#DXR3FUX>\"Z7X<6V:WN=3NKJ ,&N[J_D:2XW,S$RA2%D(+'!
M93C/&*:MU$[]!D_Q%\,6N_[1?3($=D8FQGXVABS?<^X CY?[HVGGBHM-^)WA
M'6+<7&EZH]U"T;2"2*SG(X!)7.S[^%8A/O'!P*MVG@;0K1)@;>6X:?>)&N+A
MWRK[MR@$X5?G;A0!R3U)-0_\*^T%II'N!?W/F1>3BXU*XDVC!&<E\EL,0&)+
M#/!%+H/J10?$OPU>6<-U8W,]U#<.$A:&V<[LE021CY "P!+[>>.I&;__  EM
ME_PD-SI)M;X-:P///=&#]Q&J[>-^>6.[@ $\'..,UX/A[X:MH88X;*<"&4S!
MC?3EG8L&.]B^7!8 X8D9 .,BMC^Q[$RW,GD?/=JR3'>WS@C![\=.U#WT\_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!XS\?_P#D+?#_ /[#T?\ Z$E>S5XS\?\ _D+?#_\ [#T?_H25[-0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C/Q__P"0M\/_ /L/1_\
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MT"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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B1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>halo-20240304_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X2$*17AI9@  34T *@    @ ! $2  ,
M   !  $   $R  (    4   (2H=I  0    !   (7NH<  <   @,    /@
M$'X<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 #(P,34Z,#,Z
M,3D@,#@Z,#8Z,#(   *D(  "    (0  $%KJ'  '   'W@  "'P     '.H
M   (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                         #E&1#(V1C8V140X0C0V
M-40Y.$(X-35#,#!!-#<S,4(Q       & 0,  P    $ !@   1H !0    $
M !#, 1L !0    $  !#4 2@  P    $  @   @$ !     $  !#< @( !
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MH:";5;U?)V1CY8$/!+8Z<4 =7X?TF/0M LM,C.Y;>()N]3W/YUI4 %% !10
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M)I=[!#); )*DRDY7G.,>H)':NW'3F@!:* "D//6@!$547:BA5'0 8%.H **
M"B@ HH *@NK.UO8O*N[>&>/.=DJ!A^1H =;V\%K$(K>&.*,=$C4*!^ J6@#E
M/B-K7]B>";Z97VS3K]GB]=S\'\AD_A4O@#1?[!\%Z?:.NV9T\Z;_ 'VY/Y<#
M\* .FHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@#S'QGC
MQ+\1=$\-CYK>T_TNZ';UP?P '_ JZO6?&^@:%E+B]5YEZ00?.Y]L#I^- %+2
M?$VN^(+I6L=#^R:<"-US?,59AWVJ.I_''O77B@!:* "B@ HH ** "B@ HH *
M* "B@ HH ** "B@ HH ** $-<KXF\?Z)X:1XY9Q<7@'%M"<M^)[4 >9>&M \
M0^.]5U#Q +PZ=:7DC))(ARS*"/D7'4# '..E>GZ#\/\ 0- *RQ6OVBY'_+>X
M^=L^PZ"@#J!TI: "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "J][>
M6^GVLEU=S)%#&,L[G % 'F5WXJU_QU>R:;X4B>UT]3MFOW&#CV/;\.:S_%/A
M32O!OA)EB'VW6]1<0)-+RW)^8J.WIGKS0!Z=X8TA-!\-V.FH!^YB 8CNQY8_
MF36O0 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 4]3U*UTG3Y;
MZ\E$4$2Y9C_GK7ED%OJGQ5U,7-R9;/PY _R1@X,N/Z^_:@#U33].M-*LH[.R
M@2&",855'Z_6O.48^-?BJ'7Y]*T-< ]5>7_]?_H- 'J(HH ** "B@ HH **
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
M   ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,082
M05$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+C
MY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _OXHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHIC]!\K-ST4[?ZB@!]%>8>*OC/\
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M9O=75TR [3J.J2P_,EBJG^I_X<?"[X9_!_PY#X3^%7@#P1\-?"MIM2#P_P"
M/"ECX5T6)MQ7=]GM(HXRP.X%RH(^8MGDT ?E3\(OVH/VZ/@M\%?C=^V-_P %
M/+?X'_ [X0>#O!0UKP5\!?AII4VI?$*"Z9U6UCU#6FU"Y@^TW;M:V=M8P"7?
M->$RR0",HWYZ?\$P?!J?$#Q?\;/^"\W_  42U_0OA['XSBO?^&?;;QYJ"Z=X
M6^$/@V/=:1ZG:^?\V)X8QIVF*NZ6<&[D3S7OH"/G'_@H-^U5X0_X*7?M0>+O
MAQKGC76/"'_!*[_@GK=P_$G]K#XI>&+6;6$^)>K07D>E0V>F^2CM<F[NIFT?
M3HU1RRMJ5YM9/(K\KO\ @I/^W=\1O^"L?[0/@;]F+]B;X??$+6OV9OA/9V/A
MGX&?!OP5X2NK&[\2WEK;+9S>(+[1XU!MX[5&^Q6:7#JEC;Q%V6W=YJ /[N?V
M/?V^_P!E3]N_1_&FM_LO_$U?B%:?#K5X=$\86MQX<U7POJVBR77G-9R26U];
MPR/#<"UN&AF3*R"&3NIKRS_@J3^W?HG_  3X_9(\:?&7;I^H?$?5Y%\ _!OP
MU?!C::[XEU!)!;RS0J=S6UG&ES>S*,%UL_+# R*U?F7_ ,$NO@-\+O\ @AW^
MQUXT\?\ [=?Q7\!_"KXL?'OQ-!XG\2>'3K2ZIJ>G6>FVL\.C^&=.M+1'GU&]
MM_M6H33'3$FC22^"JSI'YTGY1?%GXC^+O^#D7_@HAX#^!/P\GUSX)_LK?L\^
M"=6\9SZ[KD U;Q+?Z?+J&F6]YKDVG)BWCU'4FDTVRMK5IFCMXHYG,DK-+#0!
M\Q_\$M?V0OB-_P %,OBYX@D\?_V[_P *"'Q(_P"%U?MP?&?Q#>R6VJ?%_5(;
MJXU33?",6H K\CM-+//&N(X5N+FZ9<C3HU_O(_9I^/'[./Q]^'2Z_P#LN_$'
MP+X_^&?@W4)/AS"WP^F4:%X7N-(5(?[+%J%06XBB:W,2"-5:%X7C+1-&U?S7
M?\%3?VROV<?^"9_[(TG_  2J_8/TZ)/C#XW\*#P!KR^&K[[9JGPYL]< M]4O
M]<U2(!KCQ/K<4DT<88^;']J6>011I:QRW/"G[2'P7_X(&_L??#K]CCX8>&4_
M:,_X*$?%AH_'OCCX8>%IKB_6Q\5:[!;QQ_VT]J);A(;.*.RL;33;?_2KJ.Q,
MRK"DSRJ ?T__ !9^+_PL^!_@O5/B#\8_B'X-^&'@;1DW:KXJ\=:_:^'-!L]R
MML5KB>1%9W*X6)26?H%/-=-X.\6^&/'GAK0?&G@GQ!I'BWPAXIT6VUWPWXG\
M/ZI'K6@ZY9W4?G6]Q9W49*2QNC*RR*?F5EK_ #I_^"D?[-W_  40^*/CK]C^
M\_;C^*MQJ?[2G[:?Q%D\(?"3]GPW _LSX+:3<7^DV,336L#"QTYI[C7(XVL+
M9)I$BMYC<74DVX5_H$_LR_ 7PA^R]\ OA)^SUX"\]O"GPB\#67@W2[B[;=?:
MF;>/_2+ZX_Z:W4YN+A_]J9J /=J*** "F.,@?[V#@?,,\<>F/\:?4,X+(0"5
M8\*5 +9P?7CWYX]>,T ?EY_P5C_;]M_V!?V8]0\5>%X(=;^/_P 3[O\ X5U^
MSSX*2#^TKK5_$%XJQ_;I+,<RVVG++%,RC/F3/;P\>=7C?_!*W]B6+]@+]F?X
MA?M"_M(W$VK?M/?&C2K[XW_M0>.]73^U_$.@VT<=QK#Z*+AAYTAM4DN+F['_
M "VOI+@@%4@Q\$_L9Z9K?_!5#_@KE^T#^V1\4M&U1_V>_P!@;Q7<?!C]G#PM
MK=G,VA77B2SNKBVAU!8F^5Y[=K>ZUB;^)9M4TC/RVZ5_4)KVCZ9XAT/5=!UG
M3;76=$U_39M%UC2KR'[59:I9WD;V]S;S*?O1R)*X(. RMR5&6 !_$KXT_P""
MCO[5O_!42[^(?CK3_P!M/X8?\$Q/V!O _B&XT6[U3_A/[6T^._BN(*ICB&GV
M5Q_;]_J,T+^9]DL_LUFI80J;B2,N_P!+_P#!N]XD^+WBC]J/]KV/X:_&_P#:
M"^-W[!WACPW9Z'H'C+]H-;S^U/$GC1KBT>/4--M99YX[&22WCU26>WBD!$$N
MG_:(XY/+K[ T[_@V&_X)F:=\9-1^*+6'QGOO"]SJ9U:U^"\GQ"2#X?:=N<R+
M9QW:6R:P;-=S8C?4&D(^1IF"[3^\?PJ^$?PS^!G@/1?AE\&O 7A7X;> _#5O
MY&A^$O"&CQZ#HUGW>3RHQEFD95+RMOD?DLS$YH ^!O\ @KE_P4!TK_@G?^QY
MXZ^+&GW^EGXQ>*8F\!_ CP[J"QSMJ_B&]1@M]):N,26VE0>;J$P;]W)]E6$D
M-,F?P+_8S_9E_;W_ ."XUA\+/C=_P4>^(FOZ'^QM\/K>'_A$OA_X>T@?#>\_
M:,OK8NLVM+9VXCC2&?#1S:M_$H,5@D"B6:OV+_;%_P""/'A[]N3]O[X(_M2?
M'CXKW7BS]GOX,^ XM)M?V7;W19#HVLZQ;WUU>><]\LP1;2[EFLWO8_*,DRZ7
M#"6\N23/[.Z58V6EV=EIFEV%GI>EZ;91Z?IVG6%M':65E;P*L<,$,*!4C2)5
MV"-%VJ, =,4 <G\,OAIX ^#G@KPW\,OA;X/T/P'X \'Z4FC^&_"GAO3UTW1M
M'@B^ZD4:CDL69F=R7=B68LS,U?G+_P %K_VC-)_9I_X)O?M#^*+[2M$UW5O'
M_A]?@QX2T;Q%I,.N:-=ZCXFWV/G36DP,,HL[7[=?K')\K-8*#UK]62>G3DXY
MK\./^#@K]EWXR?M1_L!W.C? CPYJWC7Q[\+?BQHGQ;C\%:!;O?:[XCL]/M=6
MT^[CL[9&$D\L2ZJMSY$89Y4M'548D+0!]"_\$A?V)M _89_8@^%/PXATR&'X
MB>.-*@^*GQEU1D;[9J?B'6;6WEFM9F903'IT!M]/C4\%;'?]Z1Z^S/V@OVD/
M@A^RS\.M6^*GQ[^(WAOX:>"-%A+/J>O7_D76J2HK.EGI]F@,UW<R;6\NWMTD
MD?:<)@$C^=O0/^"MO_!5C]I7P]X>^'7[)W_!+SQKX"\>-I5OH/B/XJ_&FVU*
MU\">'=06 1W5Q;PWUIIEG B2KOCCN[MR$;8T#-M!_.G_ (*I_P#!+G]KSPK^
MQQ\3OVZ/VU?VD?%'[0O[1>BZQH&FZ?X'\(F9OA;\'M'U75K6TU29B(EC,,2S
M>5Y=E;6MO&UPI>28?,0#J?@?\#OCM_P<*_MTZK^UC\:;+Q+X2_X)V_![Q=<>
M'_ /AW4[J2QC\0Z;I]Q#-;^&](AC()O-1,<=QK=\-_EI<"V68M' B?VZ6-O:
MZ=9VNGZ?:6]AI]C;0VMG9V=ND%I:1*OEQPPQ1C:B1JJ* !M"KC@ D?S/?\$W
M/^"OO[#7P_\ V;_V2_V//@#\.OVC_BS\3_#WPVT#PIK_ ("^%'P7;4[C3]?N
M(UF\27EQ///:VOV8:C=7]U)=QR>48Y&96)&T_P!)/BBVUB^\,>(;/PY<#3O$
M%WH=Y;Z'>2ON6PO)K>9;6=F)Z+(R,=H.2,989- '\WWQ)_;(_:Q_X*!_\%3?
M#W[*'[!/Q1F^%'[/'[%'C.Q\9_M2_&;35:[TSXA7=C??9M3\.R1X,=Y:RLEY
MIEO92XCFN(;V[:1HK:%E\E_X+;?\%S_#OPR\/^-?V/\ ]BSQ1;>+/C/XCM[C
MP/\ $WXP>%IUU31OA=%>*\%UIFA3Q%EN=:D#20R31-ML<MM+77EI!^6_[%7_
M  3K_P""XVH:5\5_V/\ PYX?U?\ 8]^#_COXD2^(_P!H3XU>*+6#1-5^(FV#
M^SV@M]<@D.HZS:F**:6&#39(K>:34IFN+G;(?+]B\!?\$T/@!H7_  6-_9D_
M80^"MOJ7C'PQ^RAX9L_CW^U?\5?$VV^U7XC:[;K;^(([.X1,PV=FC2>$[!+*
M XC&I7.\R2;Y" ?T<?\ !%W_ ()^:/\ L _L=^$_#VJZ>!\;_B]86/Q*^.>K
M31F.\@U&YM_,L=!4'YA;Z/#<26BAOO7#7TP/[^OUUJ)"N0%( VX"9^[M[8]N
M_P"%2T %%%% #)!E<<]?X1DGU'XCC-?@7_P6F^&7[8O[6>M?LP?L(_ 'PCXO
MTGX&?';QA)KO[47QUTO3)+GPKX*T/1;BSDCT_4;S_5H&,DU]'!-\]U<6%LB_
M)YE?OO10!Y-\#?@WX _9Y^$_@#X(?"S0XO#GP^^&7A:U\)^%=)A&6AMK6,*9
M9FZO//(99Y93S))-(Y^9F-?+W_!3[1OVI/$_[#?QX\(_L:Z+/KOQ_P#&7A^W
M\(^%[6RUNQ\.ZK;V.HW]K:ZY<6-Y=RQ01W,>FR7YB<NK*^TH5<*P^^J* /RV
M_P""?G_!-[X2?LQ?L'^%_P!EOXA?#?P?XNO/B#X8AU_]I71O$FFV7B[1?'/B
M+4(;>34H+HNC0W-O8M%'96H^9$BT^W="&+.WX&_!O_@DS_P69_8C^+7[0OPS
M_83^(?P2^''P'^-?CUM;M?BWJ%[H\VLV&CQR71TFU:*[T^\U.S>R@O&A*6D+
M*TD09)#M5A_9W10!_/-^SK_P0(^&-KXRB^-__!03XO\ C3]N_P".4K)=3#Q]
MJFH_\*XTN0;6$(MYIYK_ %"-&4;4NIH[;:6#61&%7XD^/G_!+;_@JG\+/^"A
MG[3/QB_X)T>)?AW\+_A7^U/X;L_#-]\1$U[1_"MQ\,]-:#23=:/%I[PS7UH]
MK<Z;FUNM)@)CMFC$;PDL$_KTHH _DV\;?\&R.CW?P)\-2^!OVCM4/[:\'Q#_
M .%D>,_V@?&T&IZCX<\0W%PK_:;&SLTG-W:F&=DO([^62XNGN(9&8HLVVW_2
MO_@F]_P1M^#7["6K:G\8_&?BK4_VC_VK/$\<TFO?'7QYIGG76B277S7RZ):R
M27$D,ERS,L][+.]S*J[ \2221M^SU% 'XA_\%6?^"9?QJ_;(^*G[)/[1G[,_
MQ3\!_#+XW?LJ^+9-9T>;XFVE[J7A35(5U'3-6LIV^SQ2N9;6ZTM0T#QE;B*[
M=3+&5#']J-(74$L+&/5Y[:[U:.SC35+NSMWL[*XN-B><T$+LS+&6W$*7;;PN
MXXXU** "BBB@ ID@!49Y 8-C@=.<\^G7_@-/HH SM/T^QT_[0+"SL[1;RX:^
MNA96B6JW,TG^LFDV_>=^NX]<<FM&BB@ HHHH **** "BBB@ K,UG2-*U_2[_
M $37--L-8T;5;9]/U/2M5M([_3=1@F4QR0SP2*T<B.K%2CJ5.>16G10!YK\.
M_A!\)/A/!=6OPK^%WP[^&EG?_->VO@#P3I?@VUNBIZ21V<,08J1_$#VYKTJB
MFL,@<[?F'/I_^OI^- '&_$?QUX=^%_P_\;?$KQ??)IGA3X?>%-0\;>)=1E;;
M'96&EVLU]>2'_=BAD('KBOYV_P#@WG\ ^(_BM_PV/_P4C^)-F_\ PFW[77QK
MU"S\*7%RG[VQT&PO);R\A@;_ )Y"^NELA[>'XZ]Q_P"#A#X^ZO\ #O\ 8NTO
M]GGP,DE[\4/VR/B/I_P5\,:1:;OMM]IPGM[K6%7:00)V_LW3#PW_ "&!Q7V)
MX%\<?LG_ /!+3]DWX(?!+XM_&+P#\.;+X7_#BQ\/O:7VIK)X@\4ZDL)FU;4+
M728D:\G-W>R7ER66%ANF&: /TCHK\*_#7_!7[XB?M2>*H_!O_!/G]C;XG_&J
MWDNVAO/C%\8+K_A3OP9T6!-V+N2^\JX=XY!'(RJ_ESG:0EO(WRU^T?@/_A-C
MX3\/-\24\+1^/VT>%_%\?@AKN3P?#?,-]Q'IK71^T-"K-A7F57<;6*K]U0#L
M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBH+A@D,CLR(J*7:21Q$D>!]YF/  ZY.<8SB@!\A(7(!)W# '7
MT'4@=:^5_P!J#]L_]F?]C7PG_P )A^T1\5_#G@.&YBDET70+FZ-YXQ\5/'N_
M=Z3HZ%KF?+*%W*OE*<;W0?,/Q\_;3_X+/>*=8^*LW[&G_!+_ ,!3?M)?M-:A
M<RZ1J_CS2]/37?AW\/&5BEW-:?,+>]DM2K&:ZN)(]/@;&Z64>8B>)Z#_ ,$F
M? GP#^'?Q:_X*(?\%7?B/+^UC\;?!/@R\^)NI>!_$^LW%[\)=(O;2WDETS1[
MIG^?5I7N)+:PBMU2&P#W"Q1V<B,KD _-#XE_&G]J7_@O%_P41\$ZU^QEH5U\
M'_!W[*'ANWU;P9XU\=:_#&WPY:ZU822^*KR2%9'CU"\FCMOLUE8K<R"/18W6
M3$<C+^\G[-W_  0/_9G\!:W%\3OVJ?%?C/\ ;(^-%Y<1ZIK>L_%#49H_ ;W@
MPS,NC^<[W95@P\R_FF$BA"8D("CF_P#@W6_9YOO /[(_C+]IKQ?I%IIGQ%_;
M)^)-]\3+U+33X]-@M-!L;J[L]$MX8451% TTFLW<,:*D:PZA"%C0+S_050!A
M>'/#F@^$](L?#OA;0])\-^'M(@6STG1-#TZ'2-*T^)>%CAM8D6-%7& %%;M%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !113'Z#ME@-W]V@"*[EB@MYIIW2*"&-IIII3B*%%4LS/\ [( .?:OY
M2_VN_P!M3X__ /!67X[>*?\ @GC_ ,$X=7U#0O@GX>N%L?VDOVH;*61?#^H:
M>\LEM?06]W&0XTO/F1Q10LMQJTD++"?LRRR2^]?\%M/VP?BMXK\6?#;_ ()4
M?LA&:]_:&_:HBALOB5JEA>-"/!?A>^::,V,MXF3;"\AL[^>^FZP:?:28#-=(
M*_6O]@C]AWX2_L!?L_>&_@A\+[6*_P!2CBCU;XD?$"YLH[3Q#\3=>>)$NM4O
MB,D*-JQ6]ODK;PHB L=[L 8?[!__  3W_9]_X)^?"V'X?_!S0_M_B35H+<_$
M7XL:]%%<>/?B)=QJH\R[N%7]U;(>8;*';#"C$@.Y>:3\F/\ @N3\2?%7[2GQ
M3_97_P""37P1U%W\:_M#_$/3O'WQOU#39?M!\&^%-/EDDLVO(\_ZL?9;[5V4
M_P /AV ])A7[=?MA?M7_  N_8L^ /CGX_?%J_:/0O"EEY6D:':3+%K/C/5IU
M<:;HVG@]9[J1=N>D<:RR-\D;&OR,_P""+W[,WQ-\<Z[\5O\ @J3^U39E_C]^
MUK*US\--,N8C_P 6_P#!,WEM:_9%/,*7L,-A':KG"Z?86C#FXEH _=WX<> O
M#'PK\!^#?AIX*TZ+2/!_@#PM8^#/"^E1+A;"QTRWCL[6/=W(BBCR<?,VYOXJ
M[:H(N"01@XSUSCH-H]<8&34] !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4Q\[<# R<'<,KCO\ I3ZCDSM&
M.H;(7&X-Z?D>>WW>N* /Y4_^"/%CIG[3O_!6?_@JI^V)XNG&K^(?AS\0)OA+
M\,[?42LMUX:TZ^U?5M)CDCS]R2/3?"6FVBLO/EW4B]&K^A7]J/\ :W^ 7[&_
MPSU3XI_'[Q]IG@_P]903'2],>1;WQ/XLN8H]RZ?H]@/WMS<2!<@+A4&YY'2)
M7D7\2?BG_P $7?VM_A[^U5\>OVDO^"=O[<]E^S)8_M)ZS)XB^)7@76/ ?]J6
M]M>7%Q/>72VDR+-%/"UW=7MU"7ABEMS>2QB209:O5_@%_P $*? =O\1]/^/'
M[>WQ\^(7[>?Q=MA$]K8_$CS(OACI\D?*J=-FGN)KN.)P&2%Y8K7C,EJP5=H!
M\K_!;X)_'O\ X+@_'_PI^US^UEX6U?X7?\$^?AAJDE[^SG^SQJ[-%/\ &7Y_
MEU+5H3]^"=5B%U>'Y9PBVUH6A%R[?U*6$%K:P16EE;PVMI:1+;6MK;0K;VUK
M&@VK'&BC8%4<#9P H!Y%,TZUM+"VL]/T^VBM-/LK-;6SM+6".ULK&&-4CABB
MB4*%0*N%55V@+@;1@'1H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>halo-20240304_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,P,   DI(  @    ,P,   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M!]W45QGPU^)>D_$CP^+NP98+^$ 7EB6RT#'N.F5/9OPZ@UV= !1110 4444
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M7$Y/F%6SL4CC:'.&."3M&>V* '_M ?$,>&K&'X;>$5%E;0VJ1WK1.<K$4PL
MYS@H06SU!'J:\(\(^'9_%GB_3-"M6V27UPL6\C[B]6;\%!/X4[6[F?5VN=;U
MB>:34;Z=9$)"LLRD,9&+ Y!#; %QT)&1MY]D^"%G8>!/A[K?Q/U\!64/9Z:D
MD7^L)*@E3U;<^$R/NA).Q- &Q^T!X^M_"OA^V^&WA0QQ(+5([W8V6@A &R+Z
ML,$]\8_O5S&C0S?!KX-S:_.GE^*/%L/E:?L/SV=I@$R[A]TG<AQG.6C[@@97
MP<\$S_%?XEW>L>)0]QI]M(;R_<CBXE9LK%[ G)./X5(XR#4/Q:\1W'Q0^,$.
MCZ#LDM8)ETO35!PC,6VL^?0MW_N@4 =)^SE\.O\ A(O$K^,]4MVM['3)A]AB
M1<1S38/KDD1_*<]V(R3AJ^JZQ?"'A>R\&>$[#0=,R8+./;O88:1B<LY]R236
MQ)(D,3RS.L<:*69V. H'4D]A0 ZJ&LZWIOA[3'U#6KR*SM4(!DE/4GHH'4D]
M@,DUX[\1OVD-)T..6Q\$FWU>_4E#=.2;=""!\N.9#SG.0O'#'I7SM<7OB_XJ
M^*0LTMYK>IRY,4 R0@R,A%^[&HZGH* /;?&/[4L/[VU\%:>P'SH+^\3)X'#)
M%G&"<8+'CNAZ'R&SA\:?%/4[JYFFDNU2'_B8:G?'%O:1*=^YG(Q$H"YPO)"G
M@\U[1\._V8[*Q$6H>/YA>7*MN73K=_W*XZ;VZM]!@?6F_M#>,K'PCX2M?A_X
M6CAM#=Q@W26^ (;<<*F!W<@<]=JG.=U 'S;8:9/JNM0Z;IBO<S7$PBAV1LQ?
M)Z[0">G. ":^Q]*^"7AGP]8Z#+=7<\\?AXO<MYJKY<LA(=Y2I!*G*1]#TC Y
MR<\;^S3\-&TVQ;QIK5MMN;M-FFAFY6$CYI,=BW0=\9[&LS]I/XI%Y1X)\/7H
M,8!.K/%SELC;!N]L$L/=1GAA0!QWQP^,4WCR_&BZ,?)T"TDWJRMDWCX&';T
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M0$@]E51_$10!QEKHL/CKXD6?AC0;IUT]7CL;-PG#I&/WDQ3.5W!993UP6P<
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M@<YQNP,;3@#=QR0,<BNY_90LM:CAUR[E6=-%F"+%O)\MYP3N*CU"X!(]AVX
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M-)T_6]/DL-8L;>^M),;X+F(2(V.0<'N#SGM0!\R> OVG]1TN(6?CJTDU6!5
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M]Q^!8C\*ZR@#COA[\,/#_P -K":'1$EFN+ALS7ER0TKCLN0  H] />NQHHH
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MMDCK_JS7<? WP&? WPYMDOK<PZMJ)^U7H;[R$_<C.0"-J8R.S%N: /1Z***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7SE^U;K<;_P#".>'%N%C+N]Y.&8X0?<1B
M!DD<R\X)X..]?1M?(?[4MS'/\6;6./.ZWTF&.3([F25OY,* /?\ X)Z"/#WP
M?T& J1+=6_VR4D]3*=X^F%*C'M7>U!96B6&GV]I"6:.WB6)2QY(48&??BIZ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OG?]H/X2>(_%'BRT\0^%-/^WK):K;W44<BJZNK':^&89!# <=-I
M)]:^B** *^GF[.F6IU((MYY*?:!&<J),#=@\9&<U8HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>halo-20240304_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,U,   DI(  @    ,U,   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.16RDGLRTT]@HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%% !1110 5K>'O^/JY_Z]7_ *5DUK>'O^/JY_Z]7_I7JY/_ ,C"EZG+C/\
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M]>K_ -*R:UO#W_'U<_\ 7J_]*]7)_P#D84O4Y<9_N\_0\THHHK[8_.@HHHH
M**** "BBB@ HHHH **** );:XEM+F.XMW,<L;!E8=C7LOAS7HM?TI;A,+,GR
MS1_W6_P/:O%:VO"NNMH6M),Q/V>7Y)U_V?7ZCK^==N$Q'L9V>S-Z-3DEKL>S
M44BLKH&0AE89!!R"*6OHCT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** *^H2S0Z=<2VS0)*D;,CW+%8U('5B.PZFN>T36-7UR'48[+4-+F^
MRSHD.I0VKO;SJ4#,H02]5)P2'([8R#717T5Q/8RQV5R+6X9?W<QC$@0^I4]1
M[9'U'6L2#PY?QIK5R^JQ+JFJQ)%]IM[4QQPA%*JP0N26&XG);^[V% $OA/4]
M1U;3[FYU&2VEC%U)%;2VT#1++&AV[\,[=6#8YZ 'O6!9^,M633+Z;5#!'J$5
MI-/%ICZ7<6[DH>HD=R)% P2$&>1R._4Q:2]C::79Z1=?8[2Q*J\7DJ_G1A"H
M3)^[S@Y'/'O5.TT'4CJUM?ZQJT5[)90O%;"*S\D;G #/)\YW'"C@;1R>.F #
M)T[QS]JN+2REOM+:1[IXY+U6\N&6($A/*4N<NY^4 ,WW7;G 4]K7)7O@=[N*
M,C4\7$J2I?SR0;C<B1HF<K\PV$>2BK]X*H P<"NMH "<#)Z5P6L7YU#47D!_
M=K\L8]O7\:Z?Q%??9-,*(<23_(OL.Y_SZUQ5?G_%>/O*.#@]M7^B_7[CW,LH
MV3JOT04445\*>T%%%% !1110 4444 %%%% !1110 5K>'O\ CZN?^O5_Z5DU
MK>'O^/JY_P"O5_Z5ZN3_ /(PI>IRXS_=Y^AYI1117VQ^=!1110 4444 %%%%
M !1110 4444 %%%% 'J'P\UHWNE/I\[9EM/N9[QGI^1X_*NPKQ+P]JS:+KEO
M>#.Q6VR@=T/7_'\*]L5@ZAE(*D9!'>OH,#6]I3Y7NCT:$^:-NQG:]>36&EM<
M07NGV 5U\RZU#/E1*3C) 9<DD@ ;AUZ]CC6>LZS?^$DUC[9IMBD(G>::2SDE
MCGB1CME0>:I52J[N2<@C\=_4H+^>&/\ LN]BM)D?<3-;^<CK@C:5#*>X.0PY
M ZC(.(O@[.@/IDM\K)=7_P!LOMD&U)@9-[1*N[Y%. .K'&<Y)S7>=!/;ZGK1
M^'KZK-:QOK'V![E+:*%L-)M+(FS<6S]T$ YSG%8X\7WD>BRRS:C8)=)<013O
M<Z9-:+8+)_'+'))N93T#949[G&*ZB^L]2GN9'LM5^RQFU:-(OLZOMFR"LI)Y
M( !&WC.>H/-4(- U%9-1O;C5HSJE["ENMQ#:E(X(TW$!8R[9;+N<EB,D<8&"
M 4_#WC'^W;ZSMVDL[:1K19)H7?$DLI4$K$I.=J<[B0>3CJ&QU=<Q%X+CM=9M
M;BSNA%90M%(UN8MTCR1HZAO,W=#O);*DDY.>373T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !114<\H@MY)6Z1J6/X"E*2BG)[(:3;LCC_ !+=
M_:-6,:GY81L'UZG_  _"LBG2.TLC2.<LQ+$^I--K\0QF(>*Q$ZS^T[_Y?@?8
M4J:ITU!= HHHKE-0HHHH **** "BBB@ HHHH **** "M;P]_Q]7/_7J_]*R:
MUO#W_'U<_P#7J_\ 2O5R?_D84O4Y<9_N\_0\THHHK[8_.@HHHH **** "BBB
M@ HHHH **** "BBB@ KU_P $:G_:7AB .V9;;]R_/IT_3%>05VOPTOO*UBYL
MV/RSQ;U'^TI_P)_*N[ U.2LEWT-Z$N6?J>ET445]">D%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %97B.?R-%D .#*0@_F?T!K5KG
M/%\F(K:+U9F/X8_QKR,ZK.CE]6:[6^_3]3JP<.>O%?UH<O1117XX?6!1110
M4444 %%%% !1110 4444 %%%% !6MX>_X^KG_KU?^E9-:WA[_CZN?^O5_P"E
M>KD__(PI>IRXS_=Y^AYI1117VQ^=!1110 4444 %%%% !1110 4444 %%%%
M!6IX;O?[/\26-QG"B4*W^ZWRG]#672@E6!4X(.0:J,G&2DN@T[.Y[_145K,+
MFSAG'26-7'XC-2U]:M3V HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KDO%KDZE"G98L_F3_A76UQOBDYUC'I&H_G7S'%$K9<UW:/1
MRU7K_(QJ***_+#Z4**** "BBB@ HHHH **** "BBB@ HHHH *UO#W_'U<_\
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M1WIQ3D[+<3:2NPBBDGF6*%2[L<!1WJ;6-8A\+6S6=BRRZM(N)91R+<'L/?\
M_6>PHUC6(?"ULUG8LLNK2+B64<BW![#W_P#UGL*X%W:1V>1BS,<LS'))]:_7
M^%^%UADL7BU[_1=O^"?&9OF_/>A0>G5@[M([/(Q9F.69CDD^M)117Z0?)A6E
MH>N7.A7WG6_SQM\LL+?=D7T/^-9M%3**DN66PXR<7='3ZYH=M<V/]N>'OGLF
MYF@'WK=N_'I_+Z5S-:.AZY<Z%?>=;_/&WRRPM]V1?0_XUJZYH=M<V/\ ;GA[
MY[)N9H!]ZW;OQZ?R^E?"YKE3P[]K2^'\CT(R5576_5',T445\\ 4444 %%%%
M !1110 4444 %%%7=(M#?ZU:6H&?-F53],\_I32;=D"5W8]JTVW^RZ5:6^,>
M5"B?DH%6:**^M2LK'LK0****8!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %07T'VFPGA[NA ^O:IZ*BI!5(.$MGH.+<6FCS3IUHK0UVU^R
M:O,H&$<^8OT/_P!?-9]?A^(HRP]:5*6\6T?94YJ<%)=0HHHK L**** "BBB@
M HHI\44D\RQ0J7=C@*.].*<G9;B;25V$44D\RQ0J7=C@*.]3:QK$/A:V:SL6
M675I%Q+*.1;@]A[_ /ZSV%&L:Q#X6MFL[%EEU:1<2RCD6X/8>_\ ^L]A7 N[
M2.SR,69CEF8Y)/K7Z_POPNL,EB\6O?Z+M_P3XS-\WY[T*#TZL'=I'9Y&+,QR
MS,<DGUI***_2#Y,**** "BBB@ K2T/7+G0K[SK?YXV^66%ONR+Z'_&LVBIE%
M27++8<9.+NCI]<T.VN;'^W/#WSV3<S0#[UNW?CT_E]*YFM'0]<N="OO.M_GC
M;Y986^[(OH?\:U=<T.VN;'^W/#WSV3<S0#[UNW?CT_E]*^%S7*GAW[6E\/Y'
MH1DJJNM^J.9HHHKYX HHHH **** "BBB@ KK/AU9?:/$IN&'RVT3-G_:/RC]
M":Y.O5/AYIOV/P^;IUQ)>/N_X".!_4_C79@Z?/67EJ;4(\TT=91117T9Z844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8/BJR
M\VS2Z0?-"<-_NG_Z_P#.N2KTF6)9H7BD&4=2I'M7GM[:O97DEO)U1L ^H[&O
MS?BK ^SKK%16DM'ZK_-?D?09;6YH.F^GY$%%%%?&GK!1110 444^**2>98H5
M+NQP%'>G%.3LMQ-I*["**2>98H5+NQP%'>IM8UB'PM;-9V+++JTBXEE'(MP>
MP]__ -9["C6-8A\+6S6=BRRZM(N)91R+<'L/?_\ 6>PK@7=I'9Y&+,QRS,<D
MGUK]?X7X76&2Q>+7O]%V_P""?&9OF_/>A0>G5@[M([/(Q9F.69CDD^M)117Z
M0?)A1110 4444 %%%% !1110 5I:'KESH5]YUO\ /&WRRPM]V1?0_P"-9M%3
M**DN66PXR<7='3ZYH=M<V/\ ;GA[Y[)N9H!]ZW;OQZ?R^E<S6CH>N7.A7WG6
M_P \;?++"WW9%]#_ (UJZYH=M<V/]N>'OGLFYF@'WK=N_'I_+Z5\+FN5/#OV
MM+X?R/0C)55=;]4<S1117SP!1110 4444 6=/L9=2U&"S@'[R9PH]O4_@.:]
MRM;>.TM(K>$8CB0(H]@,5P?PVT?)FU:9>F8H<_\ CQ_I^=>@U[V I<E/G>[/
M0P\+1YNX4445Z)TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5@^)]-\^V%W$/WD(^?'=?\ ZU;U! 8$$9!X(/>N/'82&-P\
MJ$^OX/HS6C5E1J*:Z'FE%:>MZ4=-N\H"8).4/I[5F5^,8G#U,-5E1JJS1];3
MJ1J14X[,***?%%)/,L4*EW8X"CO6,4Y.RW+;25V$44D\RQ0J7=C@*.]3:QK$
M/A:V:SL6675I%Q+*.1;@]A[_ /ZSV%&L:Q#X6MFL[%EEU:1<2RCD6X/8>_\
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M>=;_ #QM\LL+?=D7T/\ C6;14RBI+EEL.,G%W1T^N:';7-C_ &YX>^>R;F:
M?>MV[\>G\OI7,UHZ'KESH5]YUO\ /&WRRPM]V1?0_P"-=C8^#M,UJ_@U:Q<K
MIDH+O;$$,K@_='^SG_ZWM\/F642I3YZ/PO\  ]&FU6^'?^M2IX$\+-=3IJVH
M1_Z/&<P(P_UC?WOH/YUZ32(BQHJ(H55& H& !Z4M:T*,:,.5'J4X*$;(****
MW- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\SSW4Q]-X4?H/ZUM67A?1;#!M].AW#HT@WG\VS6M16,J]6>\F:QH4H[1  *
M , = ****Q-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>halo-20240304_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+T17AI9@  34T *@    @ ! $[  (
M   .   !2H=I  0    !   !6)R=  $    <   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M0V%R;65N($=A;'9A;@  !9 #  (    4   "II $  (    4   "NI*1  (
M   #.30  )*2  (    #.30  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
M/MX?_P# *?\ ^/T?5:W;\@^M4>_YGTO17S1_PT)XW_Y]O#__ (!3_P#Q^C_A
MH3QO_P ^WA__ , I_P#X_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_
M /'Z/^&A/&__ #[>'_\ P"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P_
M_P" 4_\ \?H_X:$\;_\ /MX?_P# *?\ ^/T?5:W;\@^M4>_YGTO17S1_PT)X
MW_Y]O#__ (!3_P#Q^C_AH3QO_P ^WA__ , I_P#X_1]5K=OR#ZU1[_F?2]%?
M-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\ P"G_ /C]'U6MV_(/K5'O
M^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\ /MX?_P# *?\ ^/T?5:W;
M\@^M4>_YGTO17S1_PT)XW_Y]O#__ (!3_P#Q^C_AH3QO_P ^WA__ , I_P#X
M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O3_V>_\
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M '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S11[6I_,_O#V-/^5?<<-_PICP#_T
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M * /_DY/_P#%UW-%'M:G\S^\/8T_Y5]QPW_"F/ /_0!_\G)__BZ/^%,> ?\
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M ,77<T4>UJ?S/[P]C3_E7W'#?\*8\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\
MQ==S11[6I_,_O#V-/^5?<<-_PICP#_T ?_)R?_XNC_A3'@'_ * /_DY/_P#%
MUW-%'M:G\S^\/8T_Y5]QPW_"F/ /_0!_\G)__BZ/^%,> ?\ H _^3D__ ,77
M<T4>UJ?S/[P]C3_E7W'#?\*8\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S
M11[6I_,_O#V-/^5?<<-_PICP#_T ?_)R?_XNC_A3'@'_ * /_DY/_P#%UW-%
M'M:G\S^\/8T_Y5]QPW_"F/ /_0!_\G)__BZ/^%,> ?\ H _^3D__ ,77<T4>
MUJ?S/[P]C3_E7W'#?\*8\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S11[6
MI_,_O#V-/^5?<<-_PICP#_T ?_)R?_XNC_A3'@'_ * /_DY/_P#%UW-%'M:G
M\S^\/8T_Y5]QPW_"F/ /_0!_\G)__BZ/^%,> ?\ H _^3D__ ,77<T4>UJ?S
M/[P]C3_E7W'#?\*8\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S11[6I_,_
MO#V-/^5?<<-_PICP#_T ?_)R?_XNC_A3'@'_ * /_DY/_P#%UW-%'M:G\S^\
M/8T_Y5]QPW_"F/ /_0!_\G)__BZ/^%,> ?\ H _^3D__ ,77<T4>UJ?S/[P]
MC3_E7W'#?\*8\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S11[6I_,_O#V-
M/^5?<<-_PICP#_T ?_)R?_XNJ^D^#- \(?%/3/\ A';#[']JT6_\[]]))NVS
MV>W[['&-QZ>M>@US=]_R5/0O^P+J7_H^QI.I-JS;*5.$7=)'24445!84444
M<WX7_P"1B\9_]AJ/_P!-]G725S?A?_D8O&?_ &&H_P#TWV==)0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C/C*_O6\>>
M(8?M7C QVMO UO'H,A\F%C$23*/X02 >/1JV9/B9=:!X<T.6ZTYM5CFL89;K
M43<+ K,V 5C##]ZXY)5>1WQSC9U3P5KLWB;4M7T#Q8=(&HI$DT(T])B?+4J/
MF9N.IZ =:P=0^"D5Q'#%8ZW]GA2TCMW$]A'.Y9"2&1V(,>2<D+UYY] #3A^*
M<+^-Y=#ETOR[:.ZEM/M7VM&DWQJ2S& #<$X/S=/U M>&?B1:>(];@L$AMXUO
M(9)K9HKQ99 J-C;*@ \IBN& RW<9XJ";X9_;/%R:MJ.M27=K'/\ :%M9+93*
MK8/R"<DOY622(^@^O-:OAOPC=:!-;H^M375A90O!9VH0Q@*S[@9<,1(P&%!V
MJ,9.,F@#IZ*** "BBH+R_M-.M_/U"Z@M8=P7S)Y BY/09/&30!/1110 4444
M %%0VEY;7]JES8W$5S ^=DL+AU;!P<$<'D$5-0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5S=]_R5/0O^P+J7_H^QKI*YN^_P"2IZ%_V!=2_P#1]C0!TE%%% !1110!
MS?A?_D8O&?\ V&H__3?9UTE<WX7_ .1B\9_]AJ/_ --]G724 %%%% !1110
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MCW+?[TJC^AKQRBNN.589;IOYG#+.L8]FE\CWGQ;\3;?PI>6=O-ILES]JMEN
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M&M&_[!<?_H35YU7M7Q'\ Z]XBU#3I]*@BE6WLD@D#2A3N!)[_6O/KWX:^+K
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MX6 )C4G/L>U;-(0",$9![&E4ASP<1T:GLIJ9RVEQSO>J;8[6 .6(R />O?/
M)\=ZQX5B_LOQ)IT$-HQMQ%-9;V7 !'.>1@BO*TC2,8C55'HHQ7K/P1O<2:M8
M,>HCF0?F&_FM>5C</R85O=K4]O+\7[7&);)JWZG0_P!C_$K_ *&G2?\ P7?_
M %Z/['^)7_0TZ3_X+O\ Z]=U17S7M'V7W(^L]FN[^]G"_P!C_$K_ *&G2?\
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MKX(MM:FTX7]P7MK73;G3I80F#,LRQJ6#9^7 C]#U]JZBBE96M_77_-A=WO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:N%G5<7.6SOMYI]_+K?[SPO1Q9:?XHTZUTJ WURFH\V5W8M!>VHR<LTL9PX
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MO>$E\03WLEU>%?-LOLMJ!'G[,2VYGY/S$E4].$QWS0!KZ7J-IJFGQW6G2M+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>halo-20240304_g6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+T17AI9@  34T *@    @ ! $[  (
M   .   !2H=I  0    !   !6)R=  $    <   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M0V%R;65N($=A;'9A;@  !9 #  (    4   "II $  (    4   "NI*1  (
M   #.#0  )*2  (    #.#0  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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MC_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\
M@T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A
M8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/
M_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ
M@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\
MA8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\
M/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_X
MJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^
MAR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2
M#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHK
MF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/
M^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#
M2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C
M^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__
M .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ
M.DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%
MC^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P_
M_P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ
M/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'
M+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/
M_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;
M_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z
M'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(
M/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X
M(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\
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M$=0H89/Y4P.P/PKTU=270W\:6"^(R /[/^SOY>\C[GG9QN]L9]JQ$^'.N?\
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M\#1>([FX\L7-X;:VM_+R90JY9]V> #QC')K;U+X:S:=\.X?$W]HK).8XIY[
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M .%,>/O^@#_Y.0?_ !='_"F/'W_0!_\ )R#_ .+KZLHH^N5.R#ZE3[L^4_\
MA3'C[_H _P#DY!_\71_PICQ]_P! '_R<@_\ BZ^K**/KE3L@^I4^[/E/_A3'
MC[_H _\ DY!_\71_PICQ]_T ?_)R#_XNOJRBCZY4[(/J5/NSY3_X4QX^_P"@
M#_Y.0?\ Q='_  ICQ]_T ?\ R<@_^+KZLHH^N5.R#ZE3[L^4_P#A3'C[_H _
M^3D'_P 71_PICQ]_T ?_ "<@_P#BZ^K**/KE3L@^I4^[/E/_ (4QX^_Z /\
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M_P#)R#_XNOJRBCZY4[(/J5/NSY3_ .%,>/O^@#_Y.0?_ !='_"F/'W_0!_\
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M !=?5E%/ZY4[(GZE3[L^4_\ A3'C[_H _P#DY!_\71_PICQ]_P! '_R<@_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWO)8Y8CG(P.1Q5M:M=A/0ZFBBBI **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *YOX<?\ )+/"G_8%L_\ T0E=)7-_#C_DEGA3_L"V?_HA* .DHHHH *YO
MQY_R+MK_ -AK2O\ TX6]=)7-^//^1=M?^PUI7_IPMZ .DHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BF2S1P1-+/(L<:C+.[  #W)KCM7^*GAK
M2V:.&>34)1VM5RN?]XX'Y9K6G1J57:$;F-6O2HJ]221VE%>,ZG\:M2F)72=.
MM[5?[TS&1OTP!^M<W>?$CQ7>Y#ZM)$I[0(L>/Q S^M>C#*<1+XK+^O(\JIG>
M%AI&[^7^9]%45\O2^(M:F),VKW[YZ[KES_6NR^'EW<SZ/XK:>XED*Z8Y!=R<
M':]/$97*A2=1RO8SH9U&M55-0W\_*Y[?17R3'JNH0MF&_NHSZK,P_K6E:^-_
M$]D08->O^.@DG+C\FR*\'VR[!'.X?:@_O/J2BOGS3_C+XIL\"Z>UOE[^="%/
MYIBNPTGXY:9/M36=-GM&/!D@82K]2."/UJU5BSLIYIA:FC=O4]3K@+W3[?3_
M (PZ<^G6R)-<Z?=SR$'!ED)7DDY] /:NKT?Q-HNOQ[M'U&"Y.,F-6PX'NIY'
MY5J5IN>C&49*\7='B'@O1=*U?7!I>D6NI6D7]FR0Z['<2LSPSB0>4"S*%WAE
M)&% P#Q]X5+=W5YX9B.J:#=R1PS37%M9S2HCM<^6Q?:25Q^]F>4_* 2$4 @5
M[5104%%%% !1110 4444 %%%% !1110 4444 <+\7_\ D15_Z_[;_P!&BNZK
MA?B__P B*O\ U_VW_HT5W5:2_AKY_H91_B/Y?J'TKC[?X;Z1-XBGU_Q /[8U
M*9\J;A?W4*C[JI'TP!QSGUKL**E2<=BY14MSG/B!=:58?#O6CKE^-,TZ6T:U
MENA TOD^;^Z4[%Y;EQP/TZUX3X?\=:;X=L;#3K+X[8TVQ"(EK_PA[<QJ?N;R
MI;IQGDU]!7VK3VUX\4:1E5Q@L#GH#ZU7_MVY_N1?D?\ &M8T)_$NIE*O#X7T
M/+/''Q/^&/C./15_X37[%_9>J0ZAG^RKF3S?+S\GW!C.>O/TH;XG_#%OBJGC
M/_A-?NZ6=/\ L?\ 95SS^\W[]^S\,;?QKU/^W;G^Y%^1_P :/[=N?[D7Y'_&
MFL/46W]75OR$\1!_UYW_ #/(/$/CSX5>(O&-UK=UXUVPW.A2Z,]K_9-R>'8M
MYF_9VSTQ^-8N@ZW\*M!M_"$4'C_>?#CW<DC?V+<C[6TXQG[OR;>/[V<5[S_;
MMS_<B_(_XT?V[<_W(OR/^-+ZO/;^NO\ FQO$P?\ 7E;\CP2UUSX8#PEX=\+:
MG\1#=Z'I-Q)<W=JNBW4?]H,79T5FP=JJ6Y'.?;C'IWP4U/0)=#U#1O"WBEO$
M%AITX:!)+&6![**0L4B+2?ZP#:V" ,?E76_V[<_W(OR/^-']NW/]R+\C_C3]
MA4U\Q/$4W_7]=S?HK _MVY_N1?D?\:/[=N?[D7Y'_&CZO,/K%,WZ*P/[=N?[
MD7Y'_&K%CJT]S>)%(D85LY*@YZ$^M)T)I78U7@W9&O1116!N%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7-_#C_ ))9X4_[ MG_ .B$KI*YOX<?\DL\*?\ 8%L__1"4
M =)1110 5S?CS_D7;7_L-:5_Z<+>NDKF_'G_ "+MK_V&M*_].%O0!TE%%% !
M1110 4444 %%%% !1110 4444 %%%<UXN\<:;X3M2)F%Q?,N8K5&^8^['^$?
MY%:4Z<ZDN6"NS.K5A2@YS=DCH+JZ@LK62XO)D@AC&7DD;"J/<UYIXD^,=M;[
M[?PU;_:9.GVF<$(/HO4_CC\:\X\1^+=6\477F:E<?NE.8[>/B./Z#N?<Y-8E
M?1X;*80]ZMJ^W0^4QF=U)OEH:+OU_P" :6K^(-5UZ<RZM?37!SD(S81?HHX'
MX5FT45[48QBK15D?/RE*;YI.["BBBF2%=[\-_P#D"^+?^P6__H+UP5=[\-_^
M0+XM_P"P6_\ Z"]>?F7^Z3_KJ=^7_P"\Q^?Y,\SHHHK\],PHHHH ?#-+;S++
M!(\4B'*NC$%3[$5Z!X<^,>N:5LAU=5U6V'&9#ME _P![O^(/UKSRBFI-;&]&
MO5HN].5CZC\,^,M&\5VV_2[D><!F2VD^61/J.X]QD5O5\AVUS/9W,=Q:3203
M1G<DD;%64^H(KUWP1\8=[1Z?XN8 D[4OU&!]) /_ $(?B.]=,:J>C/H\)FT*
MEH5M'WZ?\ ]?HI$=9(U>-@Z, 593D$>H-+6Q[@4444 %%%>>:!XTU._^)MW9
M74BG1+IY[;30$7F6WV^8=W4@Y8]3TXH ]#HKB]+^*6BZK>PVT-EJD/GQS/%+
M/;!8Y#$"716W8+ #/''3)SQ4=G\6-#O89Y5LM4A2*Q:^1IK8()XU'S",[L,0
M<CTR#@F@#N**Y>Z^(.CV0G-RETBPZ;'J)/E@[DD;:B#!^^6(&.G/6L:;Q^^J
MWVAKI"7NG>9J_P!BOK6^ME24#RRV"#G'8\'- 'H-%%% '"_%_P#Y$5?^O^V_
M]&BNZKA?B_\ \B*O_7_;?^C17=5I+^&OG^AE'^(_E^H4445F:G-:M_R%)O\
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MK%@=HW9  P0">O%===^.=,M;V\M5ANKB6UE@@'DJI$\LPRD:$L,MCDYP .]
M'245G:'K=OKUE)/;1S0O#.]O/!.H#PR(<%6P2/0\$C!%:- '"_%__D15_P"O
M^V_]&BNZKA?B_P#\B*O_ %_VW_HT5W5:2_AKY_H91_B/Y?J%%%%9FIS^IVT\
MFI2M'#(RG&"J$@\"JGV.Y_Y]Y?\ O@UT4VHVL$ICEEVNO4;2?Z4S^UK+_GM_
MXXW^%=D:M11243CE2IN3;D8'V.Y_Y]Y?^^#1]CN?^?>7_O@UO_VM9?\ /;_Q
MQO\ "C^UK+_GM_XXW^%5[:I_*3[&G_,8'V.Y_P"?>7_O@T?8[G_GWE_[X-;_
M /:UE_SV_P#'&_PH_M:R_P">W_CC?X4>VJ?RA[&G_,8'V.Y_Y]Y?^^#1]CN?
M^?>7_O@UO_VM9?\ /;_QQO\ "C^UK+_GM_XXW^%'MJG\H>QI_P Q@?8[G_GW
ME_[X-'V.Y_Y]Y?\ O@UO_P!K67_/;_QQO\*/[6LO^>W_ (XW^%'MJG\H>QI_
MS&!]CN?^?>7_ +X-6],MIX]2B:2&15&<ED( X-:G]K67_/;_ ,<;_"GPZC:S
MRB.*7<[=!M(_I4RJU'%IQ*C2IJ2:D6:I:MI%CKEC]CU2#SX/-CEV;V7YD<.I
MRI!X90?PJ[17&=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<W\./\ DEGA3_L"V?\
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M*VT[3SH_@FU&FV X:=1B64],YZCZGGZ5Z%X$\2?\)#H"^>^;VVQ'/D\MZ/\
MC_,&NV,7&-F?:X2C.C15.<KM&!H?P^U73+G3))[BS86D%]')L=CDSN63&5[
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M  WIBV6F0A$'+N>6D;^\Q[FM.BBOD92E)\TG=GW$8QA%1BK)!1114E!1110
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M_P ?;_&C^R;+_GC_ ./M_C3^L0["^KS74YJBNE_LFR_YX_\ C[?XT?V39?\
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M"UO3M2>$ RK9W<<Q0'H2%)Q^-,#3HHHH **** "BBB@ HHHH **** "BBB@
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M+^3,^<>N[GZU[1157UOYI_<[D)6CR^5OS_S/'M6L[9=,^,DRV\8DD0!FV#+
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M;_<;AOR!S^%<N,I>UH2@CLP-94,3";VO^>A]+44 @@$'(/0BBOAS]%"BBB@
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M*:'L<+&^[U^__@!1117G'JA1110 4444 %%%% !1110 4444 %%%% !1110
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M,3N7C9N< 9Q@=*]%FBCN('AF4/'(I5U/0@C!%<0_P[U!;%M)L_%=Y;Z&2?\
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M*['BY-2TW_56.+ZI&\==O3O<XVZT/[7XD%IIFEQ6.G::/MA*VXBCNKL@B/H
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MO^?4RIX.$)1=[V7EVM^738\ZFTW4I;&\UNUL[FRS-%:6UK;Q-'-!8)(-^Q
MRLW)P.< 8KI_"/V[^RKC[?\ :?+^V2_9/M>[S?(S\F[?\V>OWN<8K>HK.==S
MCRM?U_7YON:0PZA/F3_K7_/\%V"BBBN<Z0HHHH **** "BBB@ HHHH ****
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M0ZM)#F]AA:&.7>WRHQ!(QG'4#G&:;=:+I][<3SW=L)9+BU-G*68D-"224QG
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M)/Z4!N,HK>L? _B74646^C70#=&F3RE_-L5UNF?!;4Y\-JVH6]HO=(5,K?T
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M_P B[:_]AK2O_3A;UTE<WX\_Y%VU_P"PUI7_ *<+>@#I**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** *<VD:;<MNN-/M96]9(%8_J*
MK-X7T!_OZ'IK?6TC_P *U:*M5)K9F;IP>\49\>@:-#_J=)L8_P#=MD']*NQ0
MQ0+M@B2-?1% 'Z4^BDY2>[*C",=D%%%%24%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %<W\./^26>%/\ L"V?_HA*Z2N;^''_
M "2SPI_V!;/_ -$)0!TE%%% !7-^//\ D7;7_L-:5_Z<+>NDK-U_18_$&D-8
M2W5Q:?OH9TGMMGF1O%*DJ$;U9?O(O!!&* -*BN;_ .$7U?\ Z'OQ!_WXT_\
M^1:/^$7U?_H>_$'_ 'XT_P#^1: .DHKF_P#A%]7_ .A[\0?]^-/_ /D6C_A%
M]7_Z'OQ!_P!^-/\ _D6@#I**YO\ X1?5_P#H>_$'_?C3_P#Y%H_X1?5_^A[\
M0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\ ^1:/^$7U?_H>_$'_ 'XT
M_P#^1: .DHKF_P#A%]7_ .A[\0?]^-/_ /D6C_A%]7_Z'OQ!_P!^-/\ _D6@
M#I**YO\ X1?5_P#H>_$'_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_
M .$7U?\ Z'OQ!_WXT_\ ^1:/^$7U?_H>_$'_ 'XT_P#^1: .DHKF_P#A%]7_
M .A[\0?]^-/_ /D6C_A%]7_Z'OQ!_P!^-/\ _D6@#I**YO\ X1?5_P#H>_$'
M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
M^1:/^$7U?_H>_$'_ 'XT_P#^1: .DKF_AQ_R2SPI_P!@6S_]$)1_PB^K_P#0
M]^(/^_&G_P#R+6MHFE0:#H&GZ19M(]OI]K':Q-*07944*"Q  S@<X H O444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>halo-20240304_g7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1[&17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#$Y.C R.C(P(#(P.C,S.C$X   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,Q,0  DI(  @    ,Q,0  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C Q.3HP,CHR," R,#HS,CHT,0 R,#$Y.C R.C(P(#(P.C,R.C0Q      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #1H         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ )P$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
M   ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!
M!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y
M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25
MEI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/D
MY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'
M" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!
M"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)
M2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*C
MI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S
M]/7V]_CY^O_:  P# 0 "$0,1 #\ R/B%\3M=U#Q)>6>FW\]C86LK0HMNY1I"
MIP68CGDCI7'_ /"8^)O^A@U/_P "G_QKV:5""@M#AE4DV'_"8^)O^A@U/_P*
M?_&C_A,?$W_0P:G_ .!3_P"-:>RAV)YY$UKX[\56=PD\7B#4"RG(#SLZGZ@Y
M!KZ;\!>)7\6>$;/594"3MF.95Z;U."1]>OXUQ8RE&,5)&]";;LRI\2?%LW@_
MPG)>VBJUY*XAA+#(4G^(CO@"OFV?QQXIN)FED\0:EN8Y.VX91^ !P*>$HQ<>
M9BK3:E9$?_"8^)O^A@U/_P "G_QH_P"$Q\3?]#!J?_@4_P#C79[*'8QYY!_P
MF/B;_H8-3_\  I_\:[SX8?$K7(O$UKI6J7TU]97C^6//;<T;'H0QYQ[5E6H0
M<'9%0J-2/HJOG[XK_$?6D\2W&B:3>2V5M:$+(T+;7D?&3\W4 9Z"N#"TU.>O
M0Z:TG&.AYU_PF/B;_H8-3_\  I_\:/\ A,?$W_0P:G_X%/\ XUZGLH=CDYY!
M_P )CXF_Z&#4_P#P*?\ QI\7C;Q3#(LB>(-2#*<C-RQ'Y$TO8P[!SR/HOX6^
M,;GQAX8::^"_;K63R9G48$G&0V.Q/>M[Q;KH\,^%=0U@H'-M'E%/0L2%4?F1
M7DSII5>3S.V,O<YCY<O_ !_XKU&[>XEUV^1G.=D,QC1?8 <"JW_"8^)O^A@U
M/_P*?_&O65&"5K'$ZD@_X3'Q-_T,&I_^!3_XT?\ "8^)O^A@U/\ \"G_ ,:?
MLH=@YY'1>#_BCX@T36[=K[4KF]T]W"SQ7#E\*3R5)Y!'6OJ2O.QE-0DFNITT
M).2LSD?B1XIG\)>$)[^U"FZ=Q#"6&0K-W_  U\S3^+O$=U,TTVN:@SL<D_:&
M'Z9K;!THN',R*\W>R(O^$FU[_H,W_P#X$/\ XT?\)-KW_09O_P#P(?\ QKL]
MG'L8<S#_ (2;7O\ H,W_ /X$/_C79?#KXCZYIGB:SL[V^GO-/NY5ADCG<N4W
M' 92>1@]N]9U:,90:L5";4D<3K__ ",>J?\ 7W+_ .AFLZM8_"B'N%%4(*^E
MO@K<0P?#JW$LJH7NY57<>IR*Y,;_  S>A\1G_'2XANO!-C+!(LD9O -RG/\
M":^>:>#_ (0J_P 845U&(5T'@;_D>=%_Z^T_G4S^%E1W/KA-1LY)!&ES&S,Y
M0 -U8=17RC\2O^2C:Y_U\?T%>=@?C?H=.(^%'+!6;. 3CK@4E>F<H8)S@=.M
M% CWSX"W$-KX;U>6>18T%R@W,<?PUU/Q9N(9_A?K@BD5S&85;:>A\Y.*\BI_
MO'S.V/\ "/EJEVMG&#GTQ7KG$&#Z&DP<9QQ2N,5?OK]:^VWN(8CMDFC0XZ,P
M%>?C]X_,Z</U/,OCJZ2> 8&1E93>IRIR/NM7SA6V#_A&=?XPHKK,0K4\-_\
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M^,4?\/C],_Z)=>?^#I/_ (Q7YC44?V-@OY?Q8?7J_<_3G_A\?IG_ $2Z\_\
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MKZF&282*LTW\SQWCZTGH['Z<_P##X_3/^B77G_@Z3_XQ1_P^/TS_ *)=>?\
M@Z3_ .,5^8U%7_8V"_E_%D_7J_<_3G_A\?IG_1+KS_P=)_\ &*/^'Q^F?]$N
MO/\ P=)_\8K\QJ*/[&P7\OXL/KU?N?IS_P /C],_Z)=>?^#I/_C%'_#X_3/^
MB77G_@Z3_P",5^8U%']C8+^7\6'UZOW/TY_X?'Z9_P!$NO/_  =)_P#&*/\
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M ,/?OB;_ -"=X4_[]W/_ ,>H_P"'OWQ-_P"A.\*?]^[G_P"/5\'44?V7@_\
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M?OMT1![LQ5?QK\ OBG\2-8^+7C[6O%>NW+W6H:E<-,Q9B?+7/RHN>BJ,  <
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M* "@444]] .D^'/C[6/AAXVTGQ/H=W+9ZEI\ZS1R1-@G!Y4]B",@@\'/-?T
M?!_XE:?\8/AKX=\8Z9Q9ZM:B?9S^[<?*Z>^UPPSWQ7\[8ZBOUO\ ^"2GC6XU
MSX*^(/#]PYD&B:D&BW,3M29,A1Z &,\>YKY?/<.IT%7ZI_@SULOJN-3D[GW3
M1117PA]$%%%)0 50U_6K/PWH>H:MJ,PM]/L;>2YN)6Z)&BEF;\ #5\FOFO\
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M*[\O_P![I^IRXK^#(_'NBBBOU0^1"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHI/8:W/Z&?@'_P D+^'?_8NZ=_Z31UWP[UP7
MP#_Y(7\._P#L7=._])HZ[T=Z_(:G\27J?9T_@0M%%%9F@4C=*6D;I0!^)O\
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M%O\ U]:C_P"@V]?F+7LY/_N4/G^;.''?QY?(****]LX0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH T/#O_(P:9_U]1?^ABOZ1,X%
M?S=^'?\ D8-,_P"OJ+_T,5_2)VKXOB#>E\_T/<RW[?R_4\+\;?M+1023V7A2
MR^WW$;-&^H7ZM';QL"0=L?#R$$$8^0<<,:[;X,?$63XA>$O/OFC&L6<K6UZD
M0VJ6'S)(!Z.A5O3.X?PUX?\ '/P;_P (?X\DO((]NF:YNNTP/E2Y&//3VW96
M3GJ6D]*Y[P-\0KSX8:Y=:K:VCZA#=6KVL]K'_'( S0,3[/E2>RR.?X:^8Y8O
MW4O0]2[7O?>>M?%#X\ZKX8\?'2]"@L[VRTZ-5OUN=P\V9P'\M'!^0JA4[L,/
MG((^6NZ^&WQ@TCXD226D$-UI^K01>=/8W*9PA(&Y9!E67/'!SZ@5\E*S[99K
MJ?S[B5VGN+E\?O)')9WXXY))]*^F/V<_!;>'_![:U=1[-1UTK<E6'S1VX'[E
M/R)<]\R$=J3Y>5^0U>Z\SUMONFOYN/$/_(?U3_KZD_\ 0C7]([?=-?S<>(?^
M0_JG_7U)_P"A&OJ>'MZOR_4\K,_L_/\ 0SZ***^S/#"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBBD 5^G7_!' X\/_ !2_Z^=._P#0
M;BOS%K].O^"-_P#R+_Q2_P"OG3__ $&XKQLY_P!RG\OS._!?QX_UT/M_XD?%
M[2?ANL-O<Q7=]JES&98+*V3[R@A2S2'"* 2.^>>%:N#^&OQ\U;Q+\0(M+UV"
MRL;#4D9+*.WW%H9E^8(\A/S;EW#.U>54 ?-71?M#^"SXD\&_VM:Q[]3T/==H
M%'S20X GC'U4;@.[1J.]?,99V2.6UG:">-EFMYX\9C=2&1U[9# $5^>+EM8^
MC=[M]CZW^,OQ"D^'O@^2YL]CZQ>2"TL4D&X>8W)<CN$4,V.Y &1FN#\%_M,P
MLT5IXNL?L+N0BZE8*TENY)P-T?+QYXZ;QU^85Y/XZ^(EY\4-9L]2N[5[*&SM
M%MXK1N@E8*T\B]\,X"*3U6-3WK<^!_@W_A,?'\$\R[M-T39>3=P\Y/[A/P*M
M(?0HGK3Y4O=9-W+WCZQ5B3Z9KXP_X*R?\FPV'_8Q6G_HFXK[07K7Q?\ \%9/
M^38;#_L8K3_T3<5TY?\ [W3]43BOX,KGX]T445^IGR(4444 %%%*N2V!UI-I
M:L!*,<9K[:^)5GX'_89\.^%?#'_"N_#GQ"^*6KZ7'JNM:CXNMS>V-DKL0L$-
MOD#@K(-_RGY03G< OBGQD^*WP[^+WA;19]$^%T'@KXB_:/*OG\.2"'2;F+ "
M^7:X)5RQ(P,8QRSY&W@IXJ56S4'ROK_P.QTRI*%US:GB%%?3R_\ !/'XF_8T
MA;5/"*^+FL_MZ^"&UI!K;18SD0[=O3_;Q[YK'^$/[#?Q$^-/@<^*M&N-%L=-
MBO;FQNEU2>:&6T>"+?(TBK"WRYPHP2=S<@ $BWC<.ES<Z[$^PJ7LD?/-%?36
MA_L"^,]6^'_AGQM=^,O ?ASP[X@MUGMKS7M9>S5"P!2)]T.-[9.%7=]TY/3/
MG?Q*_9C^('PK^)VF> ]3TA;W6]6:,:4^FR>=!J D;:AA?C/.0=VTCJ0!@TXX
MNA-N,9J_^0W1J1W1Y30>M?2?BK]@?XB>&?#^MWUMJ_A+Q'JVA6_VG5_#6A:P
M+G5=/CV[BTL.P=!V5B3_  @UGZ7^Q'X]U?X*)\5([_08O"9TBXUAGDN9A,D<
M+E?**^409'PQ4 D<<LO *6-P[7-SKL3[&I?8^?**^D?#'[!?C_7_  ?H.O:A
MK?@_PC+X@0/H^C^)-:^R7VH@@%!#'L()8,,*6!Y&0,U[%^S+^Q;<?#G]KS3_
M  K\1[OP3KJ6>DG4GT>ZD-RNH),DZ((89H0)7C:,N_'R@ @GME4S##TXR<97
M<2XX>I)K0^#**^C?^&/?%'CSXO\ Q!T?PYJOA5?#WARX>>^\2_VB(]%L8WW2
M+&9@GWE&5954[2C XQFN*^-7[-/BSX'Z;H^KZE<Z/XA\,ZQD6'B+PW>_;=/G
M< Y02[1AL D9 R <9VG'1'%4924$_>?_  Y$J4XW;1Y/111748A1110 4444
M@/Z&?@'_ ,D+^'>.O_".Z=_Z31UG?$KXZ:9X!OI-*AM;C5M<6,2&U4>5%&K?
M=:25A@ X/"!CQT[C1^ H!^!7P[![^'-.'_DK'7$?M,^#?-L;+Q=:IF:Q*VM]
MMZM;NWRO]4D/X+(Y[5^2-7J23\S[+:"L7?@O\9]3\:>(M1T?Q +2"[>/[78B
MT1E78ORR1G<225RC9ZG<W "UJ_'+XIW?P_L=,M-':W.MW\I=!<H9$C@CP9&*
MAESDE$'(^^2#\M?-&GZI=Z!JEAJ^G<W^GS+<0J#@28R&C/H&4LA]G-:'B_Q?
M-X_\5:AX@ECE@CFVPVEO*,/#;IG8I'9B69R/5R.U.T?CM\A7?PGNWP]_:(LO
M$=]9Z3KEC)I.K73B&&6#,UM.YZ!2/F0GT<8']XU[#FOFO]F_P;_;/B>Z\2W"
M@VFE9M;0'^*Y9?G<?[D;!1_UT;TKZ6XQQ64[7T+A=H_$[_@IE_R>%XM_Z];#
M_P!)(Z^6J^I?^"F7_)X7BW_KUL/_ $DCKY:K]2P/^ZTO\*_(^3Q'\6?J%%%%
M=QSA1110 4?RKM?@CI]KJWQF\!V5];0WEE<:]80SV]Q&'CEC:X0,C*>&4@D$
M'KFOJ#XN?L;ZU\:/VHOC)I?PWMO#?A_3O"KV<ITV4_88=LMLK!85CB,8Y1R=
MQ49/)KBJ8J%*?)4TTO?[O\S>-)SC>/I^!\58]*.*]L^-/[)?B_X)^&?#_B6X
MU/P]XN\-ZW.;6SU?PGJ!OK=IANQ'N*(23L?!4$94@D8Q7K_PI_8!\9:!\2OA
M[-XNU'P3%<S:C9W]UX(U+5HVU2>R$Z&;-LR;)%$8<LNXY (QGBIECJ$8>TYM
M_P!"HX>HWRV/C2BOT)\:?"[2H/B=^UI9:%\-O!5[I>B:1!+"U]FT;1U-D7,E
ME'';NN\L&;@Q?,!\Y!-?*/CO]F;Q;X$_X5TWG:=K\'CZWBGT.XTAY624R,@$
M3B2-"L@,B94 XW?6HHXZG5LGH]/RN%2A*']>9Y)17VKX'_9LU3X4Z/\ M >%
MM8T'X?\ CO6-!\-1W=UJ<U[<&31B\4[@VVZU.Z8*H;&8OX,R'Y@/)?AK^QCX
MT^(GPZ@\<W>N>%? WAB\F\BPOO%^J?85OF!*XB 5NZL/F*YQQGDU4<=1;E)N
MRT]'H#H2Z(\$HK[X_:9_91?4KS]FWX<^'-&\.^&?&6L:%/!J5W'$D,5Q=0P0
M,[S30(QD/RR8?YB2V>,YKYE\+_LR^*/%\WQ2BL[_ $>)OAS#<3ZL9YI0)EA:
M17%OB([B3$V-^W.1G'94\;2J04KV_P"'LOO"5"<'RV/(:*]\^&G[&/C/XB?#
MV#QQ>:[X5\"^&;N;R+&]\8:K]B6^?)&(L*W=2!NQG'&1S7K7PA_8WUGX*_M4
M?![1_B1;>&_$.G^)_MDPTV,F^AVQ6S$K,LD00G<ZD;=PRI(/0FJF-H0YE&2;
M7Z;BCAYMJZW/BFBN^^/VF6FC?'/XA6&GVL-C8VOB"_A@M;:,1Q11K<.%1%
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M'3=[I;KK?_(CZNK<W-IK_D?!=%?I;_PS'X&^)GQ>\ ?&S3]#TK1_@S<^'/\
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M94^@8'&>H(/>C[%UOU&_CL]NAT]?%W_!67_DV*P_[&*T_P#1-Q7VEZ5\6_\
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M^(?B)JOAV\T)M-!T^&[BFCU&YDASYK0%2I2-\X\D]0.M>;_\,Y_$+^[X9_\
M!I<?_(M=W^T-X_\ $?@[5_#%GH.I_P!EI>P7LT[B".4L8VMP@^<''^M?I7E?
M_"Y/B#_T-LG_ ( 6O_QNO$3?*N:QV6]YVO\ >;/_  SE\0O[OAG_ ,&EQ_\
M(M'_  SC\0O[OAK_ ,&EQ_\ (M8W_"Y/B%_T-LG_ ( 6O_QNC_A<?Q"/'_"6
M2'_MPMO_ (W2YEUM]P6EV?WG;_#[X#^,O#_C[0-8U0Z&ECI\\DTOV.^FEE;,
M$D8"JT"@\N/XAQGZ5]%]J^8?AI\6/&FI?$CPYINI^(&U"POKB2*:%[2"/(%O
M*XP50'J@[]J^GJFI>Z+I=>Y^3/\ P5\_Y+GX0_[%U?\ TIGKX0K[O_X*^?\
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M*](0FS=BIQ@O(NT88;<*1@U[#X3\$^'O!O[?%[#H6G6NA:EX@^'<E]J&BV@
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M*!U!_&BB@#Z<\%?M^>-/!/@CPCX:C\&>!-7B\*1;-(U'5](FN+NT?_GK&YG
M5^GS*HS@5P'@W]JKXC^!_C!JOQ*L]:^T>)-6=VU);R/S+>\1CS%)&,#RQA=H
M!&T !2,5Y%FC^5<<<)0CS>XM=S?V\]-=CZ<UC]O[QKJG@/Q3X.L?!G@/PWX?
M\1VLEM=VN@:,]H%:165YDVS8,C \E]WW%X'.<O3_ -N+QUH_PVD\(Z9H7A#2
MYI=(_L)_$5AHH@U5[/&/*\U6"@8)YV=3N^]S7SN>:*E8+#Q5N3S'[>IW/>OA
MQ^V5XP\!^!;'P?J/A_PC\0?#^GR>=IMIXTTHWXL"<Y$)WJ5')QG.,X&!7F'Q
M-^(^J_%KQMJ/BG6XK&#4+Y@7BTZU2VA7   5%'8 #<V2<9)KE,GOZYHYK:GA
MZ=*7/"*3(=24E9L^E_!O_!0'XE^#?"VC:5_9WA;7=2T.VDM-(\2:SI7VC5-.
MA9 @2&82 <*.K*V>C;AQ7#_!_P#:E\=_!C7O$.H:=/9ZY;^(]YUK2M?@^TV>
MHLQ8EI$RI+'>PR".&(.17D%'7/OUK-8/#V:4%KN5[:=UJ?1'Q(_;>\9?$?X3
MZA\.)?#/@WP_X5NKB*=+30-+>S%KY<B2!(@)2H4NA)W*Q.YN1P!E>,OVQOB'
MXN^+WASXDQ2Z?X?\3:%8QV%LVE0NL3PJ7RLB22/OW"1@PZ$8XS7AE+QU[THX
M.A!6C '6G>_,?6FG_P#!2CX@Z+J.J7NF>"?AWI-QJT;+J<NGZ')!)?.W_+65
MUGW.X&[!+8^<Y!.,>)^-OCUK_CWX4^"/ &H6VFPZ-X/\[[#/:QN+B3S6W-YI
M,A4X/3:J^^:\VHR:(8.A3=XQU_I!*M.2LV?8FO\ QAMOA;_P3_\ #WPYTOQ=
M:ZSXA\77\UWJ%C8W\4YT>RWJ_P!F<(2T9D(1BCX)WS C@BOCOIWY([]Z/2BJ
MP^'C04K;MW)J5'4M?H%%%%=9D%%%% &AX=_Y&#3/^OJ+_P!#%?TB=*_F[\._
M\C!IG_7U%_Z&*_I$/2OB^(-Z7S_0]O+?M_+]3YD_:*\9_P#"0>,8-!MY-^GZ
M'^]GV]'NG7('_ (V_.4_W:\ZT/PKK/C35&TG0U3[;';27;M(N5V1J-J]1@NY
M1!SP"Q_AKTKQY^SWK^E7M[J.A7(\0P7$\ES):W#+%>!G;<Y#<))RQ/.T@?WC
MU]#_ &?_  #/X1\+S:CJ-NUMK.K2"66*12'AA7(BB([$ LY'9I&'.!7S.B]Y
M/;8]35KEMJ]SY>S%JEB0Z_NID(9'&,9R"".?Q_&OK/X&^.I/&_@>+[9*9=7T
MUOL-ZS?>=E *R'_?0JQ]RP[5Y+\4/@_KL?Q$NF\.Z2]]8:N?M@=76.&VF)_?
M!V)X!.).,DEWP#M /I/P;^#MU\.;F\U*_P!6^UZA?0)#+:VJ;+9%0EEY/S.R
MEG ?Y1AC\HZU#246K^A=_>5EZGJK?=-?S<>(?^0_JG_7U)_Z$:_I';[IK^;C
MQ#_R']4_Z^I/_0C7U7#V]7Y?J>3F?V?G^AGT445]F>&%%%% !1110!U7PS^*
M7B?X-^+K?Q1X/U/^Q]<MTDCCNO(BGVJZE6&R167[I(Z?D>:;X+^)WBGX=>,H
M_%?AK6[K1_$".[B]M2JLV\Y<%<%65CG*D8Z#%<O[4>M9.G"3;DKW+51K8]V\
M5_MR?&_QMH>M:+K?CN6^TK6+0V-[:-IUFD<D)# J L(V9#'YEVD\<\"N \:_
M%[Q)\5+_ ,-OXVU&;7+70[6'3;:.&.&U>.S1O]6&2/ .,C>X8]"<XQ7$9I.M
M9QPM&GK&"17M)RW9^E?@7]K#P#X770;J+]I;QM+X0TR**8^"=8\,)<:M</'A
MA ^I1P@%2P52N[!7*E\'(^.?'O[3'B35/VC/$GQ7\'7][X4U+4;QI;9H9 SK
M %5$CD!!5P41<J0RD^V*\;Z\GD]:*Y*.7T:,I2WOIT-9XB4HI=CU7XL_M2_%
M/XY:5;:9XV\7W.LZ;;R>:EDL$-K"7YPS+"B!B,G!8$C)Q7-?$#XN>+?BE:>'
M[?Q/JW]J0Z!8IINF@6T,7D6Z !4S&B[^@Y;)KCZ*[84*4+<L;6,>>4MV=O=_
M%K5Y?A/9_#NTM+'3-#COVU.[ELXY%N-2N",1M<NSD,(EX1555&22&;FMG0/V
MG/BEX5^&=U\/]*\9:A9>$KE'C;3U5"51R=Z)(5\Q$8[B51@IW-D<G/E]%+V%
M-JS5];CYY7W#CG'3ZY_"BC-%=!D%%%% !1112 *_3K_@CA_R+_Q2_P"OG3__
M $&XK\Q:_3K_ ((X_P#(O_%/_KYT_P#]!N*\;.?]RG\OS._!?QX_UT/MOXW>
M.I/ _@>=[.7R]7OV^Q6..JR,#F3_ ( H9_JJCO7R1^YTO3U"J?(AC 5$^8D
M8 '<GMCU)KZG^,GPAN/B/)8W]AJHM+^QBDBBMKE-]LX<J6S@;D8[5&[YA@?=
M->:_#'X-Z\WQ&MF\1Z2]EI^D'[89/,62*ZF# 0A&!R0&!D.0""B9'S5^>Q2:
MWT/HI-WV/.=<\*ZQX)U1=*UY8_MDD$5VK18VE7'* YY*.'0^H"G^*O0/V>?&
M1\-^-)=#N)-MAK?,0)P$NT7CZ>9&,$^L2#^*O2_V@/ ,_BWPO#J6F6SW.L:2
MYDCAA7+SPM@31 =S@*X'<Q@=Z\Y\$_L]Z_K%Q:7^N7(\-6D$R7$<$#+)>ED;
M<ASRD6"JG(+G@\*>:=U+WMNXM5[NY]-J<].E?%W_  5D_P"38K#_ +&*U_\
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M-M5R!G;LW8.0I!!JC\,/V!IO%_PWU?Q=XJ\>6G@&#0=8O-)UJ'4K1'6R:W4
MD2&=%=FE*H%X'.0QX!^B_$7[='A?Q5?/XGTW]HGQ!X(TV:UWMX'C\$6UY=P3
MA<;4O'@:,J6P?G)SS\ZY&WYN\<_M':1X^_8\UGPUJ_B)[_XB:IXV?6KFV:Q:
M SP%,&5C'&(%)8#**>O..]<-.MCYKEDVE==-N_0WE"@MNQ[[^UYX,/BCX4_
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M_P"*<T[_ -)HZYG]I/QH='\*P^';63;>:X6CE*]4M%QYQ_X%E8_H['^&NF^
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M99QDDJ .6 K[)- 44IZ4IR4K6'"+CN?DO_P5\_Y+GX0_[%U?_2F>OA"ON_\
MX*^?\ES\(?\ 8NK_ .E,]?"%?I>5_P"YT_0^5Q7\:04445ZIRA5G2]2N=&U*
MTU"SD\F[M)DN(9-H;:Z,&4X((."!U&*K44GJK =7\3/BAXH^,/C"?Q/XNU/^
MV->N$CBDNC;QPE@B[4&V-448 '.*[G_AL+XN?\)]'XV'BW'B9-*_L1+XZ;:8
M%GOW^5L\K;][G=MW=1NKQNBL'1I.*CR[&GM)+4[31_C%XP\/_#GQ!X"L-7^S
M^$]?G2YU'3_LT+>?(A0J?,9/,7'EIPK <>Y%=EX'_;&^,OPW\'IX5\.^.K[3
M]"C5DAM6A@F:!3_#'))&SQ@=@I&,\5XS1_CFB6'HR5G$?M)+6Y[))^U_\7)/
MB0_CYO%V?%KZ9_9#:D=-M.;3=N\OR_*V=>=VW=U&:\U\)^,-8\"^*M-\2:'=
M_8=;TVY6[M;GRDD,<JG(8HX*G![$8-8M%.-&G%<J6CT$ZDF[MFQXP\6ZMX^\
M3:KXBUVZ^W:QJ<[W-Y<^6D9ED8Y9MJ *,^@ %>@?"G]JSXK?!'0Y]&\%^,;K
M1]+FD,K6;6\-Q&KGJ469'V$]]N,FO)Z/_P!5.5*%2/)*-T@C.47='I?Q ^./
MC7X^ZGX9M_B+XN-];::?LT%_=6L:FTBD*>8[F&,/)PBL2=S?+QR:]&_;:^.V
M@_%GQ7X7\/>"M1GU+P#X.TB'3-+NK@2J]PWEH))6$JALX2-.0"?*S_%Q\W9-
M'3'MTK+ZM3C.$HKX;V^97M9<K3ZGK7PK_:P^+/P4T.;1?!OC*ZTC29',OV*2
MWAN8D9N24$R/Y>3R=N,GFN2MOBUXRM?B*OCV+Q+J0\9"X^U?VT;@FX,F-IR3
MG<NWY-A^4K\N,<5R5'K[]:T5"DFY*.KW)]I+34]2^+G[3WQ0^.UA96'CCQ;<
M:Y86<IEBLUAAM81(<@.R0HBLP&0&;)7<P'4USOQ ^+GBSXI6GAZV\3ZM_:D/
MA^Q33--7[-#%Y%N@ 5,QJN[H.6R:X^BE&A2IVY(VL#J2>["BBBN@S"BBB@#0
M\._\C!IG_7U%_P"ABOZ1U^Z*_FX\._\ (P:9_P!?47_H8K^D=?NBOB^(-Z7S
M_0]S+/M_(_.+_@L=_P @#X6_]?6H_P#H-O7YBU^G7_!8[_D ?"W_ *^M1_\
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M^DD=?+5?JN!_W6E_A7Y'Q^(_BS]0HHHKN.<**** #)HHHH */;M110 4444
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MMQ\,5349.TUT/E\5AW2DVEH<-11Q17MG %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 *%[]J^Q?^"9_P"SW/\ %#XS0>+M0@D'A_PLRW0D
MQ\LUUG]W'G/8_,1@@A2.XKS+]F/]D#QG^TGXBACLK>32/#,3_P"G:Y<QXCC7
M@D(/XW(Z*#[\#)'[5?"/X4>'O@KX%TWPEX9LUM=-LTY)P9)I"/FED;^)V(Z_
M0#   ^:S;,84:;H4W>3_  /5P>&E*2G+8[)0./I3J*6O@3Z,**** "D-+24
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M'2_^BHWG_@E7_P"/T?\ #G'2_P#HJ-Y_X)5_^/T44?VKC?\ GY^0?4Z/8/\
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MY!]3H]@_X<XZ7_T5&\_\$J__ !^C_ASCI?\ T5&\_P#!*O\ \?HHH_M7&_\
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M_P __BS_ ,&,/_QBBBC^T\9_S\8?5:'\B#_ATU\%?^?_ ,6?^#&'_P",4?\
M#IKX*_\ /_XL_P#!C#_\8HHH_M/&?\_&'U6A_(@_X=-?!7_G_P#%G_@QA_\
MC%'_  Z:^"O_ #_^+/\ P8P__&***/[3QG_/QA]5H?R(/^'37P5_Y_\ Q9_X
M,8?_ (Q1_P .FO@K_P __BS_ ,&,/_QBBBC^T\9_S\8?5:'\B#_ATW\%O^?_
M ,5_^#&'_P",5+:_\$H?@K;R;S<>)YQ_<FU"(C](1112_M+%_P#/QA]5H?R(
M]S^%W[+'PM^#TD4_ACP=I]K>QD,M],GGSA@,;E=\E#_NXKU@*.F.***Y95)U
47S3=V="A&FK15AV!Z4445!1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>halo-20240304_g8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g8.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,Q,   DI(  @    ,Q,   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***KZA&DVF744
MLP@1X75I2<! 5.6_#K2>PF[*Y4L_$&GW^KW&G6LRO- JDL'4J^>RX.3C'/'%
M65U73WN_LJ7ULUQG'DB92^?]W.:X;1(1X<US2K#4]-L96D+K::C:-\[9!!+C
MJ1AL<_AFJ>JVB:3K6DWC6VF_V8+W=;R:>V99!NRI=FSNZ<XX]Q7)[>2C=KKK
MY'G?6JBAS26M]=]-O\]ST675=/@NA;37UM'.3@1/,H8_AG-+<ZE8V4BQWE[;
MV[O]U9954M] 37$>)]+T_6-5_L?0[.-M0>?S[R\ SY(YSEO4YZ5"UG97>H>+
MVU8)-/;0A8&G/S(H0X8>^0O/^/+=:2;5BI8JHI.*2]>FS;_(]&!R,CI56+5-
M/GNC;07UM).,YB292PQ[ YK#\/7 N/!-E9/>)'>SV3")7D ?&" P'7 XY]JX
MM;"]TVX\/6S:7;6UTEXI6[BG5VN06ZD+SM'J:<Z[232W*J8IQ49):/\ X&GX
M]3U ZIIZW@M#?6PN2<"$S+OSZ;<YJU7E_BFQ2PE@OOLVFMI?VW>);)R;A^Y#
M,V<]^!Q]*]0K2G4<VTUL:T:TJDI1DK6"BBBMCI"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJO+?VT
M-]!9R28N+@,T2;2=P7KST'7O2;2W$VEN6****8PHHHH **** "BBB@ HHHH
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M'\0^((]#MD58I;B\N0RVL$<9<NX'<#MDC/>MBN3\:OI'F60U:XN["9-SVU[
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M,2*V+>TMK1=MK;Q0+Z1H%'Z5-16\81C\*L=,:<(?"D@HHHJC0**** "BBB@
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M% '&?V=XO/\ R^8_[:C_  H_LOQ:>M]C_MM_]:NSHH XS^Q_%AZZCC_MN?\
M"C^Q/%1ZZGC_ +>&_P *[.B@#C/[ \4G_F+8_P"WE_\ "C_A'?$YZZQ_Y-2?
MX5V=% '&?\(UXD/76/\ R9D_PH_X1?Q >NL?^1Y/\*[.B@#C/^$4UP]=7_\
M(KT?\(CK)ZZM_P"1'KLZ* .,_P"$/U4]=6_\>>C_ (0S43UU7_T+_&NSHH X
MS_A";X]=5_1O\:/^$&NCUU3_ ,</^-=G10!QG_"!S'KJG_D(_P#Q58VI>&-2
ML;HQQP2W49^[+%&3GZ@9Q7IE% &-X5TV?2]%\JZ&V220R%,_=R ,?I^M;-%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH P=8U>]%^=.TBW:2XC42R-N487N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
M" RD, 01@@]Z6B@"E8Z3::<\KVT2AY9"Y;:,KG^$8' ]J<=)TXR;S86I?.=W
MDKG/KTJW10!5ETNPFD:2:QMI';EF>%23^.*<^G64KJ\EG;NR@!6:)20!Z<58
MHH C,$+3K.T2&51M60J-P'IFF)96L=P9X[:%9CUD6,!C^/6IZ* (!8V@N/M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JITVT;5EU-H
M<WB0F!9"QX0G)&,XZCKC-<]XX\<#P8MD3IYO/M9DZ3>7MV[?]DYSN_2N2_X7
MBO\ T+Y_\#/_ +"NVE@\34ASTXZ/S7^9Y]?'X2E/V=66J\G_ )'K%%>3_P#"
M\5_Z%\_^!G_V%'_"\5_Z%\_^!G_V%7_9N+_D_%?YF?\ :V"_G_!_Y'K%%>3_
M /"\5_Z%\_\ @9_]A1_PO%?^A?/_ (&?_84?V;B_Y/Q7^8?VM@OY_P '_D>L
M45Y/_P +Q7_H7S_X&?\ V%'_  O%?^A?/_@9_P#84?V;B_Y/Q7^8?VM@OY_P
M?^1ZQ17#^#/B0/%^M2:>-+-IY<#3>9]HWYPRC&-H_O?I7<5R5:,Z,N2HK,[J
M->G7ASTW=!11161L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4V16:)UC?8Y4A6QG:?7%.HH \U'AS
MQ)XD\0PQ^(?L,<6CW,;F^AMF26[XW85B,$#H<8 /K4\?ACQI#XHN=;\W0;RY
M?*P-=M,?(3)PJ!0 ./KWYY.?0Z*[7C)[)*UK;??]YYZP%/=MWO>]_N^X\_U3
MPQXNO?%JZP)=%NH[<8M(+MI=D/3Y@JC[V>Y)_08V+S2O%.IL8;K4[.VM)].:
M&>.U0Y6X((W*2,[>1W'T[UU%%0\3-VT6GD:+"03>KUU>IYQI/@#6X-1T5M0E
MTB&VTA]R264;":8>CD@#G^IZTDWPWU)_"3V4=U:QZE'J3WEO,KN%56 !4G;D
M'C/0]!7I%%7]>K7O_77_ #,UEU#EY=?O]/\ )'&Z?X)FTW7_  _=6TD'V72[
M)X)02=[NP;+ 8Q@EB>HKLJ**YZE655IR_KJ=5*C"BFH=?\K?H%%%%9&P4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5&A"BG&&W_ 2_0:5@HHHK<84444 %%%% !1110 4444 %%%% !1110 4444
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MI4_@BEZ)(Q?^$3TO^Y+_ -_#1_PB>E_W)?\ OX:VJ*Y_JF&_Y]Q^Y&ED8O\
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MEI7_ #SD_P"_AH_X1+2O^><G_?PUMT5Q?4\-_P ^X_<C:R,3_A$M*_YYR?\
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M_+?_ !5<M_PBWB#_ * 6I?\ @')_A1_PBWB#_H!:E_X!R?X4?5L%V0?7,?\
MS2.I_P"%R>)?^>5A_P!^6_\ BJ/^%R>)?^>5A_WY;_XJN6_X1;Q!_P! +4O_
M  #D_P */^$6\0?] +4O_ .3_"CZM@NR#ZYC_P":1U/_  N3Q+_SRL/^_+?_
M !57-(^*OB#5-;L;"X2S6*ZN(X7:.-E8*S!20=W!P>M<5_PBWB#_ * 6I?\
M@')_A6EX;\-ZY!XJTF6;1M0CCCO86=WM7 4!P22<<"HJ8;!\CLEL73Q>/<TG
M)[GOO]D)_P _=[_X$M_C1_9"?\_=[_X$M_C5^BOC/8T_Y5]Q]R4/[(3_ )^[
MW_P);_&C^R$_Y^[W_P "6_QJ_11[&G_*ON H?V0G_/W>_P#@2W^-']D)_P _
M=[_X$M_C5^BCV-/^5?<!0_LA/^?N]_\  EO\:/[(3_G[O?\ P);_ !J_11[&
MG_*ON B\E_\ GXD_)?\ "CRG_P"?B3\E_P *EHK4 '3UHHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%9FB:=/817<EX8_M%Y=-<2+$253("A02 3@*.<#Z5IT""BBB@ HHHH ****
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M6Z8-;PMP2$\O!<]SN] ,#JW2]#U**YTH:BUKY.D0M%"T+LS3$J$#," %^4=
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\4:Y_PC?ANZU;[/\
M:?L^S]UOV;MSJO7!Q][/2M:LGQ1H?_"2>&[K2?M'V;[1L_>[-^W:ZMTR,_=Q
MUK2ER>TCS[75_0RK<_LI>S^*SMZ]#SO_ (7E_P!2]_Y._P#VNC_A>7_4O?\
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MVD5Q->"0@S3F)5" $\A&)Z^E8<.DNGCJTMRZF&&SBN[A .LR!HD.?0@D_P#
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MKY>W"G 5<[CW..U :&CXEU[_ (1[3HKH6K76^81E%?:0,$DC@Y("GCO5>_\
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M::")=1M#)<*&A03KF4'H5&>1P>GI1;:QIE[=-;6>HVEQ.H):**=688ZY .:
M+E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !114<\\5M"9;B18HUZLYP!0!)14-M=V][%YEI,DJ9P2ASBIJ "
MBH+N^M-/@\Z_NH;6+.WS)I BY],FGV]S!=VZ3VDT<\+C*R1.&5OH1P: )***
M* "BJ]Y?V>G0B74+N"UC9MH>>0(I/7&3WX/Y5+!/%<P)-;2I-$XRDD;!E8>H
M(ZT /HHHH ***H76O:197#6][JMC;S+C='+<HC#(R,@G/2@"_151-6TZ2ZBM
MH[^U:XF0/%$LREG4C(8#.2,#.1VI(]8TV:^-E%J%H]VI(-NLZF0$=1MSGB@"
MY1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@
M>*])UG5;:!-"U'["Z,3)^\9-XXQRHSQS^=;]%3**G'E9%2"J1<6><?\ "'>-
MO^AC_P#)Z;_XFL*V\!>)5U4)'$('C;<MUYN%!'1@1S^0S7LE%<LL'3?5G!++
M:,FKM_>><?\ "'>-O^AC_P#)Z;_XFM;PWX=\3:;K"7&KZU]JM@I#1?:))-QQ
MQPP&.:[&BM(X>$7=-_>:PP=.$E)-Z>9RGAF\TV'3;?3-0:+^UEN6::VE7,QF
M+%O,VXR<@AM_3'.:R8]1G:Q@EM]1N9-89;C^T;8W#$0H$<DF/.(MK! I !.>
M^37H-%=!W7//HH;AHXT;5=3(ET+[<Y^V."9AT8'.5'S?=& <#(.*FN]4AFU'
M3&US5[BQMI]'$[F*Y:%6E..<KCG!.!WQC!Z5W=5#IT)UD:GN?SA;FWVY&W:6
M#9Z9SD>M 7//[G7KY$L?/GFAU*-;,.LMZT9<L06VP!<."I.YF/!R!T .F)+D
M7L]]]OO"\>OI:K&;AO+$1905V9P?O'J..,8KN** N<C:W%\WBL:$UQ<%+6Y>
M^:3><M R_)&6/4;W88]$%:/B?_6:)_V%8O\ T%ZTH=.BAU6YU ,[S7")&=Y!
M"*N<!>.!EB3[U;H X_5[N#3/$4TUE=V]Q<W$UO'<:7.F9)""NUXN_ (.<,N0
M>A!K/\/B>*70)KYHVL_M5VENT:;6CE9I %<DG<&&[&-O.,YKT"B@+A1110(*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH X^;P]XE>9V36?E)R/](D7] .*J7WACQ%);'S[T7BJ<B+[0[<^H# "N[HH
M X#3?#'B!(6>WN/L.X\J9F0M[G;G]:N?\(YXG_Z#/_DU+_A79T4 <=JEKJ5A
MIFCQW,R7MV-6C*>9*P4_*V 6P3^.#5+4+>^T>XA2]N(+:UOI[FZE*ZA):1+,
MQ7:GG*N3\NXX(4,<GMBN^HH'<X;4;O4(K/1([_4+=[9[9S+>+J3VL4THQL_?
M(I)^4L0. Q!/;%6M'6[NO$-G%J&I270ATJ*;-K=-Y,LGF, _RXWY '7@]P>,
M=?10%SEM2N(M/\6S76H7%O:&2S2.PN[M"88F#.9%)W*-Q&T]02![8JC8W$VK
MS>'DED:VAN/MS2QZ>[V\<VV0;6^5L\_>SGG)YP3GMZ* N<3%?2-J,'^GW']M
M'5#'/8^>VU(-S#_4YVA/+VMOQR2#GFFG6G%[!8&_D^V#7W5X?,;<(-S%01_<
M(*XSP>U=Q10%S@O">H&XFT,PZG<WEU-%-_:$4MPTFQ0/E9D)PG.T X&X'.3G
M-;WB+_D-^'/^O]O_ $3)6II>G1:1I<%A;,[10+M4R$%B/? %6Z OJ<C<W5M8
M^*F%E<V]W+>WL*W.FS1YF1@N/.C/4*J[6.01A3@BLV 3)?>;=O&=-7Q%)G8F
M)(Y<D(Q8D@H6(!  /(Y/(KT"B@+A1110(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>halo-20240304_g9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240304_g9.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,S,0  DI(  @    ,S,0  ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB761IVB2W-VND17D):>\-MYN&_A&WMD '\?:IE7C%M-,SGBHP;4D]/3O;O\
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M#INAP>7IMLL9(PTAY=_JW7\.E:-%%=22BK([HQC%6BK(****904444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'*>._$]QX=L+=+ *+FZ+!9&&0@7&3CUY%<98^._%-\/[/M62YNISB-Q"-XXY
MQC ]\D5Z+XE\-6OB6P6"X=HI(VW12J,E3WX[CV]JS?#'@2U\.WIO)+EKNYVE
M48Q[ @/7 R>>V<UPU:=>57W7:)Y5>CBIXCW96AZ_?\S)TKX<S7=Q]M\57;SR
ML<M"KDD_[S_T'YUW5I96UA;+;V4$<$2]$C7 J>BNFG2A3^%'=1P].BO<6O?J
M%%%%:FX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^C>,[#2[GS(IK: VI,; RJF0['(X.6!YQUJW9ZG<^%-&U#0+=7:36+6WGTX
M?Q3*JN!^9Q[K7JLGA?1YO[2\RSW?VKM^V?O7_>[>G?CKVQ2R>&-'ENM/N9+)
M6FTU EJY=OW8'0=><>^:V>.I.]TVG9_-)6_%?=]QSK+:T;<LDFKK2^S;O^#T
M\_O.1^&&G+I&K>)=/0[A;30Q;A_$0K G\3S7H=4K+1['3KR\NK.#RY[YQ)<-
MO8[V&<'!.!U/3%7:\[$5?;5'/O;\CU<+1="DJ?:_YMA1116!TA1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %5;;3;2SO;N[MXBL]XRM.Y=CO*C ZGC XXKS?QG\3M8\.>++O2[*UL9
M(8 FUI4<L=R*QSA@.IK"_P"%U>(/^?'3?^_<G_Q=>G3R[$S@I1V:[GD5<UPD
M)N,]XOMUV/;Z*\0_X75X@_Y\=-_[]R?_ !='_"ZO$'_/CIO_ '[D_P#BZ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% 'SU\4O\ DH^I?2+_ -%)7(UUWQ2_Y*/J7TB_]%)7(U]SA?\
M=X>B_(_.<;_O-3_$_P PHHHKH.4**** "BBB@#UCX'??UOZ0?^U*];KR3X'?
M?UOZ0?\ M2O6Z^.S+_>Y?+\D?>91_N4/G^;"BBBO//4"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY-?[[?6OK*ODU_OM]:
M^@R7_EY\OU/E^(/^7?S_ $$HHHKZ$^7"BBB@ HHHH *^A?A;_P DXTWZR_\
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MI4MY!.ENL9AD56., 8(RIZ]>/<5'X&\<WT]KJ(\4W0E>"U%]#)Y:INBQ\PX
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M  3Y[_6#_IW^/_ /K*BODW>W]X_G1O;^\?SH_L7_ *>?A_P0_P!8/^G?X_\
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MH **** "BBB@ HHHH @O+R&QM7GN'"JH)QD9;V&>IH2]MWLTNC*B0LH.YF
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M /BJ/^%;^+?^@-)_W]C_ /BJW^M4/YU]Z.;ZGB?^?<ON9R]%=1_PK?Q;_P!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;"SE*HMT6:***\4]\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA6 Q0%S)U'S[+Q18RB34(8IKP))/+<;H) T9"Q+$K''./F*KR"<DD9ZFLU=
MTY;X7?DR&02F95:>1HUD.<N(RVT'D\@=ZTJ "BBB@04444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP_!UW<77VS[3<2S;=FWS'+8^]ZUG6OB1)/&GF)JD;P7-S)8+:>>&\O:HV2;
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .8U'6Y-/U7
M6+W$DT.F6L*"V63:'>1B2WIG 4#\?6DF\67UJ]VMWI"(+$Q-=,MWN"QR8P5^
M0;F&6R#@?+PQS5F]T$WVK:C%,KBQU&UB$DJ,H9)(V/ SZ@CM_"?:K-YX<M+[
M^TO-DF']HK&LNUA\H3IMX_/.:!Z&1J^JW']N_9(IIXUAU"R4@. I5]V1@*#@
MXY!)S[5#I>OR6>CZ/+?3W$BR?;'F8N&RL>]N=P). .,%?Q'%;MQX<M+G4GO7
MDF$CSP3D!AC=%G:.G3GG^E1Q^%K!+>S@9II(K3S@JNP^<2@A@V!_M'&,4#T(
MH_$=S&/^)CIR6YELWN[8)<>9O" %D;Y1M8;EZ;AUYXYJKXPN4LVGNM(\O?8B
M^@5+C?N3< =_R_+C<"2-W&?3%:%OX:@B1EGO+N[/V8VL33LF88R,$+M4<G"Y
M+9/RCFGC0(HOL[6MY<V\MM9BSCE382$RISAE(S\@'3N>/0%H4[O4IVAT745F
MA"R7JP.MI<F:&1),K]["[B#M/3@@UT5<_+H#0G3K6U\R6(7[7UU<RLNXL,MR
M!@<L1T& !704 %%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140554611227504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">PRE 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Halozyme Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001159036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140554607733136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="text"><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Pay-Versus-Performance Table</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based on:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary of Compensation Table for PEO ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid to PEO ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Compensation Actually Paid to Non-PEO NEOs ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Peer Group Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Millions) ($) (5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue (Millions) ($) (6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,820,858</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,608,264)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,568,762</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,639</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208.46</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281.6</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,696,978</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,817,187</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415,581</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,154,512</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.65</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">660.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,453,294</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,992,078</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,398,657</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,581</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402.7</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">443.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,518,876</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,374,731</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,812,287</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,356,681</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240.89</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268.0</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Helen I Torley was our CEO for each of the four years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#8217;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span>See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2023, 2022 and 2021. The 2020 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar year 2021. The average compensation for the Non-PEO NEOs for 2023 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in calendar year 2023, 2022 and 2021, respectively.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 11,820,858<span></span>
</td>
<td class="nump">$ 9,696,978<span></span>
</td>
<td class="nump">$ 7,453,294<span></span>
</td>
<td class="nump">$ 6,518,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="num">$ (3,608,264)<span></span>
</td>
<td class="nump">22,817,187<span></span>
</td>
<td class="nump">5,992,078<span></span>
</td>
<td class="nump">24,374,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2023.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"></td><td style="width:83.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2023 ($)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,820,858</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,088,804)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,803,183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,608,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 3,568,762<span></span>
</td>
<td class="nump">2,415,581<span></span>
</td>
<td class="nump">2,398,657<span></span>
</td>
<td class="nump">1,812,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 160,639<span></span>
</td>
<td class="nump">3,154,512<span></span>
</td>
<td class="nump">591,581<span></span>
</td>
<td class="nump">4,356,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2023 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"></td><td style="width:82.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2023 ($)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,568,762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,806,488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160,639</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img alt="CAP vs TSR.jpg" src="halo-20240304_g8.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This column shows Halozyme&#8217;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our net income for each of those years.</span><div style="text-align:center"><img alt="CAP vs Net Income.jpg" src="halo-20240304_g9.jpg" style="height:369px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure [Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">This column shows Halozyme&#8217;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2023 executive compensation program because it is used in </span><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">determining each of our NEO&#8217;s annual 2023 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our revenue for each of those years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><img alt="CAP vs Revenue.jpg" src="halo-20240304_g10.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group [Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img alt="CAP vs TSR.jpg" src="halo-20240304_g8.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List [Table Text Block]</a></td>
<td class="text">ollowing is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2023 with Halozyme performance.<div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue (as used in our 2023 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA (as used in our 2023 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock Price (including relative TSR, as used in our PSUs awarded in 2021, 2022 and 2023 and as described in the Compensation Discussion and Analysis above)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial performance measures listed above, we view our stock price, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 208.46<span></span>
</td>
<td class="nump">320.93<span></span>
</td>
<td class="nump">226.79<span></span>
</td>
<td class="nump">240.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">118.87<span></span>
</td>
<td class="nump">113.65<span></span>
</td>
<td class="nump">126.45<span></span>
</td>
<td class="nump">126.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 281,600,000<span></span>
</td>
<td class="nump">$ 202,100,000<span></span>
</td>
<td class="nump">$ 402,700,000<span></span>
</td>
<td class="nump">$ 129,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">829,300,000<span></span>
</td>
<td class="nump">660,100,000<span></span>
</td>
<td class="nump">443,300,000<span></span>
</td>
<td class="nump">268,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure [Axis]: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure [Axis]: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure [Axis]: 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">relative TSR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=4', window );">Measure [Axis]: 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">stock price<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Reported Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">$ 10,000,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Outstanding, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">6,462,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(8,088,804)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(3,803,183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Reported Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">2,700,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Outstanding, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">1,755,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(1,806,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(657,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockReportedValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockReportedValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>21
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MLPX.*MF BN:CH@58:)*%W(9L<-4;()[E^=S^>?I3P]-=V^ONL%-+'ZMY5+0
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M?1]=]0<3\)AFWWFSW_T'4$L#!!0    ( +:!9%CR[WNK!@,  "T0   -
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M   3    6T-O;G1E;G1?5'EP97-=+GAM;,64ST[#, S&7Z7*=6HR=N" UEV
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +:!9%@T\+,:[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( +:!
M9%B97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ MH%D6 SY=7I] @  _08  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( +:!
M9%CBO]WNO10  "Z?   8              " @< *  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " "V@618\N][JP8#   M$   #0
M        @ &S'P  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +:!9%B7BKL<
MP    !,"   +              "  >0B  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( +:!9%BR3/MO5 $  ,4"   /              "  <TC  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " "V@618C?<L6K0   ") @  &@
M    @ %.)0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" "V@618;J<DO!X!  !7!   $P              @ $Z)@  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "@ * (0"  "))P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>20</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="halo-20240304.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="halo-20240304.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="PRE 14A" isUsgaap="true" original="halo-20240304.htm">halo-20240304.htm</File>
    <File>halo-20240304.xsd</File>
    <File>halo-20240304_def.xml</File>
    <File>halo-20240304_lab.xml</File>
    <File>halo-20240304_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>halo-20240304_g1.jpg</File>
    <File>halo-20240304_g10.jpg</File>
    <File>halo-20240304_g11.jpg</File>
    <File>halo-20240304_g12.jpg</File>
    <File>halo-20240304_g2.jpg</File>
    <File>halo-20240304_g3.jpg</File>
    <File>halo-20240304_g4.jpg</File>
    <File>halo-20240304_g5.jpg</File>
    <File>halo-20240304_g6.jpg</File>
    <File>halo-20240304_g7.jpg</File>
    <File>halo-20240304_g8.jpg</File>
    <File>halo-20240304_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2022q4</BaseTaxonomy>
    <BaseTaxonomy items="61">http://xbrl.sec.gov/ecd/2022q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>27
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "halo-20240304.htm": {
   "nsprefix": "halo",
   "nsuri": "http://www.halozyme.com/20240304",
   "dts": {
    "inline": {
     "local": [
      "halo-20240304.htm"
     ]
    },
    "schema": {
     "local": [
      "halo-20240304.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_def.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_lab.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_pre.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "halo-20240304_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "halo-20240304_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "halo-20240304_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 6,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2022q4": 3
   },
   "contextCount": 20,
   "entityCount": 1,
   "segmentCount": 9,
   "elementCount": 219,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2022q4": 61,
    "http://xbrl.sec.gov/dei/2022q4": 4,
    "http://fasb.org/us-gaap/2022": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20240304.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20240304.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20240304.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20240304.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r56",
      "r68",
      "r84",
      "r112"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r61"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240304",
     "localname": "EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240304",
     "localname": "EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240304",
     "localname": "EquityAwardsOptionsAndStockOutstandingUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Outstanding, Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockReportedValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240304",
     "localname": "EquityAwardsOptionsAndStockReportedValueMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Reported Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240304",
     "localname": "EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockVestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240304",
     "localname": "EquityAwardsOptionsAndStockVestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Vested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r72"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r129"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r104",
      "r113"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r55",
      "r67",
      "r83",
      "r111"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r63",
      "r79",
      "r107"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r52",
      "r64",
      "r80",
      "r108"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59",
      "r71",
      "r87",
      "r115"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r54",
      "r66",
      "r82",
      "r110"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>28
<FILENAME>0001159036-24-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001159036-24-000011-xbrl.zip
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MA.A ;;WK;$M2:,";O79GK]7RQLU1TSMCZ.7R/5QY$X?V1FH*>K"8) +^9](
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M?!&P3\LJ3%GM>4-I!Z3,2@7#B:\A=\2B*4YE;?>N3U^G6YV5S]=AO#G;8;Q
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MING0+97I6M_'J&7:^)EVE,O$L \LE0 %]RVWO0*K!UXSV%6?"A."O4=F"G$
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MXG%##)@=BG;$= IHT[N SQ,P*1*=;$HRV^?CK)JY-#R&+RQ-PY=DV/!NX$3
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MD/5XZ&&$6QV\29H'$PU_269>ZKU$4[?3>O<5#$3Z9_O=*Y".L3S/@R0?>-T
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MZ19\!ZXRZN>A\4<J![@!/L"()?D7VQ;'7=E,=!KYY2":*9I,A3<46I%*7\L
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MI^&6EZKJO(2P-XUED4HHD# L#G\HIXA>+(Y^4<D)" RF:>U8E[MP* <[BF&
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MA09RCBZ"1XT>C:O"W;K!G-Y@UU#1HX&?:(6F""X'<9,X&S([-*:'\FL/0M7
M!(64L"7>64UY/P2S8%IUB?<DS@XFMR4?K=OXD9U-L-;#3_I,W \7;W)"_N#$
M1 ]S9\:?T+.D!GW4D3SE6S5=WK0<.$H)ZDWGB.O%4<)N!*HWC*F\*!G!M6^@
MFSZAH&@J/_2/4[)NKTAO+@+JCHSP>;9:=+M& >9XC;XT>-*1F DM4'6L1<?1
MM3(E.:C NI]JU&N(ON3 :6UO_<O9D$NQE_=NK$*\;G(>J!I_*U".8CLN.*DB
M@1'**4SN(:L0AG0QE :Z^K>TH?)43'=YT);O2L<[-NC> 1X!2"@%1<7[O\:*
M\;@8^65,@33@+C0:W;2O$PG".))R1*^;Q\H9%#E -%\/JPX";FN=!YJZ2!R/
MKXKFS3B\E!ZIU')ZV=SS'449IT9,*J$P^F1HS!@RQM(4O=1PG<'YBL(4K:U6
M$^[#C&,C^  NQI95:CA7$5THJ&>:':<1M4'K@F%OZGJF>G@A&E,!/66?>\[D
MK=CGP5"_Q03ZT>M/H"^KKY==0;$.Q\.\P:N&Q#7S:X>U+[%Q;@@3OQWE(8)"
MA*#QXK&OO(@#@=+ZHR8 A4_$+JS@IMP49J3SG17U'?K#9AY1[!1[AL'$CD_Y
M5> !#6VOBO(0@?*%M;HXB)[F)MQ-^88OP*:6D*^QO_+U<]3(;Y[P3Q5AYI3>
MP2Q),Q?4  X//$"227=7/B3UI87])GT0BNS&[SAT9I.]]J4[<X;!C[^QLHU<
M+>QY#,\A?[/GIJXT>#7ZTRC='8M"@7M72&5UX.YB>AK[KF#=7#RQ<0772"&>
MO)=YNJMGH4I*A]^D8A+%C( 3\DT99#+TO83#145/@$K+7(&%QP83V].P_D Q
M_&" H?U8UQ2&$KO48K?6I$\(%O0>MG3-A*P)^K[&USIF[Q\%<A& N=CX<'RQ
MR1(XO89W3UPLI8-3U,,C53ZDE1D^<0JW=ZJZDS-;T2?TKL8WH2P$S"ID\#S\
MO\#MQS8//+JA^XIRX ST66'!(#W1]+/&Y#F'02CNY3S")2W8W97R0\>-7+')
MJ][*)!'CYJSXA?K8;D F!:5F7RVSES8#6L?_=QV.XK'T?]X&3O$28'Z93L @
ML&I7NE*(JM/U<)RS;9;6BF@G_4!'D;A+#7>$@=.CG'P?-Z//E6&O&(NSY?IE
M^!:%=Q7L7HS0,X9W<X:]J*$2>;=RSGD7'GEOM9%L-L#"!)*K%=1CXMX0=M?*
M98!MA_NACG/ 3/Q;RM?>XI&9FE[N,D\3,]%9FKQSWYA7D%:_]\R1AF7WANU0
M&R4.\Z:E1/1:--@Z?Q@DQ"!92?T7-F+2QY\'[G<L!\##ER_FE-PDP556>#^0
MSB??(_3SWM@P1KBENSM:M9:ZP]7#$ $\.%>CLNR!0X@3H\=6D<8)'-->4@KV
M5B[3.FAC[M>2=]B+AA@U<ITIDF&UQ%H8#A"C1NIB4NW -DR]) =1\]M2Z8&$
MA92G/B#N)GQ@F-=)@7O7BPB3FK)_/&<I5@=1;_QMC.S"QUU"$^MWF2(!N%2%
M$A'&\[+<49XRL6.%HP:G10P4%(<&QW8PQ+"VI.MO[#0<)O.2TJLTQM_C95RE
MZNWC+--/$Q<_C+2E+,<?JT-X?FAB$71>QG#1CLF+65ENA$<P(< E#(,,8)!Y
M YX*@N/"U#/X%@?T*[9?9U%H*NCS#8@5 M+C4$JM)XA)2MPH>HSV" ]5V*.(
MNPCUSJ7MK.NY>:_3%N\C^9(4VX.#B!$D.?7DJB[)+2^("#TRUO?\ZN188P9P
M@*:C7Z:Z+M]JO\C]RQO.6"M'?'I#OW,!SI(C<>!+7>V"6S:+L:46F&C$VXK,
M=#@^'[O]LUT7DR=_"Y&2:!(<IXZ;6^K<WIX<-\?I^KW__LG?/3K<[:JC=KN[
MV]X]VNNZ^X?[1VVOM=MR#[RCH][_[;1^6D2P_3E#[2\O\&KS>7%Y?G%^U?GL
MG)TWG?8C+.)29]_Y^.WTZOSR/\[&V?G9UH?3LX^G9[]M.M_.KT\FW_=69?+G
M9\[)OT^.OUZ??CMQCL^_7)R<776N3^'7&U>=_VS!"UUT_K,YRY*TVLOK!VUP
M^LOTA=8"1G!-O&MW?H( NCMTZR+[V"F<9@@<HE1YU^=.Q?KS580L>")AO\O>
M.+D,0NALZ)1?X2U\S(/'Z$IU0C<8)3"!#1TX_D@9YHY$L39UD)A!M:G;1<2A
M[0CDY08ZSF0>UC"!=!TX)HA6B.1[-.]\F$:9!:S"==5Q<"**3(E;4@O@N$P,
M="F\<W86W IW5XW/L>L<6V"%V7-HP805U&@#&_ ZCDTH<P^0=S7/^JX'PF;.
MK8'W'-=\#L5SJT(5$UVAO022(FI,W#7C?ASYG.-8:9/C$T XDQ@2.*28KN
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MX],+N*+:-Z*3DRLJF[PZN?QV>@P_O"X5G&S#<V1\RKT%59H(;3N%TF]OL7
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MQI-C-S[_N/AD$W6HX"T^Q95>F2LB>7T?]$'R2 S7BJJJOER9PSI)XXBX22K
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M=[MR4'M$!>;/M*HFN9Z11<8 WV#8=W&73!,%#V]ZM)MUY=@?HDX&48H9;NK
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M[Z*^/=H*-QYGAON*#$G)](U==,"=!F^^Y7@@5<RXP-)EO9'^Z^^(ROD&#O!
M.9TLC;9.PS^ITX1S$4=IE(Z&JN%8X0^8XHUR$Y](TD?:HOOT2AYVD*#- X/'
M[M#O.0$R8CIW/'XOSFYAK !;:(PP?>K" WUYWJ)LVQ+OT-?%/@B.'P09W\22
MG%[?<Q-L>8(W"0S9PH)X6C5,3PY,!UC=+Y35[$!4R=FPX_%Y&P;:JMOOSZ)P
MZ^2O#%?HU#SJ BZN!1-&'VZ]QW,L&QA]N<H&(/%1T=A=XVL]KO>&)/PJSQ]_
M +Y,[,%US@VB+;P?;^]L[_[?[4'SS^'M3W!8IO_]4Q+ )FQUM_?X=\7[W]'!
M\,=C&,?WP>;^('[I*2_2JDQ=OC@[.IP_S6V^E\U#C[XS/T_WY-_O[A\NA/'[
ML+F_=[1B<]IM[N_.-]+SSZD%?]B?C]O^129UL+,@YO?YAWK^]SMH'AWM/X6-
M?D[0T_,TLCLJG575%+AG[@")XG0.USG'&C>K'>QD),F,+>Q6I*W?;-+H4$,P
M^'S/^8#>TI4+CLN(PEL;/V^^4:$(FSD*819 [SJ*(-<+$@-+Q.D,HBQ,W[AV
M5&>H&8HSATA>Q;M.Q1V]T?7_Y&,IR 5ADBJWPF-;J3^69_X1L.*EH?5(@K^K
M0(7.J4%YO;YJP(W69BG[LX0NWHOM2[#4YL)'[>VQ+M^U-!\MS>5VEU\C21ZV
M#VN]?$ZX^=L5QHR<%X]2J_8");GM5,B3JB)62IR'ASN-W8/]?_Q7:W][C#5R
MD6I%XMB>51B/:>3W<,?[EXNIS*K,OH>I)PVA>I1BEUY[;GOYL-A6T KL[>XW
M6H>'M<!F%M@C?9LW*:SVP4YC^VBW%M@+>"BO]'V?<3M-\T(JI/5*'(WV4:NQ
M<]2:T]&HUH[G]R5*WN)K\"6^N/%W 8TM\][UNC8R^A%+OJB^,H$M-T;RNH1%
M?D2M72\9Z7AE[ULF_GWA:,8K]"-V=H\:>[M'CPM8U#&)&?P(W^N[*G#^:<"R
M]3UHYM-QY[#1?J3!?YL"J\,2<[@3^T>-5JU==5BB#DLL;D\='C1:.]M+#$M,
M)(UZ[B*%_8=@.U2C\'^E_TP$]$^L%YM0$EP",2V[LFFVB@T+P/+RCR]6->TW
M=W91#IT2NU-. V6*Y(0\ZEEYGZ@"$I^"A4HC[G0QO53N"04\S[?Z-.*O?@J/
M\V;0A\_7IX6ZEW6HM^P$@7,;NR$SS^,;>G9E#_)+#-R><HAGC4DGTLC[WH\"
M3 ;#\L<1THDK+B?**Y>&@1M.+8O,4I\AU6D_AA_O5-_W D65OE($1K.A<DSZ
M[1D6; HM#M9*S5Q-N63Q3U2R:A-\A>)USH>%OG.KH?_/@T&<45%1$Y,TCL);
M,&6TFJ [5(AM*221AL1@Q,#X*<_-$H4F;V0TZ@[)E5"9T!!B'5T4PF@^E[;Q
M'S6U"BV#RV1V*;P(\8O_4+'G)\ANYRG52X2,/"+N%6SD*R:VYU(%)>VKI@,V
MVQ5RKJGUR88)D$>,6 7 ?B/IN'MK<>IQ/7SD98EYHH)Y<<U^V(.1^NZ='\58
MX P;,U94,:]I 0*0X1:(:0"_2? LH'HUS6.+=:Z6!.B]\(QQJ'$%20-)='QA
M)X,GX/%"QPE6*-+@L,14KFKXV*>^-YH0O\=5BE0$2=6SYKO(;RA/<6[B:&!H
MM7!U4"S[VPZ68M/ZDT+ [['-1NHD(,Z0JNS)NM&T/%I_,\:]#P80I*7$#O&'
MZ3F\DJF2TD<_=E!H("Y=/VN-9S2#/VB&UXM(KX0J#(M'QW=1L?A;B1JZ0A>P
MD61T,&M=E8)@7*B!^\,?9 ,9FN8D=#KF&_ .1!)@SQ>$ZT5AJ(A0@>7D@:OJ
MXN_[;GBKY!.PQ0('Y98FFZ^%46!.$XO#;^%"H(Y>7GVMS6S^<-F,8+$\+&-1
ML6:T$D4<1#$Z UIUV&:Z21)Y/O51R"VRT7U4S@N0,FQDGPIC<<L-X-LX OF.
MJ#@YL087TVL[+O;8,EJYN4^([K1@NW$YG9L@0R)5K*S>R(9H'7K1?;@I6D_:
M7FWFYC;5:5F5)IKK@?O=-M.PTQ(_20LOG;_CV.O;+TT"10H"8]'!.J+;%86O
M9<-.5<&K,>T9ES(=K<H0P9!OJ(^/6Q6JV$52,?R*$^'![\+AE,5;:-WQ<N)'
M!7MI4:S1J8.Z6).+V>1B>T5IU.1BSWY(73S_N33]%"(+ [__3CML_(+'9(.X
M?9B?Q) 9FLYFXV$#.[S0'4VQL,LZD:O7XC60AXM'28815X%.7.',2G@)33EW
MX8H_A%,Y2J)A?T1GO*_*ZRD<EX7EI#.K>L &G^?)^#F>?S[B>G*.(U4?<.8<
M3:QST9K"6AQUN+07I?-,KJ;Y>8;7!ECG6R(%Q=,J\&]N^&PC,PN'&]U="J>;
MN531_9>&<&.\,AOF&)2ZX0:_OKIT!G!GRO"NZ-Z"8Y:DY8L'')B),AH1A:@>
MK!O(;"K\,&>=JX^=_^=\\*-4>?T0Y'B++#,]]</9@%NS$"CE7R/%[;L]#&N"
M.L-U+?#IAH3LX[';X[FZ3JC;BPF9*'X7QN.;"UX\S:6/[W'H7VEMXSN=2W,T
M[>Y:U.ZNC6Y>1/<VF<<M@O.1JDZ%[%$&R%=*O/L_PQ'E@!8$N&UZ2.2"5T6A
M21>YPQ?0TR@\WW,#I!B+G;\R-TY1P143QN6>'T[\QD^0@$D^1 .#Q^S1)V#]
M[O%_AAF83P]<FQY\&+8M\J4:=ELA )_XIN1*Y6_K\8T^ K&;<;=$YA;]M*4!
MM@70[YNW)>AEPC$/3LT=]D-^'"/0RFW2<Z3GZ?MQ3^MXRH7^M'&K=A9K(*X0
M.N854DN8R*FK0 1T Y(H#AMO*^8@X<^&V,FP<@E$F4Q75EGPG<:<7]AE#9GO
M2WM-YQ,HZC"+P:LU9B#)9XZ6!54YC]J$O?DLB\EDD"%H;Y..XEPPS.:"=X^7
M+?T[CL.-21;6RI8N$?W--I2\MXQ#&U7">P]NCJ;S$1,B*N3X^!V: >2V]&]@
M J,&QYZZ>-YZ,5X^8-]J_C8B8L-K4!;Z0G0H,4Q]QQ:E(PKH!*V?W(\XZ#Z,
MZ$8(P^AK$TP)73<Z4+7-HN/%J+&;"),8W)J-9<J_ACR>%$]BWPWWB2L!UV%D
M<939<NBJ]!YM.CUL[UF\J!E*V-N/+F%/^TOU_'#9#VJQS2LVT5D?3N[-R5FB
MY1PYLW%J/GANYIVZ5H"";F^O>7"X-R\#7?NPN=>>C^UM(D?;7G-O?SHWU\RS
M:C?WMZ=3JSVZWR_JS-Q5M </(TAAL"4 :@ZH#(5R$4_J&3VO5&:3QB3,R?XR
MW$B2U3,9\@.DNWWP\9,,^6ZSO9*&G"2&=$IBR/$ZB&2T5KG3X[MI6AI7U;EP
M_;9IJXR\K4V8D8WPV-46[&%1[6W7%NS1%JRV6X^P6V6(<VVW<KO5AWL_!LQK
MTS6#M)XI^%";KMIT33HK'V.Y%MW+_%6*[@.U1WB$?7L!Z;U6^_>/('W_7!'8
MV@@N7AG?AI&LLI$3*Z3&(Y]5.<152!A21L7.V%.NWN2PB@D2+QH85+ DF3C9
MZ(8AYGL2[+8BV:9)^4&K PP",Q%\8T#*P_$.T9S^2I)LP+GX"O ;)9$L5$&.
M.: &<UY?]3*,,*L8T2?%Q)5!(])S<L00)H=LL+P]LTIX>@D76H:)O!8$R)SP
M7TK*,;4\5<!T:(E?R;M.?3-,%'-B>@JT5O=?<W,)%.!*.G=)$)E"&R1K=TB=
M!S]%!K;2EU2V!$J('R4@+JB3P!W\&'>&2A*-?I)Y"/Z-9J<+ID!IATK%"!G)
MAC;<%Q64]HD/4D1,CAQ]TIM=>AOZ(6'G"&==^6B<OQG5U/>I'YA=5K!KJ/<@
M-W@J]8POP8FE 9@>\Y@!73R9Y+L?!%N8?C=@( )Q]+ YU8A>D-++73\:4NM=
M3V5T>E@9>DX7AU$._6,]X/0XPYH(\<"U@)M3"\.H=96U6 ;:QK+GI2TTP[J/
MLJ!'B72P@A[!T-M[[SBQO8%?IA#?9L/9W7Y7@4W?@<\2J'@#]?.P>;#WKN'L
M'+[C/^XTV_@SF,XA%TH&(#A\?%YZ">_3 250+L)VY,WOP28. Q 6J2=-19IP
M%31IX/\H#<;2YUH<G8'79G*+]9VZ5K-U1_ - ISAS?-R.9@.:%6,*HB3G6&S
M%;N(X4!WW(:^ E\]4]T=-L=Z\3SDT4[S<+LU;QYRM]ULMQ;5X6EO41V08%+[
M[76>U&'[8/4FM5!)37^_]6H6M<0V)Z:+QQ)>G<MTM8NV_)8_RY0%':%O7 87
MM0S^YSJ"F\Y*]/S1%Z 7$<[CVOK4W0T62!;8.-RF#CDKV-^@7MHG+NU.>Z]>
MVG5<VG;C\. M+.W;:MS3(D,\QH?\%BA57ZK-RWI2]+604O41YF!!)'WU CV\
M0-M[]0*M\ (=K,ORK!UCZ\YCSD0=' ^C4$V64/VI29]ZZ6XPAJ+DI;6KHB7,
M0J?QK+V"G=GA-75[!/LL/GQ"Q&.5KD?KN4!'NT^XVM;+\]S+L_^4R,,J+<_:
M]<II-P[>:/C@!3NRK.?]YVA_3>X_Z[D\A[OU\JSP\NRO2_1M[:('[<;NI"/Q
M(<S\:P$':T0G8Q8-#-'"=2)B-A3L)$(LO2C$-2+R</R;$V;$3H4TE,R,9"#"
M&_ZFAF!ZB*T4LF!^%G*IY9Q/!0[X,70QXV8W_/'QRHS'30W@Y,DX-ZX?YU3%
M.:9U', LN'YX0PL)RST8+,HI 0_CQ.,L4 (O)E7'WV5#DA<2J",*$Z? R%OK
M0>-3TB]Q7WIXH@GA/@2PH;:N/!PUT33D. 2C2P<J[4<](OZ;X6E,#%WU*-?Y
M DJCG&,W#B*$4F=,,H6L6C<W*D8$=%)@F+)PJZ8QQ5264:*/3OK1?:C[J1AR
M,N2/#JJGGI2*+UR$QB*S(5/8%U#;1>PZ;5.[6H.F]O$?[F#XOD,<7+V\/8%9
M1J04C%U/TX*1)N6\FO!$E]"^.2\G\73GJS"C,-:A0PO2O!$8S_G&I2KK4#8Q
M!2O?+VX<A,HS)3JK4%1F+F2N-P%]%]HM@ 8AQ#T*V<9.8 "$;U70#!YL-W?W
MWI'-S<" Y[R($TN@7IQ[E*M&X#WE739P!IJ:T/X#FJ*:^3M7OIW]M63^7I(T
MMUJ[S8-W<LKXID(D2W1#D)V]9AO^F#/8%38$:7SL)["#N.;(L#/[AM71J#)7
MV22RZ6.%'1? A>!20V$4-05]T[GPL1(PRF[[CZM.?"UU>E-7[H^\6$87\X#Q
M:Z'$K-H=7%C\42(W7&@Y_K6V*8C2E@OK:TR/&%TV)E:\RFA/K:!:P*G0>OJI
M@*13ZW,FX,YM3]NY!P?-/=A1B]NY++,G5@8_J"=5U7;S*DM[ <JRTVKN':Z1
MOK1:TPW]_E[S<*'J\KH-_<K<() '>SVKKSL)49)G29*W#S4DT%:U]<3"5%1K
M+H^M**W%>MF*TEJJGI4XB[Y;3W\@;BHFE:=#D1[ZB&+>W/!AZPK=7@&YM&F%
MRX^GD_F3ZL89ZCF3H7,O.3,Q++'%*37DMD]LZ$8Z#=Z1.%T\]\:GV]J;/MUU
M4+'K>S@T1D.VIAS9P:8%Q=-BMXE<\#?C9/H2&/*3AUM5V$>+MINN9>#)DKM)
MS_U+6W*VX8W*OEL]E8 X==3/D*(WG3+SO[:QY8.I.T-W#7O*U)**NP3(H47&
M5YH#-"9T!] &E\TO]T@A+90C!7GFX<^LO$C-SUL._K4ORKS];DM[9<6SW:HH
MSZ.2A:@K3:GJ1)\N!HFC%?H!%T^OIG-B,]GG[/A6FY-IWH\TV<3=SF:C/Z=R
MA:#[\KDPTNT2$XR5P1&<AKH?#7[,PXKU;A3+1T2?>9U93"=GOW?._O?D]5&V
M_^._6@>[[Y]EWO.PW>.VZ61IM'4:HI\248L_G*IN>\!Q>>Q*?>M[W%6JX/Y8
M_3BHB2>H?'L[5WF]T*4LP6*4< W<'[HII#Y9K0OD-OD-W<^U.)NFL&"0,Q",
M'-@,H'38 ])XW43PDKO>^K#AQCRFITE7A5X?A/$],>Z[2#$4WI4\(S!T1TZ@
M[E3 =D7W49-#:"-6-RJ6CKV430"3E:<(N),7<L&TM]_GY#/TB]9[9,FV_V;F
M+7^7BZ5%6F.]&685<)G\&]^8QVPH6E\M.<-)4^2MH;-"NH:9CTA0 ZE/:"-;
M'7CA)Z%7(1XHC\AM?NEB&@BE-XAZ*FCHEDQ\J*&L81][[I!4^V_)#)7>SJ=&
M3KZZ-WQ"L,C3DR!KX8=IHJ5B]LDT'YU*"6/ZLH-B_ABAT^'F[9 MGC&M. W=
ML*N+M(W3X@U&%2*Z@^)>  7G/<?),+PHYZMWSU$(R:W9FU)TB632D]Y5=L,@
MZ=7CWRBM30GV#8/C1'OU(5YZ^RZX@L3(5B0VHA;:A0! /C:WD(57PG[/KI%4
M+P.[ 2]/QPOQ,>DOY-U(L;N8*'$R68E-1G,;KDX_4 "[S>T?9KM8^^EO5=%&
M&@9V@Q&^5W&74;,>3@SV?'A]?!#X2]K_G')WGT?1)T3N']Y"@K>H'/AE280.
M]YI[.P?SD@CMM)OMG9V%<,<L>JCIC#:5D,JC*=B9[>W=HX.;*2R6TR@L)Y>X
MS@_&F4;C( "?15C8:I(+OB2..TC+H_I]-%/MBQ]1K39&HSP7[)!S4;"\XW&V
M)4WNUH^259U;\%W%,-[*3"<<!>"^KJBP!KZ7)>B3Q.Z0YC9I9O/GG)_, /SJ
M]_ '/_H"'GU86OP56?L/0::&,+O4^0(NCX=WB169V<D/%?@__%69SFD4^JMJ
M[4[C*+R/HMZ,TUO"+IZ;J?MQFWP9B.//_BTA64NB1RF>J2R./-A="@/L^I)%
M?[IR8S6$2V/!Z.(?O@8I]E<-1S\JA_P:^GAS&OM:54SR^=Z9'UE0E(=AU@N\
M(JUR6.&Z& &@WML&*&!?W#'I,W!['.LGSMB9PRJ%?@D[,P1:MEJ'\PBD$\.M
M_6G-.2F8MK_$6'E12*V=)DE .X8-9\*Y3#&'BETF2;I>+^\_S^M88->>*P)(
M0= 8G@32QL[N.N,\<XA\@AH\;LT7N@E6;?5WV2!T/$\%*H[*BP[J\,GOQM%O
M*FPXO],'[+7G:.J9^IZZ<852Q&I P'$3 'PNQ<!I-,KE%%/>J:L\-X-/^9QR
M#R-B.U=QN9']9(5[BUC>@[7$\JYR,P=$'0P53:V\44+LQ>&&Z3HD'*8DUV*5
M8LK,^=3\HPF_CKX[E,N"?S8;SFGH-9T-25E]^H/^KG-55%=#!2ZY" OY#,^(
MD#HQQ-&=CVF"WAV6<*%9P^*H1 5HJ 8N3"9.[%0])M+RK!RE^*-PB[%PV"["
MCREC4'RFSM;AQV6^^LEDA1B"@&U1?(]](QV!;\++"MBQ]$7,"E!&(>P)L"!6
MMR[1]YMLHM@:[MC &1.&:XSE!2J3>PS.R!*=1;?2;8+&ZC&484+ADI4Z$B@'
M&FY)KFEPHOET(;N)A4N>@!8UL-E*ANK.&#J5437]!BUJ0H(J"\8\%&%:^$1Y
MN-TF)/^^1M)PKI7:T\!Z$_K&-,Q!O1B#AV'Z$4$R/,:D\JX8EI#?NX>SB(8X
ML)RQI2D4ONC&,?K2]&D#@JO4QJ1IM(<GE,B?@I'VW28FN4E\&<@?/HO; ><Z
M4 IS;X76(!/JY&+U5T:0TNG=.^BXEY82^=;EHDJC^%F<9+)O+8 NU3!:$V7%
MD)E=G1RSK\( 7=[?NNS.] A1X:W+@K2?U_-Q<Z=.[,(2(+ #OWH#CTUI>%U,
MY_0R:@-SXR?H+IN=X64QK"R*N!?1-G]PI)6$@DQ*:.3 #[V<EW[RW>D8QVT=
M3JASV%&3E)M3P@GB AFAAM[NK$</*@@-X(?#+.7O#@C>3AH!$Q>%;.00!+:;
MC.6H.E[0S$:@5+XJ6]'4 NL[]WU%QPW\SP@T'XX[C*\X,:S>EO08$F ^]L?I
MNWC,X4F(SG> !@GF"%OFY@:/ LN;![5NPO(3_HVWGP%2-.P/.8JK?A6C7H:Q
M/T \E$'7\Y9(D\([$A8^Y,P^PTU&UHM$B;*_CVV:%-JKKAO0TA2D%5'#L QN
MM%I0^.I-9_):FVY/B7,'-^0H2Z0E40'56T ZS-3NYB4B%V_A%FMAMG.'QATY
MP[X?1$DT[(]R;PLQ'*2Z> YK_8 ;)-P>^XR.+35::F"I=YQNL9M@FF.-@UI!
M&6[\$'[A2] $C^+\-]87J!,4%J;+J0\'!_B["$6JM6:Y6E-I5G,L45CH 8>^
M(V%!*]2#(*;%3H:S%[K4J[NXU9U0P$;^O-EW>*P,W._Z8J$O=G!MX!]Z*'3V
ML_'.Z(ZB#/[)Q!KI@VJ$!U>]]B^X]A?&"R+."RZCXS5&MPKQKJ *_BUN8CS[
M&UP]B*P>7&ISC_C]OC]T;C,X-/"A8-QU,9Q8>[K166<%^0+D)5 0D6EAHK[?
ME9LJU^EBW22Z^C'X_DY?]6ZI$@.=M8!_:-"U/AMR:0>^R$@#?N_T99K-RL00
MD=9SK!=)4%2U\BWY6+$B!V91T/$%SV!(EU=4"[S2<A]'L"W=.')[TKC17.>?
M8%96^9+U(<\+5-P8JJY>+!?<V737""5L8&Y2Y=N#=?-*&E4! +0":"Y\XA R
M>8OI=KWRKL5=/@DD6PP51C<W\'<I"\K+%?7BXK8&:T51 N4F4>AV01L"_[MB
MI7CX'F9"AJ\NBG!.DB@L]A>.O*[BJ\P9R[^B(^7<'"FX_)>FU_5OYH!9AYW\
M!R;P_1!#]U..4A.KK-@<7"$#KS7$2)[*=^CQR3D79L"1*W4N2, E=&U62)M@
M]I%^/I>Q4Q$??!/V#7P/TWY8(0)CP\? B4])!O*4?+-S_(Z,C9/ 33$>23$R
M'>2!WL 5.YQRH N>:(I5LF:B\JQIDVTZQRJFI>")FNGQ:40)C:E5+5P5IWM%
MS_\>A>E'H9IW^B=8$#0F7BK&M":%-CD8Y66YEI[A[^#U;_#;V(^>I@W'; 0J
M2OZ5R_& \B/8P^)K E;;\G=+S\)(%G5<IC1 8&FZ67H<'KT].'GHR>C$#2(.
M0FG[;YHV^Z$=U,Y'&\"WT4MH.E?$X9;_14?I=/A_F,5P?^'%P;5,;D8Z+F6-
M;.3#.0_*79@AY:8+XV5!,-K"/^CJ1F<C#W7);_HJ8.ZZ.$LXI GZY ^H5H2X
M[]#$Z+#F9D.SDG3AF.[I>C5=.ED:$N]E4M\L=(7B]VJ&"E$W#./9'#@Y404J
MFSA0VG./P@#4ZLKZHO7Y+&2981G;>/-L/03X#CV=>J+9@/+$'J5H2F7Z<IC3
MW#&!UE>ACGSJ2JC QR=,4W3+BOQ*5)38(QZ37@'H3.I(538:HU"E9J$H :]_
M0F4EJ6(F#;_--U@G=7\X43? 6Q!.>%,S6QH:2I8JOOC[G+JR\OFH8709#DCA
M<"I8\ C?:*IF@\0PICN%J3#W(<E1<VD2CY%H\?A<?=L03?#4<IM4VH?V0IGG
M@GHA)V:@)U-:"QB/2L2T$?"+O(F3#[OI::]R:)]"3F@S)YPJ XG/1UQJ[_5]
M^&)!F\R<DH(IU :MQ-G#Y]A-WJV=W4P:E[-Q/F@-&%L?)F&]G\[5DOP- 0;S
M\NRNI ,ZI]=V#1KW46%]'ES@ [SDPXN>F$6QUW,='#?G2K !K?WVQF!3[ZI3
M3$PB?>@E%R#">_>459O8\Q.D>[C'_85[M,<2XX#:6('E31D6X>/V\Z34^>>6
M R\6T,W*]84,JEP.C(IY4[$]*=\JWH[V)?!WA#FH\M$H4Z6-0L.YUXZ./E3M
M>Q[.!MEX1XK9U<QFL9\Z\4D3WS(7X[V/!ARL9%=I$<))W:@9)6T4VN%:HM"6
M)$W+[PG\ 6%[44?9=YEZ9.5:FRCUG>/AL(M4?*>*)H#W^P3,"WA#"!Z^<_V
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M=4O+WNBVYO2G,TZXVH1[%P;SF-.MN<#1HB5*N+1?<4K#4^7L5..4K$_)SRR
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M'56#4DQ)-0T^J)J#,C<^JEG>A8#_M0Z56&K7##*CF3_@T=?+3'[-_'0AF?3
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M>;P(GS !TJ"7Z9/OQ,?K"[,JAF0P(N".)AY<-I:$O4A",R';]3';,@#T0@+
MED>E<J4[=%[K\-[IP2Q=F\7[TK-\>7&+>P^;M7E2?<N:XCG0ZBDDV#(L\L*_
MDSS!:>9^A241$??;N?L @WWM^H_N4XP*N,A0X.8R"5=GOY$+U3^N,:I'L1O;
MD@Q+:QJ[41Q)U_26(A)FPR=5#LJ&0:EM/4IN&"=Y@?DYDBDW>WGEHRQ)-:TV
M@C?/20<SGU>"^Y+J:G7'MG96KH#@O;W(S>//-)S\'C]^0//X>YY>43!WS/0*
MIQ\61KM^ZP5.V4:45<LHV]MNY^5$NG:GI!WY*6Q5=CGCW4:=C@G7NRS=Y";+
M-_J<YALM<HP68E?'TSOD;$Y_:M"_94C<_>3^\*;S:5%1'!,O^8+F"WI8W#V:
M!;WKN7YKW,[=OI<.=%"B_$)\$@@?)>$NC'SR5%_8>Q#8/DAHEU)5%6W+J%FD
M>]R4T$5-445#J0.(QF5JLTS))E!2?58[H:.@A";*CB9:CKZ/O)%.YHNP+:8'
M;R*(JAJ%<=RO/)'#48WVQE#M-JC5@]DJHH+=9O3=>K0-3SH,&;$T6J%6#V;+
MUD(C^(2VVH4=ULLM:0O<H_ZZAQ,8$[W8=AH8]F"V"J@"\+"L?C52ZJ?R[-]L
M6U&>S_$Y#Z8\JQ']F^O0X;D8)ETEN_6"ZM]L'3I;D[N?]65#'LKFA,E&28^O
MNCF+_4-Y48\)Y25,Z_#;A'E!M!;AXO:28Z[T&G/E>'&:M"ZNX"HX&N#3? HD
M?Z)-KTD0,QF]HW%8%($EN"9<F&Q-9]],W2<A").%7EA:='DB,<,-\7P?EG,"
M$N<_P1W P;_@)5$X+:*X"'],"/P9B2R/.10>\2' 7MH_ 0B*<#GIS7&J<.B3
MQV2&A2=AD(X9D3W@\?X<WYA"QZ29T?"(' 4*EC$LN#D0A$QG?OB$RP6#6[#J
M28JG@VHBGKC18F+9@W)]EY-C3"JT'--OV4/IBJ%1;1KCOO'=X)R%2M-L*)98
M>D_\\%$2+BI5"Y 2(5)BA*I"M9&.PXLS_* %HS\7+KOZ[QQQ5])W 7TKUC0=
MA72\:U7OWEJ]62L<N \#L!/ )A# KZQC/:R?F>N-$=TG-WRHSUVFS[T /3D$
MKIJ!8#%QS=<]F(#K,#A/1>!C?BG*X)(68-@ZZX4,V7@6:SY;%F C$!$HA9VB
MP$%P!9:&X0N*EF0!&K1 <RH6%]"*@YAI($3\*=PK"IA<&(W!Q-.U\\CT16K7
M(K8D4J"@)> J2C'T*."W^YC\=XY#7X+%.EY!-[HGZ"A<!2TG^%Z<%=ED/AM)
M4 + H5B!3F,(4@4LMI!*P*AHPE@=#<KAJ7=&Y=H-GJBVC[S[.;,'L&I^<?WP
M+U#Z*.N1.R/PRPB\)5@6DJ#+RNFW,[J&F#4Z]0J/FKG45C AQ9W63$!,+'AQ
M/(^H$,/RF'KS:?QR"G2W4JP>5#Z8CJ08:M/*!]60#*V=R@!%LN36RA4THQTH
MK18'I4FZO;G&X "# J8[[4!IM3@H6=+4S8_J0V]6:VL&G+&:I'XL4$KUIIXJ
M_]PK0I7_R4U&$S0IETMFI)@G."PBW;A/L/M "WPQ&D6XB;I!)PM?@:WM!DR9
MS]0C6=I4#Y<8=V$"/O;J_%M/I-V2E?9"R5E;P0DI2:K2:+N4[-B5++]Z%%4T
MT:[5,(D3<C,A.P"M<224U&IV]QUH'G/-=6V)FGDLF;OUILP3=W>1$T54C=WT
M_^!H]1P5/SAB&=IN.GQPA((5:-F--/7ANV_U^ZH7S<4^@$25I6$/-,6VYA(T
M:G:-Y;3JPCZG/\121:T6JCXG%=VPJ"5)BT>\8=F0\<T]IOVHZ\'1BN]97N3D
M:7"D4NPU6AUYCKG9O62@3[&4'W<Q.-G9+/2"-%_M<N*1AT)>\V?6CK&87RRH
M+'G\B),5K0ZR+9+2[1DF7TU),%K*HV79X'F*%;#KGVY N:5MX]80X7.596JL
MXM5ZXW^<>+ICZ_?$4=5[7=4=X]XU;=-11XJNN-;(<<9_ZLY)=S%W]TW8\E:<
M6Y.M=X>57M(/!U4/9=#E,6'IB; (05TFK@>C2M/]BWGD=)6FB;J8$XD)C^6@
MY7E#V09U(6EJ,J;#U^JG69J#^.()AXXI679CJ&5+,EKJDJE(BN&TA&EL&,V2
MZ*IFAPFB;>%(VT:S;,.J,3F2K+;5E[2M,1F2H6]NMMEOWK4W)E/6.C8F75):
MRH,];CJU*>.ZW [FNBEI#2'7]S\F7;*<ML;4%N\L254VVY;TO'+%&==DEOF_
M-XSY@URF&+U+JF0]M_*JY0]S6K',DG%CX;< ]V/4#:\N]&*>[ZGR[)34XR0?
MI=XFR@F%2OUG9/-&X2/[K':-BF8M*E[XOL!2G8L-BEX+UW/<">!NZQ8+9V,L
MS/LM\)+X]&]G0J%$FI,.J/29E527T(Z,8,.5>"252O\)=U_L<D9)G5,2NP^2
M:.3%!(4,]_7"#2W]!@(N49:NZ=.?7MU..-%.WE:VYF +&<L=EZAW^A.(FU&:
MP;_B)JAF#3>AV\5/E$+[*7XZDKJ.%1EJCT[MIGX?DCIW$S!\D] ?IXJGCM:I
M-?OA4-"-OI*$DV]'\J4M%QK0;W D6EFC?^-"]IPURLGWO#7Z8O3;\V7E?J%B
MK/F%9JD??;25GY3C>>4GY?FQE7_N9RW5HVSPRMT;(=N43EDH(2<%8>D2-=-\
M.Q;-7:5KFT)%J2'7I<7NF<.<KY2OMFICTBGGZY'Q51%-PQP 9]LR:<\M1."#
MXX/C@WOQP=7>6W2Q)NF0]D%]I9BO,".O"U5<_'Y^_]'=7\/G[)];:5JB[CB[
M^90]<QN/^OZC%$Y-U+![H:P<1CZ?"[_024'A?D^'*<[O'XIJ4W51L<S^V]VC
M9(YNBYJA<N9TDCD6-CVW^\\<?C\W*^V;%='&%KW*CE$"[C%SC[E?%.?W\_OY
M_4,P;8JCB9IY(,/&N;-MR^1(*M_.=I,WM'."*,O609W"7=-%^Y+XV1S5O5\U
M0VTF:=9<@_U;:G6R*O>C[XZ6I*JEB;*C<Y*V1U)#-T7%WGR&=@"2\LL&==D.
MJ5[':#&;',=T@W'\LA>[K,]61E5$3=F\)^1&YFBXK8BR 9O,+8< >PXP')2E
MW-H<YV5]7I6FJ&TY]N%;IV9J3A5-A6]&VZ2H+3KJY@Q/[B9P]5:>"T1=COT>
M9'"7@[L<_+)^7-9G76;"#LKLG!WL,T6WQZ0Y01ON\54:2-ZOE';9X/++N%(_
M@G@POXR+X@%4]^$[:O.K^%7'=15?<OPJ?A5?3/PJ?E4?K]H7F/"&(_).I8U_
M<J-O:9/=+M3C]2*B<& DX./<^_'ZG(-FN.\*[,JY\P+)\D?!'7X_OY_?W^Q^
M#D?+02;X_?S^#MY_E,Z6XHB*O3F]EOM:/;C_*(73T1&,]D#2R:&UN-?#[S_X
M_4>IV S1M X$#L-YL\TC4D3-T#ASNLD<2Y0U?C3([^>+HZRU"+C+^H%ZBW!W
MF;O+_'Y^/[^?&[;V(\*B8QC]]_J.DCD<B+:[O%%$V<;ZP0-M9P<"1/O)&TU<
MX@O_E!",UHTBCD7+L6B[4WO89Y*JIB,J6W+!.$F;.5.:C57E72,IOVQ0EW$L
M6@[5PR\[7BN#@9HM431N9(Z&V[8.NTQMN"@UW-8<YV5]7I,8"^1@7&V:--!Q
M#L>+:Y.BAJAHG4-+'LYE?98=$X'Q%.YR<)>#7\8OZ[<NTVW1WI*WQ3T+CD1[
MT%(<$^/(FW,P6C&WKQ+WWB?PW['W_>W_T']:G:ZY,EUK=;HJ3O?/E?_E,\Y&
ME8UGZD9?O> \"6?TR2D)SC$^_5I5)6.9K?^9QXGW\,2^\H(Q&.S7Y^RRMMFJ
MR-OX2B=ZJIQE<WOYUR^32Y$E6T="? @CP17&)!Y%WBSQPD ('X1D0@3BDRF0
M+,[^=H-@[OJ"%Z#GXWTGPLR'*;BSF0_R!5(D)*$0SB/A^NIS+ H1>2 1?H5Q
M6E5^<QE.9R2(7?J&]UX\FL<Q?G2#L7 1N/Y3[,7"N7!5>.G5#S*:TS<MW?P
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M-GZ.R[G3!>XHJB0WK23O(&^.4X^KU7J<"S-7-9P[/*#7/>IRV>\:=WA]78U
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ME/6@C,$EX&JQ$Q+5?;6X)')[5X*IL%8[ 2LRNG9\4/+->@?25&2'T8'4J>Y
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MQ)JK*@[\".S^.EF%^R]@"Q=R3B4!!42@$B*T/3.:\'IQ^_[B?X5W7IB0T20
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ME"23<)SV+(_GT_1&*HQ?24 B*GZT!7KZ\NQ-(*KX&&0DEEUEKT1EM&C]'2=
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MCSN=O;E@>P))N,N>#[R "=-C-> R3'-*0;QPJ$_4*ZD@/.BLN##XU?&,0Z
M+ON4!(WFOY\Y'X,&N2L<TBVI$B8Q^4(&0X-+UGOPBJ@+2^:0 27A7;A&5?G-
MI1M/EG&4Z _*&W:4NO1\&$?DS@CP903$_QB,I((SD[\OQ6;:_-HR *?LQ9+P
M6P[TM#X\L5(XI^X36]HHP10T2IBY3]/,E\930^JFA]'&(ZI478WPS463):9
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MZ'HTN5JGT23:<(/;T73SEFLS=H'FBKMOS7;;$!@>[;P@)#8>=@>C[O&X?S9
M$OJS\>\ R3Y^'O4'O=%F5/(;U">>U>2Z2]H;B)UXGT!X.J<-/P(?1,;&J& 5
M01&_.UDB;!;>S,5(EW.7?DK%"[FT,:M9CEDY:Y#8,IAX.ICDNFI+DR)W3^?S
M=!U8 &[6V+Y*+""#=!GAUVK<G%O(0_ .>\,NP0HCZLV%/X&_72X@P^7WT^(E
M 45Q-C^P_H*K7FT)5A3=J)O ='O-\=OL5L!O7,5+9=W\#=5"*.K8A:R/C@$(
M6X&?N$S]"Y+'6PJ;I;"=)TEA.V\I[*,=YTGO4_]+;_@-O2:DL%^_B=/NN#?L
M8R+;'9S8I'78.S\;CC?SI-L.7OY0!.1L?@<I6U;*I/9HK2[ A:(+\%6(X.(V
M<P.)]6N,#27[1EOFA'AN+J'#:@#2%L?V4<<1H)KN%<!/.0E"K$'"!^PN3UT"
M@:?XD>O&-\?E^-C =4Q>$]UB'MM@<PSX.,*L<$' WIY\,RZK7GT_B]-$F6ZI
M _I;[3U?Y)8W5\M9[%,[-PR;AICUP!]E!)=,TQ " WBP1%[!6\Y+4X3QX$LU
M-99#RB&_XR,$5Y*[7&V B@E5T<,-5"FE"K 9E2JB5%)6CY33'"8:+$*UBO5(
M;#DY5@ ETJ,/^*R$1GP41,E2IQYG\]=*YY)GR)1B;?.HN>1B+,;= T!AZ-_A
M?0CKH0(&Y1[EX?&U\?VN6YX"&VR)B8R^5S#.?5<:134-,,IH$QY-(@KKA>G
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MEF9S.W3F(E+TW$>GZ^)N7\E5GP/99''U@I+2N+:^ [@M*O:OSMCW; )&W'E
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M\N0*.%'<4,1]6S['R2 H0H=GSXW9";!=/J0<U^$!KPM+.HKZ=]_9QXI\*=L
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MULPH+K^V"[5JEIGUX*RD]K\O-?_-9I_\3%P>^><T_]L,8Y3^$U!+ P04
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MR,/"P<*@!S!O8V#=QD!U 2!T7,#!^.7XU4%B8&)AXUS#O7X##Q]= 7H+P,3
MPL+$QL+!P4:'<@P?]'4 ^S;.G7N\TM>(E0UQZ1U(^/QB/EQG>%C93JHRLL_(
M;^3H?P./C)R"\B[3?6865C8!02%A$5&Q1X]E9.6>R#]5?:FFKJ&II6UL8OK:
MS-S"TLG9Q=7-W<,SX&U@4/"[D-#8N/B$Q*3WR2G9.;EY^06%1<55U370VKKZ
MAL:.SJ[NGM[/?5]&Q\8G)F'?OD\M+"XMKZRNK6]L'AP>'9^<GIU?7/Z<%P:
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MZ_=V_[JH,8QOKTSDCQDGN<S<+JV2JX$7SQ(Z1'4*<LXX#IA*N!YZ.#9;%Z*
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M&AN2^&3B[0?7/6PSD9V,^J*BVV0B$PPOWF7AJ%$ GGC:V/^H&_O_BW@8=*$
M2JLYF@/!EOPHR*D[[8"IR:&Q=Z4;93^K)% NC"0+#@>O<Z. V(\_.>6.-BS
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M9S$Q+FIP9^R\!5@<W[8G6EAP".X.@:#!@T,('@(1W-V"6Z.=X!"<  G!$B!
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MU/##Q<65%OB/PO_9&P)_&7VHUM_&*NI,YO\#V_^?A?Q]OMNXH":Y+VHV(Q<
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MZH%P1SNEM-'GG6"_&@VZ^]C9UPM\6V2C6( O&%8NC1IWCUQ1N &FA_UG4)2
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M\Z"*%-\V(LI_XN_7O'W_L)*K[0U\A"H%5FL)UQA+2& GO7SVGU:K>.O2-$B
M66/LFM QY\I,QL>[#R2,D$_/.:>=D3MM\P=V_KJ0_U^AP7^Z+K#9PO#[<@ U
M^(>CW"US3?F7?]!&>JZ[_<0]6Q!EG$GZB>BNSDE"WQ@U/*53CNY,*H%PCW1W
MS,_&A6%6U%7PT?'%FW7FT].O3,0(/E!%#Z-@W=2-P3%>$)UFDG[K1 36!A&5
MY[V9L>+U7[G$%4Y_K)._<F)DA> K&L=//UE] FT%:3P-\=$(:*_NDIXYNWXO
M^X&>WEHO/WC$E'566F\M@<)QF;DY8.%+?6U<H;7.*LT#66UL=>""B72WWK ^
MTI7W='^^U)51>F%1D459#9MG0#HV7L4]X]=++7J3^5W)V7Q1(Z>% Q<2F?#J
MX4T(Y+-0UM!#O._BI,I$>I!6_YB/P3GOO:Z1 ,6M<-^-0 $\[;KC(D3SA7%D
M#Z[+O3A^Z#0K#ZOL:OAF8@_T-1"FL_I+<ZJTC7W/L"SRO&!FLS8ARM9HN#8Z
M/ZXF/W9[ %M"<[^&,7.[S6F^J*2]%;Q_M7!(IJ<)-IN[S Y86R"F-@M4K#'#
M=_2E]:[QMZ),UH=HZ'HR/Z<.6H*J6:QP2]DV%+A&I9M23YXVJ[:HNI;&S2Q>
M.+_/L".MC!!W,%!DH4_%S'3NJ/#]7,## S:JAY.?(5K*X-D.SE;@$OBP>KO]
MC8J=C6^!FK>GRT5]4C_%[%D7Q3(Z$J D>ZUBR?-^"GK\#.[JHS0693-G8D%(
MD.BH/92SB]],VOR-*;TX[N6;'/\+[OM(P.PMN*R51'+!;/]J\7A8*H=J5Z_)
M=8'O[-*J:L8U8PU3>+%$8=.6@Y3D0[HTC[C$>JR.!ET.$P048%8__?/FD8NW
MIN@1'X=$4EFYAR>YK9@5[0%/K9'#4#;/0E&!,]^F:S>")J$,"92A9@KPBXG*
M43*M$'K O_TXQ=B@=.Q*Z<U4+;Y/JW/HII!RS'[H1'5-RIBZ6;2O*2<89Z<2
M'CRL4]?XD=CSW.!>$K0'O#?_>3AM$!J-IW[3CXT]9?_EK+VL2])HT.@*T:XX
M<F:T0FD,YU0[OA=I Z8LLWN7KI:UL>1)%_@A":]HF6CNNL4S1$7TW95KE->7
MENJY(VG-P%T+FLE#D7D7>IE!S,&6_@ZI 4#C!.O&:<[^TSY8;E_K.V7:":+V
MII58M'Z\=K!%!QHQ>V]6!2)R:3/3-E*T6-;0H/U1 >>:+&N%JT,:YB#+H%)"
M&'REZ;.O*TSW-C'1U,@LC.2RT()4.L>.S>4!.D;\K=/D3F&0ZSZ\?=>?S)EO
M%RZP>Y7M?JR.F'MRS!DBX(T?=5"6.\.PF:;<E4N2K?:IQ6+-C+Y: 78^_)/6
MBK1LC5"9E2*R5)#1: ]TAM[,Y]1-*Q?UI3K(I4]JPH8EC7IK$X,D-G5G13')
M,.83.3?PNTH#>$KT%1&RC Z,],W.ZKH?=6;SMTR>W[8,1A_52S/O=QST:7I[
M/9.G[^\A=%(9E^:4N8@ZK9WA?>%S;1O-3AAF"0J61)>CA9DX=3(R'!,UWJMW
MA1WU0\P@8M)N#MJ&G9@@;30EB'NFB_09^UQI( K!)QN@_F @@0G2N3306.<*
M6:U M*(V;$.RQ#X^35D8"Z9Z7DJ"W77$U$,G[3^.-2+JQ2?J$N@9Y%NV: ;R
M.7:^5WO<VF7<]!JSU[D#*+T)#,M$?^JH&OC"H1B^W951]V;-W56LNJS$>,=0
M9R(>Z\T)M)R%GBY$E51,E5VGU5-G2F2);>TQ[;2@:%OQFMQ/J#NWB]&]M!]<
M#7VX4A*OB(*XES] B0EV,K0B3D<D<0[XO\3@CU#UC.(7+-TDQ4NWM]8SR<Y>
M*KO/OF8^OO,)FA,-)KOA<\Y;6K1O:E^HQ7?:+Y-\'*JM%$&%%]B!"_&Y*WS#
M'B]L$,PP40"W6C<CK@CCO7FRLC KSB>64C10:IFJSZK&ZQY.IR<5O?$:5"I'
M/F^/D(3/?=EA)&Q"C,Q%)4L=>,QYN0]RR_>>]XBE2JA@AHX>GMGIP#A&^OMW
M:N1PX1 HO_/$MH+;KR>S4A1TP[:VE]UVTO16H?*,4U#O8Y>4]>*:,KN@\X]^
MA5E/UVX^,#X4R%!2=,80O+3 :4[%8;?.6EQK;OKE&CX!&E.;.3O@[-/5HU+C
M.YVKW%?6(5$G3OLL\I8]]Z$M1FZ%VG^R"HZD=V?0_Y*NWH$$)JOV9BW/X M*
M)ZO19]C=L%YAWP*G*S>8"3=<&+HQ8W7C7@$\X0W5DZ7.6T\.DGFL=8UCZ>\*
MC\^& Y[M=]LWWL/S$!T7X"N._=I_U^51B@]K:D<'+>+@>[&Q5Y')NC\PEZ*)
M\50[5TEQ5V%<M#,97GHI6FL5422;*RKM,1P:11N@5X&K'%(M97GV2:F/BI<V
MH6\3G\ICF_7(<L[JKM&<OJ^%VO)-="W8CUI_Y)A]U*4:K6Q\;Z9C\%7B<(88
MR<Y+/;0"8_C7A^9ISNI(0+M>3,!7L&$*\WDT23RSSDGBYC>TH8VP 0Q?ZJ;@
MO&-B!&D)@[AA2Q,EPK*TGK+)/5Y"5G]LY5JZ9+K-PXJ&_D&O2/E/GA+CLPR>
MC&/+_3O[FHB^]FD^-D(>$WPI4/[R6[H'V(&N$;SD!%82,D\%^W8A_3VX9TM"
M8P;7)N^40A;5G!V_)UM8;7^_9BL:%++12I/"7N?@,XDXU9,QC3GQ7"..>N:@
M-WDOITC36W1H!!-LK7PM6GDY*A2=K,@>0'2!*4'7].*,064-4Y.B,WN/SOG1
M98][YROK9 A@YG)0YT$]2"=[U>86;%/HNG^%J,?^M%>CEZGAOLZ@O@FM:Y_Q
MV@PY=AXN"#-KT<T,F4\FQ2OEIO. ^LJ]B-6I.&#PD9)QM @H4R-U)#'L&BD(
MY7T0KB5D/_Z((*PJD%[RE-F<5D,'O%]X&6G$<$#1;>_?5TW9[GY;ZUXLFT7X
ME6!Q=^TN.X?\Z ^$+WNVE4?>)QUFLO:UZX56N2[)V"L[2!N$A7418D2S0<I(
M'H8W3[.?J,QE7NLC5E0A%F365]>4>J/D:C>U]M:+2KF'!@>+U?*9MLNKHW>
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MZG2%'.ZJT=J0K@3++G:0S9+XIO^IE21O2,TW1HGTI^T+]C"R5DEHA+OV\)H
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MRQ/UZ ^T=IYD?LUFP[;OZV8'^FD <W]QEY6O[6OX.H5G"S!"L#X\ +P*)M&
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M#)S)(Z!WUL8=?_5#?Z(H:\8/#G;JO0FOB;U-:UD3=!,,OEBE#5246)=(_?H
M<EU]'5MM$8VD3I=GB[J&A:#NH1\)]?,B8<G&+#@HN(1?>O&7O$)@RPT,N(N&
M>Y^4S(J6+#5;M<,/>9V_ V3>O&CXL?GB.G([PP,,Q#DW5.QAE;7.45&S=20'
M=;PZW?QQ'%@^V(I"^7TI*7HKZHNA\7(M>%3S*G)&N64E[MK)3,8;$>M._3')
M_MV,\FU&-QX*2S&0!N)7%41O&D&/:;>978@8Z;A5G0*9-\;ZVG]VW+!7FB!"
M^X$LQ!J\ZEWL%M/NF;G^NH8!<1G4)/P9ZE+;?%HH[?FZGY-#EYBGT+#@>23
M]&,#O2@7[T0EVU.Z&/IYI[HH]6*PU(4BC5C4=]["H>#7P%!;UNV'!DQ7 ,,J
M9A!?+7#F$8  XIU %HIWB\\OJ8I2U_V9-)2EIPSUY8J7V;]7N""SI%'8/)?O
M8TU!%H>LFDSH7-UV^D1'UJ4>WAYO5NL-13&5SU@B58ZMBZJBH5;Y25O"_%G;
MP54&&4NB*C,#&>"ZH3(9.J8-QZN!F&*SP]U8*;KJG8 7#8C:RV^OJB&)W6:)
MGGBJ+B@1FXF&:AAO(J+>8.8[R5]7*RPQ;3[HQ?CV,T($')J\80OW-+=:T!O5
M/]X@](;$&9NQJA+SX $>U G>27JR42*5_37G<,?R?+!<<WV*K/LSUC=2UYI1
M5$,_<5\F,^ C?W89-J/!O>.K0RQ24V8.$F>J'9I79T_L"!XN]G5N&2Z$//.P
M]JS#$AD/H+'/I@NFH/!=B!IL*'2(J^V*%]+FH7=BH6=BTZ-%ZD>I\"EQNO9X
M:%V-7]B<!.X_($%(NEI?#@W0M]8S%J"C7?BWB<7G/@*F$5_C!>\7,ZV*&HX/
M@\S+%VU)P 3M[DYM$HX6-@@U _R]0@W3/X*X"BB8LYQKACAM*>DS65C+^;Y%
MACH'"_:V]'&U!;ZZ]'ZE)!_@0B@6Y_V43'>O)3&=W!F;(8V)D^K3'1_&1ZF&
M>)((35-9X[Z'FDB38F5C:"S? HUG6F>*LFA@CP"T#<='0,<,XI=;BZ,T_<G7
MTC<3AQY5L/Y=:ED4!Q6I-= >#>X7"B0OP>6EYH1G,':VUZF#C,&K?PQ_GK:-
MR.^F#X[=B:[JQ^#[:RM60WSY@W6L3J%'OJ]G5AJ%L4^Z#4XT*E%,SLIV<J^L
M;68]_A@8_1XJ!W.D>@XE_AFDFD"%3F!RHR2NHSG+*"_#.?<K!2\_M1KO;WW!
M..;ME+2,M.5PBN^G=*J,(BNPX@2_A."%_%G^^95-FUX(I(S1K2<9H>>29\C?
M%TCG<<+POA,SFI<9ZXH@]CS&^:<7Q\B(LA4ZF>/9R3@)K\H@QML%"CN"6>Y
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M3^$Q!6S/CGC2KC$M[,)>>#WRC>,AOC'SGU/<7C!=1+0)7OWZ9L&1L[CV"#1
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MWB0!Z7Y0>Z.$I._]*K3@E7@$O)UT%Q>AH-AW%H#B@\B=+:$:)J[8/FKWX<5
M<X-=8^NG3S2>-NV P<-;U7R9V_2,&;GK8F8US$482OJY0ZJ(_8Y+D6J[3[8G
M_(,-"=^:?M +/_<DQ $+F?%&KTZ7<C[?$?&HOB^QM#HVO$Y4E&_XGNO-VSQ
M#-4YI!<:X1(!H,()'5CI<=013D%E]MQ[T)3TI)5WN Q#!URXU9R ]>!>\ F1
MP15RIY7W:Z4W>=ZFN$J;1J.DZ=RDT:RAGRF??P0XK"=-)3T)AEV 1O_[Z@0<
MSNY$6XGE>!'&,1+N@BE%$780C1 UCTT.1>N,P^JT?@Z!*G&%(:-NU;NOQ+<U
M:+! $/#30/3%S^_=^=2K\!4<+/6][!5K$7?I; )'%R_\.HZ;3D2Y/=BZ(-P.
M*0S;PL/6@IVC6/V_WON*@Z8N\1Q93NT$\2U32:VPZ#!7F"EB50!DW5^F/OE
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MXNZ\*;$Y%LB,LS&SC]+M+GD]H\IMMAL7O_7VQ?[L<FBI$7 3>/5J ;B[O(+
M8A;3Q>J->CVV5MEDCGSM:HBN^KUB,X)+GY22ZV@V6E/S.*%APKT$SG>I!.)Y
M':]O("3[6=#TVQ[2W&<?ZJZ+;':YSI.KEG=*C.2_&VH%K6:?_Y!EF&/HE:0;
MW=7B=&03$\^W$TPWBL",'4]-Q/!ZFS8J1O5;8<^78!9P5O! DZ"XN,)#=J?$
MGYUARCZ2.>SI23#@N);\.3*J(78]:)*4^A'P2;WBV\/X;SWHW.[I8F%WC:<R
MEZ4:I9,\2K"T.(\4_%J+O0<$BU)%UEG<OS'\JA>P-8^"#L9]-PAA5!GC[O1
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M7_LLS# JFE,3+<GP.:'GZ4/K.U9VL5CA![)=MD[+PUQ">3.O/+DX!U>F%)3
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MY$F/K-<A?(+1#%M:O3RZ'NHR*69-.ZTLV'83D%HF\TM_:9G[&^H)PQ?FD^L
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ME<#]V%%3H$T5OPWY"Z_2-L+D81@X/Y2XM?#"Q567K9XE73DU/1DAHD+X[B,
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M'X=OJ',E9]1<VS25:&/%U6U;CZ'D-=KOQJ#NOV&:52\>L4T!7&A<N4=OO'Q
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M?^X:%NAK_2TMGM4_\?:$X\B[H#O:1\#G0O$S_X/J(J9N\1/*HS^X*?<OW-2
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MZRH_558',]4J5#HZ!L:G_ +ZVO:>,Z'5>DL6I;UX!RH"N29O:,DO?1/?!9H
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M&@0BC6=R-8TB^YPMN.D@XH_K]L!Z3-Q"6QY8O!\X/SCLUJXL)J,VO.A+"[,
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M:T!A?$/%[]'(J>7G1+NYWIQ]GMC('.D]"FIUM<_UX(<\V/2 J,04M"?B9;
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M>ROG4+[]X&*7P=<1]#0CR6TS-EJC&K.)X\+RU+:4X1$07!Q:,3VP00EKY32
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M6;AV_!EAFM-<7F5F1YF.FFGG]7/YEHF;$<X#]Q^R6XZ+56\2AD6'!<;]11W
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M#PN9+-$LR#^)"'>"'!76 ])P8Y1)[#/88%NIGV>_TS/"%)+HTVFSE?8[>A]
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MX>137G6;C"J*ZCZY0&B54>R+_PCT3SO)EMI3KVG%R-QAYW'N/5:CI25/TD4
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MOXL=W#51&'X>6! ?Z^\P ?Z3_HKJV$&.D*[LCUX&&]0B(:?S1W<\RY6._8+
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M,"9^&<T%1:LSR'#O\_>2 B-][N)P(UV]L$>]V-H;)".2I\.@92&S?RK"G+S
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M_OSK2_47!CA+].^C=]76P)1  -CG[>"?;+;2%USO$4!H#ISLZ->7:HU1,,R
M  &0F)"1HB#)Z6B&F=UB4Q/ <>XA@#6D @U^N])Z12K(<$/^& %TS<C_.G@%
M5NY#@0#D0I"("^P#7Z1(_\[,,4T9VKRS@!Q//PGG?6XF]8FGYS36PNY%1*^9
M0$'5N#_0/3Z J.,G XPS0\%3^N"9&?AX7",R0)YBO<[VI_O+;@(,O??@#<+6
MHQK[Z?\L_6\]>_S?.U?\=XSLE*0?\]Y$T!,B9=WUZ^@9&3JRO^Z!^$V8O_)1
M_;UT_^-1>J(UAN!6\E,"DMVD1O6HEH$7("^NVE&PPV)! HD86Y/.PX=8E+2X
MNAXW'+R1##\U6G_4(,GKTAM#DHP4*:RP11 \)H< ^J>V$0"1XA\\%7!S3XI[
M7$IXSY3BV.-#V:E-Y7A$1+DO%^SP94 06SQML(\-:E&Y3SD5;.8F?3L<R0 "
M!GB G>F0#&4&BV@(4J],_!)A)&:OBP-U*3G.R\K+MGUVUSAQ1ZK;#<N/WZ/>
M'BNOO7Y*SNAVK=E[>Q67)#/NHV[G45";]]99D*]GV396?81'[]V+NBW&E?=]
MZXQ1/[G;]]TF_YIVR],#+HL#O]:%_%?I3_-T_4]?(# 1 MA(]"R'M]5E7MW;
M4ZAJ84( 7[F.S6X#G*5_/IZ.!,B&+Y+@"@18X&\6OU+]_#K%BQ@!]+6O$ESC
M_L=>%U>4L;_J,#V)]>A+BH/6?;Y\\'<?LK&_KY/^UX._E-VZ%#4"B(<>@V\#
MUI'3GIMSMJ3'1P@!L'JM(8!KU%X$D&6H5Z6!P?J/,ZM!F@0!%%5L,WPW 1]\
M3(A<I9,[6^\Z?LP#K;OWV"MK43(<] ,!# CR%9<12'/28_I5<YL$[)1Y/_H+
M7*E,Z1! #!)(+5,E!G]3EJ%U#H?:%7M:/K?-&N-VANBIIUSTN6&$R562X7Z6
MS.9_&AZ=F@&*VDHZEI"?$KHVH93U</1]/4(C+_T1EY\]AO(;9YSZ868"+A0W
M1@FC/,HMG7I&LZENTM4A76X+#W_K57DJM:1\O*M1VS<<1UJD=RT=5@65+O?D
M<*8Q[+3)7T;&0,1#S0\:VI3/!PU,T'(%K*T[T:TU7E-Y $I[SIE;"*!<Y[SH
MT<'$3?FME_',L6)7JAGV12T>"WR)H*JFHC[.TJU6HV!PN,\]??6)%^OKGM7V
M(K,UTP3<:4+C63-9%R^!]@VE%P0X9:(OMD#I _U.J$RBI:WT ZL?)$W,6QC'
M>7AQIY^K@D22WS"J>LHZ)Q,]?4,X_)J!!I06J$W)[2B( WDLIVJ&/QQ0QE+G
M7&O_IA3V+'0;A5'7A4U"=F'X6U^;Y.3;Z8F1$W@2I,5:L?^P&@%(@#-:0HIO
MGH8X[[<[9]F'N6'Z![ELWN\F+2N.JZ6+PC\$T#8(W:>7&M::N.]<3<\=TB0_
MO;#Q).1O"YY";5$27=B5TE 7ZT%A>M<XX\/MF/M=/*0NRU11."Y8EUOJ8"-J
M]D5:-Z6%H;0@%1.*!_MV?)2:6=.Q<XB/3I$=1>*<24^14]*!;=V>:!2S=?A(
MN\;E1VL*;#VGS6%95!'7J>D9L(?Z!7.9S;F?1&NG\T"KSNHO8'4\SUVPOVO#
MG:NYJ(KFP*$4L1M9YX(?'OC:D\;_>UH@!D;D,<NZ%K7WP@X>SK*J<TC(L952
M]B<^10L=(X^^3MOG(SX@#3MI8DEIASQF=VH>".!AES&5>/\X-T0,M]1G7#BS
M^G.;A<*^(V59M"+,+S1_[H.CX->#<9J$1+Y'$_VST?>P+/;=@6>D,8"TJ^;+
MC!8SF!]LJE?M]-;Q%JS.L;V6&&]-/.!;L$L^VCPPW\O5HE+:1)6H:+9D59P@
MZ;L>&RQ60GPC5ZU*R8N14'2;L7;%J?1 N'O:S9UIR(S7:[Y]-3 C#3=L*K/#
MD+N[!DI@NR;AE>%YTQ1*&.+.=<G1EL"<5M2?^8SCWDHZBN/ABZAAI>DM[>1!
M#ZT23DYRDP@:/G]E1G; ZOAK;KD;F'<<B<G3*I_EF1$XYFF+3R91]3%SI6R^
MO1Y_Z0 I44\L*JAA$97E.S#?(FSVJ6C')1#/UE:*Y\LQ!J3P^_3TN? YM8M.
MLM,=]J\CL! N<3=&U$DKD'H=S#W8SOW\H0&1P' =>HH7#7[>)T?TBAQ0Y=Q#
M_JYUEM)O%V^?3KBI0A2&%^-VCVX=JH?7BRS(]&.RXI2Q,=0%%1" P]4\G. T
M2^(G4@\@C3O0,>7'9'<E.1>X^'WN?8*E^+Q0[Z&NF/4](XLJ);&YE<W:*/R[
M3*0[+?>^GPO'F1C8S24,U6Y$+=FN1SM.1FA[V:I&/.1"6:YVV_!W,#WIN)(_
M;9X4(1^IW5TQ41D;87;>"L:F,M#G3V-C8&<H*H[SI.C\(KG_RL303>>E:K)V
M_G@NZ;U6]UF=!TEH"6CQRB"W'[>\%TMMEXU@DU:"R?7#%ND+W6FO'&'QK@R5
M$G(EID[4J.08VHBTH.A&WZH<AAXS_)'@VMK6%-TP5B5M.6:;F"RB _X[E%[%
MRJ*F]1:R9&_65PD"RG*]6$8_5F4]KMVRII%IH\0'ULK;8>>=PO-/J$'9A1%H
M%,]?#;XJA=3YX=P)/;%D9D.+[3:L,]N[FH&Q'^4OP\!]/0SDU9?60RW118]*
M751.AI]8#KA&B'W@.4E""5''EH9ZE45*ZEC \=6)BU5>&1+Q8??M%Z61)%CD
MXN>&2.*?/O41AW4L0+\7],5).E+->HE'?S*OT+C \\> B;P66]&YO'ETQ_/9
MNMRX3Y-^7O#:<_[J%>?AM;8*&U;FM%KE1_9TER9UQ,^N6O?4+UC(9KJYJ<>9
M!!-3 OPY2?A[J31DX\VO+P<^I"?5\L7E!AAQKPV0P0[.OHP9XQA1Y86\J/$@
MX)"+6G2I-L]HZ'6:,H*3G;^G'Y_&*2&0-#* I&SIZ5AA:1 7MZL"@ZB63"[M
M5! :!KSOWN[!/-&.3CT]S@)#4089SUD_*?L.;U1^M9P\+_9F=4XZO06G1,[I
M_4J"Y!*) '!HE$^R-1W\OMY/Y,_EV/5ORK4*MN@=Y*M=S,I([I%__.)80@D:
MW;EFZ\2]-7-/V3*RS8S590X%7^<3^0K9\[VVK5HFF'L06?>[,7TT1RFRP 6N
M,C)-4#79,(/3,YP["L_$4QP+ G]*4'%E3,^Y"E.17T*3 \O>D 9>6&,>%O69
MMFG4S3C J>$2J%NUJ?/'".!^1NLZ[[X9F8'MM> H#Z- U9*]U),(5/-2S4O'
MK1:Q'MV&OA:>0;=FZ:>9CP/9CZ@%-A& [>;@&R]Y7(?-FWURQ\$&&CF^K[0S
MGVO3[:\"6CQEZVVEAHWC![V&%USW]!.7": "MI:V@M-ZH4&*]QH2TI6LF'"-
M1.D- 7&@29%6*WC">![<#LYK)4PXW80C8[.@"[H'I)I/L_Z[C@%.O8A& ,Q5
MW> S="@"&",P%$K_S7.M:OUM=:DVRI@>W_K=R+SSD/*4N4-/;B'=./ 70^77
M??G#FZBDD0:5#9,V=-VJ_W+%*S(@8:76N[ER6+Y0-T,VC P.1,=;MR=,D1;"
M&P$@@(BQ_SUM?#VF^ !Q&Z"1H!/O-?2:UYG8N#T,]2(.5NTS^=;412:C8QFG
MJ#+]^]I<S=\[RL(/"T-&C[]Q[_<EOJC9V0W+_W)Q-;!36.;Q.^&*OR\]]A>H
M'GF_/+M,41--BP#L+C/GW!T<SGBKU@?:/C@M-V6>/A*.;CX8L3$^^I>+E@&U
M-?"I,*W-+6=!^6%N&:C=(V9D;0<R/BG0P2"\YA "'[E4^L[Z%3XRL-=+]O;Y
ML?K[FMZJVK&:11'-=!M^05V/V/[5)TXX+Y1%OZ)*K57=D%\Y>.8/W3-0DD$
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MM8Q#4=<]5;FG7K,U4<QBF$//*$"XZ6V.KUQMVN=P'!?-\:>74!)&I)S3]Q#
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MR/6>H0L"*%8_ET?'_^L+"<[.UA]89N=S-0[_6;)%E=8:K3XP]629Y+Z9J4,
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M;K^^SM#0YU3'Z@S+?=!O^2<F$(:/U2B^R%!X<%!4YF8Y;= ^77ZRFTZEF*R
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M??;B,Z;Y)V8*3)@"F"6)G7R_B%$%W^3,0K"+UM?'<P6P_^G2ZU_[\1Z+P&_
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MI[3/9_J 0/[(,FN'/(3P+'0XH5.KQJWV!8['@=GY!5TA^%W05RD-';H4C9X
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M)ML=F!HVO^G.&]5N\[FE92<0GR"A>'I/W#$/.E0F;>P2/2L]7D8C/[J+8%!
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MKDZSV-A^NY2HJOL0O(Y^*K,A@>U"@H0Y74=9YG;SKE<8*6XUC%R['O2%X>@
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MGC>V[*#XFDY%W7A>HR;KJX:*J7?+233?;>!IXOQY'#9"_-T1S_'9KY?R_KC
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M**P4HL3/**=G%"V]*UT@<\7*XZ;*E0?:47HPR_YJ/%^T:@B'^'Q$@EN<?54
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MDB97VKBFLA'!RN+Z59&0;K.;M@3TYD7-I)JAO2>5^]#AG)$DL:LZ-2A(F2,
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MC,"+T$+86X6^0^DNX3-M\O]T0<GM@<X1HZ>Y'E"GY"KKJX.SHP5S%R@B YX
M3!-L;,BFY,7FVTUHY2/<;X]6ZAMJZZ07F<_JR?KZ<7S%\[?+*(BNAF0&+?Y3
M/7'M'S;" >.B<B3,'OZS_U FJ:J!_U,U*"+%X2=?)B_=[" _W((?&?YAYN'^
MJWX!EDJ:S?_I<XN]_E]P5(2_)GJ*,,Q "6/?$U<9:^W*(WW.J;5/_J'V,6:@
M,A'12'>D[+2WQ5O O!HT?$]N^2L"6QOM#C8W7:R4L'_%(P=ON64 IRS>/7A8
M=U._1=V<(4N41 BI?.O,H"F/,FSW!93TNX$@B2<'_W?2&,%V+_E,$<%+("+
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M@&0X !"+)<O5,6G(G525Z2,WSV2[,:VLK+J<$(F?DQ4'R^0^:35?QGU2X/S
MM 3C("G]<9[9BN< AZ@@!_$== KQ_=DNL,$:M[FJYXQ(&4$L'D(L;<'.49T6
M.&J3EVC.11SRG_O<<KEUO$X5?8I.K=*8<^A]6)^N%J+LCQ6)W0B<$?6PL-;7
M96]0RMP%>+C% _7=WZ-B>H\XA=P'I_W0V%]=9__$\S,R&@L+!=_E]Z#69OO&
M=CXE"Z,NO'KTQT$LQ]NVXY$U#HJ<2HN9GO>+SVX:#AH]K=4[Y>JKHED."RBR
MGF&2'YUJ*GE>SM#R?DF(5;+N[*;8+K 3!M[9)F^C@G>!BWLI&42#:)1,[P@B
MS.S#R?8+6OEO[;'0'8ZD$D<??<:4A$NO-?H-@3F\HU'R7)-J1R*DHZY@6M4-
M,]LL%@Y+^&K99.L3_3 'O6[B'M0?OP%Y8+L?>,[^9EW/\"/K QHE#2.&*"QM
MT:7,^9[+G#058C)@ Q^\EJDS:S4/ZFQ+E-2=07VT*Q^NHD[L#!JKUS%GRZ<]
MX\W#11N3'.-5K@B,M]J>7.A0+X8__ROX;SNM];M UM.]RN)CJQ]L+0Y";".\
M(YXO]]<SOIPY5S)<MT/I5V[H8:BM3&3"/EG-M&($(^RM_$W6PFS.2*$#0FR?
M9EN:4Z[6C,GXE_(?JA<11GL(RWLEPM/I[Q%>W*%EL--U] 93&@F/F@HW"9@[
MUH&R\U-JU35K-7_V6#;>*W3+"D=]K3]"FTB3SJ^.TKLMWC0'0(Z#69QGB'GZ
M/_$^-+(=Y-"=..JE$F"W98TL("G=0B814DK4_![VM03-J3_/IA]#R%(ZTJDY
M$GO3><73E@.*.^XN5?/F>>[B527VF^AQQ88O%2%7M!Q.=*=8+TA45D4E^]T;
MC!0U]1:G)N0<&\C"\J\'R-WS0CN=8ZX1II-OV7>EL*?Y#M,YQH_*+C+T9F2Q
MO7I%3XPADJ]7J>8;,4E5*:5LMU+]JGFNZ(P8_@0D>-\1 )(0+[DEV6<7*$MD
M2^D8<+272MW>7A^L^7)J9,1=Q%G9N862?M^!IRW5-I @$J&0T33.N9Q#GQX&
M:P.RW*F(U")1A_NMRK4)M=%KM&0[ XF(Q_FTQ%KJF4+>6,4/A%*PW&#;+'&I
M\"\[C-O'IGG$V.@GO]+8!P<8:&O1WQ7 2SPNRH?VKX!J  C:CR6ZAR4;Y.CA
MTTN92K"&K"V-O[4.G6!D>I0@H8;2"GTND2BG&- PNX?W5]X>YQ"$D'OMAFV4
M_/*"_:U(_/?%3GD?&O_EZZW<6AX,[WF-";YM1./(9:AW\]EC>#]J<L_1CT^M
MPG$OI1UEN+:*6\\/C.$,%0&1'B?$R%N(>)J^U7#H)'*QPF\J_\JRG>I+;].?
MP'%!K5H-1A6XF.O"J.W.XA$"D:*H'^MF#OTG^*N''5\0^M$+L=WG*%LP]]%"
M5[:LV(FV*@^"OH6F%K.<=T(6%KBG W\B5AU')R]RWOCL7=+!8'.*>-D"1^:"
MYTJ;\ZD6 1^Y3^?N]F1M]IK;XU\:L?WVIG@9P=7(NIA5[9@Y.FH91':6BQ&K
M;&-]4I#$Y 3V%+1_(U8C298?) ^M'\\Y?^DV$[9%&7I.W+1^GSI65<MQGNDF
MZF<3'0]<#T<@<D(?6MZV*(K"- PVN)T4'&-AK'0-N(.\JE-O<T,O[:+ZM^Z9
MM--F,IQ\<>S0T#%!:B>=;"=3A.J1G9 ZZI83QH7[YMW/\(+7;/;>6"TO05PI
MJ<QC^R.4(1*D"4LJU\F$J:ZHKL;TO/<<<+GQT!TIYU6!!:&C(+WMK5L.R>N:
M4+7)//]@.GEVB6PIA)N4SI\*DGU+KA28;KV-SV1=0+A038+FUZ\V5L^"O< ,
MWHT@;0.,RX/G0\4%2(*!P =W[Y6G<,GHH-G+K"-Z8Z)/.P5".Y@556WWES4X
M(=&;U*Z02)+AK4]0UORF0FO;HGTQ^F:)R::K/LV_S6J&OW$")LIU#7JZ$7*4
M+QR-$1M3A;XKOH 0G/%>Z=>/[';B)(6>?=AX=6'QMQ<- @;.G<4!N)8AA"0;
MKB P7XKT)L5-[ZN'$8%%!"_H0VL\/1A,1WD2F)WZDC4 4MXF4013O7^O[#?:
M=E>LMCY]G9Z1*/VG'H;E,[O""ZAD'M#^&RJD@3#65JCV:=&HLTZQI\QO,?(9
ML1&O=6G0<SX)L^M&K[(UOP'-D'^)6;[*G[I(VZRBX._27Y-5_ ,G,(H29SR1
MU=1N@/?/Y_C_9U_P;M]_ %!+ P04    " "V@618?A7_Z^+!  "X_P  %0
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MMZAK%94S3ROZ:!+$B$IQ$Q@4\^/YH/93O^AV&@QQ/;+)A)2U"/O7(1#@*-)
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MO9$L8;,R*EBAOAEBGSR8>OZ=MU'$>_WD(*.V(I*W3@^[NA7@[.!L&WGUQW!
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MG"37VL%&S#GSU/*E+B$WB2<I7YBGL6TF6YI%FD?V98;SAB0+K!G!A "QG-+
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M/UB V.348B_[V/TEN*K6WO[!X<_LIKI3%TVX'1_D ;??W[F%0*T+40[]Y"'
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M,0Q)YAF?K\J0&;OV(TK]]DE <DLAJ1[V*;^&S(@XQE-C#1&</2.!<NC]-#Q
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M0?O ATC1BID<[Y:W2<PLS %D\G\A%+-VA\KG\^VK IT0^+1D3P8TY_)\X1W
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MUQ&I$JP <33TV0EY6P#OKF.\DA;+N#L%1P868&Z(<#-R7*VEKB92EJ\N"4
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M5S9:B4@NMN3FAI42163JQ^OG-J$E$Q^;YJI7M*-9% @454$!D<?<-;9K\6W
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M?B&QF?.<>[:_69-*ECZAD($1WDBL8*X*]_ *Y$-K$",W+C6+(<-Z$3!P^;C
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M"J<YH%";B--B$AB==B-A:4:?)6[ C_92>\XUW;5+=_7W;ZGW!>+5*373R"3
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MFVRNR*'Q3UFP'BMU)MC@@B.,WVS,BL1[\1P7)NWOJAI0:\UP'^I8?>!\!R;
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MQR.1A Z50\-Z;:SD<8R_$/D^20?J^3(2'"UO&0& D <3[K@]<BW"M#7J[,)
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MHO["'01AJQVWE*$^?QQ[US]47M8L=(TX:8'4VSA.\XGR[T2<--\ .X:^6F^
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ME7)KL[!;_-TZ^Z&;1NF6/8%HYX*ZXMOK1C*YL\F'M2#\7Q>><ZXXL\2O=&?
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MZJJIZ:JKK7Y2PUW=^<C?&^A[ZR_X?]H53#QF'CV30#>G8/_ J_[^/H962)=
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MZ$VF+C4R #8R+=<0:DF4:M,;TNONX,TU7:Y.FI:<NEL@Z3":J':_X,+ !OA
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MKF@\V$XW:()%#!,PQ'/37S.@7WG)'F ,Q9@^H'O :[IZJROY.(6 63Y->.<
MKZ&:Y$^82W>]VE%ZZS1_UO>R95+.:P:@6EGX5E;TK#K1>LFCV!M#O"8(*F<N
MLU)<49?[:\QI>0S@-W_1;R@)VA.8:OG8IW'1T025E0K5IT-B"MN.=T+K&D84
MZ$=SK@YHKDT482YFDU.+P^-,AH.E/:QJ1H*M,%8YIB-:9>_1PVXO;DR9D;=T
MUH]1^M\_?"L[HU%WU.PZ@!%NUF).V13Z,(YXU1(7C]8;9"[L\%@(\;SU5ZD6
M^N&W_7Z;UJ#ULJ^A/E@A^\(E'DFVA4QL[3SX@LLB6\*K;I0Z\>0DR#'GO25S
M"6B<D@??X5.9>_^[U-G*+N;>P$L(6Y*>3>4?^WF;\P'.4[N)/D123);$]Q.&
MM"9N>.3I'Y2O2[V:<2>\D.VT&I8<3TCOJ7REM0KJ2-&YLTI0KD-HI9JXKCNK
MO-]^>=C4@%#%#OGH67)N_:<D#^EQ>X57/J-!SKI#DL:&9EE1R_ FYG(C1-4$
M#\X8B,]FME:RA-O.UD52M?V_>Z*%B;&I,M$%-[8B8,^[;A2Z75ZKW88\_-0Q
M%VG(P>R">DRK47 EJ(A9BB!4)DG>I6>@U<.+%8B0EE2!7[R'ELO V$T)U8V,
M"O6CM8\Y<YZ?E]H*O/O825[K [8%][6/[$9[Q^1R;T<@O(:ZF%;SYB/>.Y E
M7^+.% 0\TPP![YR%\*_"/7L6G1=UJFM#\2<'#A+[>\LPPM&B44;/;I21H62F
M^QH%"[]#_D[#-7/1A[ RALJ3X57D.Z#FS,GJ',18Z);I[S_'/[_VOQL2,6^P
M]DG(5^U'=N^JR]J#=+5,OJ--]?)]2RN/7=R*QL:0V0XQ>9E%"[67%G9"<YU\
MI8L>/V[B>=W.=B+_:O*1:U_E3,<+@.!.(!##URP9SCHS']6D2^R9]8_>@+.
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M'OOG@ZGXRJX<WW.C+7G20V(LTL.=3;HCV6Y/N!Y6@(3&QD"A6BV^B=/4!>:
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M&8^/ZGWF(M('3D1 56LCL<%<Z)%5S-%C;OJP4EHOI_?&#^S2&=E>)17[['Z
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MMR]5\0U0Y2YIM6RY;GT1-A'WR\><$AJB^$JYRBG;-_^!S@[CT)C*=V#@KOI
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MUU-SBBWAFD+O6*<QCU>F&*=[S<'*%(,^JXN8'[CQ6*5>\KA+);9\TFKD1LS
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MEW 'A]BLDN;UU'<NS7*.X![OK[]!Z*(=)GWV='8C:4EYW,,7?T=)0-[TG]1
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M*RK=H:ENIU14(O),"_6D\/%3QW2LNI<UWU&1@VH>H^3RYD_3OZH$[9P^J7^
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MUK>(Y*_E$'HHM>$8;R7=_NGVVDB='8ORG5?XWV^ WN#M'#_X4W-C:$V/&),
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MS9B6MK^3(V*J+>EO([V?@[S^G7\:[S"5&!0*F7AA+@XN'4FX;O#\5\N4_P"
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M4$MPPB!0>/(3+-T\KX4+?3>&$4"&T4CEVX;%]=7K.KUSM;Q(!-#>&)/3&8(
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M*<&.8Z:,6<4MNKU.,IB-L1":L9AG@N'GX TA*<]8BDZ5"V:3X32)^IZB"JN
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M"6.W,%]JR'NTEPQ8(K%7* 6:JX)ZCZDJ@H=CP^?#]XJHP?G?EX],:K1V!H_
MQ7:K18179@Z'R.S.YZW_>W91_2N?4I7Y)=/RJ!:Y#&'P2*CJ/7$_IS!'4K+)
MAXF_.S,+-YN3"Y'F:%Z2QL!GE1<%^\E](SH_)73*I0?9':U2TI\&2ZMW#I55
M2V_%\YF2TX9J^U"#6+PMAH[_*0RIFNU^-?@#P[AA[XK<J9J6MFV0K'.(AUC:
MV6B7_?."&-!T6G^GRL9EB 5]:@.S\(??RTY,O\R_CW^5F^NTDZ_%".IDM4TO
M:J]PN9'<;RN\Y[]C?[@6NV69MMAK75,1J$7+;8<%%E]WI7=VK?T1@'';TB:3
M1WUN<!U? XU'WZD\DLSD&/S1!$;;-.@&".8-5=))=*!@UK: )[7B779[-1"T
MGGE?2/ID940WS%Z&@)$:81%^_]L:2290E.-LP8YQX<,6& QR<-$*+(L:@Q!$
M=L&?94R'H88=V2  [?+=0"TW/#804=L$_QE4M\8G"P$4>F('JX\\VBTOU1@K
MZ<R3J(I6:*_$+#Y! $=)C55$+A'C2X9=;<Q=#I)'1:.G>J^CR9EU.3QWC">O
M;^[%UMLM33_ E<U?*^^^,['2=N'8-"L4Z<B-MJ-5Z2,D$C-0'=??=]29B'W1
M4WFV:!NMKK7=7O_VTE)-NV^KT,JW4E#H8)R7ZXGP48WKXN"9-U,IZ%L2^86F
M'NZ26P0LM[!R/<P$&0N2_BZ2_!EH8UYW:KQ(H3NU"&!Q2^LH=)Y@_Y(V*X#C
M(O_:*'E#"W2DK)(#<:<>>?L%:?X"Z=^-*/];K'CI/>0I"3_^</WQNGQ0E3>(
M\L IG-TYL,D',WQ#E]53<K@SM\5)[2*QIY:@VA[/E!3IJXNKPZ__SD^5%H(D
M5]13%+?;4,0][&5E.^UY8#58J3#W:'KE&O@7A9G,$= [+Q:K$1?FDO4!5MH/
M#BQ?-Y%+_LJT..U_8KP1$F9=%L\K(MM3NE:3LP:A[_(>SOK; P*"(1H?EV/#
M)(7+/BCHI3]\3)B1LA$#)CQ)M#UHG64NKIR.\,8]';$FY R"+4<WA23H] ]N
MQ)&7=X<?K[ZM]WR\8H8Y4VESZ>'+EN$(2ONM1PNK4R:UQQ" C9OG:HF-B9_W
MALM.6];^N5KC2K524X.E]/QE^#-.%961*X6N?@CAP9>_)R=J3L&BO@6:FO[)
M/,9*A[TB&=SQ+D^BIL,M!JVO.S,TM18IE.F38?ZJ9JGUY4Q,%-_ZD(ZA_T<?
M1A%B'#XT+TZBV'Z%6V21%!3T7H5RGB7I9;"]>5HWV#FU##2I5V)Q0$\L+FQX
MA8L ]$#)>F\7Z#MQ-94S:K7$QY7B$@ABD,F1";7QY_C#L >A.6"6SW&%^J75
M\671&5?%2^J\4I 4["1@U!F;H]]1LGS0+'R_PE+@OH:S.1'^-_[[<\=(MG==
M.J:0;WGW5',\?U/#>#A=6YI^2>OEF"<"..\UT+Y5([&YSV$"C3;AISD?W;AD
M:]S B6:[7W<=7'EY;Y'+:S;ID%X(7.QJ3IXDAEP?76TTR9I2]$4#N)$_K^Z!
MWW)=GJ!8B*1#IT&K+.OWM:,_Q.OG';5SYF?+,W:OQ5-(&',W?+)7S%*#SN9^
MY6H;PN0:WFG-F?-O.ZWO\?A.B-!?W2R4K5.:7XD_%L&-S]*6=+MHF*/VOY);
MU/D(]CJ*B<X<HN[F=OYQ\D"R]O<>]\> 6)BQY,!J8 VS^V:3[V??<P304\UX
M&&NHD>*63B*NF.ZIEC0S41>U%+WO+/9%. U>U'V:A[:YD:^L"NL_+SK0BS@D
ML;8Q ]MF+?TX66E-*OY3\A>F3T\R#B)DW;0C<,TB6-JLO&?.5!S$0!=K^%JZ
MA@R#?-T:JOZV<:3;U+"3M8!J04.<:HJB:18!C'AB@T(-'][2 B4&,W\N"PXT
M)@NV\\3U10 :FTS^O[+UE>_K4QT#6,O":$._"P((\#*QC3^8>8V9I7IGB[JT
MO24V3./C4N2&)(3P_.G^WR4\34V*:L<4/?<1!"!HO=]YRWN<J \!A)KT*]'G
ML&I8\76T3),+_Y[+<VF"?_-IB]\)*5ZLEE&" L=E]0_;#ZEI571LA\FZD;L8
MP;_,!B-1N%5'6B&@!^6B(X'^^$C$;Z7NV\B,@+1$P3QQ& U6VAB.&N;NI'A'
MO&JLAPD]DC.$/UP[&_TT6N>7T2&7N-TKBGM+/+X*F=F_)S[Z9YU1J O3#7I=
M&+C>O5JB7FUS1@ ;JD?H-]#QWKM1GA0*NN 33PEFRQ7-G7-I@HS%4N.0&S7"
MK((U<9F:;ZCZD1^$DX9C]4(,[8[8AXW%<DO%1P9S'D0HA77].N^/<" SA\/D
M_XWH\;?XMT>3FO2U4HOS=!Y5!. AM@QO#%NZPE L4ML5?],3KF^S/4H4@\V)
M>UDJF^)3UXL -#_;#9%;1*\-C43Q\JM_S\^?']PT**O0@3]+4?9-.A(B4!M(
MAY4(R2")1>8_\T,SAN<&W\X6Q<W/O*+3<E!M\JV$"B(9]$4<,$67$,2#5F'8
MJ:I<P#ITO[TV[?SA;E%\KX-S>-86@R^^@'OA[)(',;-><0QS_7T[^"^2C,SO
M&EYVI%S]DL[*:K,]4B66<W_QG?+YCQ^N\GJG)\1-(X*YR$HY.NA&/E<AJ03Y
MSU3BCFU\M>X_&CK^):'$A4?XSB H[Q1D2<24*76K#H[.627BY%N:?%U9V;2B
M\3Q'+BF\$0&@]6<.V[[UW5#,\A=D'E7*+,@6OPXGZ<)JNH+Z>GX72?20H:)J
M#7J7HB*&ZN^'F<%B^2S$K"F*(H./7JP=R2ZF^OX5'WC:]W#?L@B*FB[W"%;W
M^:SK\RNM;0OEM1]94^U ZBVUOA\7+ZM[CU)\&JT>%I*3*AW>NEUWR<3H(C1T
M_G)LU(:4B%%X8YC,+8398KW,]+6"SL- 05+W%"Z9.QOQK /9RR(SY/5U3 E%
M'H34BH+]IH%\4KC1/XX22_[[C1QL9L8R9X#4+$Y#>U[AAF21^&ZOGV'IN&L!
M1MR<0['S\_/SY,$-==4B;,9]GK1GSCJIAJ?B7VUS">J'"6%=#A%).+-S#3UU
M8+X!XFB^"(6[!BIB ,6'^38IIM6-T2AS7?$:L1"SUA\Z_C+UK_R8AH5^5^SI
M^FT'\(D?<SGYX%J&U38N[9.KR>0LVZ;]PL]! XD:@ZXON7)D"0G3PV\/'0J)
MBT>:I%CLA<SKD:B>X[7(%_G"Z%="TV+O/S=XHTJ"N5LHIWKJGJD+AWV=:!4=
M%UL2>6O[9;1 FCUX(!6^//Q%TE)F:O\;4_I0[<T"\S.S.2+[\(5*?I&37KU.
M4$\':?,RK9@8N<H;K*)GA(] ;C4)][+X!"35K0D4-._^BIFJ=)+3R0_-6K].
M+[W(O4Q;]\!>/YQ]$Q-I<"2=7JF[U\I;N=KG4QXJ=;AV^6(D\4&4,($]Y7U]
M GS)+VAUS@\>^AVQR$1+#_.H3CM2GHUYLIV.II@+DPR4R=].+.8,*Y4\X+_T
M]"$NL#A@,KF])N/5*Q6-PF+!)2#1YW2%_Y"U$<@7>Z"Z/+ONFR75GQIT0$M'
MY^*A$!14@HS[Z7_X7OD?A?S4^*3NX\X:MRP]R;OL5Q86#)DC7X9/^"<;4,UX
MGQ>7FQ&?O&Z_NB.^IL%UR5%B=14O7Q4^V 7Q70[:IB]8#"P@3S=@%B*QO=>C
M-^_=C@#4<I[/[CP7/P*A>7$.O9VJ*Q/1:3I7R^S7O/)H<&3+4=ATS[WD:!#Q
MN1[S)@Q5?SOO:7I%K0QXT(@,Q1TR,@A:NPY98D*<^$Z%'ZSA'0B>*#V4F1?_
M+E)@K>&F!RG^6CF8,@7F?NE^.0DJ@$ 9CTQK8_/-%,/Z 50_X LY<J_+=$__
M=S;!_W)DLQDD+70OE'WF@<&!%]GD[XU,4:IZ.%$H_>PDA'".I#4&B33ZM[E/
M/E>7:;T>&]0LUB P?7\3W8%/T.FQ'S]A[1YH)93W6&5X>E\T[R-L'[U"8[5<
M^:Q]!OUY(.<G/Z[*/0&>N%TY=%V+0-KIK@H\66.B_E0IFG![^@5V(LH0KUIH
M]8:2^'S'?''0!-M="_LS'!RV!UI9T2E2F]AP=*:7?3E?T8A;6!I>6VUMZ5<2
M$85CW[P\='>K-:^_> &<A4E2$Z,)VOL_(>M>R5L08F%.T9%:E(]1'KSNCRH/
MJ2NE;EDACE):(:4U)'R9\&EI:<6:M.5 V^*^*OCU9C]6AE.T!@N69S0GP6LR
M]$FBVR2&+LOM3P/(Q;83YR7*5EA!0L\6C,HN",L&!8T+#!=?-0*R*K*K.++]
MD:,LD5_C'"6-#*-7B+<4:<P4/A1\"7M*Y?[Z _Q1Z\)3=)AC0A_F;Y[L_P?R
M-[0I: 8*0=!,4>?/NP*/PCOM#U@=N$)<A-;K\XJF)BSN::Q%W_1D*<^:6#U@
M%?R4!R-4PQZ'EE?QD3FOY(R[<6WZ,%O;;EV<R##7RT6&UY.&3M;8'&XI67P6
MSG0.CK]ZN!EF:P5)[W2DIHM6AJL1JTZ?3#*U/>V&2@Z97T"L?5$IET9K-89J
M(83)+R?U*H)[WVZNV3\0V)PJ"#&:6WRYH_1](CVNX.446E;'&\8WK2=;> EW
M=N!VWL46!85^$\*)P("1>^'67!"Z5E[UJSNYA'(=5;FP7+MG"?>2W+OB'L>Z
M6F=;:(:ELBQ6-3@])G5AS<Z.%^]2D;ZWX3_F4A#,I.Y6(G 1K(Y1_$84IV0V
MD+9MK+:T.,"^1_LNV.Z62HTO@3D1NPRW*VL>CC3737T8CY$-893&4SN)+XQW
MY-#B<A  5@?,]YZM66JX)@3BUM:5UC$F[;1*DU2W <:]M1YA7GD+&V*9#?K\
M) :J6IU0\D;Q&V_1MC^P7TTMZ/3I=M:>;CA%TFC)5 <9D\CX1Z':H U6KN(4
MG2\1(3B.$>N,W@(Z\&%3M_S0)N*O4[WFS!98E(13WV[,R6*O4B?Q@7K4W405
MW[)Q?<F?:%9;]AEF7H8J8ZMUV5?'AR& +*GAX@';N3WNRJ^4):7O)8S?W*JF
M);HCM>40D@M_3P!3XV?I\>B[<:56WU QR)Q>4Q?Y+4#0QCM]D0;ERVH.H6'I
MT33;A24D6>Z@-ES =H=GNY68]T6X5+9#-:MU8 QG\/(4=YVK[$CM[&9GN$A'
M*P*(B"'I ?M_M^25VC,"MY8<5\AE?505?P':O9"V:F>FQ/;1#MN\P]]FX?JZ
ME@6IM]&)AD'AP>/0Y/U.D^F:NAZ?(X72W8Q]4%3HI!9K<M:TC#W.KM2".^].
M(YY_*85!YPV:+7*N"!5E@HG,[<#,E;F$X5CX KF%]9T!IG>;#]9YXOB6?$$*
MT#OK?B<TRVT ]"6,KUM&K7GT/J]FP/A:GO.-&.QN3VIM=ZO<IX9X+HG-]#TW
M=1MCB\S4!LU>ONA7Y(>:I\4N-0P]-E&$4<_=5Z,AKUKG^&Y1=_PR?THZUSMY
MDZ.M0"M=#;+B8/V108QAW^=@61"M-$(CCI3H?$D5WWQ?(N^8M(W>)GCNN=3V
MBQ G*[PD=OL-Y;D][_<#6T4@&MC0-'4W#EX+S3[QTP4Q9>UL:O0E?2.<H>M'
M?3TY\TRA%*.=&(L2BP>!$SSOQ=R$DZ+D=':73N*:B8XE2A@UXTTJ+[Q&H*3^
MZ()/8.#0=&A*+P%*AOV"$..(V6+T!M635Y)DLGO9CJ^8U[&SH7UPDFRZ/9=0
M6W>AO*D7@UKM5!%4Y=$RA?:OSY27$G8Q=;UO&UA<WQVV-0P;Z)X/:J&L"".6
MN5RO2.6*UO&WY[%C[VT_7"A+;CIALLUCTM*<(9V6T&D.=Z:A4+])?+M.OJ3*
M:&MCM!QPXCG(Z/XL0QRAT/H$QA/Z=E@=501/487\_L1^+Z2\<JA0>-"93%^2
M5;+CL&-I,5..CD0PKNX)@0TH_I;TFS<+WC!6SAKB16JAUP]Z4GABTGO=;4U&
M0_'O<P02 @"^)-VGQ6*ZL6%R\29?VP;8ZI:N[J57O:Z]'Z;VA4JWRZW)NOLK
MH[)A-Q]7A:8*>[6"Y+^).1"6B'E ]XH$;BJ1@LM5']^$B#@7YNYXZTF[@!E;
M@T)T>%V'TNC>V=#J\)!S-@H$3V[HE7_,J-H?H/^BO=P(IW/,1K,53.)0+=NY
MJZFWINF]N.TWVQ!%]H+SN1\'0T0;*6E2@JI,?6BA1D6L)SK84U=3 Q127#=X
M9I/,H(:[O,2CE#FE?Y0=^67>RLDM:=T%UN/+N9Q6FT2KKRHS2:B%[<JW^C+D
M8.R<CK\A=[UA7,9DO^GSA/O(39/I<)I*K&;H>ZU;0U"[#67K6BV3<RO>RD :
MO&EIRC*)B%68VZA([5B0!#K.(24JIWN>,.6 GLINQG&4E9K7<3>.M<!]8!&
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M<9)D.2V?_;&?&/Z-$$&,_Q=02P,$%     @ MH%D6+C[%,@290  #8X  !0
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M=R=49-/?<L7;WZ!0)C]"P-Y)G]B@4]Z+H^V->1]NI0/3*%/-JN:J.B?+OD,
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MB@%1[U]=9W\?Y9<?N6O2%/G=FSS:?,<T_LU!3OT+>.:5"7\"+^SG@WJWFZL
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M975M?6-SZ_#H^.3T["?B_.*77%@ -M9?VS^4BQ0CUS4<'&P<O%]R85WS^(5
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M$N9%#7=SB/7)TJQ?#W=LJJA T<4;'[0'WQD_N?2DE$BKV,?Y2+E %AY3GBR
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M!&LK].;R8+G=9;T V%^G:BA3T8W;>G=*P*&_::H5N2SI%+FIL]= 6D!9&3>
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MDPB+N3M:GD>UY'9]A%CB'>27Z]),_,^N,";9%,ULV$V"0_2_1 #8N=]N,M%
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MJ2%]*J88'>+4@\>R53=?@4"O9DYPX^28W@(H^*:6KL1[\",._Y9^"*CJ_-(
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MY9C">O#B$QV._=&Z321VZOI8/;::2)!JI7A*[%D+[9=6YO<D$8]68L(N1T.
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M7$K5SKTH7>A@]  3ES,[;8QS<_LSN,1&-/7I"I^W73'_]Q"><D/YCGC-CE1
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M[@?758?(?WS%&"[2<T-$9-_XXW;GPAG,?;UTR@<*\H7)# ;?*U5UF?+<S&N
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MWH]7X*9+,&)PAVIV:3I<;D9*4L3LB9"CE@@B(JJENAH1)<'64BME>6A4Z]$
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M]=RK6#O=5Y7$L+U0EN+#)=V+ST\?6$<Y$-VMIVO2R?<*:-L,H"TK-W=[_J)
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MW7UL?7')&@5],9+OY(D47Q9@&/(VT-$7;[B^P99K:1;.'_GC)>*?)FWH>LY
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M@!R '( <@!R '( <@!R '( <@!R '( <@!R '( <@!R '( <@!R '( <@!R
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MM,QN8O=.#R$)*D9D&=CS?F-27 @9UA:S/+"/+(;B""0Y<I3///EH,@6(-:8
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M.WTIN,(PO?!(7_Q'PJ)>I\$;D!R9@)Y20/6[*?^KPQ18#>WC%U^%$LX8K;)
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MUW9QOWXC3F9'V#I/;DR#=4>P!5$L>*T!LJ:6T)@[("$I3,\Q)JN\4'HJV=P
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MZ:]"(]$_TL4#<WM*5FM]H0YLFO+#;8XYEF)ZY:?\-GONIR=T5 /?PXDVK*C
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M@!D;%PAP?CE^72!Q</'P"2X17B8B)L$"5%\%<''P\'#Q\0@(\+&A'"< >Q_
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M?8RUQV?)RF%):XVP<-SP* >JCA_)VD]QZXZ9JE/;^N;4M\RVZB-:1_W'C3!
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M3HWH4?SLHU>@3,/A"1U(&ZAI?!,>ZD\E>P+^^JWR !92^H)",_HVJ$U<8.E
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MW;K@06C98[4/&BEVKT)[G!A^26$ET8_R:PNI_EGI@3Y]/%;9R70(:Z852_M
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MJR5&,;.E?6 %J"AT#4?].3,17OV;W ZT+N9K,I8_#M86JA2<<=%;/(T7_L%
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M<[IDJO[T7%54]RA[\"=9AL1TS*WCTX+VI\/)<H.O2N.W5]4Z(;8X+>\CE7
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MN%\9=$?AZ9IL91%VSG>Z*A*<2=60NY7]X\DZD?.-^>"<C>5NRG*7,0)+9IL
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MZTU87CYB.*V+.4ZNPG,2_H.NQR^.8:R]B,+ J=CY#U,I*,!*Z.#":P3:5'^
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M??#5=C&9Y-SHA<=L[)0Q)BY;<)NGUU8CG-KB]##@P 3,_Y4@OR_V8 '=$!>
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MN\O>;)U0+^5KI4;)YG+SQ94(B7+ZQ6C W\3MPN7CG6T"Q>JJ3MF3H !K?OG
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M1,<_LD7K8FLQ%O'16WZ#! F36[8N.$<[!".-"EP27?-'5I%?)G!>UHJ3+/M
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MBRS%K;)1>UKLY._8V8U=F$^=UF[C)BERPY(L9IE&.!?)(OLN>]J_)J5=:#)
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M^;M\ENBTK5\+!9Q_/>.)*]TX.NIDK_#)ZC/_:#5ZZM/'/G7)>BILQ8I>1?W
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MO2X8@;V]$K06.:MM/_3\4EO:2]!.](3JFWN!@'!!PG0SV-6-+U%>36MGQ3.
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M5[/'UY?RP6/>IWXFV7.MKHXEP8$O4V7Q1HJ(53MIZ/$;AGS38D?6&@[Y+W/
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MP2>C\\O;0/BQMJ(.5VA!+>&A4#>[?D<H"]"1W3]T?8+<[%>"!1JL,(7W6>M
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M9@L.K\N5!3GCN?;!7G>JL+ID*/Q^0><S=;$U1[:HU;BR1.<RJI5DO)R,WE]
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M'4[LC4<0?9RTU\Z3_8,_4$L! A0#%     @ MH%D6/R#C\VP4P$ $U\. !$
M             ( !     &AA;&\M,C R-# S,#0N:'1M4$L! A0#%     @
MMH%D6&M'9D4O P  6PX  !$              ( !WU,! &AA;&\M,C R-# S
M,#0N>'-D4$L! A0#%     @ MH%D6+%\,W.O P  *!,  !4
M ( !/5<! &AA;&\M,C R-# S,#1?9&5F+GAM;%!+ 0(4 Q0    ( +:!9%AL
M,Z-_5TT  !R6   4              "  1]; 0!H86QO+3(P,C0P,S T7V<Q
M+FIP9U!+ 0(4 Q0    ( +:!9%C R8A[SE(  (AJ   5              "
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M! !H86QO+3(P,C0P,S T7V<S+FIP9U!+ 0(4 Q0    ( +:!9%A6.)[STB0
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M              "  84E!@!H86QO+3(P,C0P,S T7V<X+FIP9U!+ 0(4 Q0
M   ( +>!9%B<?\7Z.%8  -1M   4              "  <:"!@!H86QO+3(P
M,C0P,S T7V<Y+FIP9U!+ 0(4 Q0    ( +>!9%@I]6)^I0,  %(;   5
M          "  3#9!@!H86QO+3(P,C0P,S T7VQA8BYX;6Q02P$"% ,4
M" "W@618%9"]%L "   R#P  %0              @ $(W08 :&%L;RTR,#(T
B,#,P-%]P<F4N>&UL4$L%!@     1 !$ 8@0  /O?!@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>halo-20240304_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022q4"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4"
  xmlns:halo="http://www.halozyme.com/20240304"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="halo-20240304.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-2">0001159036</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-3">PRE 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-4">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">Halozyme Therapeutics, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-5">&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.105%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023 Pay-Versus-Performance Table&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Value of Initial Fixed $100 Investment Based on:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Summary of Compensation Table for PEO ($) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation Actually Paid to PEO ($) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Compensation Actually Paid to Non-PEO NEOs ($) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Shareholder Return ($) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Peer Group Total Shareholder Return ($) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income (Millions) ($) (5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue (Millions) ($) (6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,820,858&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,608,264)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,568,762&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,639&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208.46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;829.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,696,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,817,187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,154,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;660.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,453,294&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,992,078&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,398,657&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;591,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;443.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,518,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,374,731&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,812,287&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,356,681&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;240.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-6" unitRef="usd">11820858</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-7" unitRef="usd">-3608264</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-8" unitRef="usd">3568762</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-9" unitRef="usd">160639</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-10" unitRef="usd">208.46</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-11" unitRef="usd">118.87</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-12" unitRef="usd">281600000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-1" decimals="-5" id="f-13" unitRef="usd">829300000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-14" unitRef="usd">9696978</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-15" unitRef="usd">22817187</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-16" unitRef="usd">2415581</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-17" unitRef="usd">3154512</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-18" unitRef="usd">320.93</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-19" unitRef="usd">113.65</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-2" decimals="-5" id="f-20" unitRef="usd">202100000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-2" decimals="-5" id="f-21" unitRef="usd">660100000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-22" unitRef="usd">7453294</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-23" unitRef="usd">5992078</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-24" unitRef="usd">2398657</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-25" unitRef="usd">591581</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-26" unitRef="usd">226.79</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-27" unitRef="usd">126.45</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-5" id="f-28" unitRef="usd">402700000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-3" decimals="-5" id="f-29" unitRef="usd">443300000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-4" decimals="0" id="f-30" unitRef="usd">6518876</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-4" decimals="0" id="f-31" unitRef="usd">24374731</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-32" unitRef="usd">1812287</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-33" unitRef="usd">4356681</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-34" unitRef="usd">240.89</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-35" unitRef="usd">126.42</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-36" unitRef="usd">129000000.0</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-4" decimals="-5" id="f-37" unitRef="usd">268000000.0</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-38">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;Helen I Torley was our CEO for each of the four years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#x2019;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.&lt;/span&gt;See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2023, 2022 and 2021. The 2020 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar year 2021. The average compensation for the Non-PEO NEOs for 2023 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in calendar year 2023, 2022 and 2021, respectively.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-1" id="f-39">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-4" id="f-40">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-3" id="f-41">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-2" id="f-42">Helen I Torley</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-44">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#x2019;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#x2019;s LTI awards granted to the Named Executive Officer:&lt;/span&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the vesting date value of awards which were granted and vested during the same covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Less&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#x2019;s Halozyme LTI awards during the fiscal years covered by the table),&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In making each of these adjustments, the &#x201c;value&#x201d; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.593%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2023 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,820,858&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,088,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,803,183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,608,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-43">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#x2019;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#x2019;s LTI awards granted to the Named Executive Officer:&lt;/span&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the vesting date value of awards which were granted and vested during the same covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Less&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#x2019;s Halozyme LTI awards during the fiscal years covered by the table),&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In making each of these adjustments, the &#x201c;value&#x201d; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2023 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.808%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.171%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2023 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,568,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,806,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(657,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;160,639&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-45" unitRef="usd">11820858</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-5" decimals="0" id="f-46" unitRef="usd">10000018</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-6" decimals="0" id="f-47" unitRef="usd">6462883</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-7" decimals="0" id="f-48" unitRef="usd">-8088804</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-8" decimals="0" id="f-49" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-9" decimals="0" id="f-50" unitRef="usd">-3803183</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-51" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-52" unitRef="usd">-3608264</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-53" unitRef="usd">3568762</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-54" unitRef="usd">2700053</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-55" unitRef="usd">1755631</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-13" decimals="0" id="f-56" unitRef="usd">-1806488</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-14" decimals="0" id="f-57" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-15" decimals="0" id="f-58" unitRef="usd">-657214</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-16" decimals="0" id="f-59" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-60" unitRef="usd">160639</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c-1" id="f-62">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"&gt;Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#x2019;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.&lt;/span&gt;&lt;div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"&gt;&lt;img alt="CAP vs TSR.jpg" src="halo-20240304_g8.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/&gt;&lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-61">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"&gt;Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#x2019;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.&lt;/span&gt;&lt;div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"&gt;&lt;img alt="CAP vs TSR.jpg" src="halo-20240304_g8.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-63">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;This column shows Halozyme&#x2019;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our net income for each of those years.&lt;/span&gt;&lt;div style="text-align:center"&gt;&lt;img alt="CAP vs Net Income.jpg" src="halo-20240304_g9.jpg" style="height:369px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="c-1" id="f-64">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt"&gt;This column shows Halozyme&#x2019;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2023 executive compensation program because it is used in &lt;/span&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;determining each of our NEO&#x2019;s annual 2023 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our revenue for each of those years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;img alt="CAP vs Revenue.jpg" src="halo-20240304_g10.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TabularListTableTextBlock contextRef="c-1" id="f-65">ollowing is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2023 with Halozyme performance.&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenue (as used in our 2023 EBP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Adjusted EBITDA (as used in our 2023 EBP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Stock Price (including relative TSR, as used in our PSUs awarded in 2021, 2022 and 2023 and as described in the Compensation Discussion and Analysis above)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the financial performance measures listed above, we view our stock price, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.&lt;/span&gt;&lt;/div&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="c-17" id="f-66">Revenue</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-18" id="f-67">Adjusted EBITDA</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-19" id="f-68">relative TSR</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-20" id="f-69">stock price</ecd:MeasureName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
